<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="cfr.xsl"?>
<CFRGRANULE xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="CFRMergedXML.xsd">
  <FDSYS>
    <CFRTITLE>40</CFRTITLE>
    <CFRTITLETEXT>Protection of Environment</CFRTITLETEXT>
    <VOL>23</VOL>
    <DATE>2000-07-01</DATE>
    <ORIGINALDATE>2000-07-01</ORIGINALDATE>
    <COVERONLY>false</COVERONLY>
    <TITLE>TOXIC SUBSTANCES CONTROL ACT</TITLE>
    <GRANULENUM>R</GRANULENUM>
    <HEADING>SUBCHAPTER R</HEADING>
    <ANCESTORS>
      <PARENT HEADING="Title 40" SEQ="1">Protection of Environment</PARENT>
      <PARENT HEADING="CHAPTER I" SEQ="0">ENVIRONMENTAL PROTECTION AGENCY (CONTINUED)</PARENT>
    </ANCESTORS>
  </FDSYS>
  <SUBCHAP TYPE="N">
    <PRTPAGE P="5"/>
    <HD SOURCE="HED">SUBCHAPTER R—TOXIC SUBSTANCES CONTROL ACT</HD>
    <PART>
      <EAR>Pt. 700</EAR>
      <HD SOURCE="HED">PART 700—GENERAL</HD>
      <CONTENTS>
        <SUBPART>
          <RESERVED>Subparts A-B[Reserved]</RESERVED>
        </SUBPART>
        <SUBPART>
          <HD SOURCE="HED">Subpart C—Fees</HD>
          <SECHD>Sec.</SECHD>
          <SECTNO>700.40</SECTNO>
          <SUBJECT>Purpose and applicability.</SUBJECT>
          <SECTNO>700.41</SECTNO>
          <SUBJECT>Radon user fees.</SUBJECT>
          <SECTNO>700.43</SECTNO>
          <SUBJECT>Definitions.</SUBJECT>
          <SECTNO>700.45</SECTNO>
          <SUBJECT>Fee payments.</SUBJECT>
          <SECTNO>700.49</SECTNO>
          <SUBJECT>Failure to remit fees.</SUBJECT>
        </SUBPART>
      </CONTENTS>
      <AUTH>
        <HD SOURCE="HED">Authority:</HD>
        <P>15 U.S.C. 2625 and 2665.</P>
      </AUTH>
      <SOURCE>
        <HD SOURCE="HED">Source:</HD>
        <P>53 FR 31252, Aug. 17, 1988, unless otherwise noted.</P>
      </SOURCE>
      <SUBPART>
        <RESERVED>Subparts A-B[Reserved]</RESERVED>
      </SUBPART>
      <SUBPART>
        <HD SOURCE="HED">Subpart C—Fees</HD>
        <SECTION>
          <SECTNO>§ 700.40</SECTNO>
          <SUBJECT>Purpose and applicability.</SUBJECT>
          <P>(a) <E T="03">Purpose.</E> The purpose of this subpart is to collect fees from manufacturers, importers, and processors who submit notices and applications to EPA under section 5 of the Toxic Substances Control Act (15 U.S.C. 2604) to defray part of EPA's cost of administering the Act.</P>
          <P>(b) <E T="03">Applicability.</E> This subpart applies to all manufacturers, importers, and processors who submit certain notices and applications to EPA under section 5 of the Act.</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 700.41</SECTNO>
          <SUBJECT>Radon user fees.</SUBJECT>
          <P>User fees relating to radon proficiency programs authorized under the Toxic Substances Control Act appear at 40 CFR part 195.</P>
          <CITA>[59 FR 13177, Mar. 18, 1994]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 700.43</SECTNO>
          <SUBJECT>Definitions.</SUBJECT>
          <P>Definitions in section 3 of the Act (15 U.S.C. 2602), as well as definitions contained in §§ 704.3, 720.3, and 725.3 of this chapter, apply to this subpart unless otherwise specified in this section. In addition, the following definitions apply:</P>
          <P>
            <E T="03">Consolidated microbial commercial activity notice</E> or <E T="03">consolidated MCAN</E> means any MCAN submitted to EPA that covers more than one microorganism (each being assigned a separate MCAN number by EPA) as a result of a prenotice agreement with EPA.</P>
          <P>
            <E T="03">Consolidated premanufacture notice</E> or <E T="03">consolidated PMN</E> means any PMN submitted to EPA that covers more than one chemical substance (each being assigned a separate PMN number by EPA) as a result of a prenotice agreement with EPA (<E T="03">See</E> 48 FR 21734).</P>
          <P>
            <E T="03">Exemption application</E> means any application submitted to EPA under section 5(h)(2) of the Act.</P>
          <P>
            <E T="03">Exemption notice</E> means any notice submitted to EPA under § 723.175 of this chapter.</P>
          <P>
            <E T="03">Final product</E> means a new chemical substance (as “new chemical substance” is defined in § 720.3 of this chapter) that is manufactured by a person for distribution in commerce, or for use by the person other than as an intermediate.</P>
          <P>
            <E T="03">Intermediate premanufacture notice</E> or <E T="03">intermediate PMN</E> means any PMN submitted to EPA for a chemical substance which is an intermediate (as “intermediate” is defined in § 720.3 of this chapter) in the production of a final product, provided that the PMN for the intermediate is submitted to EPA at the same time as, and together with, the PMN for the final product and that the PMN for the intermediate identifies the final product and describes the chemical reactions leading from the intermediate to the final product. If PMNs are submitted to EPA at the same time for several intermediates used in the production of a final product, each of those is an intermediate PMN if they all identify the final product and every other associated intermediate PMN and are submitted to EPA at the same time as, and together with, the PMN for the final product.</P>
          <P>
            <E T="03">Joint submitters</E> means two or more persons who submit a section 5 notice together.</P>
          <P>
            <E T="03">Microbial commercial activity notice</E> or <E T="03">MCAN</E> means any notice for microorganisms submitted to EPA pursuant to section 5(a)(1) of the Act in accordance with subpart D of part 725 of this chapter.<PRTPAGE P="6"/>
          </P>
          <P>
            <E T="03">Person</E> means a manufacturer, importer, or processor.</P>
          <P>
            <E T="03">Premanufacture notice</E> or <E T="03">PMN</E> means any notice submitted to EPA pursuant to section 5(a)(1)(A) of the Act in accordance with part 720 of this chapter or § 723.250 of this chapter.</P>
          <P>
            <E T="03">Section 5 notice</E> means any PMN, consolidated PMN, intermediate PMN, significant new use notice, exemption notice, exemption application, any MCAN or consolidated MCAN submitted under section 5 of the Act.</P>
          <P>
            <E T="03">Significant new use notice</E> means any notice submitted to EPA pursuant to section 5(a)(1)(B) of the Act in accordance with part 721 of this chapter.</P>
          <P>
            <E T="03">Small business concern</E> means any person whose total annual sales in the person's fiscal year preceding the date of the submission of the applicable section 5 notice, when combined with those of the parent company (if any), are less than $40 million.</P>
          <CITA>[53 FR 31252, Aug. 17, 1988, as amended at 62 FR 17931, April 11, 1997]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 700.45</SECTNO>
          <SUBJECT>Fee payments.</SUBJECT>
          <P>(a) <E T="03">Persons who must pay fees.</E> Persons submitting a section 5 notice to EPA shall remit for each such notice the appropriate fee identified in paragraph (b) of this section in accordance with the procedures in paragraph (e) of this section.</P>
          <P>(b) <E T="03">Fees.</E> Persons shall remit fee payments to EPA as follows:</P>
          <P>(1) <E T="03">Small business concerns.</E> Small business concerns shall remit a fee of $100 for each section 5 notice submitted.</P>
          <P>(2) <E T="03">Others.</E> Persons other than small business concerns shall remit fees according to the type of section 5 notice as follows:</P>
          <P>(i) <E T="03">Premanufacture notices and consolidated premanufacture notices.</E> Persons shall remit a fee of $2,500 for each PMN or consolidated PMN submitted.</P>
          <P>(ii) <E T="03">Intermediate premanufacture notices.</E> Persons shall remit a fee of $1,000 for each intermediate PMN. However, for the PMN for the final product the person shall submit the fee in paragraph (b)(2)(i) of this section.</P>
          <P>(iii) <E T="03">Significant new use notices.</E> Persons shall remit a fee of $2,500 for each significant new use notice submitted.</P>
          <P>(iv) <E T="03">Exemption applications.</E> Persons shall remit a fee of $2,500 for each exemption application submitted under section 5(h)(2) of the Act.</P>
          <P>(v) <E T="03">Exemption notices.</E> Persons shall remit a fee of $2,500 for each exemption notice submitted under § 723.175 of this chapter.</P>
          <P>(vi) <E T="03">MCAN and consolidated MCAN</E>. Persons shall remit a fee of $2,500 for each MCAN or consolidated MCAN submitted.</P>
          <P>(c) <E T="03">No fee required</E>. Persons are exempt from remitting any fee for submissions under §§ 720.38, 723.50, and subparts E, F, and G of part 725 of this chapter.</P>
          <P>(d) <E T="03">Joint submitters.</E> Joint submitters of a section 5 notice are required to remit the appropriate fee identified in paragraph (b) of this section for each section 5 notice regardless of the number of joint submitters for that notice. To qualify for the fee identified in paragraph (b)(1) of this section, each joint submitter of a section 5 notice must qualify as a small business concern under § 700.43.</P>
          <P>(e) <E T="03">Remittance procedure.</E> (1) Each remittance under this section shall be in United States currency and shall be paid by money order, bank draft, or certified check drawn to the order of the Environmental Protection Agency.</P>
          <P>(2) Each remittance shall be sent to the Environmental Protection Agency, HQ Accounting Operations Branch (PM-226), P.O. 360399M, Pittsburgh, PA 15251-6399, ATTN: TSCA User Fee.</P>

          <P>(3) Persons who submit a section 5 notice shall place a unique identifying number, which must include the letters “TS” followed by a combination of 6 numbers (letters may be substituted for some numbers), on the front page of each section 5 notice submitted. The same identifying number and the submitter's name must appear on the corresponding fee remittance under this section. If a remittance applies to more than one section 5 notice, the person shall include the name of the submitter, the identifying number for each section 5 notice to which the remittance applies, and the amount of the remittance which applies to each notice. Any remittance not having the identifying name and number described above will be returned to the remitter.<PRTPAGE P="7"/>
          </P>
          <P>(4)(i) Each person who remits the fee identified in paragraph (b)(1) of this section for a PMN, consolidated PMN, intermediate PMN, or significant new use notice shall write or type the words, “The company named in part 1, section A is a small business concern under 40 CFR 700.43 and has remitted a fee of $100 in accordance with 40 CFR 700.45(b).” under “CERTIFICATION” on Page 2 of the Premanufacture Notice for New Chemical Substances (EPA Form 7710-25 (4-26-83)).</P>
          <P>(ii) Each person who remits the fee identified in paragraph (b)(1) of this section for an exemption application under section 5(h)(2) of the Act shall include the words, “Each company identified in this application is a small business concern under 40 CFR 700.43 and has remitted a fee of $100 in accordance with 40 CFR 700.45(b).” in the exemption application.</P>
          <P>(iii) Each person who remits the fee identified in paragraph (b)(1) of this section for an exemption notice under § 723.175 of this chapter shall include the words, “Each company identified in this notice is a small business concern under 40 CFR 700.43 and has remitted a fee of $100 in accordance with 40 CFR 700.45(b).” in the certification required in § 723.175(i)(1)(x) of this chapter.</P>
          <P>(iv) Each person who remits the fee identified in paragraph (b)(1) of this section for a MCAN for a microorganism shall include the words, “The company identified in this notice is a small business concern under 40 CFR 700.43 and has remitted a fee of $100 in accordance with 40 CFR 700.45(d),” in the certification required in § 725.25(b) of this chapter.</P>
          <P>(5)(i) Each person who remits a fee identified in paragraph (b)(2) of this section for a PMN, consolidated PMN, intermediate PMN, or significant new use notice shall write or type the words, “The company named in part 1, section A has remitted the fee specified in 40 CFR 700.45(b).” under “CERTIFICATION” on page 2 of the Premanufacture Notice for New Chemical Substances (EPA Form 7710-25 (4-26-83)).</P>
          <P>(ii) Each person who remits the fee identified in paragraph (b)(2) of this section for an exemption application under section (5)(h)(2) of the Act shall include the words, “Each company identified in this application has remitted a fee of $2,500 in accordance with 40 CFR 700.45(b).” in the exemption application.</P>
          <P>(iii) Each person who remits the fee identified in paragraph (b)(2) of this section for an exemption notice under § 723.175 of this chapter shall include the words, “Each company identified in this notice has remitted a fee of $2,500 in accordance with 40 CFR 700.45(b).” in the certification required in § 723.175(i)(1)(x) of this chapter.</P>
          <P>(iv) Each person who remits a fee identified in paragraph (b)(2) of this section for a MCAN for a microorganism shall include the words, “The company identified in this notice has remitted the fee specified in 40 CFR 700.45(b),” in the certification required in § 725.25(b) of this chapter.</P>
          <P>(f) <E T="03">Fee refunds.</E> EPA will refund any fee paid for a section 5 notice whenever the Agency determines:</P>
          <P>(1) That the chemical substance that is the subject of a PMN, intermediate PMN, exemption application, or exemption notice is not a new chemical substance as of the date of submission of the notice.</P>
          <P>(2) In the case of a significant new use notice, that the notice was not required.</P>
          <P>(3) The notice is incomplete under either § 720.65(c) or 725.33, of this chapter.</P>
          <P>(4) That as of the date of submission of the notice: the microorganism that is the subject of a MCAN is not a new microorganism; nor is the use involving the microorganism a significant new use.</P>
          <CITA>[53 FR 31252, Aug. 17, 1988, as amended at 54 FR 21429, May 18, 1989; 58 FR 34204, June 23, 1993; 62 FR 17932, April 11, 1997]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 700.49</SECTNO>
          <SUBJECT>Failure to remit fees.</SUBJECT>
          <P>EPA will not consider a section 5 notice to be complete unless the appropriate certification under § 700.45(e) is included and until the appropriate remittance under § 700.45(b) has been sent to EPA as provided in § 700.45(e) and received by EPA. EPA will notify the submitter that the section 5 notice is incomplete in accordance with §§ 720.65(c) and 725.33 of this chapter.</P>
          <CITA>[62 FR 17932, April 11, 1997]</CITA>
        </SECTION>
      </SUBPART>
    </PART>
    <PART>
      <PRTPAGE P="8"/>
      <EAR>Pt. 702</EAR>
      <HD SOURCE="HED">PART 702—GENERAL PRACTICES AND PROCEDURES</HD>
      <CONTENTS>
        <SUBPART>
          <RESERVED>Subparts A-B[Reserved]</RESERVED>
        </SUBPART>
        <SUBPART>
          <HD SOURCE="HED">Subpart C—Citizen Suit</HD>
          <SECHD>Sec.</SECHD>
          <SECTNO>702.60</SECTNO>
          <SUBJECT>Purpose.</SUBJECT>
          <SECTNO>702.61</SECTNO>
          <SUBJECT>Service of notice.</SUBJECT>
          <SECTNO>702.62</SECTNO>
          <SUBJECT>Contents of notice.</SUBJECT>
        </SUBPART>
      </CONTENTS>
      <AUTH>
        <HD SOURCE="HED">Authority:</HD>
        <P>15 U.S.C. 2619.</P>
      </AUTH>
      <SOURCE>
        <HD SOURCE="HED">Source:</HD>
        <P>47 FR 2773, Jan. 19, 1982, unless otherwise noted.</P>
      </SOURCE>
      <SUBPART>
        <RESERVED>Subparts A-B[Reserved]</RESERVED>
      </SUBPART>
      <SUBPART>
        <HD SOURCE="HED">Subpart C—Citizen Suit</HD>
        <SECTION>
          <SECTNO>§ 702.60</SECTNO>
          <SUBJECT>Purpose.</SUBJECT>
          <P>Section 20 of the Toxic Substances Control Act (TSCA) authorizes any person to begin a civil action to compel performance by the Environmental Protection Agency (EPA) of TSCA non-discretionary acts or duties (section 20(a)(2)) or to restrain any violation of TSCA, or of any rule promulgated under sections 4, 5, or 6, or of any order issued under section 5 of TSCA (section 20(a)(1)). The purpose of this regulation is to prescribe procedures governing the giving of a notice of intent to file suit required by section 20(b) of TSCA as a prerequisite to beginning such civil actions.</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 702.61</SECTNO>
          <SUBJECT>Service of notice.</SUBJECT>
          <P>(a) <E T="03">Notice as a prerequisite to suit.</E> Under section 20 of TSCA, no civil action may be commenced by a citizen to restrain a violation of TSCA, or a rule or order thereunder, unless at least 60 days in advance the citizen has given notice of the intent to file suit to the Administrator and to the person who is alleged to have committed the violation. No civil action may be commenced by a citizen to compel the Administrator to perform any non-discretionary act or duty under TSCA, unless at least 60 days in advance the citizen has given notice of the intent to file suit to the Administrator. However, in the case of an alleged failure by the Administrator to file an action under section 7 of TSCA, the citizen must give notice to the Administrator only 10 days in advance of filing the civil action.</P>
          <P>(b) <E T="03">Method of service.</E> Notice of intent to file suit can be either personally served or served by certified mail—return receipt requested—to persons identified in paragraph (d) of this section.</P>
          <P>(c) <E T="03">Date of service.</E> The effective date of service of a notice given in accordance with this rule shall be the date of the return receipt, if served by mail, or the date of receipt if personally served.</P>
          <P>(d) <E T="03">Persons to be served—</E>(1) <E T="03">Violations of TSCA rules or TSCA order.</E> (i) If the alleged violator is a private individual or a corporation, notice of intent to file suit shall be served on the individual or the owner or managing agent of the plant, facility, or activity alleged to be in violation. If the alleged violator is a corporation, a copy of the notice shall also be sent to the registered agent, if any, of such corporation in the State in which such violation is alleged to have occurred. Notice shall also be served on the Administrator of the EPA.</P>
          <P>(ii) If the alleged violator is a State or local government entity, notice of intent to file suit shall be served on the head of the agency. Notice shall also be served on the Administrator of the EPA, and a copy shall be sent to the Attorney General of the United States.</P>
          <P>(iii) If the alleged violator is a Federal agency, notice of intent to file suit shall be served on the head of the agency. Notice shall also be served on the Administrator of the EPA, and a copy shall be sent to the Attorney General of the United States.</P>
          <P>(2) <E T="03">Performance of non-discretionary TSCA acts or duties.</E> Notice of intent to file suit shall be served on the Administrator of the EPA and a copy shall be sent to the Attorney General of the United States.</P>
          <P>(3) <E T="03">Address of persons to be served.</E> (i) EPA Administrator: 401 M St., SW., Washington, DC 20460. (ii) Attorney General of the United States: 10th and Constitution Avenue, NW., Washington, DC 20530.</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 702.62</SECTNO>
          <SUBJECT>Contents of notice.</SUBJECT>
          <P>(a) <E T="03">Violation of TSCA rule or TSCA order.</E> Notice of intent to file suit regarding an alleged violation of TSCA <PRTPAGE P="9"/>or any rule promulgated under sections 4, 5, or 6, or an order issued under section 5, shall include sufficient information to permit the recipient to identify:</P>
          <P>(1) The specific provision of TSCA or of the rule or order under TSCA alleged to have been violated.</P>
          <P>(2) The activity alleged to constitute a violation.</P>
          <P>(3) The person or persons responsible for the alleged violation.</P>
          <P>(4) The location of the alleged violation.</P>
          <P>(5) The date or dates of the alleged violation as closely as the citizen is able to specify them.</P>
          <P>(6) The full name, address, and telephone number of the citizen giving notice.</P>
          <P>(b) <E T="03">Failure to act.</E> Notice regarding an alleged failure of the Administrator to perform any act or duty which is not discretionary shall:</P>
          <P>(1) Identify the specific provision of TSCA which requires an act or creates a duty.</P>
          <P>(2) Describe with reasonable specificity the action taken or not taken by the Administrator which is alleged to constitute a failure to perform the act or duty.</P>
          <P>(3) State the full name, address, and telephone number of the citizen giving the notice.</P>
          <P>(c) <E T="03">Identification of Counsel.</E> The notice shall state the name, address, and telephone number of the Legal Counsel, if any, representing the citizen giving the notice.</P>
        </SECTION>
      </SUBPART>
    </PART>
    <PART>
      <EAR>Pt. 704</EAR>
      <HD SOURCE="HED">PART 704—REPORTING AND RECORDKEEPING REQUIREMENTS</HD>
      <CONTENTS>
        <SUBPART>
          <HD SOURCE="HED">Subpart A—General Reporting and Recordkeeping Provisions for Section 8(a) Information-Gathering Rules</HD>
          <SECHD>Sec.</SECHD>
          <SECTNO>704.1</SECTNO>
          <SUBJECT>Scope.</SUBJECT>
          <SECTNO>704.3</SECTNO>
          <SUBJECT>Definitions.</SUBJECT>
          <SECTNO>704.5</SECTNO>
          <SUBJECT>Exemptions.</SUBJECT>
          <SECTNO>704.7</SECTNO>
          <SUBJECT>Confidential business information claims.</SUBJECT>
          <SECTNO>704.9</SECTNO>
          <SUBJECT>Where to send reports.</SUBJECT>
          <SECTNO>704.11</SECTNO>
          <SUBJECT>Recordkeeping.</SUBJECT>
          <SECTNO>704.13</SECTNO>
          <SUBJECT>Compliance and enforcement.</SUBJECT>
        </SUBPART>
        <SUBPART>
          <HD SOURCE="HED">Subpart B—Chemical-Specific Reporting and Recordkeeping Rules</HD>
          <SECTNO>704.25</SECTNO>
          <SUBJECT>11-Aminoundecanoic acid.</SUBJECT>
          <SECTNO>704.33</SECTNO>
          <SUBJECT>P-tert-butylbenzoic acid (P-TBBA), p-tert-butyltoluene (P-TBT) and p-tert-butylbenzaldehyde (P-TBB).</SUBJECT>
          <SECTNO>704.43</SECTNO>
          <SUBJECT>Chlorinated naphthalenes.</SUBJECT>
          <SECTNO>704.45</SECTNO>
          <SUBJECT>Chlorinated terphenyl.</SUBJECT>
          <SECTNO>704.95</SECTNO>
          <SUBJECT>Phosphonic acid, [1,2-ethanediyl-bis[nitrilobis-(methylene)]]tetrakis-(EDTMPA) and its salts.</SUBJECT>
          <SECTNO>704.102</SECTNO>
          <SUBJECT>Hexachloronorbornadiene.</SUBJECT>
          <SECTNO>704.104</SECTNO>
          <SUBJECT>Hexafluoropropylene oxide.</SUBJECT>
          <SECTNO>704.175</SECTNO>
          <SUBJECT>4,4<E T="61">′</E>-methylenebis(2-chloroaniline) (MBOCA).</SUBJECT>
        </SUBPART>
      </CONTENTS>
      <AUTH>
        <HD SOURCE="HED">Authority:</HD>
        <P>15 U.S.C. 2607(a).</P>
      </AUTH>
      <SUBPART>
        <HD SOURCE="HED">Subpart A—General Reporting and Recordkeeping Provisions for Section 8(a) Information-Gathering Rules</HD>
        <SECTION>
          <SECTNO>§ 704.1</SECTNO>
          <SUBJECT>Scope.</SUBJECT>
          <P>(a) This part specifies reporting and recordkeeping procedures under section 8(a) of the Toxic Substances Control Act (TSCA) for manufacturers, importers, and processors of chemical substances and mixtures (hereafter collectively referred to as substances) that are identified in subpart B of this part. The reporting and recordkeeping provisions in subpart A of this part apply throughout this part unless revised in any other subpart.</P>
          <P>(b) Subpart B of this part sets out chemical-specific reporting and recordkeeping requirements under section 8(a) of TSCA.</P>
          <CITA>[53 FR 51715, Dec. 22, 1988, as amended at 60 FR 31920, June 19, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 704.3</SECTNO>
          <SUBJECT>Definitions.</SUBJECT>
          <P>All definitions as set forth in section 3 of TSCA apply in this part. In addition, the following definitions are provided for the purposes of this part.</P>
          <P>
            <E T="03">Annual</E> means the corporate fiscal year.</P>
          <P>
            <E T="03">Article</E> means a manufactured item (1) which is formed to a specific shape or design during manufacture, (2) which has end use function(s) dependent in whole or in part upon its shape or design during end use, and (3) which has either no change of chemical composition during its end use or only those changes of composition which have no commercial purpose separate from that of the article, and that result from a chemical reaction that occurs upon end use of other chemical <PRTPAGE P="10"/>substances, mixtures, or articles; except that fluids and particles are not considered articles regardless of shape or design.</P>
          <P>
            <E T="03">Byproduct</E> means a chemical substance produced without a separate commercial intent during the manufacture, processing, use, or disposal of another chemical substance(s) or mixture(s).</P>
          <P>
            <E T="03">CAS Number</E> means Chemical Abstracts Service Registry Number.</P>
          <P>
            <E T="03">Coproduct</E> means a chemical substance produced for a commercial purpose during the manufacture, processing, use, or disposal of another chemical substance or mixture.</P>
          <P>
            <E T="03">Customer</E> means any person to whom a manufacturer, importer, or processor directly distributes any quantity of a chemical substance, mixture, mixture containing the substance or mixture, or article containing the substance or mixture, whether or not a sale is involved.</P>
          <P>
            <E T="03">Domestic</E> means within the geographical boundaries of the 50 United States, including the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam, American Samoa, the Northern Mariana Islands, and any other territory or possession of the United States.</P>
          <P>
            <E T="03">Enclosed process</E> means a manufacturing or processing operation that is designed and operated so that there is no intentional release into the environment of any substance present in the operation. An operation with fugitive, inadvertent, or emergency pressure relief releases remains an enclosed process so long as measures are taken to prevent worker exposure to and environmental contamination from the releases.</P>
          <P>
            <E T="03">EPA</E> means the United States Environmental Protection Agency.</P>
          <P>
            <E T="03">Import</E> means to import for commercial purposes.</P>
          <P>
            <E T="03">Import for commercial purposes</E> means to import with the purpose of obtaining an immediate or eventual commercial advantage for the importer, and includes the importation of any amount of a chemical substance or mixture. If a chemical substance or mixture containing impurities is imported for commercial purposes, then those impurities also are imported for commercial purposes.</P>
          <P>
            <E T="03">Import in bulk form</E> means to import a chemical substance (other than as part of a mixture or article) in any quantity, in cans, bottles, drums, barrels, packages, tanks, bags, or other containers, if the chemical substance is intended to be removed from the container and the substance has an end use or commercial purpose separate from the container.</P>
          <P>
            <E T="03">Importer</E> means (1) any person who imports any chemical substance or any chemical substance as part of a mixture or article into the customs territory of the United States, and includes:</P>
          <P>(i) The person primarily liable for the payment of any duties on the merchandise, or</P>
          <P>(ii) An authorized agent acting on his behalf (as defined in 19 CFR 1.11).</P>
          <P>(2) Importer also includes, as appropriate:</P>
          <P>(i) The consignee.</P>
          <P>(ii) The importer of record.</P>
          <P>(iii) The actual owner if an actual owner's declaration and superseding bond have been filed in accordance with 19 CFR 141.20.</P>
          <P>(iv) The transferee, if the right to draw merchandise in a bonded warehouse has been transferred in accordance with subpart C of 19 CFR part 144.</P>
          <P>(3) For the purposes of this definition, the customs territory of the United States consists of the 50 States, Puerto Rico, and the District of Columbia.</P>
          <P>
            <E T="03">Impurity</E> means a chemical substance which is unintentionally present with another chemical substance.</P>
          <P>
            <E T="03">Intermediate</E> means any chemical substance that is consumed, in whole or in part, in chemical reactions used for the intentional manufacture of other chemical substances or mixtures, or that is intentionally present for the purpose of altering the rates of such chemical reactions.</P>
          <P>
            <E T="03">Known to or reasonably ascertainable by</E> means all information in a person's possession or control, plus all information that a reasonable person similarly situated might be expected to possess, control, or know.</P>
          <P>
            <E T="03">Manufacture</E> means to manufacture for commercial purposes.<PRTPAGE P="11"/>
          </P>
          <P>
            <E T="03">Manufacture for commercial purposes</E> means: (1) To import, produce, or manufacture with the purpose of obtaining an immediate or eventual commercial advantage for the manufacturer, and includes among other things, such “manufacture” of any amount of a chemical substance or mixture:</P>
          <P>(i) For commercial distribution, including for test marketing.</P>
          <P>(ii) For use by the manufacturer, including use for product research and development, or as an intermediate.</P>
          <P>(2) Manufacture for commercial purposes also applies to substances that are produced coincidentally during the manufacture, processing, use, or disposal of another substance or mixture, including both byproducts that are separated from that other substance or mixture and impurities that remain in that substance or mixture. Such byproducts and impurities may, or may not, in themselves have commercial value. They are nonetheless produced for the purpose of obtaining a commercial advantage since they are part of the manufacture of a chemical product for a commercial purpose.</P>
          <P>
            <E T="03">Manufacturer</E> means a person who imports, produces, or manufactures a chemical substance. A person who extracts a component chemical substance from a previously existing chemical substance or a complex combination of substances is a manufacturer of that component chemical substance.</P>
          <P>
            <E T="03">Non-isolated intermediate</E> means any intermediate that is not intentionally removed from the equipment in which it is manufactured, including the reaction vessel in which it is manufactured, equipment which is ancillary to the reaction vessel, and any equipment through which the substance passes during a continuous flow process, but not including tanks or other vessels in which the substance is stored after its manufacture. Mechanical or gravity transfer through a closed system is not considered to be intentional removal, but storage or transfer to shipping containers “isolates” the substance by removing it from process equipment in which it is manufactured.</P>
          <P>
            <E T="03">Own or control</E> means ownership of 50 percent or more of a company's voting stock or other equity rights, or the power to control the management and policies of that company. A company may own or control one or more sites. A company may be owned or controlled by a foreign or domestic parent company.</P>
          <P>
            <E T="03">Parent company</E> is a company that owns or controls another company.</P>
          <P>
            <E T="03">Person</E> includes any individual, firm, company, corporation, joint venture, partnership, sole proprietorship, association, or any other business entity; any State or political subdivision thereof; any municipality; any interstate body; and any department, agency, or instrumentality of the Federal Government.</P>
          <P>
            <E T="03">Possession or control</E> means in the possession or control of any person, or of any subsidiary, partnership in which the person is a general partner, parent company, or any company or partnership which the parent company owns or controls, if the subsidiary, parent company, or other company or partnership is associated with the person in the research, development, test marketing, or commercial marketing of the substance in question. Information is in the possession or control of a person if it is:</P>
          <P>(1) In the person's own files including files maintained by employees of the person in the course of their employment.</P>
          <P>(2) In commercially available data bases to which the person has purchased access.</P>
          <P>(3) Maintained in the files in the course of employment by other agents of the person who are associated with research, development, test marketing, or commercial marketing of the chemical substance in question.</P>
          <P>
            <E T="03">Process</E> means to process for commercial purposes.</P>
          <P>
            <E T="03">Process for commercial purposes</E> means the preparation of a chemical substance or mixture after its manufacture for distribution in commerce with the purpose of obtaining an immediate or eventual commercial advantage for the processor. Processing of any amount of a chemical substance or mixture is included in this definition. If a chemical substance or mixture containing impurities is processed for commercial purposes, then the impurities also are processed for commercial purposes.<PRTPAGE P="12"/>
          </P>
          <P>
            <E T="03">Processor</E> means any person who processes a chemical substance or mixture.</P>
          <P>
            <E T="03">Production volume</E> means the quantity of a substance which is produced by a manufacturer, as measured in kilograms or pounds.</P>
          <P>
            <E T="03">Propose to manufacture, import, or process</E> means that a person has made a firm management decision to commit financial resources for the manufacture, import, or processing of a specified chemical substance or mixture.</P>
          <P>
            <E T="03">Site</E> means a contiguous property unit. Property divided only by a public right-of-way shall be considered one site. There may be more than one plant on a single site. The site for a person who imports a substance is the site of the operating unit within the person's organization which is directly responsible for importing the substance and which controls the import transaction and may in some cases be the organization's headquarters office in the United States.</P>
          <P>
            <E T="03">Small manufacturer or importer</E> means a manufacturer or importer that meets either of the following standards:</P>
          <P>(1) <E T="03">First standard</E>. A manufacturer or importer of a substance is small if its total annual sales, when combined with those of its parent company (if any), are less than $40 million. However, if the annual production or importation volume of a particular substance at any individual site owned or controlled by the manufacturer or importer is greater than 45,400 kilograms (100,000 pounds), the manufacturer or importer shall not qualify as small for purposes of reporting on the production or importation of that substance at that site, unless the manufacturer or importer qualifies as small under standard (2) of this definition.</P>
          <P>(2) <E T="03">Second standard.</E> A manufacturer or importer of a substance is small if its total annual sales, when combined with those of its parent company (if any), are less than $4 million, regardless of the quantity of substances produced or imported by that manufacturer or importer.</P>
          <P>(3) <E T="03">Inflation index</E>. EPA shall make use of the Producer Price Index for Chemicals and Allied Products, as compiled by the U.S. Bureau of Labor Statistics, for purposes of determining the need to adjust the total annual sales values and for determining new sales values when adjustments are made. EPA may adjust the total annual sales values whenever the Agency deems it necessary to do so, provided that the Producer Price Index for Chemicals and Allied Products has changed more than 20 percent since either the most recent previous change in sales values or the date of promulgation of this rule, whichever is later. EPA shall provide <E T="04">Federal Register</E> notification when changing the total annual sales values.</P>
          <P>
            <E T="03">Small quantities solely for research and development</E> (or “small quantities solely for purposes of scientific experimentation or analysis or chemical research on, or analysis of, such substance or another substance, including such research or analysis for the development of a product”) means quantities of a chemical substance manufactured, imported, or processed or proposed to be manufactured, imported, or processed solely for research and development that are not greater than reasonably necessary for such purposes.</P>
          <P>
            <E T="03">Substance</E> means either a chemical substance or mixture unless otherwise indicated.</P>
          <P>
            <E T="03">Test marketing</E> means the distribution in commerce of no more than a predetermined amount of a chemical substance, mixture, article containing that chemical substance or mixture, or a mixture containing that substance, by a manufacturer or processor, to no more than a defined number of potential customers to explore market capability in a competitive situation during a predetermined testing period prior to the broader distribution of that chemical substance, mixture, or article in commerce.</P>
          <P>
            <E T="03">Total annual sales</E> means the total annual revenue (in dollars) generated by the sale of all products of a company. Total annual sales must include the total annual sales revenue of all sites owned or controlled by that company and the total annual sales revenue of that company's subsidiaries and foreign or domestic parent company, if any.</P>
          <P>
            <E T="03">TSCA</E> means the Toxic Substances Control Act, 15 U.S.C. 2601 et seq.</P>
          <CITA>[53 FR 51715, Dec. 22, 1988]</CITA>
        </SECTION>
        <SECTION>
          <PRTPAGE P="13"/>
          <SECTNO>§ 704.5</SECTNO>
          <SUBJECT>Exemptions.</SUBJECT>
          <P>A person who is subject to reporting requirements for a substance identified in this part is exempt from those requirements to the extent that the person and that person's use of the substance is described in this section. This section is superseded by any TSCA section 8(a) rule that adds to, removes, or revises the exemptions described in this section.</P>
          <P>(a) <E T="03">Articles.</E> A person who imports, processes, or proposes to import or process a substance identified in this part solely as part of an article is exempt from the reporting requirements of this part with regard to that substance.</P>
          <P>(b) <E T="03">Byproducts.</E> A person who manufactures, imports, or proposes to manufacture or import a substance identified in this part solely as a byproduct is exempt from the reporting requirements of this part.</P>
          <P>(c) <E T="03">Impurities.</E> A person who manufactures, imports, processes, or proposes to manufacture, import, or process a substance identified in this part solely as an impurity is exempt from the reporting requirements of this part.</P>
          <P>(d) <E T="03">Non-isolated intermediate.</E> A person who manufactures or proposes to manufacture a substance identified in this part solely as a non-isolated intermediate is exempt from the reporting requirements of this part.</P>
          <P>(e) <E T="03">Research and development.</E> A person who manufactures, imports, processes, or proposes to manufacture, import, or process a substance identified in this part only in small quantities solely for research and development is exempt from the reporting requirements of this part.</P>
          <P>(f) <E T="03">Small manufacturers and importers.</E> Small manufacturers and importers are exempt from the reporting requirements of this part.</P>
          <CITA>[53 FR 51717, Dec. 22, 1988]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 704.7</SECTNO>
          <SUBJECT>Confidential business information claims.</SUBJECT>
          <P>(a) Any person submitting a notice under this rule may assert a business confidentiality claim covering all or any part of the notice. Any information covered by a claim will be disclosed by EPA only to the extent and by means of the procedures set forth in part 2 of this title.</P>
          <P>(b) If no claim accompanies the notice at the time it is submitted to EPA, the notice will be placed in an open file available to the public without further notice to the respondent.</P>
          <P>(c) To assert a claim of confidentiality for data contained in a notice, the respondent must submit two copies of the notice.</P>
          <P>(1) One copy of the notice must be complete. In that copy the respondent must indicate what data, if any, are claimed as confidential by marking the specific information on each page with a label such as “confidential”, “proprietary”, or “trade secret”.</P>
          <P>(2) If some data in the notice are claimed as confidential, the respondent must submit a second copy. The second copy must be complete except that all information claimed as confidential in the first copy must be deleted.</P>
          <P>(3) The first copy of the notice will be for internal use by EPA. The second copy will be placed in an open file to be available to the public.</P>
          <P>(4) Failure to furnish a second copy of the notice when information is claimed as confidential in the first copy will be considered a presumptive waiver of the claim of confidentiality. EPA will notify the respondent by certified mail that a finding of a presumptive waiver of the claim of confidentiality has been made. The respondent has 15 days from the date of receipt of notification to submit the required second copy. Failure to submit the second copy will cause EPA to place the first copy in the public file.</P>
          <P>(d) In submitting a claim of confidentiality, a person attests to the truth of the following four statements concerning all information which is claimed confidential:</P>
          <P>(1) My company has taken measures to protect the confidentiality of the information, and it intends to continue to take such measures.</P>

          <P>(2) The information is not, and has not been, reasonably obtainable without our consent by other persons (other than government bodies) by use of legitimate means (other than discovery based on a showing of special need in a judicial or quasi-judicial proceeding).<PRTPAGE P="14"/>
          </P>
          <P>(3) The information is not publicly available elsewhere.</P>
          <P>(4) Disclosure of the information would cause substantial harm to our competitive position.</P>
          <CITA>[48 FR 23420, May 25, 1983, as amended at 53 FR 51717, Dec. 22, 1988]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 704.9</SECTNO>
          <SUBJECT>Where to send reports.</SUBJECT>
          <P>Reports must be submitted by certified mail to the Document Control Office (7407), Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Room G-099, 401 M St., SW., Washington, DC., 20460, ATT: 8(a) Reporting.</P>
          <CITA>[60 FR 34463, July 3, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 704.11</SECTNO>
          <SUBJECT>Recordkeeping.</SUBJECT>
          <P>Each person who is subject to the reporting requirements of this part must retain the following records for 3 years following the creation or compilation of the record.</P>
          <P>(a) A copy of each report submitted by the person in response to the requirements of this part.</P>
          <P>(b) Materials and documentation sufficient to verify or reconstruct the values submitted in the report.</P>
          <P>(c) A copy of each notice sent by the person, return receipt requested, to that person's customers for the purpose of notifying their customers of the customer's reporting obligations under this part.</P>
          <P>(d) All return receipts signed by the person's customers who received the notice described in paragraph (c) of this section.</P>
          <CITA>[53 FR 51717, Dec. 22, 1988, as amended at 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 704.13</SECTNO>
          <SUBJECT>Compliance and enforcement.</SUBJECT>
          <P>Violators of the requirements of this part may be subject to civil administrative penalties up to $25,000 per day of violation or criminal prosecution, as provided in sections 15 and 16 of TSCA. In addition, under section 17, EPA may seek judicial relief to compel submission of required information.</P>
          <CITA>[53 FR 51717, Dec. 22, 1989]</CITA>
        </SECTION>
      </SUBPART>
      <SUBPART>
        <HD SOURCE="HED">Subpart B—Chemical-Specific Reporting and Recordkeeping Rules</HD>
        <SECTION>
          <SECTNO>§ 704.25</SECTNO>
          <SUBJECT>11-Aminoundecanoic acid.</SUBJECT>
          <P>(a) <E T="03">Definitions.</E> (1) <E T="03">11-AA</E> means the chemical substance 11-ami-no-un-de-ca-no-ic acid, CAS Number 2432-99-7.</P>
          <P>(2) <E T="03">Enclosed process</E> means a process that is designed and operated so that there is no intentional release of any substance present in the process. A process with fugitive, inadvertent, or emergency pressure relief releases remains an enclosed process so long as measures are taken to prevent worker exposure to an environmental contamination from the releases.</P>
          <P>(3) <E T="03">Internal subunit</E> means a subunit that is covalently linked to at least two other subunits. <E T="03">Internal subunits</E> of polymer molecules are chemically derived from monomer molecules that have formed covalent links between two or more other molecules.</P>
          <P>(4) <E T="03">Monomer</E> means a chemical substance that has the capacity to form links between two or more other molecules.</P>
          <P>(5) <E T="03">Polymer</E> means a chemical substance that consists of at least a simple weight majority of polymer molecules but consists of less than a simple weight majority of molecules with the same molecular weight. Collectively, such polymer molecules must be distributed over a range of molecular weights wherein differences in molecular weight are primarily attributable to differences in the number of internal subunits.</P>
          <P>(6) <E T="03">Polymer molecule</E> means a molecule which includes at least four covalently linked subunits, at least two of which are internal subunits.</P>
          <P>(7) <E T="03">Small processor</E> means a processor that meets either the standard in paragraph (a)(7)(i) of this section or the standard in paragraph (a)(7)(ii) of this section.</P>
          <P>(i) <E T="03">First standard.</E> A processor of a chemical substance is small if its total annual sales, when combined with those of its parent company, if any, are less than $40 million. However, if the annual processing volume of a particular chemical substance at any individual site owned or controlled by the <PRTPAGE P="15"/>processor is greater than 45,400 kilograms (100,000 pounds), the processor shall not qualify as small for purposes of reporting on the processing of that chemical substance at that site, unless the processor qualifies as small under paragraph (a)(7)(ii) of this section.</P>
          <P>(ii) <E T="03">Second standard.</E> A processor of a chemical substance is small if its total annual sales, when combined with those of its parent company (if any), are less than $4 million, regardless of the quantity of the particular chemical substance processed by that company.</P>
          <P>(iii) <E T="03">Inflation index.</E> EPA will use the Inflation Index described in the definition of <E T="03">small manufacturer</E> set forth in § 704.3, for purposes of adjusting the total annual sales values of this small processor definition. EPA will provide notice in the <E T="04">Federal Register</E> when changing the total annual sales values of this definition.</P>
          <P>(8) <E T="03">Subunit</E> means an atom or group of associated atoms chemically derived from corresponding reactants.</P>
          <P>(b) <E T="03">Persons who must report.</E> Except as provided in paragraph (c) of this section, the following persons are subject to this section:</P>
          <P>(1) Persons who manufacture or propose to manufacture 11-AA:</P>
          <P>(i) For use as an intermediate in the manufacture of polymers in an enclosed process when it is expected that the 11-AA will be fully polymerized during the manufacturing process, or</P>
          <P>(ii) For use as a component in photoprocessing solutions.</P>
          <P>(2) Persons who import or propose to import 11-AA:</P>
          <P>(i) For use as an intermediate in the manufacture of polymers in an enclosed process when it is expected that the 11-AA will be fully polymerized during the manufacturing process, or</P>
          <P>(ii) For use as a component in photoprocessing solutions.</P>
          <P>(3) Persons who process or propose to process 11-AA:</P>
          <P>(i) For use as an intermediate in the manufacture of polymers in an enclosed process when it is expected that the 11-AA will be fully polymerized during the manufacturing process, or</P>
          <P>(ii) For use as a component in photoprocessing solutions.</P>
          <P>(c) <E T="03">Persons not subject to this section.</E> The following persons are not subject to this section:</P>
          <P>(1) Small manufacturers (includes importers) as described in § 704.3.</P>
          <P>(2) Small processors.</P>
          <P>(3) Persons described in § 704.5.</P>
          <P>(4) Persons who, at any time during the 3-year period ending July 22, 1986, manufactured, imported, or processed 11-AA:</P>
          <P>(i) For use as an intermediate in the manufacture of polymers in an enclosed process when it is expected that the 11-AA will be fully polymerized during the manufacturing process, or</P>
          <P>(ii) For use as a component in photoprocessing solutions.</P>
          <P>(d) <E T="03">What information to report</E>. Persons identified in paragraph (b) of this section must submit a Premanufacture Notice Form (EPA Form 7710-25).</P>
          <P>(e) <E T="03">When to report.</E> (1) Persons who intend to manufacture, import, or process 11-AA for use as an intermediate in the manufacture of polymers in an enclosed process when it is expected that the 11-AA will be fully polymerized during the manufacturing process or for use as a component in photoprocessing solutions must notify EPA within 30 days after making a firm management decision to commit financial resources for the manufacturing, importing, or processing of 11-AA.</P>
          <P>(2) Persons who initiated manufacturing, importing, or processing of 11-AA for use as an intermediate in the manufacture of polymers in an enclosed process when it is expected that the 11-AA will be fully polymerized during the manufacturing process, or for use as a component in photoprocessing solutions during the time period between July 22, 1986 and July 13, 1987 must notify EPA by August 10, 1987.</P>
          <P>(f) <E T="03">Recordkeeping.</E> Persons subject to the reporting requirements of this section must retain documentation of information contained in their reports for a period of 5 years from the date of submission of the report.</P>
          <P>(g) <E T="03">Where to send reports.</E> Reports must be submitted by certified mail to the Document Control Office (7407), Office of Pollution Prevention and Toxics, U.S. Environmental Protection <PRTPAGE P="16"/>Agency, Room G-099, 401 M St., SW., Washington, DC., 20460, ATT: 11-AA Notification.</P>
          <CITA>[52 FR 19864, May 28, 1987, as amended at 60 FR 16308, Mar. 29, 1995; 60 FR 34463, July 3, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 704.33</SECTNO>
          <SUBJECT>P-tert-butylbenzoic acid (P-TBBA), p-tert-butyltoluene (P-TBT) and p-tert-butylbenzaldehyde (P-TBB).</SUBJECT>
          <P>(a) <E T="03">Definitions.</E> (1) <E T="03">P-TBBA</E> means the substance p-tert-butylbenzoic acid, also identified as 4-(1,1-dimethylethyl)benzoic acid, CAS No. 98-73-7.</P>
          <P>(2) <E T="03">P-TBT</E> means the substance p-tert-butyltoluene, also identified as 1-(1,1-dimethylethyl)-4-methylbenzene, CAS No. 98-51-1.</P>
          <P>(3) <E T="03">P-TBB</E> means the substance p-tert-butylbenzaldehyde, also identified as 4-(1,1-dimethylethyl)benzaldehyde, CAS No. 939-97-9.</P>
          <P>(4) <E T="03">Small processor</E> means a processor that meets either the standard in paragraph (a)(4)(i) of this section or the standard in paragraph (a)(4)(ii) of this section.</P>
          <P>(i) <E T="03">First standard.</E> A processor of a chemical substance is small if its total annual sales, when combined with those of its parent company, if any, are less than $40 million. However, if the annual processing volume of a particular chemical substance at any individual site owned or controlled by the processor is greater than 45,400 kilograms (100,000 pounds), the processor shall not qualify as small for purposes of reporting on the processing of that chemical substance at that site, unless the processor qualifies as small under paragraph (a)(1)(ii) of this section.</P>
          <P>(ii) <E T="03">Second standard.</E> A processor of a chemical substance is small if its total annual sales, when combined with those of its parent company (if any), are less than $4 million, regardless of the quantity of the particular chemical substance processed by that company.</P>
          <P>(iii) <E T="03">Inflation index.</E> EPA shall use the Inflation Index described in the definition of <E T="03">small manufacturer</E> that is set forth in § 704.3, for purposes of adjusting the total annual sales values of this small processor definition. EPA shall provide <E T="04">Federal Register</E> notification when changing the total annual sales values of this definition.</P>
          <P>(b) <E T="03">Persons who must report.</E> Except as provided in paragraph (c) of this section, the following persons are subject to the reporting requirements of this rule; a person may become subject to this rule more than once, for more than one substance or under more than one of the criteria listed in this paragraph (b).</P>
          <P>(1) Persons who manufactured, imported, or processed P-TBBA, P-TBT, and/or P-TBB for commercial purposes during the person's latest complete corporate fiscal year prior to June 25, 1986. For purposes of this provision, processors of P-TBBA, P-TBT, and/or P-TBB shall include only those persons who processed the substances other than as non-isolated intermediates.</P>
          <P>(2) Persons who commence manufacture or importation of P-TBBA, P-TBT, and/or P-TBB for commercial purposes after June 25, 1986. This provision is applicable to persons who cease manufacture or importation of P-TBBA, P-TBT, and/or P-TBB after June 25, 1986 and then subsequently resume manufacture or importation of the substance(s).</P>
          <P>(3) Persons who process P-TBBA, P-TBT, and/or P-TBB for commercial purposes in any way other than as a non-isolated intermediate after June 25, 1986.</P>
          <P>(c) <E T="03">Persons not subject to this rule.</E> In addition to the persons described in § 704.5, small processors, as defined in paragraph (a)(4) of this section, are not subject to this rule.</P>
          <P>(d) <E T="03">Information to report.</E> Persons subject to this rule as described in paragraph (b) of this section shall report information to EPA as specified in this paragraph (d). Respondents to this rule shall report all information that is known to or reasonably ascertainable by the person reporting. For purposes of importer reporting under this paragraph, a site is the operating unit within the person's organization which is directly responsible for importing the substance and which controls the import transaction. The import site may in some cases be the organization's headquarters office in the United States.</P>

          <P>(1) All manufacturers, importers, and processors specified in paragraph (b) of <PRTPAGE P="17"/>this section shall report their name and headquarters address.</P>
          <P>(2) All manufacturers, importers, and processors specified in paragraph (b) of this section shall report the name, address, and office telephone number (including area code) of their principal technical contact.</P>
          <P>(3) All manufacturers, importers, and processors specified in paragraph (b) of this section shall report the name and address of each site where P-TBBA, P-TBT, and/or P-TBB is manufactured, imported, or processed.</P>
          <P>(4) All manufacturers, importers, and processors specified in paragraph (b)(1) of this section only shall report the information described in this paragraph (d)(4). Respondents to this paragraph (d)(4) shall report separately for each substance that they manufacture, import, or process, and for each site at which they do so. However, if the information to be reported in response to this paragraph (d)(4) is the same for different sites, the respondent need not report separately for each site but need only notify EPA that the information is the same for each site. The information to be reported under this paragraph (d)(4) shall cover the respondent's latest complete corporate fiscal year prior to June 25, 1986. Respondents to this paragraph (d)(4) shall report the following information:</P>
          <P>(i) The total quantity (by weight) of P-TBBA, P-TBT, or P-TBB manufactured, imported, or processed for commercial purposes per site.</P>
          <P>(ii) A narrative description of the manufacturing, importing, or processing operation(s) involving P-TBBA, P-TBT, or P-TBB at each site.</P>
          <P>(iii) A narrative description of worker activities involving P-TBBA, P-TBT, or P-TBB at each site, including the number of workers potentially exposed to each substance and, if applicable, the number of workers potentially exposed to more than one substance.</P>
          <P>(iv) The potential routes of worker exposure to P-TBBA, P-TBT, or P-TBB at each site (e.g., inhalation, ingestion, dermal absorption).</P>
          <P>(v) Available monitoring data from employee breathing zones with potential exposure to P-TBBA, P-TBT, or P-TBB at each site, including a description of the method of monitoring, the number of samples taken, and the potential number of workers similarly exposed for each worker job category. Respondents to this paragraph (d)(4)(v) shall submit data showing a range of 8-hour time weighted averages (TWAs), provided that the data are available in that form. Respondents also shall submit a calculated geometric mean of these data, with an explanation of the method by which the mean was derived. However, if the monitoring data are not available in the form of 8-hour TWAs, respondents shall submit raw sample data results and the duration time of sampling for each job category.</P>
          <P>(vi) A narrative description of any personal protective equipment and/or engineering controls used to prevent exposure to P-TBBA, P-TBT, or P-TBB at each site.</P>
          <P>(vii) A listing of the estimated quantities of P-TBBA, P-TBT, or P-TBB released directly into air, water, or land from each site.</P>
          <P>(viii) A narrative description of the times during the manufacturing, importing, or processing operations involving P-TBBA, P-TBT, or P-TBB when environmental release occurs at each site.</P>
          <P>(ix) A narrative description of any engineering controls used to prevent environmental release of P-TBBA, P-TBT, or P-TBB at each site.</P>
          <P>(x) A narrative description of all known end uses of any P-TBBA, P-TBT, or P-TBB that is manufactured, imported, or processed by the respondent. The narrative need not include customer identity.</P>
          <P>(xi) A narrative description of the methods used at each site for disposing of wastes generated during the manufacture, importation, or processing of P-TBBA, P-TBT, or P-TBB, including the quantity and content of such wastes (per site), the method of disposal, and an identification of the disposal site(s).</P>

          <P>(5) All manufactureres, importers, and processors specified in paragraph (b) of this section shall report the information described in this paragraph (d)(5). Respondents to this paragraph (d)(5) shall report separately for each substance that they intend to manufacture, import, or process during the first 2 years following the date on which <PRTPAGE P="18"/>they become subject to this rule. The data reported under this paragraph (d)(5) shall cover that 2-year period. Respondents to this paragraph (d)(5) shall report separately for each site at which they intend to manufacture, import, or process each substance. Respondents need not comply with this paragraph (d)(5) if the information to be reported is identical to that reported by the respondent under paragraph (d)(4) of this section, provided that the respondent makes note of that fact to EPA. Respondents to this paragraph (d)(5) shall report the following information:</P>
          <P>(i) An estimate of the total quantity (by weight) of P-TBBA, P-TBT, or P-TBB that the respondent intends to manufacture, import, or process for commercial purposes per site during each of the first 2 years following the date on which the respondent becomes subject to this rule.</P>
          <P>(ii) A narrative description of the intended manufacturing, importing, or processing activities involving P-TBBA, P-TBT, or P-TBB at each site during the first 2 years following the date on which the respondent becomes subject to this rule. The description shall include a summary of the intended manufacturing, importing, or processing operation(s); a summary of intended worker activities involving the substances, including an estimate of the number of persons anticipated to be exposed annually to P-TBBA, P-TBT, or P-TBB (per site) during the 2-year period, the anticipated routes of worker exposure to the substances (e.g., inhalation, ingestion, dermal absorption); and a summary of any personal protective equipment and/or engineering controls that the respondent intends to use to prevent exposure to the substances.</P>
          <P>(iii) A narrative description of anticipated environmental releases of P-TBBA, P-TBT, or P-TBB at each site from the manufacture, importation, or processing of these substances during the first 2 years following the date on which the respondent becomes subject to this rule. The narrative shall include the anticipated quantities of each substance released directly into air, water, or land, the anticipated routes of environmental release, and any intended engineering controls to be used to prevent environmental release of the substances.</P>
          <P>(iv) A narrative description of all anticipated end uses or P-TBBA, P-TBT, or P-TBB resulting from the respondent's manufacture, importation, or processing of the substances during the first 2 years following the date on which the respondent becomes subject to this rule. The summary need not include customer identity.</P>
          <P>(v) A narrative summary of the anticipated disposal of wastes generated from the manufacture, importation, or processing of P-TBBA, P-TBT, or P-TBB during the first 2 years following the date on which the respondent becomes subject to this rule. The summary shall include the anticipated quantity and content of such wastes (per site), the intended method of disposal, and an identification of intended disposal site(s).</P>
          <P>(e) <E T="03">When to report.</E> Persons subject to this rule must submit the requisite information to EPA within 60 days of becoming subject to the rule under the standards set forth in paragraph (b) of this section.</P>
          <P>(f) <E T="03">Certification.</E> Persons subject to this rule must attach the following statement to any information submitted to EPA in response to this rule: “I hereby certify that, to the best of my knowledge and belief, all of the attached information is complete and accurate.” This statement shall be signed and dated by the company's principal technical contact.</P>
          <P>(g) <E T="03">Recordkeeping.</E> Persons subject to the reporting requirements of this section must retain documentation of information contained in their reports for a period of 5 years from the date of the submission of the report.</P>
          <CITA>[51 FR 17339, May 12, 1986; 51 FR 18323, May 19, 1986, as amended at 52 FR 20083, May 29, 1987; 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 704.43</SECTNO>
          <SUBJECT>Chlorinated naphthalenes.</SUBJECT>
          <P>(a) <E T="03">Definitions.</E> (1) <E T="03">Extent of chlor-i-na-tion</E> means the percent by weight of chlorine.</P>
          <P>(2) <E T="03">Import</E> means to import in bulk form or as part of a mixture.</P>
          <P>(3) <E T="03">Isomeric ratio</E> means the relative amounts of each isomeric chlorinated <PRTPAGE P="19"/>naphthalene that composes the chemical substance; and for each isomer the relative amounts of each chlorinated naphthalene designated by the position of the chlorine atom(s) on the naphthalene.</P>
          <P>(4) <E T="03">Polychlorinated biphenyl</E> means any chemical substance that is limited to the biphenyl molecule and that has been chlorinated to varying degrees.</P>
          <P>(5) <E T="03">Small manufacturer</E> means a manufacturer (including importers) who meets either paragraph (a)(5) (i) or (ii) of this section:</P>
          <P>(i) A manufacturer of a chemical substance is small if its total annual sales, when combined with those of its parent company (if any), are less than $40 million. However, if the annual production volume of a particular chemical substance at any individual site owned or controlled by the manufacturer is greater than 45,400 kilograms (100,000 pounds), the manufacturer shall not qualify as small for purposes of reporting on the production of that chemical substance at that site, unless the manufacturer qualifies as small under paragraph (a)(5)(ii) of this section.</P>
          <P>(ii) A manufacturer of a chemical substance is small if its total annual sales, when combined with those of its parent company (if any), are less than $4 million, regardless of the quantity of the particular chemical substance produced by that manufacturer.</P>
          <P>(iii) For imported mixtures containing a chemical substance identified in paragraph (b) of this section, the 45,400 kilograms (100,000 pounds) standard in paragraph (a)(5)(i) of this section applies only to the amount of the chemical substance in a mixture and not the other components of the mixture.</P>
          <P>(6) <E T="03">Waste</E> means any solid liquid, semisolid, or contained gaseous material that results from the production of a chemical substance identified in paragraph (b) of this section and which is to be disposed.</P>
          <P>(b) <E T="03">Substances for which reports must be submitted.</E>
          </P>
          <GPOTABLE CDEF="s40,xs94" COLS="2" OPTS="L2,i1">
            <BOXHD>
              <CHED H="1">CAS registry number</CHED>
              <CHED H="1">Chemical substance</CHED>
            </BOXHD>
            <ROW>
              <ENT I="01"> 90-13-1</ENT>
              <ENT>Naphthalene, 1-chloro-</ENT>
            </ROW>
            <ROW>
              <ENT I="01"> 91-58-7</ENT>
              <ENT>Naphthalene, 2-chloro-</ENT>
            </ROW>
            <ROW>
              <ENT I="01"> 1321-64-8</ENT>
              <ENT>Naphthalene, pentachloro-</ENT>
            </ROW>
            <ROW>
              <ENT I="01"> 1321-65-9</ENT>
              <ENT>Naphthalene, trichloro-</ENT>
            </ROW>
            <ROW>
              <ENT I="01"> 1335-87-1</ENT>
              <ENT>Naphthalene, hexachloro-</ENT>
            </ROW>
            <ROW>
              <ENT I="01"> 1335-88-2</ENT>
              <ENT>Naphthalene, tetrachloro-</ENT>
            </ROW>
            <ROW>
              <ENT I="01"> 1825-30-5</ENT>
              <ENT>Naphthalene, 1,5-dichloro-</ENT>
            </ROW>
            <ROW>
              <ENT I="01"> 1825-31-6</ENT>
              <ENT>Naphthalene, 1,4-dichloro-</ENT>
            </ROW>
            <ROW>
              <ENT I="01"> 2050-69-3</ENT>
              <ENT>Naphthalene, 1,2-dichloro-</ENT>
            </ROW>
            <ROW>
              <ENT I="01"> 2050-72-8</ENT>
              <ENT>Naphthalene, 1,6-dichloro-</ENT>
            </ROW>
            <ROW>
              <ENT I="01"> 2050-73-9</ENT>
              <ENT>Naphthalene, 1,7-dichloro-</ENT>
            </ROW>
            <ROW>
              <ENT I="01"> 2050-74-0</ENT>
              <ENT>Naphthalene, 1,8-dichloro-</ENT>
            </ROW>
            <ROW>
              <ENT I="01"> 2050-75-1</ENT>
              <ENT>Naphthalene, 2,3-dichloro-</ENT>
            </ROW>
            <ROW>
              <ENT I="01"> 2065-70-5</ENT>
              <ENT>Naphthalene, 2,6-dichloro-</ENT>
            </ROW>
            <ROW>
              <ENT I="01"> 2198-75-6</ENT>
              <ENT>Naphthalene, 1,3-dichloro-</ENT>
            </ROW>
            <ROW>
              <ENT I="01"> 2198-77-8</ENT>
              <ENT>Naphthalene, 2,7-dichloro-</ENT>
            </ROW>
            <ROW>
              <ENT I="01"> 2234-13-1</ENT>
              <ENT>Naphthalene, octachloro-</ENT>
            </ROW>
            <ROW>
              <ENT I="01">25586-43-0</ENT>
              <ENT>Naphthalene, chloro-</ENT>
            </ROW>
            <ROW>
              <ENT I="01">32241-08-0</ENT>
              <ENT>Naphthalene, heptachloro-</ENT>
            </ROW>
            <ROW>
              <ENT I="01">70776-03-3</ENT>
              <ENT>Naphthalene, chloro derivatives.</ENT>
            </ROW>
          </GPOTABLE>
          <P>(c) <E T="03">Persons who must report.</E> (1) Persons who are manufacturing or importing a chemical substance identified in paragraph (b) of this section on October 8, 1984.</P>
          <P>(2) Persons who propose to import a chemical substance identified in paragraph (b) of this section on or after October 8, 1984.</P>
          <P>(3) Persons who manufacture a chemical substance identified in paragraph (b) of this section after October 8, 1984.</P>
          <P>(4) A person is required to report only once for each chemical substance identified in paragraph (b) of this section.</P>
          <P>(d) <E T="03">Persons exempt from reporting.</E> (1) Small manufacturers.</P>
          <P>(2) Persons described in § 704.5.</P>
          <P>(e) <E T="03">What information to report.</E> Persons described in paragraph (c) of this section must notify EPA of current or prospective manufacture or import. The notice must include, to the extent that it is known to or reasonably ascertainable by the person making the report, the following information:</P>
          <P>(1) Company name and address.</P>
          <P>(2) Name, address, and telephone number of the principal technical contact.</P>
          <P>(3) For chemical substances proposed to be imported, the proposed date of import.</P>
          <P>(4) A description of the use(s) or intended use(s) for the chemical substance.</P>
          <P>(5) A description of the isomeric ratio and extent of chlorination of the chemical substance and the impurity level of polychlorinated biphenyls.</P>

          <P>(6) The quantity (by weight) manufactured or imported within 12 months prior to October 8, 1984, if any, and the estimated quantity (by weight) to be manufactured or imported for the first <PRTPAGE P="20"/>3 years following the date of the report or the date of the intended start of import whichever occurs later.</P>
          <P>(7) The number of persons exposed to the chemical substance during manufacture, import, processing, distribution in commerce, use, and disposal.</P>
          <P>(8) If a manufacturer's waste contains one or more of the chemical substances identified in paragraph (b) of this section, the manufacturer must:</P>
          <P>(i) Provide the quantity (by weight) of the chemical substances identified in paragraph (b) of this section present in the waste.</P>
          <P>(ii) Identify the constituents of the waste and their concentrations,</P>
          <P>(iii) State the rate of waste generation as a percentage of production volume,</P>
          <P>(iv) Describe where in the manufacturing process the waste is generated, and</P>
          <P>(v) Describe the method for disposal of the waste.</P>
          <P>(f) <E T="03">When to report.</E> (1) Persons who are manufacturing or importing a chemical substance identified in paragraph (b) of this section on October 8, 1984 must notify EPA by November 6, 1984.</P>
          <P>(2) Persons who propose to import a chemical substance identified in paragraph (b) of this section on or after October 8, 1984 must notify EPA by November 6, 1984, or 15 days after making the management decision described in § 704.3, whichever is later in time.</P>
          <P>(3) Persons who manufacture a chemical substance identified in paragraph (b) of this section after October 8, 1984 must notify EPA within 30 days after the initial date of manufacture.</P>
          <CITA>[49 FR 33653, Aug. 24, 1984; 49 FR 45133, Nov. 15, 1984; 50 FR 1215, Jan. 10, 1985; 51 FR 19839, June 3, 1986; 52 FR 20083, May 29, 1987. Redesignated at 53 FR 51717, Dec. 22, 1988]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 704.45</SECTNO>
          <SUBJECT>Chlorinated terphenyl.</SUBJECT>
          <P>(a) <E T="03">Definitions</E>. (1) <E T="03">Chlorinated ter-phenyl</E> means a chemical substance, CAS No. 61788-33-6, comprised of chlor-inated ortho-, meta-, and paraterphenyl.</P>
          <P>(2) <E T="03">Extent of chlorination</E> means the percent by weight of chlorine for each isomer (ortho, meta, and para).</P>
          <P>(3) <E T="03">Isomeric ratio</E> means the ratios of ortho-, meta-, and parachlorinated terphenyls.</P>
          <P>(4) <E T="03">Polychlorinated biphenyl</E> means any chemical substance that is limited to the biphenyl molecule that has been chlorinated to varying degrees.</P>
          <P>(5) <E T="03">Small manufacturer</E> means a manufacturer (importers are defined as manufacturers under TSCA) who meets either of the following standards under this rule:</P>
          <P>(i) <E T="03">First standard</E>. A manufacturer of an existing chemical substance is small if its total annual sales, when combined with those of its parent company (if any), are less than $40 million. However, if the annual production volume of a particular chemical substance at any individual site owned or controlled by the manufacturer is greater than 45,400 kilograms (100,000 pounds), the manufacturer shall not qualify as small for purposes of reporting on the production of that chemical substance at the site, unless the manufacturer qualified as small under paragraph (a)(5)(ii) of this section.</P>
          <P>(ii) <E T="03">Second standard</E>. A manufacturer of an existing chemical substance is small if its total annual sales, when combined with those of its parent company (if any), are less than $4 million, regardless of the quantity of chemicals produced by that manufacturer.</P>
          <P>(b) <E T="03">Persons who must report.</E> Except for small manufacturers and as provided in § 704.5, the following persons are subject to the rule:</P>
          <P>(1) Persons who manufacture or propose to manufacture chlorinated terphenyl.</P>
          <P>(2) Persons who import (importers) or propose to import chlorinated terphenyl as a chemical substance in bulk or as part of a mixture.</P>
          <P>(c) <E T="03">What information to report.</E> Persons subject to this rule as described in paragraph (b) of this section must notify EPA of current or proposed manufacture or import of chlorinated terphenyl. The notice must include, to the extent that it is known to the person making the report or is reasonably ascertainable, the following information:</P>
          <P>(1) Company name and address.</P>
          <P>(2) Name, address, and telephone number of principal technical contact.</P>

          <P>(3) A description of the use(s) or intended use(s) for chlorinated terphenyl.<PRTPAGE P="21"/>
          </P>
          <P>(4) A description of the isomeric ratio and extent of chlorination of the chlorinated terphenyl and the impurity level of polychlorinated biphenyls.</P>
          <P>(5) The quantity (by weight) manufactured or imported within 12 months prior to the effective date of the rule, if any, and the estimated quantity (by weight) to be manufactured or imported for the first three years following the date of the report or the date of the intended start of production, whichever occurs later.</P>
          <P>(6) The proposed date for the initiation of manufacturing or importation of chlorinated terphenyl, if appropriate.</P>
          <P>(d) <E T="03">When to report.</E> Persons who are manufacturing or importing chlorinated terphenyl on the effective date of the rule must notify EPA within 30 days of the effective date of the rule. Persons who propose to manufacture or import chlorinated terphenyl must notify EPA within 15 days after making the management decision described in § 704.3 “Proposed to manufacture or import”.</P>
          <CITA>[49 FR 11184, Mar. 26, 1984, as amended at 49 FR 32068, Aug. 10, 1984; 50 FR 2048, Jan. 15, 1985; 52 FR 20083, May 29, 1987. Redesignated at 53 FR 51717, Dec. 22, 1988; 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 704.95</SECTNO>
          <SUBJECT>Phosphonic acid, [1,2-ethanediyl-bis[nitrilobis-(methylene)]]tetrakis- (EDTMPA) and its salts.</SUBJECT>
          <P>(a) <E T="03">Substances for which reporting is required.</E> The chemical substances for which reporting is required under this section are:</P>
          <GPOTABLE CDEF="10,r25" COLS="2" OPTS="L2,i1">
            <BOXHD>
              <CHED H="1">CAS No.</CHED>
              <CHED H="1">Chemical name</CHED>
            </BOXHD>
            <ROW>
              <ENT I="01">1429-50-1</ENT>
              <ENT>Phosphonic acid, [1,2-ethanediyl-bis[nitrilobis (methylene)]] tetrakis- (EDTMPA)</ENT>
            </ROW>
            <ROW>
              <ENT I="01">15142-96-8</ENT>
              <ENT>Phosphonic acid, [1,2-ethanediyl-bis[nitrilobis(methylene)]] tetrakis-, hexasodium salt</ENT>
            </ROW>
            <ROW>
              <ENT I="01">34274-30-1</ENT>
              <ENT>Phosphonic acid, [1,2-ethanediyl-bis[nitrilobis(methylene)]] tetrakis-, potassium salt</ENT>
            </ROW>
            <ROW>
              <ENT I="01">57011-27-5</ENT>
              <ENT>Phosphonic acid, [1,2-ethanediyl-bis[nitrilobis (methylene)]] tetrakis-, ammonium salt</ENT>
            </ROW>
            <ROW>
              <ENT I="01">67924-23-6</ENT>
              <ENT>Cobaltate (6-), [[[1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis-[phosphonato]] (8-)]-, pentapotassium hydrogen, (OC-6-21)-</ENT>
            </ROW>
            <ROW>
              <ENT I="01">67969-67-9</ENT>
              <ENT>Cobaltate (6-), [[[1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis- [phosphonato]] (8-)-N,N’,O,O”,O””,O”””]-, pentasodium hydrogen, (OC-6-21)-</ENT>
            </ROW>
            <ROW>
              <ENT I="01">67989-89-3</ENT>
              <ENT>Cuprate (6-), [[[1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis- [phosphonato]] (8-)]-, pentapotassium hydrogen, (OC-6-21)-</ENT>
            </ROW>
            <ROW>
              <ENT I="01">68025-39-8</ENT>
              <ENT>Cobaltate (6-), [[[1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis- [phosphonato]] (6-)-N,N’,O,O”,O””,O”””]-, pentaammonium hydrogen, (OC-6-21)-</ENT>
            </ROW>
            <ROW>
              <ENT I="01">68188-96-5</ENT>
              <ENT>Phosphonic acid, [1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis-, tetrapotassium salt</ENT>
            </ROW>
            <ROW>
              <ENT I="01">68309-98-8</ENT>
              <ENT>Cadmate (6-), [[[1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis- [phosphonato]] (8-)]-, pentapotassium hydrogen, (OC-6-21)-</ENT>
            </ROW>
            <ROW>
              <ENT I="01">68901-17-7</ENT>
              <ENT>Phosphonic acid, [1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis-, octaammonium salt</ENT>
            </ROW>
            <ROW>
              <ENT I="01">68958-86-1</ENT>
              <ENT>Nickelate (6-), [[[1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis- [phosphonato]] (8-)]-, pentaammonium hydrogen, (OC-6-21)-</ENT>
            </ROW>
            <ROW>
              <ENT I="01">68958-87-2</ENT>
              <ENT>Nickelate (6-), [[[1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis- [phosphonato]] (8-)]-, pentapotassium hydrogen, (OC-6-21)-</ENT>
            </ROW>
            <ROW>
              <ENT I="01">68958-88-3</ENT>
              <ENT>Nickelate (6-), [[[1,2-ethanediylbis [nitrilobis (methylene)]] tetrakis [phosphonato]] (8-)]-, pentasodium hydrogen, (OC-6-21)-</ENT>
            </ROW>
          </GPOTABLE>
          <P>(b) <E T="03">Persons who must report.</E> Unless exempt as provided in § 704.5, reports must be submitted by:</P>
          <P>(1) Persons who manufacture or import any of the substances identified in paragraph (a) of this section.</P>
          <P>(2) Persons who propose to manufacture or propose to import any of the substances identified in paragraph (a) of this section. For the purposes of importer reporting under this section, an import site is the operating unit within the person's organization which is directly responsible for importing the substance and which controls the import transaction; the import site may in some cases be the organization's headquarters office in the United States.</P>
          <P>(c) <E T="03">What information to report.</E> Persons identified in paragraph (b) of this section must report to EPA, for each of the substances identified in paragraph (a) of this section, the following information to the extent known to or reasonably ascertainable by them.</P>
          <P>(1) Initial Report:</P>
          <P>(i) Name and Chemical Abstracts Service Registry Number of the substance for which the report is submitted.</P>
          <P>(ii) Company name and headquarters address.</P>
          <P>(iii) Name, address, and telephone number of the principal technical contact.</P>

          <P>(iv) The total quantity (by weight in pounds) of the substance manufactured or imported for the person's most recently completed corporate fiscal year.<PRTPAGE P="22"/>
          </P>
          <P>(v) A description of the commercial uses of the substance during the person's most recently completed corporate fiscal year, including the production volume for each use.</P>
          <P>(vi) The estimated quantity (by weight in pounds) of the substance proposed to be manufactured or imported in the person's current corporate fiscal year.</P>
          <P>(vii) A description of the intended commercial uses of the substance during the person's current corporate fiscal year, including the estimated production volume for each use.</P>
          <P>(2) Follow-up Report:</P>
          <P>(i) Name and Chemical Abstracts Service Registry Number of the substance for which the report is submitted.</P>
          <P>(ii) Company name and headquarters address.</P>
          <P>(iii) Name, address, and telephone number of the principal technical contact.</P>
          <P>(iv) The estimated quantity (by weight in pounds) of the substance proposed to be manufactured or imported in the person's current corporate fiscal year.</P>
          <P>(v) A description of the intended commercial uses of the substance during the person's current corporate fiscal year, including the estimated production volume for each use.</P>
          <P>(d) <E T="03">When to report.</E> (1) Persons specified in paragraph (b)(1) of this section who are manufacturing or importing the substance as of December 5, 1988 must submit an initial report described in paragraph (c)(1) of this section by January 3, 1989.</P>
          <P>(2) Persons specified in paragraph (b)(2) of this section must submit an initial report within 30 days after making the management decision described in § 704.3 or by January 3, 1989, whichever is later.</P>
          <P>(3) Persons specified in paragraph (b) of this section, who submitted a report described in paragraph (c)(1) of this section, must submit a follow-up report described in paragraph (c)(2) of this section within 30 days of making the management decision, described at § 704.3, to do either of the following events:</P>
          <P>(i) Manufacture or import the substance in a quantity 50 percent greater than the quantity reported in the most recently submitted report.</P>
          <P>(ii) Manufacture or import the substance for a use not reported for that substance in any previous report.</P>
          <P>(e) <E T="03">Certification.</E> Persons subject to this section must attach the following statement to any information submitted to EPA in response to this section: “I hereby certify that, to the best of my knowledge and belief, all of the attached information is complete and accurate.” This statement must be signed and dated by the company's principal technical contact.</P>
          <P>(f) <E T="03">Recordkeeping.</E> Persons subject to the reporting requirements of this section must retain documentation of information contained in their reports for a period of 5 years from the date of the submission of the report.</P>
          <CITA>[53 FR 41337, Oct. 21, 1988, as amended at 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 704.102</SECTNO>
          <SUBJECT>Hexachloronorbornadiene.</SUBJECT>
          <P>(a) <E T="03">Definitions.</E> (1) <E T="03">Endrin</E> means the pesticide 2,7:3,6-Dimethanonaphth[2,3-b]oxirene,3,4,5,6,9,9-hexachloro-1a,2,2a,3,6,6a,7,7a-octahydro-, (1a<E T="03">alpha</E>, 2<E T="03">beta</E>, 2a<E T="03">beta</E>, 3<E T="03">alpha</E>, 6<E T="03">alpha</E>, 6<E T="03">abeta</E>, 7<E T="03">beta</E>, 7a<E T="03">alpha</E>)-, CAS Number 72-20-8.</P>
          <P>(2) <E T="03">HEX-BCH</E> means the chemical substance 1,2,3,4,7,7-hex-a-chlor-onor-born-a-diene, CAS Number 3389-71-7.</P>
          <P>(3) <E T="03">Isodrin</E> means the pesticide 1,4:5,8-Dimethanonaphthalene,1,2,3,4,10,10-hexacholoro-1,4,4a,5,8,8a-hexahydro-, (1<E T="03">alpha</E>, 4<E T="03">alpha</E>, 4a<E T="03">beta</E>, 5<E T="03">beta</E>, 8<E T="03">beta</E>, 8a<E T="03">beta</E>)-, CAS Number 465-73-6.</P>
          <P>(4) <E T="03">Small business</E> means any manufacturer, importer, or processor who meets either paragraph (a)(4)(i) or (ii) of this section:</P>

          <P>(i) A business is small if its total annual sales, when combined with those of its parent (if any), are less than $40 million. However, if the annual manufacture, importation, or processing volume of a particular chemical substance at any individual site owned or controlled by the business is greater than 45,400 kilograms (100,000 pounds), the business shall not qualify as small for purposes of reporting on the manufacture, importation, or processing of that chemical substance at that site, unless the business qualifies as small under paragraph (a)(4)(ii) of this section.<PRTPAGE P="23"/>
          </P>
          <P>(ii) A business is small if its total annual sales, when combined with those of its parent company (if any), are less than $4 million, regardless of the quantity of the particular chemical substance manufactured, imported, or processed by that business.</P>
          <P>(iii) For imported and processed mixtures containing HEX-BCH, the 45,400 kilograms (100,000 pounds) standard in paragraph (a)(4)(i) of this section applies only to the amount of HEX-BCH in a mixture and not the other components of the mixture.</P>
          <P>(5) <E T="03">8-hour time weighted average</E> means the cumulative exposure for an 8-hour work shift computed as follows:</P>
          <GPOTABLE CDEF="s4,3,xs100,r4" COLS="4" OPTS="L1(0,0,0),b2,p7,7/1,g1,t1">
            <BOXHD>
              <CHED H="1"/>
              <CHED H="1">E=</CHED>
              <CHED H="1">C<E T="52">a</E> T<E T="52">a</E>+C<E T="52">b</E> T<E T="52">b</E>+ . . . C<E T="52">n</E> T<E T="52">n</E>
              </CHED>
              <CHED H="2">8</CHED>
              <CHED H="1"/>
            </BOXHD>
            <ROW>
              <ENT I="22"/>
            </ROW>
          </GPOTABLE>
          <FP SOURCE="FP-2">Where:</FP>
          <FP SOURCE="FP1-2">E is the equivalent exposure for the working shift.</FP>
          <FP SOURCE="FP1-2">C<E T="52">i</E> is the concentration (i.e., parts per million) during any period of time (T<E T="52">i</E>) where the concentration remains constant.</FP>
          <FP SOURCE="FP1-2">T<E T="52">i</E> is the duration in hours of the exposure at the concentration C<E T="52">i</E>.</FP>
          
          <P>(6) <E T="03">Year</E> means corporate fiscal year.</P>
          <P>(b) <E T="03">Persons who must report.</E> (1) Reports must be submitted by:</P>
          <P>(i) Persons who are manufacturing, importing, or processing HEX-BCH for use as an intermediate in the production or isodrin or endrin on or after January 2, 1986; and</P>
          <P>(ii) Persons who propose to manufacture, import, or process HEX-BCH for use as an intermediate in the production of isodrin or endrin, on or after January 2, 1986.</P>
          <P>(2) Persons described in paragraph (b)(1) of this section who engage or propose to engage in more than one activity (i.e., manufacture and processing) must report the information required in paragraph (d) separately for each activity.</P>
          <P>(c) <E T="03">Persons exempt from reporting.</E> (1) Small businesses.</P>
          <P>(2) Persons described in § 704.5(a) and (c).</P>
          <P>(d) <E T="03">Information to report.</E> (1) Initial reports must include, to the extent that it is known to or reasonably ascertainable by the person reporting, the following information:</P>
          <P>(i) Company name and address.</P>
          <P>(ii) Name, address, and telephone number of the principal contact.</P>
          <P>(iii) Name and address of plant sites where HEX-BCH is or is proposed to be manufactured, imported, or processed, noting for each plant site which activity takes or would take place at each site.</P>
          <P>(iv) If applicable, the intended date for initiating the manufacture, import, or processing of HEX-BCH.</P>
          <P>(v) If applicable, the actual quantity (by weight) of HEX-BCH manufactured, imported, or processed during the most recently concluded year.</P>
          <P>(vi) The estimated quantity (by weight) of HEX-BCH to be manufactured, imported, or processed each year during the first 3 years following the date of the report or the date of the intended start of manufacture, import, or processing, whichever occurs later.</P>
          <P>(vii) For each year described in paragraphs (d)(1) (v) and (vi) of this section: the number or expected number of employees exposed to HEX-BCH during the manufacture, import, processing, distribution in commerce, use, and disposal; the routes of exposure; and the 8-hour time weighted average of exposure.</P>
          <P>(viii) If employees are exposed or expected to be exposed to HEX-BCH, state for each reported route of exposure, whether personal protective equipment is used or expected to be used, and a description of the personal protective equipment.</P>
          <P>(ix) The actual or anticipated quantity, content, method of disposal, and disposal site of any wastes generated or expected to be generated during the manufacture, importation, or processing of HEX-BCH.</P>
          <P>(2) Subsequent reports must provide, to the extent known to or reasonably ascertainable by the person reporting, the information in paragraph (d)(1) of this section and a statement explaining why the subsequent report is required.</P>
          <P>(e) <E T="03">When to report.</E> (1) Persons who are manufacturing, importing, or processing HEX-BCH on January 2, 1986, must submit an initial report to EPA by February 3, 1986.<PRTPAGE P="24"/>
          </P>
          <P>(2) Persons who propose to manufacture, import, or process HEX-BCH on or after January 2, 1986, must submit an initial report to EPA by February 3, 1986, or 30 days after making the management decision described in § 704.3 “Propose to manufacture, import, or process,” whichever is later in time.</P>
          <P>(3) Persons described in paragraph (b) of this section, who have submitted a report described in paragraph (d) of this section, must submit a subsequent report within 30 days of any of the following events. Based on the most recently submitted report:</P>
          <P>(i) The manufacture, importation, or processing of HEX-BCH begins at a plant site different than that reported pursuant to paragraph (d)(1)(iii) of this section.</P>
          <P>(ii) The actual quantity (by weight) of HEX-BCH manufactured, imported, or processed in a given year is greater than or equal to 200 percent of the estimated value for that year reported pursuant to paragraph (d)(1)(vi) of this section.</P>
          <P>(iii) The total number of employees exposed to HEX-BCH is greater than 130 percent of the projected value reported pursuant to paragraph (d)(1)(vii) of this section.</P>
          <P>(iv) The route of exposures to HEX-BCH differs from that reported pursuant to paragraph (d)(1)(vii) of this section.</P>
          <P>(v) The actual 8-hour time weighted average exposure for any activity exceeds the projection reported pursuant to paragraph (d)(1)(vii) of this section by more than 100 percent.</P>
          <P>(vi) The method of disposal or disposal site reported pursuant to paragraph (d)(1)(ix) of this section has changed.</P>
          <P>(vii) Three years have passed since the most recent submission of a report and the person is still engaged in the manufacture, importation, or processing of HEX-BCH.</P>
          <P>(f) <E T="03">Certification of review.</E> Each person who submits a report under this section must for 3 years following the submission date of the most recent submission, review their activities at the end of each year to determine whether any reportable event specified in paragraph (e)(3) of this section has occurred. If a review shows that none of these events has occurred, the person is required to certify this fact in writing.</P>
          <P>(g) <E T="03">Recordkeeping.</E> Any person subject to the reporting requirements of this section must:</P>
          <P>(1) Retain documentation of information contained in their reports. This documentation must be maintained for a period of 3 years from the date of the submission of the report; and</P>
          <P>(2) Retain the certification required by paragraph (f) of this section for 3 years from the date of its creation.</P>
          <CITA>[50 FR 47536, Nov. 19, 1985, as amended at 52 FR 20083, May 29, 1987. Redesignated at 53 FR 51717, Dec. 22, 1988; 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 704.104</SECTNO>
          <SUBJECT>Hexafluoropropylene oxide.</SUBJECT>
          <P>(a) <E T="03">Definitions.</E> (1) “HFPO” means the chemical substance hexafluoropropylene oxide, CAS Number 428-59-1. [Listed in TSCA Inventory as oxirane, trifluoro(trifluoromethyl)-]</P>
          <P>(2) “Enclosed process” means a process that is designed and operated so that there is no intentional release of any substance present in the process. A process with fugitive, inadvertent, or emergency pressure relief releases remains an enclosed process so long as measures are taken to prevent worker exposure to and environmental contamination from the releases.</P>
          <P>(3) “Small processor” means a processor that meets either the standard in paragraph (a)(3)(i) of this section or the standard in paragraph (a)(3)(ii) of this section.</P>
          <P>(i) <E T="03">First standard.</E> A processor of a chemical substance is small if its total annual sales, when combined with those of its parent company, if any, are less than $40 million. However, if the annual processing volume of a particular chemical substance at any individual site owned or controlled by the processor is greater than 45,400 kilograms (100,000 pounds), the processor shall not qualify as small for purposes of reporting on the processing of that chemical substance at that site, unless the processor qualifies as small under paragraph (a)(3)(ii) of this section.</P>
          <P>(ii) <E T="03">Second standard.</E> A processor of a chemical substance is small if its total annual sales, when combined with those of its parent company (if any), are less than $4 million, regardless of <PRTPAGE P="25"/>the quantity of the particular chemical substance processed by that company.</P>
          <P>(iii) <E T="03">Inflation index.</E> EPA will use the Inflation Index described in the definition of “small manufacturer” that is set forth in § 704.3 for purposes of adjusting the total annual sales values of this small processor definition. EPA will provide <E T="04">Federal Register</E> notification when changing the total annual sales values of this definition.</P>
          <P>(b) <E T="03">Persons who must report.</E> Except as provided in paragraph (c) of this section, the following persons are subject to this section:</P>
          <P>(1) Persons who manufacture or propose to manufacture HFPO for use as an intermediate in the manufacture of fluorinated substances in an enclosed process.</P>
          <P>(2) Persons who import or propose to import HFPO for use as an intermediate in the manufacture of fluorinated substances in an enclosed process.</P>
          <P>(3) Persons who process or propose to process HFPO as an intermediate in the manufacture of fluorinated substances in an enclosed process.</P>
          <P>(c) <E T="03">Persons not subject to this rule.</E> The following persons are not subject to this rule:</P>
          <P>(1) Small processors.</P>
          <P>(2) Persons described in § 704.5 (a) through (d).</P>
          <P>(3) Persons who have already submitted to EPA a completed copy of the Preliminary Assessment Information Manufacturer's Report (EPA Form 7710-35, as described at § 712.28 of this chapter) for HFPO are not required to report under this section with respect to activities previously reported on.</P>
          <P>(d) <E T="03">What information to report</E>. Persons identified in paragraph (b) of this section must submit a Premanufacture Notice Form (EPA Form 7710-25).</P>
          <P>(e) <E T="03">When to report.</E> (1) Persons who are manufacturing, importing, or processing, or who propose to manufacture, import, or process HFPO for use as an intermediate in the manufacture of fluorinated substances in an enclosed process as of December 10, 1987, must report by February 8, 1988.</P>
          <P>(2) Persons who propose to manufacture, import, or process HFPO for use as an intermediate in the manufacture of fluorinated substances in an enclosed process after December 10, 1987, must report within 30 days after making a firm management decision to commit financial resources for the manufacturing, importing, or processing of HFPO.</P>
          <P>(f) <E T="03">Recordkeeping.</E> Persons subject to the reporting requirements of this section must retain documentation of information contained in their reports for a period of 5 years from the date of submission of the reports.</P>
          <P>(g) <E T="03">Where to send reports.</E> Reports must be submitted by certified mail to the Document Control Office (7407), Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Room G-099, 401 M St., SW., Washington, DC., 20460, ATTN: HFPO Reporting.</P>
          <CITA>[52 FR 41299, Oct. 27, 1987, as amended at 58 FR 34204, June 23, 1993; 60 FR 16308, Mar. 29, 1995; 60 FR 31920, June 19, 1995; 60 FR 34463, July 3, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 704.175</SECTNO>
          <SUBJECT>4,4<E T="61">′</E>-methylenebis(2-chlo-ro-an-i-line) (MBOCA).</SUBJECT>
          <P>(a) <E T="03">Substance subject to reporting.</E> The chemical substance 4,4<E T="61">′</E>-methylenebis(2-chloroaniline) (CAS No. 101-14-4) is subject to reporting under this section. The substance also is identified as 4,4<E T="61">′</E>-methylenebis(2-chlorobenzenamine) and MBOCA.</P>
          <P>(b) <E T="03">Persons who must report.</E> Except as provided in paragraph (c) of this section, the following persons are subject to this rule.</P>
          <P>(1) Persons who propose to manufacture MBOCA in the United States on or after June 2, 1986.</P>
          <P>(2) Persons who are manufacturing MBOCA in the United States as of June 2, 1986.</P>
          <P>(3) Persons manufacturing MBOCA in the United States on or after June 2, 1986 who propose to change their manner or method of manufacturing the substance from a manner or method of manufacturing that previously was reported under this section.</P>
          <P>(c) <E T="03">Persons not subject to this rule.</E> The following persons are exempt from the reporting requirements of this section:</P>

          <P>(1) Persons who import MBOCA into the customs territory of the United States and do not otherwise manufacture the substance in the United States.<PRTPAGE P="26"/>
          </P>
          <P>(2) Persons who complied with the requirements of this section prior to June 2, 1986 and received written notification of compliance from EPA.</P>
          <P>(d) <E T="03">What information to report.</E> Persons who are subject to this rule as described in paragraph (b) of this section must report information to EPA by completing the following parts of the notice form contained in appendix A to part 720 of this chapter: Parts I.A., I.B., I.C.1., I.C.3., and II.A.; also, part III as appropriate. Persons subject to the requirements of this section also must submit a narrative description of any processing and packaging of MBOCA that occurs at the manufacturing plant site, including the number of workers potentially exposed to MBOCA during on-site processing and packaging of MBOCA and a description of any personal protective equipment and/or engineering controls that would be used to prevent release of and exposure to MBOCA during on-site processing and packaging. Persons subject to the requirements of this section are not required to submit information on processing or use of MBOCA away from the manufacturing plant site. Respondents to this rule shall report all information that is known to or reasonably ascertainable by the person reporting.</P>
          <P>(e) <E T="03">When to report.</E> (1) Persons specified in paragraph (b)(1) of this section must report by July 2, 1986 or within 30 days after making a firm management decision to commit financial resources for the manufacture of MBOCA, whichever is later in time.</P>
          <P>(2) Persons specified in paragraph (b)(2) of this section must report by July 2, 1986.</P>
          <P>(3) Persons specified in paragraph (b)(3) of this section must report within 30 days of making a firm management decision to commit financial resources to change their manner or method of manufacturing the substance from a manner or method of manufacturing that previously was reported under this section.</P>
          <CITA>[51 FR 13223, Apr. 18, 1986, as amended at 52 FR 20083, May 29, 1987; 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
      </SUBPART>
    </PART>
    <PART>
      <EAR>Pt. 707</EAR>
      <HD SOURCE="HED">PART 707—CHEMICAL IMPORTS AND EXPORTS</HD>
      <CONTENTS>
        <SUBPART>
          <RESERVED>Subpart A[Reserved]</RESERVED>
        </SUBPART>
        <SUBPART>
          <HD SOURCE="HED">Subpart B—General Import Requirements and Restrictions</HD>
          <SECHD>Sec.</SECHD>
          <SECTNO>707.20</SECTNO>
          <SUBJECT>Chemical substances import policy.</SUBJECT>
        </SUBPART>
        <SUBPART>
          <RESERVED>Subpart C[Reserved]</RESERVED>
        </SUBPART>
        <SUBPART>
          <HD SOURCE="HED">Subpart D—Notices of Export Under Section 12(b)</HD>
          <SECTNO>707.60</SECTNO>
          <SUBJECT>Applicability and compliance.</SUBJECT>
          <SECTNO>707.63</SECTNO>
          <SUBJECT>Definitions.</SUBJECT>
          <SECTNO>707.65</SECTNO>
          <SUBJECT>Submission to agency.</SUBJECT>
          <SECTNO>707.67</SECTNO>
          <SUBJECT>Contents of notice.</SUBJECT>
          <SECTNO>707.70</SECTNO>
          <SUBJECT>EPA notice to foreign governments.</SUBJECT>
          <SECTNO>707.72</SECTNO>
          <SUBJECT>Termination of reporting requirements.</SUBJECT>
          <SECTNO>707.75</SECTNO>
          <SUBJECT>Confidentiality.</SUBJECT>
        </SUBPART>
      </CONTENTS>
      <AUTH>
        <HD SOURCE="HED">Authority:</HD>
        <P>15 U.S.C. 2611(b) and 2612.</P>
      </AUTH>
      <SOURCE>
        <HD SOURCE="HED">Source:</HD>
        <P>45 FR 82850, Dec. 16, 1980, unless otherwise noted.</P>
      </SOURCE>
      <SUBPART>
        <RESERVED>Subpart A[Reserved]</RESERVED>
      </SUBPART>
      <SUBPART>
        <HD SOURCE="HED">Subpart B—General Import Requirements and Restrictions</HD>
        <SECTION>
          <SECTNO>§ 707.20</SECTNO>
          <SUBJECT>Chemical substances import policy.</SUBJECT>
          <P>(a) <E T="03">Scope.</E> (1) This statement addresses the policy of the Environmental Protection Agency (EPA) on importation of chemical substances, mixtures, and articles under section 13 of the Toxic Substances Control Act (TSCA; 15 U.S.C. 2601 et seq.). In particular, it addresses aspects of the regulation promulgated by the United States Customs Service (Customs), Department of the Treasury (19 CFR 12.118 through 12.127, and 127.28 [amended]) to implement section 13 of TSCA, 15 U.S.C. 2612. Section 13 requires the Secretary of the Treasury to refuse entry into the Customs territory of the United States of a chemical substance, mixture, or article if it does not comply with rules in effect under TSCA, or if it is offered for entry in violation of TSCA or rules or orders under TSCA.</P>

          <P>(2) In addition to this statement of policy, EPA will continue, as necessary, to address problems associated <PRTPAGE P="27"/>with imports in rulemaking and other actions under individual sections of TSCA, i.e., sections 4, 5, 6, 7, 8, and 12. Sections 5, 6, and 7 apply directly to imports subject to the section 13 requirements. Section 12 may apply to export of a shipment that is refused entry under section 13. Importers may have obligations under sections 4 and 8; section 4 and 8 requirements for importers would not apply to individual chemical shipments and thus are not included under section 13 requirements. Interested persons should refer to the records of these individual rulemaking actions for specific information and guidance.</P>
          <P>(b) <E T="03">Objectives.</E> (1) TSCA is intended to be comprehensive, and assure protection of health and the environment from unreasonable risks associated with chemicals whether the chemicals are imported or produced domestically. This intent is manifested by the inclusion of importation in the Act's definition of the term “manufacture”: “[M]anufacture means to import * * *, produce, or manufacture” (15 U.S.C. 2602(7)). Thus, importers are responsible for insuring that chemical importation complies with TSCA just as domestic manufacturers are responsible for insuring that chemical manufacture complies with TSCA.</P>
          <P>(2)(i) The section 13 rule requires importers to sign the following statement for each import of chemical substances subject to TSCA: “I certify that all chemical substances in this shipment comply with all applicable rules or orders under TSCA and that I am not offering a chemical substance for entry in violation of TSCA or any applicable rule or order under TSCA.” The certification will document that, in accordance with TSCA, the importer has taken the necessary steps to insure compliance.</P>
          <P>(ii) The section 13 rule requires importers of chemicals not subject to TSCA (e.g., pesticides) to certify that compliance with TSCA is not required. Importers must certify this by signing the statement: “I certify that all chemicals in this shipment are not subject to TSCA.” This is appropriate when a chemical import is not clearly identified as a pesticide or other chemical not subject to TSCA.</P>
          <P>(3) The United States is involved in a major effort toward international harmonization in the control of chemicals. At such time as international agreement is reached on this issue, EPA would be prepared to modify its policy if necessary. EPA believes that its international harmonization efforts in the control of chemicals will protect health and the environment while fulfilling its obligations under the Trade Agreements Act of 1979.</P>
          <P>(c) <E T="03">The section 13 rule</E>—(1) <E T="03">General certification.</E> (i) The rule promulgated under section 13 of TSCA by Customs, in consultation with EPA, implements the requirement of section 13 that chemical substances, mixtures, or articles not in compliance with TSCA, or whose importation is not in compliance with TSCA, shall be denied entry into the customs territory of the United States. The rule requires that importers certify by a statement, on the entry document or invoice, that any shipment of a chemical substance subject to TSCA, imported in bulk or as part of a mixture, complies with TSCA, and that it is not offered for entry in violation of TSCA or any rule or order under TSCA, or that the chemicals imported are not subject to TSCA.</P>
          <P>(ii) The certification applies to TSCA sections 5, 6, and 7.</P>

          <P>(iii) EPA expects that this certification will be based upon actual knowledge of the importer in most cases. However, EPA realizes that sometimes importers may not have actual knowledge of the chemical composition of imported mixtures. In these cases, the importer should attempt to discover the chemical constituents of the shipment by contacting another party to the transaction (e.g., his principal or the foreign manufacturer). This person may be able to identify the components of the mixture, or at least state that the substances comply with TSCA. The greater the effort an importer makes to learn the identities of the imported substances and their compliance with TSCA, the smaller his chance of committing a violation by importing a noncomplying shipment. If a shipment is ultimately determined to have violated TSCA, the good faith efforts of the importer to verify compliance, as evidenced by documents contained in <PRTPAGE P="28"/>his files, may obviate or mitigate the assessment of a civil penalty under section 16 of TSCA.</P>
          <P>(2) <E T="03">EPA enforcement.</E> (i) EPA and Customs will monitor chemical imports to determine if shipments and their import comply with the certification requirements and the substantive mandates of TSCA. Customs will refuse entry to any shipment until such time as the certification is properly submitted. Customs will also detain a shipment if there are reasonable grounds to believe that such shipment or its import violates TSCA or regulations or orders thereunder. A violative shipment must either be brought into compliance, exported, destroyed, or voluntarily abandoned within the time periods prescribed in 19 CFR 12.124 of the section 13 rule.</P>
          <P>(ii) When EPA determines that a shipment should be detained, EPA will identify the reasons for the detention and the necessary actions for an importer to bring the shipment into compliance with TSCA. If EPA has given this information to Customs before the district director issues the detention notice, the information will become part of the detention notice. The importer should contact one of the following EPA regional offices for guidance as to the proper procedures to correct any deficiencies in the shipment.</P>
          <EXTRACT>
            <HD SOURCE="HD1">Region I</HD>
            <FP SOURCE="FP-1">John F. Kennedy Federal Building, Boston, MA 02203 (617-223-0586)</FP>
            <HD SOURCE="HD1">Region II</HD>
            <FP SOURCE="FP-1">26 Federal Plaza, New York, NY 10278 (201-321-6669)</FP>
            <HD SOURCE="HD1">Region III</HD>
            <FP SOURCE="FP-1">Curtis Building, 6th and Walnut Streets, Philadelphia, PA 19106 (215-597-7668)</FP>
            <HD SOURCE="HD1">Region IV</HD>
            <FP SOURCE="FP-1">345 Courtland Street, NE., Atlanta, GA 30365 (404-881-3864)</FP>
            <HD SOURCE="HD1">Region V</HD>
            <FP SOURCE="FP-1">77 West Jackson Boulevard, Chicago, IL 60604 (312-353-2291)</FP>
            <HD SOURCE="HD1">Region VI</HD>
            <FP SOURCE="FP-1">1201 Elm Street, Dallas, TX 75270 (214-767-2734)</FP>
            <HD SOURCE="HD1">Region VII</HD>
            <FP SOURCE="FP-1">324 East 11th Street, Kansas City, MO 64106 (816-374-3036)</FP>
            <HD SOURCE="HD1">Region VIII</HD>
            <FP SOURCE="FP-1">1860 Lincoln Street, Denver, CO 80295 (303-837-3926)</FP>
            <HD SOURCE="HD1">Region IX</HD>
            <FP SOURCE="FP-1">215 Fremont Street, San Francisco, CA 94105 (415-974-8119)</FP>
            <HD SOURCE="HD1">Region X</HD>
            <FP SOURCE="FP-1">1200 Sixth Avenue, Seattle, WA 98101 (206-442-2871)</FP>
          </EXTRACT>
          
          <P>(iii) If Customs detains or refuses entry of a shipment (other than for failure to make the general certification) and the importer takes measures necessary to bring the shipment into conformity with the requirements of TSCA, EPA officials will reassess the shipment to determine its current compliance status. When a shipment is no longer in violation, EPA will notify the district director and the importer. The district director will then release the shipment. This notice will also serve as a determination to permit entry under 19 CFR 12.123(c) if a shipment is brought into compliance before the 19 CFR 12.123(c) decisionmaking process has been completed. If compliance is achieved after a 19 CFR 12.123(c) determination (adverse to the importer) has been made, the EPA notice to the district director will serve as a reversal of the decision to refuse entry.</P>
          <P>(3) <E T="03">EPA assistance.</E> Assistance in determining whether a chemical shipment is in compliance with TSCA can be obtained from the Director, Environmental Assistance Division (7408), Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Room E-543B, 401 M St., SW., Washington, DC, 20460, Telephone: (202) 554-1404, TDD: (202) 544-0551.</P>
          <CITA>[48 FR 55464, Dec. 13, 1983, as amended at 60 FR 34463, July 3, 1995; 62 FR 1834, Jan. 14, 1997]</CITA>
        </SECTION>
      </SUBPART>
      <SUBPART>
        <RESERVED>Subpart C[Reserved]</RESERVED>
      </SUBPART>
      <SUBPART>
        <PRTPAGE P="29"/>
        <HD SOURCE="HED">Subpart D—Notices of Export Under Section 12(b)</HD>
        <SECTION>
          <SECTNO>§ 707.60</SECTNO>
          <SUBJECT>Applicability and compliance.</SUBJECT>
          <P>(a) Section 12(b) of the Toxic Substances Control Act requires any person who exports or intends to export a chemical substance or mixture to notify the Environmental Protection Agency of such exportation to a particular country if any of the following actions have been taken under the Act with respect to that chemical substance or mixture:</P>
          <P>(1) Data are required under section 4 or 5(b),</P>
          <P>(2) An order has been issued under section 5,</P>
          <P>(3) A rule has been proposed or promulgated under section 5 or 6, or</P>
          <P>(4) An action is pending, or relief has been granted under section 5 or 7.</P>
          <P>(b) No notice of export will be required for articles, except PCB articles, unless the Agency so requires in the context of individual section 5, 6, or 7 actions.</P>
          <P>(c) Any person who exports or intends to export polychlorinated biphenyls (PCBs) or PCB articles, for any purpose other than disposal, shall notify EPA of such intent or exportation under section 12(b). PCBs and PCB articles have the definitions published in § 761.3 of this title respectively.</P>
          <P>(d) Any person who would be prohibited by a section 5 or 6 regulation from exporting a chemical substance or mixture, but who is granted an exemption by EPA to export that chemical substance or mixture, shall notify EPA under section 12(b) of such intent to export or exportation.</P>

          <P>(e) Failure to comply with section 12(b) as set forth in these rules will be considered a violation of section 15(3) of the Toxic Substances Control Act, and will subject the exporter to the penalty, enforcement, and seizure provisions of sections 16 and 17 of the Toxic Substances Control Act.
          </P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 707.63</SECTNO>
          <SUBJECT>Definitions.</SUBJECT>
          <P>The definitions set forth in the Toxic Substances Control Act, section 3, apply for this part. In addition, the following abbreviations and definitions are provided for purposes of this rule:</P>
          <P>(a) <E T="03">EPA</E> means the Environmental Protection Agency.</P>
          <P>(b) <E T="03">Exporter</E> means the person who, as the principal party in interest in the export transaction, has the power and responsibility for determining and controlling the sending of the chemical substance or mixture to a destination out of the customs territory of the United States.</P>
          <P>(c) <E T="03">Regulated chemical</E> means any chemical substance or mixture for which export notice is required under § 707.60.</P>
          <P>(d) <E T="03">TSCA</E> means the Toxic Substances Control Act.
          </P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 707.65</SECTNO>
          <SUBJECT>Submission to agency.</SUBJECT>
          <P>(a) Exporters must notify EPA of their export or intended export of each regulated chemical in accordance with the following:</P>
          <P>(1) The notice must be in writing;</P>
          <P>(2)(i) The notice must be for the first export or intended export to a particular country in a calendar year when data are required under section 5(b), an order has been issued under section 5, a rule has been proposed or promulgated under section 5 or 6, or an action is pending or relief has been granted under section 5 or 7.</P>
          <P>(ii) The notice must be for the first export or intended export to a particular country when data are required under section 4.</P>
          <P>(3) The notice must be postmarked within seven days of forming the intent to export or on the date of export, whichever is earlier. A notice of intent to export must be based on a definite contractual obligation, or an equivalent intra-company agreement, to export the regulated chemical.</P>

          <P>(b) If the EPA action that prompts the notice is a proposed rule, the requirement to submit export notices to EPA shall begin thirty days after publication of the action in the <E T="04">Federal Register.</E>
          </P>

          <P>(c) Notices shall be marked “Section 12(b) Notice” and sent to the Document Control Office (7407), Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Room <PRTPAGE P="30"/>G-099, 401 M St., SW., Washington, DC., 20460.</P>
          <CITA>[45 FR 82850, Dec. 16, 1980, as amended at 53 FR 12522, Apr. 15, 1988; 58 FR 40242, July 27, 1993; 60 FR 34463, July 3, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 707.67</SECTNO>
          <SUBJECT>Contents of notice.</SUBJECT>
          <P>The notice to EPA shall include:</P>
          <P>(a) The name of the regulated chemical as it appears in the section 4, 5, 6, or 7 action. If a category is regulated, the name of the individual regulated chemical within that category, as well as the category, must be given. The name shall be that which appears in Volume I of the EPA Chemical Substance Inventory, or its supplements, if the chemical appears there.</P>
          <P>(b) The name and address of the exporter.</P>
          <P>(c) The country (countries) of import.</P>
          <P>(d) The date(s) of export or intended export.</P>
          <P>(e) The section (4, 5, 6, or 7) of TSCA under which EPA has taken action.</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 707.70</SECTNO>
          <SUBJECT>EPA notice to foreign governments.</SUBJECT>
          <P>(a)(1) Notice by EPA to the importing country shall be sent no later than 5 working days after receipt by the TSCA Document Processing Center of the first annual notification for each regulated chemical when data are required under section 5(b), an order has been issued under section 5, a rule has been proposed or promulgated under section 5 or 6, or an action is pending or relief has been granted under section 5 or 7.</P>
          <P>(2) Notice by EPA to the importing country shall be sent no later than 5 working days after receipt by the TSCA Document Processing Center of the first notification for each regulated chemical when data are required under section 4.</P>
          <P>(b) Notices shall:</P>
          <P>(1) Identify the regulated chemical.</P>
          <P>(2) Summarize the regulatory action taken, or indicate the availability of data under section 4 or 5(b) of TSCA.</P>
          <P>(3) Identify an EPA official to contact for further information.</P>
          <P>(4) Include a copy of the pertinent <E T="04">Federal Register</E> notice.</P>
          <P>(c) Notices shall be sent to the country's ambassador in Washington, DC, or other official designated by the foreign government, and to the United States Department of State.</P>
          <CITA>[45 FR 82850, Dec. 16, 1980, as amended at 58 FR 40242, July 27, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 707.72</SECTNO>
          <SUBJECT>Termination of reporting requirements.</SUBJECT>
          <P>(a) The reporting requirements of subpart D of this part are terminated for certain specific chemical substances and mixtures as set forth in this paragraph.</P>
          <P>(1) When data required under part 766 of this chapter have been submitted to EPA for a specific chemical substance produced by a specific process, and the data show no positive test result as defined in § 766.3 of this chapter, reporting is no longer required by persons who export or intend to export that substance produced by that process.</P>
          <P>(2) [Reserved]</P>
          <P>(b) [Reserved]</P>
          <CITA>[52 FR 21437, June 5, 1987]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 707.75</SECTNO>
          <SUBJECT>Confidentiality.</SUBJECT>
          <P>(a) A person may assert a claim of confidentiality for any information which is submitted to EPA in a notice.</P>
          <P>(b) Any claim of confidentiality must accompany the information at the time it is submitted to EPA. In the notice, the submitter must clearly identify the information that is claimed confidential by marking the specific information on each page with a label such as “confidential business information”, “proprietary”, or “trade secret”.</P>
          <P>(c) Notwithstanding any claim of confidentiality, information outlined in § 707.70 will be included in the EPA notice to the foreign government. With this exception, EPA will disclose information that is covered by a claim of confidentiality asserted in accordance with this section only to the extent permitted by, and in accordance with, the procedures set forth in TSCA and part 2 of this chapter.</P>
          <P>(d) If a person does not assert a claim of confidentiality for information at the time a notice is submitted to EPA, the Agency may make the information public, including placement in a public file, without further notice to the person.</P>
        </SECTION>
      </SUBPART>
    </PART>
    <PART>
      <PRTPAGE P="31"/>
      <EAR>Pt. 710</EAR>
      <HD SOURCE="HED">PART 710—INVENTORY REPORTING REGULATIONS</HD>
      <CONTENTS>
        <SECHD>Sec.</SECHD>
        <SECTNO>710.1</SECTNO>
        <SUBJECT>Scope and compliance.</SUBJECT>
        <SECTNO>710.2</SECTNO>
        <SUBJECT>Definitions.</SUBJECT>
        <SECTNO>710.3</SECTNO>
        <SUBJECT>[Reserved]</SUBJECT>
        <SECTNO>710.4</SECTNO>
        <SUBJECT>Scope of the inventory.</SUBJECT>
        <SECTNO>710.25</SECTNO>
        <SUBJECT>Chemical substances for which information must be reported.</SUBJECT>
        <SECTNO>710.26</SECTNO>
        <SUBJECT>Chemical substances for which information is not required.</SUBJECT>
        <SECTNO>710.28</SECTNO>
        <SUBJECT>Persons who must report.</SUBJECT>
        <SECTNO>710.29</SECTNO>
        <SUBJECT>Persons not subject to this subpart.</SUBJECT>
        <SECTNO>710.30</SECTNO>
        <SUBJECT>Activities for which reporting is not required.</SUBJECT>
        <SECTNO>710.32</SECTNO>
        <SUBJECT>Reporting information to EPA.</SUBJECT>
        <SECTNO>710.33</SECTNO>
        <SUBJECT>When to report.</SUBJECT>
        <SECTNO>710.35</SECTNO>
        <SUBJECT>Duplicative reporting.</SUBJECT>
        <SECTNO>710.37</SECTNO>
        <SUBJECT>Recordkeeping requirements.</SUBJECT>
        <SECTNO>710.38</SECTNO>
        <SUBJECT>Confidentiality.</SUBJECT>
        <SECTNO>710.39</SECTNO>
        <SUBJECT>How do I submit the required information for the 1998 reporting cycle?</SUBJECT>
      </CONTENTS>
      <AUTH>
        <HD SOURCE="HED">Authority:</HD>
        <P>15 U.S.C. 2607(a).</P>
      </AUTH>
      <SECTION>
        <SECTNO>§ 710.1</SECTNO>
        <SUBJECT>Scope and compliance.</SUBJECT>
        <P>(a) This part establishes regulations governing reporting by certain persons who manufacture, import, or process chemical substances for commercial purposes under section 8(a) of the Toxic Substances Control Act (15 U.S.C. 2607(a)). Section 8(a) authorizes the Administrator to require reporting of information necessary for administration of the Act and requires EPA to issue regulations for the purpose of compiling an inventory of chemical substances manufactured or processed for a commercial purpose, as required by section 8(b) of the Act. Following an initial reporting period, EPA published an initial inventory of chemical substances manufactured, processed or imported for commercial purposes. In accordance with section 8(b), EPA periodically amends the inventory to include new chemical substances which are manufactured or imported for a commercial purpose and reported under section 5(a)(1) of the Act. EPA also revises the categories of chemical substances and makes other amendments as appropriate.</P>
        <P>(b) Section 15(3) of TSCA makes it unlawful for any person to fail or refuse to submit information required under these reporting regulations. In addition, section 15(3) makes it unlawful for any person to fail to keep, and permit access to, records required by these regulations. Section 16 provides that any person who violates a provision of section 15 is liable to the United States for a civil penalty and may be criminally prosecuted. Pursuant to section 17, the Government may seek judicial relief to compel submission of section 8(a) information and to otherwise restrain any violation of section 15.</P>
        <NOTE>
          <HD SOURCE="HED">Note:</HD>
          <P>As a matter of traditional Agency policy, EPA does not intend to concentrate its enforcement efforts on insignificant clerical errors in reporting.</P>
        </NOTE>
        <P>(c) Each person who reports under these regulations shall maintain records that document information reported under these regulations and, in accordance with the Act, permit access to, and the copying of, such records by EPA officials.</P>
        <CITA>[42 FR 64572, Dec. 23, 1977, as amended at 45 FR 18375, Mar. 21, 1980; 60 FR 31921, June 19, 1995]</CITA>
      </SECTION>
      <SECTION>
        <SECTNO>§ 710.2</SECTNO>
        <SUBJECT>Definitions.</SUBJECT>
        <P>In addition to the definitions in § 704.3 in this chapter, the following definitions also apply to this part:</P>

        <P>(a) The following terms shall have the meaning contained in the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 321 et seq., and the regulations issued under such Act: <E T="03">Cosmetic, device, drug, food,</E> and <E T="03">food additive.</E> In addition, the term <E T="03">food</E> includes poultry and poultry products, as defined in the Poultry Products Inspection Act, 21 U.S.C. 453 et seq.; meats and meat food products, as defined in the Federal Meat Inspection Act, 21 U.S.C. 60 et seq.; and eggs and egg products, as defined in the Egg Products Inspection Act, 21 U.S.C. 1033 et seq.</P>
        <P>(b) The term <E T="03">pesticide</E> shall have the meaning contained in the Federal Insecticide, Fungicide, and Rodenticide Act, 7 U.S.C. 136 et seq., and the regulations issued thereunder.</P>

        <P>(c) The following terms shall have the meaning contained in the Atomic Energy Act of 1954, 42 U.S.C. 2014 et seq., and the regulations issued thereunder: <E T="03">byproduct material, source material,</E> and <E T="03">special nuclear material.</E>
        </P>
        <P>(d) <E T="03">Act</E> means the Toxic Substances Control Act, 15 U.S.C. 2601 et seq.<PRTPAGE P="32"/>
        </P>
        <P>(e) <E T="03">Administrator</E> means the Administrator of the U.S. Environmental Protection Agency, any employee or authorized representative of the Agency to whom the Administrator may either herein or by order delegate his authority to carry out his functions, or any other person who shall by operation of law be authorized to carry out such functions.</P>
        <P>(f) An <E T="03">article</E> is a manufactured item: (1) Which is formed to a specific shape or design during manufacture, (2) which has end use function(s) dependent in whole or in part upon its shape or design during end use, and (3) which has either no change of chemical composition during its end use or only those changes of composition which have no commercial purpose separate from that of the article and that may occur as described in § 710.4(d)(5); except that fluids and particles are not considered articles regardless of shape or design.</P>
        <P>(g) <E T="03">Byproduct</E> means a chemical substance produced without separate commercial intent during the manufacture or processing of another chemical substance(s) or mixture(s).</P>
        <P>(h) <E T="03">Chemical substance</E> means any organic or inorganic substance of a particular molecular identity, including any combination of such substances occurring in whole or in part as a result of a chemical reaction or occurring in nature, and any chemical element or uncombined radical; except that “chemical substance” does <E T="03">not</E> include:</P>
        <P>(1) Any mixture,</P>
        <P>(2) Any pesticide when manufactured, processed, or distributed in commerce for use as a pesticide,</P>
        <P>(3) Tobacco or any tobacco product, but not including any derivative products,</P>
        <P>(4) Any source material, special nuclear material, or byproduct material,</P>
        <P>(5) Any pistol, firearm, revolver, shells, and cartridges, and</P>
        <P>(6) Any food, food additive, drug, cosmetic, or device, when manufactured, processed, or distributed in commerce for use as a food, food additive, drug, cosmetic, or device.</P>
        <P>(i) <E T="03">Commerce</E> means trade, traffic, transportation, or other commerce: (1) Between a place in a State and any place outside of such State, or (2) which affects trade, traffic, transportation, or commerce described in paragraph (i)(1) of this section.</P>
        <P>(j) <E T="03">Distribute in commerce</E> and <E T="03">distribution in commerce</E> when used to describe an action taken with respect to a chemical substance or mixture or article containing a substance or mixture, mean to sell or the sale of, the substance, mixture, or article in commerce; to introduce or deliver for introduction into commerce, or the introduction or delivery for introduction into commerce of, the substance, mixture, or article; or to hold, or the holding of, the substance, mixture, or article after its introduction into commerce.</P>
        <P>(k) <E T="03">EPA</E> means the U.S. Environmental Protection Agency.</P>
        <P>(l) <E T="03">Importer</E> means any person who imports any chemical substance or any chemical substance as part of a mixture or article into the customs territory of the U.S. and includes:</P>
        <P>(1) The person primarily liable for the payment of any duties on the merchandise, or</P>
        <P>(2) An authorized agent acting on his behalf (as defined in 19 CFR 1.11).</P>
        <P>(m) <E T="03">Impurity</E> means a chemical substance which is unintentionally pres-ent with another chemical substance.</P>
        <P>(n) <E T="03">Intermediate</E> means any chemical substance:</P>
        <P>(1) Which is intentionally removed from the equipment in which it is manufactured, and (2) which either is consumed in whole or in part in chemical reaction(s) used for the intentional manufacture of other chemical substance(s) or mixture(s), or is intentionally present for the purpose of altering the rate of such chemical reaction(s).</P>
        <NOTE>
          <HD SOURCE="HED">Note:</HD>
          <P>The <E T="03">equipment in which it was manufactured</E> includes the reaction vessel in which the chemical substance was manufactured and other equipment which is strictly ancillary to the reaction vessel, and any other equipment through which the chemical substance may flow during a continuous flow process, but does not include tanks or other vessels in which the chemical substance is stored after its manufacture.</P>
        </NOTE>
        <P>(o) <E T="03">Manufacture</E> means to produce or manufacture in the United States or import into the customs territory of the United States.<PRTPAGE P="33"/>
        </P>
        <P>(p) <E T="03">Manufacture or import “for commercial purposes”</E> means to manufacture or import:</P>
        <P>(1) For distribution in commerce, including for test marketing purposes, or</P>
        <P>(2) For use by the manufacturer, including for use as an intermediate.</P>
        <P>(q) <E T="03">Mixture</E> means any combination of two or more chemical substances if the combination does not occur in nature and is not, in whole or in part, the result of a chemical reaction; except that “mixture” does include:</P>
        <P>(1) Any combination which occurs, in whole or in part, as a result of a chemical reaction if the combination could have been manufactured for commercial purposes without a chemical reaction at the time the chemical substances comprising the combination were combined and if, after the effective date or premanufacture notification requirements, none of the chemical substances comprising the combination is a new chemical substance, and</P>
        <P>(2) Hydrates of a chemical substance or hydrated ions formed by association of a chemical substance with water.</P>
        <P>(r) <E T="03">New chemical substance</E> means any chemical substance which is not included in the inventory compiled and published under subsection 8(b) of the Act.</P>
        <P>(s) <E T="03">Person</E> means any natural or juridicial person including any individual, corporation, partnership, or association, any State or political subdivision thereof, or any municipality, any interstate body and any department, agency, or instrumentality of the Federal Government.</P>
        <P>(t) <E T="03">Process</E> means the preparation of a chemical substance or mixture, after its manufacture, for distribution in commerce (1) in the same form or physical state as, or in a different form or physical state from, that in which it was received by the person so preparing such substance or mixture, or (2) as part of a mixture or article containing the chemical substance or mixture.</P>
        <P>(u) <E T="03">Process for “commercial purposes”</E> means to process (1) for distribution in commerce, including for test marketing purposes, or (2) for use as an intermediate.</P>
        <P>(v) <E T="03">Processor</E> means any person who processes a chemical substance or mixture.</P>
        <P>(w) <E T="03">Site</E> means a contiguous property unit. Property divided only by a public right-of-way shall be considered one site. There may be more than one manufacturing plant on a single site. For the purposes of imported chemical substances, the site shall be the business address of the importer.</P>
        <P>(x) <E T="03">Small maufacturer or importer</E> means a manufacturer or importer whose total annual sales are less than $5,000,000, based upon the manufacturer's or importer's latest complete fiscal year as of January 1, 1978, except that no manufacturer or importer is a “small manufacturer or importer” with respect to any chemical substance which such person manufactured at one site or imported in quantities greater than 100,000 pounds during calendar year 1977. In the case of a company which is owned or controlled by another company, total annual sales shall be based on the total annual sales of the owned or controlled company, the parent company, and all companies owned or controlled by the parent company taken together.</P>
        <NOTE>
          <HD SOURCE="HED">Note:</HD>
          <P>The purpose of the exception to the definition is to ensure that manufacturing and importers report production volumes for all chemical substances which they manufactured at one site or imported in quantities equal to or greater than 100,000 pounds during calendar year 1977.</P>
        </NOTE>
        <P>(y) <E T="03">Small quantities for purposes of scientific experimentation or analysis or chemical research on, or analysis of, such substance or another substance, including any such research or analysis for the development of a product</E> (hereinafter sometimes shortened to <E T="03">small quantities for research and development</E>) means quantities of a chemical substance manufactured, imported, or processed or proposed to be manufactured, imported, or processed that (1) are no greater than reasonably necessary for such purposes and (2) after the publication of the revised inventory, are used by, or directly under the supervision of, a technically qualified individual(s).</P>
        <NOTE>
          <HD SOURCE="HED">Note:</HD>

          <P>Any chemical substances manufactured, imported or processed in quantities less than 1,000 pounds annually shall be presumed to be manufactured, imported or processed for research and development purposes. <PRTPAGE P="34"/>No person may report for the inventory any chemical substance in such quantities unless that person can certify, that the substance was not manufactured, imported, or processed solely in small quantities for research and development, as defined in this section.</P>
        </NOTE>
        <P>(z) <E T="03">State</E> means any State of the United States, the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam, the Canal Zone, American Samoa, the Northern Mariana Islands, or any other territory or possession of the United States.</P>
        <P>(aa) <E T="03">Technically qualified individual</E> means a person: (1) Who because of his education, training, or experience, or a combination of these factors, is capable of appreciating the health and environmental risks associated with the chemical substance which is used under his supervision, (2) who is responsible for enforcing appropriated methods of conducting scientific experimentation, analysis, or chemical research in order to minimize such risks, and (3) who is responsible for the safety assessments and clearances related to the procurement, storage, use, and disposal of the chemical substance as may be appropriate or required within the scope of conducting the research and development activity. The responsibilities in paragraph (aa)(3) of this section may be delegated to another individual, or other individuals, as long as each meets the criteria in paragraph (aa)(1) of this section.</P>
        <P>(bb) <E T="03">Test marketing</E> means the distribution in commerce of no more than a predetermined amount of a chemical substance, mixture, or article containing that chemical substance or mixture, by a manufacturer or processor to no more than a defined number of potential customers to explore market capability in a competitive situation during a predetermined testing period prior to the broader distribution of that chemical substance, mixture or article in commerce.</P>
        <P>(cc) <E T="03">United States,</E> when used in the geographic sense, means all of the States, territories, and possessions of the United States.</P>
        <P>(dd) <E T="03">Master Inventory File</E> means EPA's comprehensive list of chemical substances which constitute the Chemical Substances Inventory compiled under section 8(b) of the Act. It includes substances reported under subpart A of this part and substances reported under part 720 of this chapter for which a Notice of Commencement of Manufacture or Import has been received under § 720.120 of this chapter.</P>
        <P>(ee) <E T="03">Nonisolated intermediate</E> means any intermediate that is not intentionally removed from the equipment in which it is manufactured, including the reaction vessel in which it is manufactured, equipment which is ancillary to the reaction vessel, and any equipment through which the substance passes during a continuous flow process, but not including tanks or other vessels in which the substance is stored after its manufacture.</P>
        <P>(ff) <E T="03">Site-limited</E> means a chemical substance is manufactured and processed only within a site and is not distributed for commercial purposes as a substance or as part of a mixture or article outside the site. Imported substances are never site-limited.</P>
        <CITA>[42 FR 64572, Dec. 23, 1977, as amended at 60 FR 31921, June 19, 1995]</CITA>
      </SECTION>
      <SECTION>
        <SECTNO>§ 710.3</SECTNO>
        <SUBJECT>[Reserved]</SUBJECT>
      </SECTION>
      <SECTION>
        <SECTNO>§ 710.4</SECTNO>
        <SUBJECT>Scope of the inventory.</SUBJECT>
        <P>(a) <E T="03">Chemical substances subject to these regulations.</E> Only chemical substances which are manufactured, imported, or processed “for a commercial purpose,” as defined in § 710.2, are subject to these regulations.</P>
        <P>(b) <E T="03">Naturally occurring chemical substances automatically included.</E> Any chemical substance which is naturally occurring and:</P>
        <P>(1) Which is (i) unprocessed or (ii) processed only by manual, mechanical, or gravitational means; by dissolution in water; by flotation; or by heating solely to remove water; or</P>
        <P>(2) Which is extracted from air by any means, shall automatically be included in the inventory under the category “Naturally Occurring Chemical Substances.” Examples of such substances are: raw agricultural commodities; water, air, natural gas, and crude oil; and rocks, ores, and minerals.</P>
        <P>(c) <E T="03">Substances excluded by definition or section 8(b) of TSCA.</E> The following substances are excluded from the inventory:<PRTPAGE P="35"/>
        </P>
        <P>(1) Any substance which is not considered a “chemical substance” as provided in subsection 3(2)(B) of the Act and in the definition of “chemical substance” in § 710.2(h);</P>
        <P>(2) Any mixture as defined in § 710.2(q);</P>
        <NOTE>
          <HD SOURCE="HED">Note:</HD>
          <P>A chemical substance that is manufactured as part of a mixture is subject to these reporting regulations. This exclusion applies only to the mixture and not to the chemical substances of which the mixture is comprised. The term “mixture” includes alloys, inorganic glasses, ceramics, frits, and cements, including Portland cement.</P>
        </NOTE>
        <P>(3) Any chemical substance which is manufactured, imported, or processed solely in small quantities for research and development, as defined in § 710.2(y); and</P>
        <P>(4) Any chemical substance not manufactured, processed or imported for a commercial purpose since January 1, 1975.</P>
        <P>(d) <E T="03">Chemical substances excluded from the inventory.</E> The following chemical substances are excluded from the inventory. Although they are considered to be manufactured or processed for a commercial purpose for the purpose of section 8 of the Act, they are not manufactured or processed for distribution in commerce as chemical substances <E T="03">per se</E> and have no commercial purpose separate from the substance, mixture, or article of which they may be a part.</P>
        <NOTE>
          <HD SOURCE="HED">Note:</HD>
          <P>In addition, chemical substances excluded here will not be subject to premanufacture notification under section 5 of the Act.</P>
        </NOTE>
        <P>(1) Any impurity.</P>
        <P>(2) Any byproduct which has no commercial purpose.</P>
        <NOTE>
          <HD SOURCE="HED">Note:</HD>
          <P>A byproduct which has commercial value only to municipal or private organizations who (i) burn it as a fuel, (ii) dispose of it as a waste, including in a landfill or for enriching soil, or (iii) extract component chemical substances which have commercial value, may be reported for the inventory, but will not be subject to premanufacturing notification under section 5 of the Act if not included.</P>
        </NOTE>
        <P>(3) Any chemical substance which results from a chemical reaction that occurs incidental to exposure of another chemical substance, mixture, or article to environmental factors such as air, moisture, microbial organisms, or sunlight.</P>
        <P>(4) Any chemical substance which results from a chemical reaction that occurs incidental to storage of another chemical substance, mixture, or article.</P>
        <P>(5) Any chemical substance which results from a chemical reaction that occurs upon end use of other chemical substances, mixtures, or articles such as adhesives, paints, miscellaneous cleansers or other housekeeping products, fuels and fuel additives, water softening and treatment agents, photographic, films, batteries, matches, and safety flares, and which is not itself manufactured for distribution in commerce or for use as an intermediate.</P>
        <P>(6) Any chemical substance which results from a chemical reaction that occurs upon use of curable plastic or rubber molding compounds, inks, drying oils, metal finishing compounds, adhesives, or paints; or other chemical substances formed during manufacture of an article destined for the marketplace without further chemical change of the chemical substance except for those chemical changes that may occur as described elsewhere in this § 710.4(d).</P>
        <P>(7) Any chemical substance which results from a chemical reaction that occurs when (i) a stabilizer, colorant, odorant, antioxidant, filler, solvent, carrier, surfactant, plasticizer, corrosion inhibitor, antifoamer or de-foamer, dispersant, precipitation inhibitor, binder, emulsifier, de-emulsifier, de-wa-ter-ing agent, agglomerating agent, adhesion promoter, flow modifier, pH neutralizer, sequesterant, coagulant, flocculant, fire retardant, lubricant, chelating agent, or quality control reagent functions as intended or (ii) a chemical substance, solely intended to impart a specific physicochemical characteristic, functions as intended.</P>
        <P>(8) Chemical substances which are not intentionally removed from the equipment in which they were manufactured.</P>
        <NOTE>
          <HD SOURCE="HED">Note:</HD>
          <P>See note to definition of “intermediate” at § 710.2(n) for explanation of “equipment in which it was manufactured.”</P>
        </NOTE>
        <CITA>[42 FR 64572, Dec. 23, 1977]</CITA>
      </SECTION>
      <SECTION>
        <PRTPAGE P="36"/>
        <SECTNO>§ 710.25</SECTNO>
        <SUBJECT>Chemical substances for which information must be reported.</SUBJECT>
        <P>Any chemical substance which is in the Master Inventory File at the beginning of a reporting period described in § 710.33, unless the chemical substance is specifically excluded by § 710.26.</P>
        <CITA>[51 FR 21447, June 12, 1986]</CITA>
      </SECTION>
      <SECTION>
        <SECTNO>§ 710.26</SECTNO>
        <SUBJECT>Chemical substances for which information is not required.</SUBJECT>
        <P>The following categories of chemical substances are excluded from the reporting requirements of this subpart. However, a chemical substance described in paragraphs (a), (b), or (c) of this section is not excluded from the reporting requirements of this subpart if that substance is the subject of a rule proposed or promulgated under section 4, 5(a)(2), 5(b)(4), or 6 of the Act, or is the subject of an order issued under section 5(e) or 5(f) of the Act, or is the subject of relief that has been granted under a civil action under section 5 or 7 of the Act.</P>
        <P>(a) <E T="03">Inorganic chemical substances.</E> Any chemical substance which does not contain carbon or contains carbon only in the form of carbonato [=CO<E T="52">3</E>], cyano [^CN], cyanato [^OCN], isocyano [^NC], or isocyanato [^NCO] groups, or the chalcogen analogues of such groups.</P>
        <P>(b) <E T="03">Polymers.</E> (1) Any chemical substance described with the word fragments “*polym*”, “*alkyd”, or “*oxylated” in the Chemical Abstracts Service Index or Preferred Nomenclature in the Chemical Substance Identities section of the 1985 edition of the Inventory or in the Master Inventory File, where the asterisk (*) indicates that any sets of characters may precede, or follow, the character string defined.</P>
        <P>(2) Any chemical substance which is identified in the 1985 edition of the Inventory or the Master Inventory File as siloxane and silicone, silsesquioxane, a protein (albumin, casein, gelatin, gluten, hemoglobin), an enzyme, a polysaccharide (starch, cellulose, gum), rubber, or lignin. This exclusion, however, does not apply to a chemical substance which has been hydrolyzed, depolymerized, or chemically modified to the extent that the final product is no longer polymeric in structure.</P>
        <P>(c) <E T="03">Microorganisms.</E> Any combination of chemical substances that is a living organism, such as bacteria, eimeria, fungi, and yeasts. Any chemical substance produced from such a living organism is reportable unless otherwise excluded.</P>
        <P>(d) <E T="03">Naturally occurring chemical substances.</E> Any naturally occurring chemical substance, as described in § 710.4(b). The applicability of this exclusion is determined in each case by the specific activities of the person who manufactures the substance in question. Some chemical substances can be manufactured both as described in § 710.4(b) and by means other than those described in § 710.4(b). If a person described in § 710.28 manufactures a chemical substance by means other than those described in § 710.4(b), the person must report regardless of whether the substance also could have been produced as described in § 710.4(b). Any chemical substance that is produced from such a naturally occurring chemical substance described in § 710.4(b) is reportable unless otherwise excluded.</P>
        <CITA>[51 FR 21447, June 12, 1986]</CITA>
      </SECTION>
      <SECTION>
        <SECTNO>§ 710.28</SECTNO>
        <SUBJECT>Persons who must report.</SUBJECT>
        <P>Except as provided in §§ 710.29 and 710.30, the following persons are subject to the requirements of this subpart. Persons must determine whether they must report under this § 710.28 for each chemical substance that they manufacture at an individual site.</P>
        <P>(a) <E T="03">Persons subject to initial reportinq.</E> Any person who manufactured for commercial purposes 10,000 pounds (4,540 kilograms) or more of a chemical substance described in § 710.25 at any single site owned or controlled by that person at any time during the person's latest complete corporate fiscal year before August 25, 1986.</P>
        <P>(b) <E T="03">Persons subject to recurring reporting.</E> Any person who manufactured for commercial purposes 10,000 pounds (4,540 kilograms) or more of a chemical substance described in § 710.25 at any single site owned or controlled by that person at any time during the person's latest complete corporate fiscal year before August 25, 1990, or before August 25 at four-year intervals thereafter.<PRTPAGE P="37"/>
        </P>
        <P>(c) <E T="03">Special provisions for importers.</E> For purposes of paragraphs (a) and (b) of this section, the site for a person who imports a chemical substance described in § 710.25 is the site of the operating unit within the person's organization which is directly responsible for importing the substance and which controls the import transaction. The import site may in some cases be the organization's headquarters in the U.S. (See also § 710.35(b).)</P>
        <CITA>[51 FR 21447, June 12, 1986]</CITA>
      </SECTION>
      <SECTION>
        <SECTNO>§ 710.29</SECTNO>
        <SUBJECT>Persons not subject to this subpart.</SUBJECT>
        <P>A person described in § 710.28 is not subject to the requirements of this subpart if that person qualifies as a small manufacturer as that term is defined in § 704.3 of this chapter. Notwithstanding this exclusion, a person who qualifies as a small manufacturer is subject to this subpart with respect to any chemical substance that is the subject of a rule proposed or promulgated under section 4, 5(b)(4), or 6 of the Act, or is the subject of an order in effect under section 5(e) of the Act, or is the subject of relief that has been granted under a civil action under section 5 or 7 of the Act.</P>
        <CITA>[51 FR 21447, June 12, 1986]</CITA>
      </SECTION>
      <SECTION>
        <SECTNO>§ 710.30</SECTNO>
        <SUBJECT>Activities for which reporting is not required.</SUBJECT>
        <P>A person described in § 710.28 is not subject to the requirements of this subpart with respect to any chemical substance described in § 710.25 that the person manufactured or imported under the following circumstances:</P>
        <P>(a) The person manufactured or imported the chemical substance described in § 710.25 solely in small quantities for research and development,</P>
        <P>(b) The person imported the chemical substance described in § 710.25 as part of an article,</P>
        <P>(c) The person manufactured the chemical substance described in § 710.25 in a manner described in § 720.30(g) or (h) of this chapter.</P>
        <CITA>[51 FR 21447, June 12, 1986]</CITA>
      </SECTION>
      <SECTION>
        <SECTNO>§ 710.32</SECTNO>
        <SUBJECT>Reporting information to EPA.</SUBJECT>
        <P>Any person who must report under this part must submit the information prescribed in this section for each chemical substance described in § 710.25 that the person manufactured for commercial purposes in an amount of 10,000 pounds (4,540 kilograms) or more at a single site during a corporate fiscal year described in § 710.28. (The site for a person who imports a chemical substance is the site of the operating unit within the person's organization which is directly responsible for importing the substance and which controls the import transaction, and may in some cases be the organization's headquarters office in the U.S.). A respondent to this subpart must report information in writing or by magnetic media as prescribed in this section, to the extent that such information is known to or reasonably ascertainable by that person. A respondent to this subpart must report information that applies to the specific corporate fiscal year for which the person is required to report.</P>
        <P>(a) <E T="03">Reporting in writing</E>. Any person who chooses to report information to EPA in writing must do so by completing the reporting form available from EPA at the address set forth in § 710.39(b). The form must include all information prescribed in paragraph (c) of this section. Persons reporting in writing must submit a separate form for each site for which the person is required to report.</P>
        <P>(b) <E T="03">Reporting by magnetic media</E>. Any person who chooses to report information to EPA by means of magnetic media must submit the information prescribed in paragraph (c) of this section. Magnetic media submitted in response to this subpart must meet EPA specifications, as described in the instruction booklet available from EPA at the address set forth in § 710.39(b).</P>
        <P>(c) <E T="03">Information to be reported</E>. Persons reporting information under this subpart must report the following:</P>

        <P>(1) The name, company, address, city, State, Zip code, and telephone number of a person who will serve as technical contact for the respondent company, and will be able to answer questions about the information submitted by the company to EPA. Persons reporting by means of magnetic media must <PRTPAGE P="38"/>submit this information on the reporting form available from EPA at the address set forth in § 710.39.</P>
        <P>(2) A certification statement signed and dated by an authorized official of the respondent company. Persons reporting by means of magnetic media must submit this information on the reporting form available from EPA at the address set forth in § 710.39.</P>

        <P>(3) The specific chemical name and Chemical Abstracts Service (CAS) Registry Number of each chemical substance for which reporting is required under this subpart. A respondent to this subpart may use other chemical identification numbers in lieu of CAS Registry Numbers when a CAS Registry Number is not known to the respondent as provided in the instruction booklet identified in § 710.39(b), including EPA-designated Accession Numbers for confidential substances, EPA-assigned numbers for <E T="03">bona fide</E> or Premanufacture Notification submissions, or Test Market Exemption Applications, or original Inventory form numbers.</P>
        <P>(4) The name, street address, city, State, and Zip code of each site at which 10,000 pounds (4,540 kilograms) or more of a chemical substance for which reporting is required under this subpart is manufactured or imported. (The site for a person who imports a chemical substance is the site of the operating unit within the person's organization which is directly responsible for importing the substance and which controls the import transaction, and may in some cases be the organization's headquarters office in the U.S.) A respondent to this subpart must include the appropriate Dun and Bradstreet Number for each plant site reported.</P>
        <P>(5) A statement for each substance for which information is being submitted indicating whether the substance is manufactured in the United States or imported into the United States.</P>
        <P>(6) A statement for each substance for which information is being submitted indicating whether the substance is site-limited.</P>

        <P>(7) The total volume (in pounds) of each subject chemical substance manufactured or imported at each site. This amount must be reported to two significant figures of accuracy provided that the reported figures are within <E T="61">±</E>10 percent of the actual volume.</P>
        <CITA>[55 FR 39587, Sept. 27, 1990, as amended at 60 FR 31921, June 19, 1995]</CITA>
      </SECTION>
      <SECTION>
        <SECTNO>§ 710.33</SECTNO>
        <SUBJECT>When to report.</SUBJECT>
        <P>All information reported to EPA in response to the requirements of this subpart must be submitted during an applicable reporting period. The following reporting periods are prescribed for this subpart.</P>
        <P>(a) <E T="03">Initial reporting period.</E> The first reporting period is from August 25, 1986 to December 23, 1986. Any person described in § 710.28(a) must report during this period for each chemical substance described in § 710.25 that the person manufactured during the corporate fiscal year described in § 710.28(a).</P>
        <P>(b)<E T="03"> Recurring reporting periods.</E>  The first recurring reporting period is from August 25, 1990 to December 23, 1990.  Subsequent reporting periods, except as provided in paragraph (c) of this section, are from August 25 to December 23 at 4-year intervals thereafter.  Any person described in § 710.28(b) must report during the appropriate reporting period for each chemical substance described in § 710.25 that the person manufactured during the applicable corporate fiscal year described in § 710.28(b).</P>
        <P>(c)<E T="03"> Reporting in 1998</E>.  The 1998 reporting period is from August 25, 1998 until January 31, 1999.  Any person described in § 710.28(b) must report during this reporting period for each chemical substance described in § 710.25 that the person manufactured during the applicable corporate fiscal year described in § 710.28(b). This reporting period is applicable to 1998 reporting only.</P>
        <CITA>[51 FR 21447, June 12, 1986: 51 FR 22521, June 20, 1986, as amended at 63 FR 71600, Dec. 29, 1998]</CITA>
      </SECTION>
      <SECTION>
        <SECTNO>§ 710.35</SECTNO>
        <SUBJECT>Duplicative reporting.</SUBJECT>
        <P>(a) <E T="03">With regard to section 8(a) rules.</E> Any person subject to the requirements of this part who previously has complied with reporting requirements of a rule under section 8(a) of the Act by submitting the information described <PRTPAGE P="39"/>in § 710.32 for a chemical substance described in § 710.25 to EPA, and has done so within one year of the start of a reporting period described in § 710.33, is not required to report again on the manufacture of that substance at that site during that reporting period.</P>
        <P>(b) <E T="03">With regard to importers.</E> This part requires that only one report be submitted on each import transaction involving a chemical substance described in § 710.25. When two or more persons are involved in a particular import transaction and each person meets the Agency's definition of “importer” as set forth in §§ 710.2(l) and 704.3 of this chapter, they may determine among themselves who should submit the required report; if no report is submitted as required under this part, EPA will hold each such person liable for failure to report.</P>
        <CITA>[51 FR 21447, June 12, 1986, as amended at 60 FR 31921, June 19, 1995]</CITA>
      </SECTION>
      <SECTION>
        <SECTNO>§ 710.37</SECTNO>
        <SUBJECT>Recordkeeping requirements.</SUBJECT>
        <P>Each person who is subject to the reporting requirements of this part must maintain records that document any information reported to EPA. For substances that are manufactured or imported at less than 10,000 pounds annually, volume records must be maintained as evidence to support a decision not to submit a report. Records relevant to reporting during a reporting period described in § 710.33 must be retained for a period of four years beginning with the effective date of that reporting period.</P>
        <CITA>[51 FR 21447, June 12, 1986, as amended at 58 FR 34204, June 23, 1993; 60 FR 31921, June 19, 1995]</CITA>
      </SECTION>
      <SECTION>
        <SECTNO>§ 710.38</SECTNO>
        <SUBJECT>Confidentiality.</SUBJECT>
        <P>(a) Any person submitting information under this part may assert a business confidentiality claim for the information. The procedures for asserting confidentiality claims are described in the instruction booklet identified in § 710.39. Information claimed as confidential in accordance with this section and those instructions will be treated and disclosed in accordance with the procedures in part 2 of this chapter.</P>
        <P>(b) A person may assert a claim of confidentiality for the chemical identity of a specific chemical substance only if the identity of that substance is treated as confidential in the Master Inventory File as of the time the report is submitted for that substance under this part.</P>
        <P>(c) To assert a claim of confidentiality for the chemical identity of a specific chemical substance, the person must take the following steps:</P>
        <P>(1) The person must submit with the report detailed written answers to the following questions signed and dated by an authorized official.</P>
        <P>(i) What harmful effects to your competitive position, if any, do you think would result from the identity of the chemical substance being disclosed in connection with reporting under this part? How could a competitor use such information? Would the effects of disclosure be substantial? What is the causal relationship between the disclosure and the harmful effects?</P>
        <P>(ii) How long should confidential treatment be given? Until a specific date, the occurrence of a specific event, or permanently? Why?</P>
        <P>(iii) Has the chemical substance been patented? If so, have you granted licenses to others with respect to the patent as it applies to the chemical substance? If the chemical substance has been patented and therefore disclosed through the patent, why should it be treated as confidential?</P>
        <P>(iv) Has the identity of the chemical substance been kept confidential to the extent that your competitors do not know it is being manufactured or imported for a commercial purpose by anyone?</P>
        <P>(v) Is the fact that the chemical substance is being manufactured or imported for a commercial purpose available to the public, for example in technical journals, libraries, or State, local, or Federal agency public files?</P>
        <P>(vi) What measures have you taken to prevent undesired disclosure of the fact that this chemical substance is being manufactured or imported for a commercial purpose?</P>

        <P>(vii) To what extent has the fact that this chemical substance is manufactured or imported for commercial purposes been revealed to others? What <PRTPAGE P="40"/>precautions have been taken regarding these disclosures? Have there been public disclosures or disclosures to competitors?</P>
        <P>(viii) Does this particular chemical substance leave the site of manufacture in any form, as product, effluent, emission, etc.? If so, what measures have you taken to guard against discovery of its identity?</P>
        <P>(ix) If the chemical substance leaves the site in a product that is available to the public or your competitors, can the substance be identified by analysis of the product?</P>
        <P>(x) For what purpose do you manufacture or import the substance?</P>
        <P>(xi) Has EPA, another Federal agency, or any Federal court made any pertinent confidentiality determinations regarding this chemical substance? If so, please attach copies of such determinations.</P>
        <P>(2) If any of the information contained in the answers to the questions is asserted to contain confidential business information, the person must mark that information as “trade secret,” “confidential,” or other appropriate designation.</P>
        <P>(d) If no claim of confidentiality accompanies information at the time it is submitted to EPA under this part or if substantiation required under paragraph (c) of this section is not submitted with the reporting form, EPA may make the information available to the public without further notice to the submitter.</P>
        <CITA>[51 FR 21447, June 12, 1986, as amended at 55 FR 39588, Sept. 27, 1990; 60 FR 31921, June 19, 1995]</CITA>
      </SECTION>
      <SECTION>
        <SECTNO>§ 710.39</SECTNO>
        <SUBJECT> How do I submit the required information for the 1998 reporting cycle?</SUBJECT>
        <P>(a) <E T="03">Use the proper EPA form</E>. You must use the EPA form identified as “Form U” to submit written information in response to the requirements of this subpart. Copies of the Form U are available from EPA at the address set forth in paragraph (c) of this section, from the EPA Internet Home Page at http://www.epa.gov/opptintr/iur98, or via Fax-on-Demand by using a faxphone to call (202) 401-0527 and selecting item 5119.</P>
        <P>(b) <E T="03">Follow the reporting instructions</E>. You should follow the detailed instructions for completing the reporting form and preparing a magnetic media report, which are given in the EPA publication entitled “Instructions for Reporting for Partial Updating of the TSCA Chemical Inventory Data Base,” via the Internet or the TSCA Hotline.</P>
        <P>(c) <E T="03">Obtain the reporting package and copies of the form</E>. EPA is mailing the reporting package to those companies that reported in 1994. Failure to receive a reporting package does not obviate or otherwise affect the requirement to submit a timely report. If you did not receive a reporting package, but are required to report, you may obtain a copy of the reporting package and the reporting form from EPA by submitting a request for this information as follows:</P>
        <P>(1) <E T="03">By phone</E>. Call the EPA TSCA Hotline at (202) 554-1404, or TDD 202-554-0551.</P>
        <P>(2) <E T="03">By e-mail</E>. Send an e-mail request for this information to the EPA TSCA Hotline at TSCA-Hotline@epamail.epa.gov.</P>
        <P>(3) <E T="03">By mail</E>. Send a written request for this information to the following address: TSCA Hotline, Mail Code 7408, ATTN: Inventory Update Rule, Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, 401 M St., SW., Washington, DC 20460.</P>
        <P>(d) <E T="03">Submit the completed reports</E>. You must submit your completed reporting form(s) and/or magnetic media to EPA at the following address: Document Control Officer, Mail Code 7407, ATTN: Inventory Update Rule, Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, 401 M St., SW., Washington, DC 20460.</P>
        <CITA>[63 FR 45953, Aug. 28, 1998]</CITA>
      </SECTION>
    </PART>
    <PART>
      <EAR>Pt. 712</EAR>
      <HD SOURCE="HED">PART 712—CHEMICAL INFORMATION RULES</HD>
      <CONTENTS>
        <SUBPART>
          <HD SOURCE="HED">Subpart A—General Provisions</HD>
          <SECHD>Sec.</SECHD>
          <SECTNO>712.1</SECTNO>
          <SUBJECT>Scope and compliance.</SUBJECT>
          <SECTNO>712.3</SECTNO>
          <SUBJECT>Definitions.</SUBJECT>
          <SECTNO>712.5</SECTNO>
          <SUBJECT>Method of identification of substances for reporting purposes.</SUBJECT>
          <SECTNO>712.7</SECTNO>

          <SUBJECT>Report of readily obtainable information for subparts B and C.<PRTPAGE P="41"/>
          </SUBJECT>
          <SECTNO>712.15</SECTNO>
          <SUBJECT>Confidentiality.</SUBJECT>
        </SUBPART>
        <SUBPART>
          <HD SOURCE="HED">Subpart B—Manufacturers Reporting—Preliminary Assessment Information</HD>
          <SECTNO>712.20</SECTNO>
          <SUBJECT>Manufacturers and importers who must report.</SUBJECT>
          <SECTNO>712.25</SECTNO>
          <SUBJECT>Exempt manufacturers and importers.</SUBJECT>
          <SECTNO>712.28</SECTNO>
          <SUBJECT>Form and instructions.</SUBJECT>
          <SECTNO>712.30</SECTNO>
          <SUBJECT>Chemical lists and reporting periods.</SUBJECT>
        </SUBPART>
      </CONTENTS>
      <AUTH>
        <HD SOURCE="HED">Authority:</HD>
        <P>15 U.S.C. 2607(a).</P>
      </AUTH>
      <SOURCE>
        <HD SOURCE="HED">Source:</HD>
        <P>47 FR 26998, June 22, 1982, unless otherwise noted.</P>
      </SOURCE>
      <SUBPART>
        <HD SOURCE="HED">Subpart A—General Provisions</HD>
        <SECTION>
          <SECTNO>§ 712.1</SECTNO>
          <SUBJECT>Scope and compliance.</SUBJECT>
          <P>(a) This part establishes procedures for chemical manufacturers and processors to report production, use, and exposure-related information on listed chemical substances. Subpart A establishes requirements that apply to all reporting under this part. Subpart B covers manufacturers’ and processors’ reporting.</P>
          <P>(b) Chemical substances, mixtures, and categories of substances or mixtures which have been recommended by the Interagency Testing Committee for testing consideration by the Agency but not designated for Agency response within 12 months, will be added to § 712.30 using the procedure specified in § 712.30(c) only to the extent that the total number of designated and recommended chemicals has not exceeded 50 in any 1 year. Additional recommended but not designated chemicals may be added after proposal, and consideration of public comment.</P>
          <CITA>[47 FR 26998, June 22, 1982, as amended at 50 FR 34809, Aug. 28, 1985; 60 FR 31921, June 19, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 712.3</SECTNO>
          <SUBJECT>Definitions.</SUBJECT>
          <P>The definitions in section 3 of TSCA, 15 U.S.C. 2602, apply for this part. In addition, the following definitions apply:</P>
          <P>(a) <E T="03">Byproduct</E> means any chemical substance or mixture produced without a separate commercial intent during the manufacture, processing, use, or disposal of another chemical substance or mixture.</P>
          <P>(b) <E T="03">EPA</E> means the U.S. Environmental Protection Agency.</P>
          <P>(c) <E T="03">Import in bulk form</E> means to import a chemical substance (other than as part of a mixture or article) in any quantity, in cans, bottles, drums, barrels, packages, tanks, bags, or other containers used for purposes of transportation or containment, if the chemical substance has an end use or commercial purpose separate from the container.</P>
          <P>(d) <E T="03">Importer</E> means anyone who imports a chemical substance, including a chemical substance as part of a mixture or article, into the customs territory of the U.S. and includes the person liable for the payment of any duties on the merchandise, or an authorized agent on his behalf. Importer also includes, as appropriate:</P>
          <P>(1) The consignee.</P>
          <P>(2) The importer of record.</P>
          <P>(3) The actual owner if an actual owner's declaration and superseding bond has been filed in accordance with 19 CFR 141.20.</P>
          <P>(4) The transferee, if the right to withdraw merchandise in a bonded warehouse has been transferred in accordance with subpart C of 19 CFR part 144. For the purposes of this definition, the customs territory of the U.S. consists of the 50 states, Puerto Rico, and the District of Columbia.</P>
          <P>(e) <E T="03">Impurity</E> means a chemical substance unintentionally present with another chemical substance or mixture.</P>
          <P>(f) <E T="03">Intermediate</E> means any chemical substance that is consumed, in whole or in part, in chemical reactions used for the intentional manufacture of other chemical substances or mixtures, or that is intentionally present for the purpose of altering the rates of such chemical reactions. (See also paragraph (j) of this section.)</P>
          <P>(g) <E T="03">Known to or reasonably ascertainable by</E> means all information in a person's possession or control, plus all information that a reasonable person similarly situated might be expected to possess, control, or know, or could obtain without unreasonable burden.</P>
          <P>(h) <E T="03">Manufacture for commercial purposes</E> means to import, produce, or manufacture with the purpose of obtaining an immediate or eventual commercial advantage for the manufacturer and includes, among other <PRTPAGE P="42"/>things, such “manufacture” of any amount of a chemical substance or mixture:</P>
          <P>(1) For commercial distribution, including for test marketing.</P>
          <P>(2) For use by the manufacturer, including use for product research and development, or as an intermediate. Manufacture for commercial purposes also applies to substances that are produced coincidentally during the manufacture, processing, use, or disposal of another substance or mixture, including byproducts and coproducts that are separated from that other substance or mixture, and impurities that remain in that substance or mixture. Byproducts and impurities may not in themselves have commercial value. They are nonetheless produced for the purpose of obtaining a commercial advantage since they are part of the manufacture of a chemical produced for a commercial purpose.</P>
          <P>(i) <E T="03">Mixture</E> means any combination of two or more chemical substances if the combination does not occur in nature and is not, in whole or in part, the result of a chemical reaction; except that <E T="03">mixture</E> does include (1) any combination which occurs, in whole or in part, as a result of a chemical reaction if the combination could have been manufactured for commercial purposes without a chemical reaction at the time the chemical substances comprising the combination were combined, and if all of the chemical substances comprising the combination are included in the EPA, TSCA Chemical Substance Inventory after the effective date of the premanufacture notification requirement under 40 CFR part 720, and (2) hydrates of a chemical substance or hydrated ions formed by association of a chemical substance with water. The term mixture includes alloys, inorganic glasses, ceramics, frits, and cements, including Portland cement.</P>
          <P>(j) <E T="03">Non-isolated intermediate</E> means any intermediate that is not intentionally removed from the equipment in which it is manufactured, including the reaction vessel in which it is manufactured, equipment which is ancillary to the reaction vessel, and any equipment through which the substance passes during a continuous flow process, but not including tanks or other vessels in which the substance is stored after its manufacture. (See also paragraph (f) of this section.)</P>
          <P>(k) <E T="03">Owned or controlled by the parent company</E> means the parent owns or controls 50 percent or more of the other company's voting stock or other equity rights, or has the power to control the management and policies of the other company.</P>
          <P>(l) <E T="03">Person</E> means any natural person, firm, company, corporation, joint venture, partnership, sole proprietorship, association, or any other business entity, any State or political subdivision thereof, any municipality, any interstate body, and any department, agency, or instrumentality of the Federal government.</P>
          <P>(m) <E T="03">Process for commercial purposes</E> means the preparation of a chemical substance or mixture, after its manufacture, for distribution in commerce with the purpose of obtaining an immediate or eventual commercial advantage for the processor. Processing of any amount of a chemical substance or mixture is included. If a chemical or mixture containing impurities is processed for commercial purposes, then those impurities are also processed for commercial purposes.</P>
          <P>(n) <E T="03">Site</E> means a contiguous property unit. Property divided only by a public right-of-way shall be considered one site. There may be more than one manufacturing plant on a single site.</P>
          <P>(o) <E T="03">Test marketing</E> means distributing in commerce a limited amount of a chemical substance or mixture, or article containing such substance or mixture, to a defined number of potential customers, during a predetermined testing period, to explore market capability prior to broader distribution in commerce.</P>
          <P>(p) <E T="03">TSCA</E> means the Toxic Substances Control Act, 15 U.S.C. 2601 et seq.
            
          </P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 712.5</SECTNO>
          <SUBJECT>Method of identification of substances for reporting purposes.</SUBJECT>
          <P>(a) <E T="03">Report on TSCA-regulable quantities.</E> Unless specifically otherwise required, respondents must report only about quantities of a chemical that is defined as a chemical substance under TSCA section 3(2).</P>
          <P>(b) <E T="03">Chemicals from natural sources.</E> A manufacturer of a chemical substance <PRTPAGE P="43"/>which is extracted from an ore, from oil, or from any other natural source must report only about the manufacturing steps for, and the uses of, that chemical, not about production of the natural source material or other crude precursors derived from the natural source material.
          </P>
          <EXTRACT>
            <P>For example, persons who manufacture a chemical substance such as “sweetened naphtha, 64741-87-3,” but do not refine the naphtha to produce “hexane, 110-54-3” would not report on hexane. Only the production of “hexane” as an isolated product must be reported—not previous production of more crude, complex substances such as naphtha from which hexane is extracted. Thus, persons who produce crude oil, ores, and other crude natural materials, but do not carry them through further manufacturing steps that produce a listed chemical have no reporting responsibilities under this Part. Note, however, that any method of extraction, refinement, or purification of a listed chemical substance is considered to be manufacturing for the purposes of this rule.</P>
          </EXTRACT>
          
          <P>(c) <E T="03">Chemical substances as marketed.</E> This part requires reporting about chemical substances as they are marketed or used in practice. The following preparations of a chemical substance must be reported as the substance itself, not as a mixture, since these preparations are regarded as the substance in practice.</P>
          <P>(1) The chemical substance in aqueous solution.</P>
          <P>(2) The chemical substance containing an additive (such as a stabilizer or other chemical) to maintain the integrity or physical form of the substance.</P>
          <P>(3) The chemical substance in any grade of purity.
            
          </P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 712.7</SECTNO>
          <SUBJECT>Report of readily obtainable information for subparts B and C.</SUBJECT>
          <P>TSCA section 8(a) authorizes EPA to require persons to report information that is known to or reasonably ascertainable by them. For purposes of subpart B, however, a lesser standard applies. Companies must report information that is readily obtainable by management and supervisory employees responsible for manufacturing, processing, distributing, technical services, and marketing. Extensive file searches are not required.</P>
          <CITA>[47 FR 26998, June 22, 1982, as amended at 60 FR 31921, June 19, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 712.15</SECTNO>
          <SUBJECT>Confidentiality.</SUBJECT>
          <P>(a) Any person submitting information under this part may assert business confidentiality claims for the information as described in the pertinent reporting form and its instructions. Any information covered by a claim will be disclosed by EPA only as provided in the procedures set forth at 40 CFR part 2.</P>
          <P>(b) Persons must certify to the validity of a claim of confidentiality they make for information reported under this part, as specified on the reporting form.</P>
          <P>(c) If no claim accompanies the information at the time it is submitted to EPA or if certification as to the claim is not made on the reporting form, EPA may place the information in an open file available to the public without further notice to the submitter.</P>
        </SECTION>
      </SUBPART>
      <SUBPART>
        <HD SOURCE="HED">Subpart B—Manufacturers Reporting—Preliminary Assessment Information</HD>
        <SECTION>
          <SECTNO>§ 712.20</SECTNO>
          <SUBJECT>Manufacturers and importers who must report.</SUBJECT>
          <P>Except as described in § 712.25, at the time a chemical substance is listed in § 712.3, the following persons must submit the “Manufacturer's Report—Preliminary Assessment Information” (as described in § 712.28) for each plant site at which they manufactured or imported the chemical substance during the reporting period specified in § 712.30:</P>
          <P>(a) Persons who manufactured one or more of the chemical substances listed in § 712.30 for commercial purposes.</P>
          <P>(b) Persons who imported in bulk form one or more of the chemical substances listed in § 712.30 for commercial purposes.</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 712.25</SECTNO>
          <SUBJECT>Exempt manufacturers and importers.</SUBJECT>

          <P>(a) Persons who manufactured or imported the chemical substance during the reporting period, solely for purposes of scientific experimentation, <PRTPAGE P="44"/>analysis, or research, including research or analysis for product development, are not subject to reporting under § 712.20.</P>
          <P>(b) Persons who, during the reporting period, manufactured or imported fewer than 500 kilograms (1100 pounds) of the chemical substance at a single plant site are not subject to reporting for that site under § 712.20.</P>
          <P>(c) Persons who qualify as small manufacturers or importers in respect to a specific chemical substance listed in § 712.30 are exempt. However, this exemption does not apply with respect to any chemical in § 712.30 designated by an asterisk. A manufacturer is qualified as small and is exempt from submitting a report under this subpart for a chemical substance manufactured at a particular plant site if both of the following criteria are met:</P>
          <P>(1) Total annual sales taken together of all sites owned or controlled by the foreign or domestic parent company were below $30 million for the reporting period;</P>
          <P>(2) Total production of the listed substance for the reporting period was below 45,400 kilograms (100,000 pounds) at the plant site.</P>
          <P>(d) Persons are not subject to reporting under § 712.20 if they manufactured or imported the chemical substance during the reporting period only in the following forms:</P>
          <P>(1) As a byproduct that was not used or sold or that was formed as described in 40 CFR 710.4(d) (3) through (7).</P>
          <P>(2) As a non-isolated intermediate.</P>
          <P>(3) As an impurity.</P>
          <CITA>[47 FR 26998, June 22, 1982; 47 FR 28382, June 30, 1982]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 712.28</SECTNO>
          <SUBJECT>Form and instructions.</SUBJECT>
          <P>(a) Manufacturers and importers subject to this subpart must submit a single EPA Form No. 7710-35, “Manufacturer's Report—Preliminary Assessment Information,” for each plant site manufacturing or importing a chemical substance listed in § 712.30.</P>
          <P>(b) Reporting companies may submit their reports through individual plant sites or company headquarters as they choose. A separate form must be submitted for each plant site manufacturing the chemical substance.</P>
          <P>(c) Forms must be sent (preferably by certified mail) to the Document Control Office (7407), Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Room G-099, 401 M St., SW., Washington, DC., 20460, ATTN: 8(a) PAIR Reporting.</P>
          <P>(d) Form 7710-35, Manufacturer's Report--Preliminary Assessment Information or PAIR form and instructions may be obtained by telephoning or writing the Environmental Assistance Division. The telephone number and the address of the Environmental Assistance Division is: Phone Number (202) 554-1404, TDD (202) 554-0551. Address: Environmental Assistance Division (7406), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 401 M St., SW., Washington, DC 20460.</P>
          <CITA>[47 FR 26998, June 22, 1982, as amended at 52 FR 20083, May 29, 1987; 53 FR 12523, Apr. 15, 1988; 60 FR 31921, June 19, 1995; 60 FR 34463, July 3, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 712.30</SECTNO>
          <SUBJECT>Chemical lists and reporting periods.</SUBJECT>
          <P>(a)(1) Persons subject to this subpart B must submit a Preliminary Assessment Information Manufacturer's Report for each chemical substance or mixture that is listed or designated in this section.</P>

          <P>(2) Unless a respondent has already prepared a Manufacturer's Report in conformity with conditions set forth in paragraph (a)(3) of this section, the information in each Manufacturer's Report must cover the respondent's latest complete corporate fiscal year as of the effective date. The effective date will be 30 days after the <E T="04">Federal Register</E> publishes a rule amendment making the substance or mixture subject to this subpart B.</P>
          <P>(3) Persons subject to this subpart B need not comply with the requirements of paragraph (a)(2) of this section if they meet either one of the following conditions:</P>

          <P>(i) The respondent has previously and voluntarily provided EPA with a Manufacturer's Report on a chemical substance or mixture subject to this subpart B, which contains data for a one-year period ending no more than three <PRTPAGE P="45"/>years prior to the effective date described in paragraph (a)(2) of this section. Respondents meeting this condition must notify EPA by letter of their desire to have the voluntary submission used in lieu of a current data submission and must verify the completeness and current accuracy of the voluntarily submitted data. Such letters must contain the following language: “I hereby certify that, to the best of my knowledge and belief, all information entered on this form is complete and accurate. I agree to permit access to, and the copying of records by, a duly authorized representative of the EPA Administrator, in accordance with the Toxic Substances Control Act, to document any information reported on the form.” Notification letters must be submitted prior to the reporting deadline.</P>
          <P>(ii) The respondent has previously submitted a Manufacturer's Report on a chemical substance or mixture subject to this subpart B to the Interagency Testing Committee, but not to EPA, and that Report contained data for a one-year period ending less than three years prior to the effective date described in paragraph (a)(2) of this section. Respondents meeting this condition must submit a copy of the Manufacturer's Report to EPA, and must submit an accompanying letter notifying EPA of the respondent's intent that the submission be used in lieu of a current Manufacturer's Report. The notification letter must verify the completeness and current accuracy of the voluntarily submitted data. Such a letter must contain the following language: “I hereby certify that, to the best of my knowledge and belief, all information entered on this form is complete and accurate. I agree to permit access to, and the copying of records by, a duly authorized representative of the EPA Administrator, in accordance with the Toxic Substances Control Act, to document any information reported on the form.” The submission must be made prior to the reporting deadline.</P>

          <P>(b) Except as provided in paragraph (c) of this section, chemical substances and designated mixtures will be added after a notice of proposed amendment of this subpart is published in the <E T="04">Federal Register.</E> There will be a 30 day public comment period on each notice; after consideration of the comments, a final amendment will identify the substances and mixtures added.</P>

          <P>(c) Chemical substances, mixtures, and categories of substances or mixtures that have been added by the Interagency Testing Committee, established under section 4(e) of TSCA, to the section 4(e) Priority List, for testing consideration by the Agency, will be added to this section 30 days after EPA issues for publication in the <E T="04">Federal Register</E> a rule amendment listing these chemical substances, mixtures and categories. A Preliminary Assessment Information—Manufacturer's Report must be submitted for each chemical substance and mixture within 60 days after the effective date of the listing. At the discretion of the Assistant Administrator for Prevention, Pesticides and Toxic Substances, a listed substance, mixture or category may be withdrawn, for good cause, from the rule's reporting requirements prior to the effective date. Any information submitted showing why a substance, mixture or category should be removed from the rule must be received by EPA within 14 days after the date of publication of the notice under this paragraph. If a substance, mixture or category is removed, a <E T="04">Federal Register</E> notice announcing this decision will be published no later than the effective date of the amendment. Any information submitted must be addressed to the Document Control Office (7407), Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Room G-099, 401 M St., SW., Washington, DC., 20460, ATTN: 8(a) Auto-ITC.</P>

          <P>(d) Manufacturers and importers of the substances listed below must submit a Preliminary Assessment Information Manufacturer's Report for each site at which they manufacture or import each substance by the reporting date shown in the table below. The substances are listed in Chemical Abstracts Service Registry Number order. Typically EPA lists the trivial or common name first, then, following the symbol “- -”, EPA lists the substance by its TSCA Chemical Substance Inventory name. Whenever EPA lists a single name, the name may be either <PRTPAGE P="46"/>the TSCA Chemical Substance Inventory name, a trivial name, or a common name. Generally, when a single name is listed, it is the TSCA Chemical Substances Inventory name.</P>
          <GPOTABLE CDEF="xs48R,r200,10,10" COLS="4" OPTS="L2,i1">
            <BOXHD>
              <CHED H="1">CAS No.</CHED>
              <CHED H="1">Substance</CHED>
              <CHED H="1">Effective date</CHED>
              <CHED H="1">Reporting date</CHED>
            </BOXHD>
            <ROW>
              <ENT I="01" O="xl">90-30-2</ENT>
              <ENT>N-Phenyl-1-naphthylamine </ENT>
              <ENT O="xl">9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">100-40-3</ENT>
              <ENT> 4-Vinylcyclohexene </ENT>
              <ENT O="xl">1/11/90</ENT>
              <ENT>3/12/90</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">108-95-5</ENT>
              <ENT> Thiophenol </ENT>
              <ENT O="xl">1/26/94</ENT>
              <ENT> 3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">118-79-6</ENT>
              <ENT> 2,4,6-tribromophenol </ENT>
              <ENT O="xl"> 1/11/90</ENT>
              <ENT>3/12/90</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">143-33-9</ENT>
              <ENT> Sodium cyanide </ENT>
              <ENT O="xl">10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">632-79-1</ENT>
              <ENT> Tetrabromophthalic anhydride </ENT>
              <ENT O="xl"> 1/11/90</ENT>
              <ENT> 3/12/90</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">637-92-3</ENT>
              <ENT> Ethyl tert-butyl ether </ENT>
              <ENT O="xl">12/28/94</ENT>
              <ENT> 2/27/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">994-05-8</ENT>
              <ENT> Tert-amyl methyl ether </ENT>
              <ENT O="xl">12/28/94</ENT>
              <ENT>2/27/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">1163-19-5</ENT>
              <ENT> Decabromodiphenyl ether </ENT>
              <ENT O="xl">1/11/90</ENT>
              <ENT>3/12/90</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">3194-55-6</ENT>
              <ENT> Hexabromocyclododecane </ENT>
              <ENT O="xl">1/11/90</ENT>
              <ENT>3/12/90</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">3296-90-0</ENT>
              <ENT> Dibromoneopentyl glycol </ENT>
              <ENT O="xl">1/11/90</ENT>
              <ENT>3/12/90</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">12185-10-3</ENT>
              <ENT>White phosphorus </ENT>
              <ENT O="xl">1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">32534-81-9</ENT>
              <ENT>Pentabromodiphenyl ether </ENT>
              <ENT O="xl">1/11/90</ENT>
              <ENT>3/12/90</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">32536-52-0</ENT>
              <ENT>Octabromodiphenyl ether </ENT>
              <ENT O="xl">1/11/90</ENT>
              <ENT>3/12/90</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">32588-76-4</ENT>
              <ENT> Ethylene Bis-(tetrabromophthalimide) </ENT>
              <ENT O="xl">1/11/90</ENT>
              <ENT>3/12/90</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">37853-59-1</ENT>
              <ENT>1,2-Bis(tribromophenoxy) ethane </ENT>
              <ENT O="xl"> 1/11/90</ENT>
              <ENT> 3/12/90</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">41291-34-3</ENT>
              <ENT> Ethylene(5,6-dibromonorbornane-2,3-dicarboximide) </ENT>
              <ENT O="xl"> 1/11/90</ENT>
              <ENT>3/12/90</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">52907-07-0</ENT>
              <ENT> Ethylene bis(5,6-dibromonorbornane-2,3-dicarboximide) </ENT>
              <ENT O="xl">1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">57137-10-7</ENT>
              <ENT> Tribrominated polystyrene </ENT>
              <ENT O="xl">1/11/90</ENT>
              <ENT>3/12/90</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">61262-53-1</ENT>
              <ENT>Ethylene bis(pentabromophenoxide) </ENT>
              <ENT O="xl">1/11/90</ENT>
              <ENT>3/12/90</ENT>
            </ROW>
          </GPOTABLE>
          <P>(e) Manufacturers and importers of the substances listed below by category must submit a Preliminary Assessment Information Manufacturers Report for each site at which they manufacture or import each substance by the reporting date shown in the table below. The categories are listed in alphabetic order with the chemical substances within each category listed by ascending numerical CAS number.</P>
          <GPOTABLE CDEF="xs48,r200,10,10" COLS="4" OPTS="L2,i1">
            <BOXHD>
              <CHED H="1">CAS No.</CHED>
              <CHED H="1">Substance</CHED>
              <CHED H="1">Effective date</CHED>
              <CHED H="1">Reporting date</CHED>
            </BOXHD>
            <ROW>
              <ENT I="01" O="xl">Aldehydes:</ENT>
              <ENT O="xl"/>
              <ENT O="xl"/>
              <ENT O="xl"/>
            </ROW>
            <ROW>
              <ENT I="02">66-77-3</ENT>
              <ENT>1-Naphthalenecarboxaldehyde</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">75-07-0</ENT>
              <ENT>Acetaldehyde</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">75-87-6</ENT>
              <ENT>Acetaldehyde, trichloro-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">78-84-2</ENT>
              <ENT>Propanal, 2-methyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">78-85-3</ENT>
              <ENT>2-Propenal, 2-methyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">80-54-6</ENT>
              <ENT>Benzenepropanal,4-(1,1-dimethylethyl)-.alpha.-methyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">84-83-3</ENT>
              <ENT>Acetaldehyde, (1,3-dihydro-1,3, 3-trimethyl-2H-indol-2-ylidene)</ENT>
            </ROW>
            <ROW>
              <ENT I="02">89-98-5</ENT>
              <ENT>Benzaldehyde, 2-chloro-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">90-02-8</ENT>
              <ENT>Benzaldehyde, 2-hydroxy-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">93-02-7</ENT>
              <ENT>Benzaldehyde, 2,5-dimethoxy-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">93-53-8</ENT>
              <ENT>Benzeneacetaldehyde, .alpha.-methyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">95-01-2</ENT>
              <ENT>Benzaldehyde, 2,4-dihydroxy-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">97-51-8</ENT>
              <ENT>Benzaldehyde, 2-hydroxy-5-nitro-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">98-01-1</ENT>
              <ENT>2-Furancarboxaldehyde</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">98-03-3</ENT>
              <ENT>2-Thiophenecarboxaldehyde</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">100-10-7</ENT>
              <ENT>Benzaldehyde, 4-(dimethylamino)-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">100-50-5</ENT>
              <ENT>3-Cyclohexene-1-carboxaldehyde</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">100-52-7</ENT>
              <ENT>Benzaldehyde</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">101-39-3</ENT>
              <ENT>2-Propenal, 2-methyl-3-phenyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">101-86-0</ENT>
              <ENT>Octanal, 2-(phenylmethylene)-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">103-95-7</ENT>
              <ENT>Benzenepropanal, .alpha.-methyl-4-(1-methylethyl)-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">104-09-6</ENT>
              <ENT>Benzeneacetaldehyde, 4-methyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">104-55-2</ENT>
              <ENT>2-Propenal, 3-phenyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">104-87-0</ENT>
              <ENT>Benzaldehyde, 4-methyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">104-88-1</ENT>
              <ENT>Benzaldehyde, 4-chloro-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">106-23-0</ENT>
              <ENT>6-Octenal, 3,7-dimethyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">106-26-3</ENT>
              <ENT>2,6-Octadienal, 3,7-dimethyl-, (Z)-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">106-72-9</ENT>
              <ENT>5-Heptenal, 2,6-dimethyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">107-02-8</ENT>
              <ENT>2-Propenal</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">107-20-0</ENT>
              <ENT>Acetaldehyde, chloro-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">107-22-2</ENT>
              <ENT>Ethanedial</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">107-75-5</ENT>
              <ENT>Octanal, 7-hydroxy-3,7-dimethyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">110-41-8</ENT>
              <ENT>Undecanal, 2-methyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="47"/>
              <ENT I="02">110-62-3</ENT>
              <ENT>Pentanal</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">111-30-8</ENT>
              <ENT>Pentanedial</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">111-71-7</ENT>
              <ENT>Heptanal</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">112-31-2</ENT>
              <ENT>Decanal</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">112-44-7</ENT>
              <ENT>Undecanal</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">112-45-8</ENT>
              <ENT>10-Undecenal</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">112-54-9</ENT>
              <ENT>Dodecanal</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">120-14-9</ENT>
              <ENT>Benzaldehyde, 3,4-dimethoxy-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">120-21-8</ENT>
              <ENT>Benzaldehyde, 4-(diethylamino)-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">120-57-0</ENT>
              <ENT>1,3-Benzodioxole-5-carboxaldehyde</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">121-32-4</ENT>
              <ENT>Benzaldehyde, 3-ethoxy-4-hydroxy-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">121-33-5</ENT>
              <ENT>Benzaldehyde, 4-hydroxy-3-methoxy-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">122-40-7</ENT>
              <ENT>Heptanal, 2-(phenylmethylene)-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">122-78-1</ENT>
              <ENT>Benzeneacetaldehyde</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">123-05-7</ENT>
              <ENT>Hexanal, 2-ethyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">123-08-0</ENT>
              <ENT>Benzaldehyde, 4-hydroxy-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">123-11-5</ENT>
              <ENT>Benzaldehyde, 4-methoxy-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">123-38-6</ENT>
              <ENT>Propanal</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">124-13-0</ENT>
              <ENT>Octanal</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">124-19-6</ENT>
              <ENT>Nonanal</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">126-15-8</ENT>
              <ENT>4a(4H)-Dibenzofurancarboxaldehyde, 1,5a,6,9,9a,9b-hexahydro-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">135-02-4</ENT>
              <ENT>Benzaldehyde, 2-methoxy-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">141-27-5</ENT>
              <ENT>2,6-Octadienal, 3,7-dimethyl-, (E)-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">143-14-6</ENT>
              <ENT>9-Undecenal</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">455-19-6</ENT>
              <ENT>Benzaldehyde, 4-(trifluoromethyl)-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">505-57-7</ENT>
              <ENT>02-Hexenal</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">552-89-6</ENT>
              <ENT>Benzaldehyde, 2-nitro-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">590-86-3</ENT>
              <ENT>Butanal, 3-methyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">597-31-9</ENT>
              <ENT>Propanal, 3-hydroxy-2,2-dimethyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">939-97-9</ENT>
              <ENT>Benzaldehyde, 4-(1,1-dimethylethyl)-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1121-60-4</ENT>
              <ENT>2-Pyridinecarboxaldehyde</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1200-14-2</ENT>
              <ENT>Benzaldehyde, 4-butyl</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1331-92-6</ENT>
              <ENT>2-Propenal, 3-phenyl-, monopentyl deriv.</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1334-78-7</ENT>
              <ENT>Benzaldehyde, methyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1423-46-7</ENT>
              <ENT>3-Cyclohexene-1-carboxaldehyde, 2,4,6-trimethyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1504-74-1</ENT>
              <ENT>2-Propenal, 3-(2-methoxyphenyl)-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2591-86-8</ENT>
              <ENT>1-Piperidinecarboxaldehyde</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3132-99-8</ENT>
              <ENT>Benzaldehyde, 3-bromo-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3268-49-3</ENT>
              <ENT>Propanal, 3-(methylthio)-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3613-30-7</ENT>
              <ENT>Octanal, 7-methoxy-3,7-dimethyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4501-58-0</ENT>
              <ENT>3-Cyclopentene-1-acetaldehyde, 2,2,3-trimethyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">5435-64-3</ENT>
              <ENT>Hexanal, 3,5,5-trimethyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">5780-07-4</ENT>
              <ENT>1,3-Benzodioxole-5-carboxaldehyde, 7-methoxy-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">5949-05-3</ENT>
              <ENT>6-Octenal, 3,7-dimethyl-, (S)-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">5988-91-0</ENT>
              <ENT>Octanal, 3,7-dimethyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">10031-82-0</ENT>
              <ENT>Benzaldehyde, 4-ethoxy-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">13586-68-0</ENT>
              <ENT>2-Propenal, 3- 4-(1,1-dimethylethyl)phenyl-2-methyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">17754-90-4</ENT>
              <ENT>Benzaldehyde, 4-(diethylamino)-2-hydroxy-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">26266-68-2</ENT>
              <ENT>Hexenal, 2-ethyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">27939-60-2</ENT>
              <ENT>3-Cyclohexene-1-carboxaldehyde, dimethyl-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">28602-27-9</ENT>
              <ENT>Benzaldehyde, (dimethylamino)-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">31906-04-4</ENT>
              <ENT>3-Cyclohexene-1-carboxaldehyde, 4-(4-hydroxy-4-methylpentyl)-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">37677-14-8</ENT>
              <ENT>3-Cyclohexene-1-carboxaldehyde, 4-(4-methyl-3-pentenyl)-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">39515-51-0</ENT>
              <ENT>Benzaldehyde, 3-phenoxy-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">52475-86-2</ENT>
              <ENT>3-Cyclohexene-1-carboxaldehyde, 1-methyl-4-(4-methyl-3-pentenyl)-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">66327-54-6</ENT>
              <ENT>3-Cyclohexene-1-carboxaldehyde, 1-methyl-4-(4-methylpentyl)-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Alkyl-, Chloro-, and Hydroxymethyl Diaryl Ethers</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3061-36-7</ENT>
              <ENT>1,4-Diphenoxybenzene</ENT>
              <ENT>04/12/93</ENT>
              <ENT>06/10/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3586-14-9</ENT>
              <ENT>Benzene, 1-methyl-3-phenoxy-</ENT>
              <ENT>04/12/93</ENT>
              <ENT>06/10/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">13826-35-2</ENT>
              <ENT>Benzenemethanol, 3-phenoxy-,</ENT>
              <ENT>04/12/93</ENT>
              <ENT>06/10/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">28299-41-4</ENT>
              <ENT>Benzene, 1,1,<E T="61">′</E>-oxybis[methyl-</ENT>
              <ENT>04/12/93</ENT>
              <ENT>06/10/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">28984-89-6</ENT>
              <ENT>1,1<E T="61">′</E>-Biphenyl, phenoxy-</ENT>
              <ENT>04/12/93</ENT>
              <ENT>06/10/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">42874-96-4</ENT>
              <ENT>2-Chloro-1-(3-methylphenoxy)-4-(trifluoromethyl)benzene</ENT>
              <ENT>04/12/93</ENT>
              <ENT>06/10/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">50594-77-9</ENT>
              <ENT>Phenol, 3-[2-chloro-4-(trifluoromethyl)phenoxy]-, acetate</ENT>
              <ENT>04/12/93</ENT>
              <ENT>06/10/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">50789-44-1</ENT>
              <ENT>Benzenemethanol, 3-phenoxy-, acetate</ENT>
              <ENT>04/12/93</ENT>
              <ENT>06/10/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">51632-16-7</ENT>
              <ENT>Benzene, 1-(bromomethyl)-3-phenoxy-</ENT>
              <ENT>04/12/93</ENT>
              <ENT>06/10/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">61702-88-3</ENT>
              <ENT>Benzene, 1,1<E T="61">′</E>-oxybis[(1,1,3,3-tetramethylbutyl)-</ENT>
              <ENT>04/12/93</ENT>
              <ENT>06/10/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">63734-62-3</ENT>
              <ENT>Benzoic acid, 3-[2-chloro-4-(trifluoromethyl)phenoxy]-,</ENT>
              <ENT>04/12/93</ENT>
              <ENT>06/10/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">69834-19-1</ENT>
              <ENT>Benzene, 1,1<E T="61">′</E>-oxybis[dodecyl-</ENT>
              <ENT>04/12/93</ENT>
              <ENT>06/10/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">72252-48-3</ENT>
              <ENT>Benzoic acid, 3-[2-chloro-4-(trifluoromethyl)phenoxy]-, potassium salt</ENT>
              <ENT>04/12/93</ENT>
              <ENT>06/10/93</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="48"/>
              <ENT I="01">Alkylphenols and Alkylphenol Ethoxylates:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">80-46-6</ENT>
              <ENT>4-tert-Pentylphenol</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">88-18-6</ENT>
              <ENT>2-tert-Butylphenol</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">94-06-4</ENT>
              <ENT>4-(1-Methylbutyl)phenol</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">98-54-4</ENT>
              <ENT>4-tert-Butylphenol</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">99-71-8</ENT>
              <ENT>4-sec-Butylphenol</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">104-40-5</ENT>
              <ENT>4-Nonylphenol</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">104-43-8</ENT>
              <ENT>4-Dodecylphenol</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">949-13-3</ENT>
              <ENT>2-Octylphenol</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1300-16-9</ENT>
              <ENT>Nonylphenol (mixed isomers)</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1322-69-6</ENT>
              <ENT>(1,1,3,3-Tetramethylbutyl)phenol (mixed isomers)</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1331-57-3</ENT>
              <ENT>Dodecylphenol (mixed isomers)</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1638-22-8</ENT>
              <ENT>4-n-Butylphenol</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1806-26-4</ENT>
              <ENT>4-Octylphenol</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2315-66-4</ENT>
              <ENT>Decaethylene glycol 4-isooctylphenyl ether</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2497-58-7</ENT>
              <ENT>Hexaethylene glycol 4-isooctylphenyl ether</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3180-09-4</ENT>
              <ENT>2-Butylphenol</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3884-95-5</ENT>
              <ENT>2-(1,1,3,3-Tetramethylbutyl)phenol</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">9002-93-1</ENT>
              <ENT>Polyethylene glycol 4-(tert-octyl)phenyl ether</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">9036-19-5</ENT>
              <ENT>Polyethylene glycol mono(octyl)phenyl ether</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">11066-49-2</ENT>
              <ENT>Isononylphenol (mixed isomers)</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">14938-35-3</ENT>
              <ENT>4-Pentylphenol</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">17404-66-9</ENT>
              <ENT>4-(1-Methyloctyl)phenol</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">25154-52-3</ENT>
              <ENT>Nonylphenol (mixed isomers)</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">27178-34-3</ENT>
              <ENT>tert-Butylphenol (mixed isomers)</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">27193-28-8</ENT>
              <ENT>(1,1,3,3-Tetramethylbutyl)phenol (mixed isomers)</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">27193-86-8</ENT>
              <ENT>Dodecylphenol (mixed isomers)</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">27985-70-2</ENT>
              <ENT>(1-Methylheptyl)phenol (mixed isomers)</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">29932-96-5</ENT>
              <ENT>(1,1,3,3-Tetramethylbutyl)phenol (mixed isomers)</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">30105-54-5</ENT>
              <ENT>(1,1,3,3-Tetramethylbutyl)phenol (mixed isomers)</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">31195-95-6</ENT>
              <ENT>Isobutylphenol (mixed isomers)</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">54932-78-4</ENT>
              <ENT>4-(2,2,3,3-Tetramethylbutyl)phenol</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">62744-41-6</ENT>
              <ENT>(1,1,3,3-Tetramethylbutyl)phenol (mixed isomers)</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">68987-90-6</ENT>
              <ENT>Poly(oxy-1,2-ethanediyl), <E T="02">α</E>-(octylphenyl)-<E T="61">ω</E>-hydroxy-, branched</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="02">84852-15-3</ENT>
              <ENT>Branched 4-nonylphenol (mixed isomers)</ENT>
              <ENT>3/29/96</ENT>
              <ENT>5/29/96</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">Alkyl phosphates:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">78-40-0</ENT>
              <ENT>Phosphoric acid, triethyl ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">78-42-2</ENT>
              <ENT>Phosphoric acid, tris(2-ethylhexyl)ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">78-51-3</ENT>
              <ENT>Ethanol, 2-butoxy-, phosphate (3:1)</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">107-66-4</ENT>
              <ENT>Phosphoric acid, dibutyl ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">126-71-6</ENT>
              <ENT>Phosphoric acid, tris(2-methylpropyl) ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">126-73-8</ENT>
              <ENT>Phosphoric acid tributyl ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">298-07-7</ENT>
              <ENT>Phosphoric acid, bis(2-ethylhexyl)ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">812-00-0</ENT>
              <ENT>Phosphoric acid, monomethyl ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1070-03-7</ENT>
              <ENT>Phosphoric acid, mono(2-ethylhexyl)ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1498-51-7</ENT>
              <ENT>Phosphorodichloridic acid, ethylester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1623-15-0</ENT>
              <ENT>Phosphoric acid, monobutyl ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1623-24-1</ENT>
              <ENT>Phosphoric acid, mono(1-methylethyl)ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2958-09-0</ENT>
              <ENT>Phosphoric acid, monooctadecyl ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3900-04-7</ENT>
              <ENT>Phosphoric acid, monohexyl ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3991-73-9</ENT>
              <ENT>Phosphoric acid, monooctyl ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">7057-92-3</ENT>
              <ENT>Phosphoric acid, didodecyl ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">7332-46-9</ENT>
              <ENT>Ethanol, 2-(2-butoxyethoxy)-, phosphate (3:1)</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">12645-31-7</ENT>
              <ENT>Phosphoric acid, 2-ethylhexyl ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">12751-23-4</ENT>
              <ENT>Phosphoric acid, dodecyl ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">27215-10-7</ENT>
              <ENT>Phosphoric acid, diisooctyl ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">Brominated flame retardants:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">74-97-5</ENT>
              <ENT>Methane, bromochloro-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">87-10-5</ENT>
              <ENT>Benzamide, 3,5-dibromo-N-(4-bromophenyl)-2-hydroxy-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">87-83-2</ENT>
              <ENT>Benzene, pentabromomethyl-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">87-84-3</ENT>
              <ENT>Cyclohexane,1,2,3,4,5-pentabromo-6-chloro-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">96-13-9</ENT>
              <ENT>1-Propanol, 2,3-dibromo-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">593-60-2</ENT>
              <ENT>Ethene, bromo-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">615-58-7</ENT>
              <ENT>Phenol, 2,4-dibromo-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4162-45-2</ENT>
              <ENT>Ethanol,2,2’-((1-methylethylidene)bis((2,6-dibromo-4,1-phenylene)oxy))bis-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">25327-89-3</ENT>
              <ENT>Benzene, 1,1’-(1-methylethylidene)bis(3,5-dibromo-4-(2-propenyloxy)-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">30554-72-4</ENT>
              <ENT>Cyclohexane, tetrabromodichloro-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">30554-73-5</ENT>
              <ENT>Cyclohexane, tribromotrichloro-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">36483-57-5</ENT>
              <ENT>1-Propanol, 2,2-dimethyl-, tribromo deriv.</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">55205-38-4</ENT>
              <ENT>2-Propenoic acid, (1-methylethylidene)bis(2,6-dibromo-4,1-phenylene) ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49"/>
              <ENT I="02">68955-41-9</ENT>
              <ENT>Alkanes, C10-18, bromochloro-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">69882-11-7</ENT>
              <ENT>Phenol, 2,4(or 2,6)-dibromo-, homopolymer</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">88497-56-7</ENT>
              <ENT>Benzene, ethenyl-, homopolymer, brominated</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Chloralkyl phosphates</ENT>
            </ROW>
            <ROW>
              <ENT I="02">34621-99-3</ENT>
              <ENT>1,2-Ethanediyltetrakis(2-chloro-1-methylethylene) phosphate</ENT>
              <ENT>6/14/93</ENT>
              <ENT>8/12/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">38051-10-4</ENT>
              <ENT>2,2-Bis(chloromethyl)-1,3-propanediyltetrakis(2-chloroethyl) phosphate</ENT>
              <ENT>6/14/93</ENT>
              <ENT>8/12/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">53461-82-8</ENT>
              <ENT>Oxydi-2,1-ethanediyltetrakis(2-chloroethyl) phosphate</ENT>
              <ENT>6/14/93</ENT>
              <ENT>8/12/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">76649-15-5</ENT>
              <ENT>2-Chloro-1-methylethylbis(2-chloropropyl) phosphate</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">Cyanoacrylates:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">137-05-3</ENT>
              <ENT>2-Propenoic acid, 2-cyano-, methyl ester</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1069-55-2</ENT>
              <ENT>2-Propenoic acid, 2-cyano-, isobutyl ester</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">6197-30-4</ENT>
              <ENT>2-Propenoic acid, 2-cyano-3,3-diphenyl-, 2-ethylhexyl ester</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">6606-65-1</ENT>
              <ENT>2-Propenoic acid, 2-cyano-, butyl ester</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">7085-85-0</ENT>
              <ENT>2-Propenoic acid, 2-cyano-, ethyl ester</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">7324-02-9</ENT>
              <ENT>2-Propenoic acid, 2-cyano-, 2-propenyl ester</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">10586-17-1</ENT>
              <ENT>2-Propenoic acid, 2-cyano-, 1-methylethyl ester</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">21982-43-4</ENT>
              <ENT>2-Propenoic acid, 2-cyano-, ethoxyethyl ester</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">23023-91-8</ENT>
              <ENT>2-Propenoic acid, 2-cyano-, 2,2,2-trifluoromethyl ester</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">27816-23-5</ENT>
              <ENT>2-Propenoic acid, 2-cyano-, 2-methoxyethyl ester</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">64992-16-1</ENT>

              <ENT>Ethanaminium, 2-[[2-cyano-3-[4-(diethylamino)phenyl]-1-oxo-2-propenyl]oxy]-<E T="03">N,N,N</E>-trimethyl-, chloride</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">IRIS Chemicals:</ENT>
              <ENT O="xl"/>
              <ENT O="xl"/>
              <ENT O="xl"/>
            </ROW>
            <ROW>
              <ENT I="02">51-28-5</ENT>
              <ENT>2,4 Dinitrophenol</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">95-65-8</ENT>
              <ENT>3,4 Dinethylphenol</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">Isocyanates:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">91-97-4</ENT>
              <ENT>1,1’-Biphenyl, 4,4’-diisocyanato-3,3’-dimethyl-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">100-28-7</ENT>
              <ENT>Benzene, 1-isocyanato-4-nitro-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">101-68-8</ENT>
              <ENT>Benzene, 1,1’-methylenebis(4-isocyanato-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">102-36-3</ENT>
              <ENT>Benzene, 1,2-dichloro-4-isocyanato-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">103-71-9</ENT>
              <ENT>Benzene, isocyanato-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">104-12-1</ENT>
              <ENT>Benzene, 1-chloro-4-isocyanato-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">104-49-4</ENT>
              <ENT>Benzene, 1,4-diisocyanato-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">109-90-0</ENT>
              <ENT>Ethane, isocyanato-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">110-78-1</ENT>
              <ENT>Propane, 1-isocyanato-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">111-36-4</ENT>
              <ENT>Butane, 1-isocyanato-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">112-96-9</ENT>
              <ENT>Octadecane, 1-isocyanato-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">123-61-5</ENT>
              <ENT>Benzene, 1,3-diisocyanato-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">329-01-1</ENT>
              <ENT>Benzene, 1-isocyanato-3-(trifluoromethyl)-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">614-68-6</ENT>
              <ENT>Benzene, 1-isocyanato-2-methyl-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">622-58-2</ENT>
              <ENT>Benzene, 1-isocyanato-4-methyl-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">624-83-9</ENT>
              <ENT>Methane, isocyanato-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1476-23-9</ENT>
              <ENT>1-Propene, 3-isocyanato-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2422-91-5</ENT>
              <ENT>Benzene, 1,1’,1”-methylidynetris(4-isocyanato-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2493-02-9</ENT>
              <ENT>Benzene, 1-bromo-4-isocyanato-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2909-38-8</ENT>
              <ENT>Benzene, 1-chloro-3-isocyanato-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2949-22-6</ENT>
              <ENT>Acetic acid, isocyanato-, ethyl ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3173-53-3</ENT>
              <ENT>Cyclohexane, isocyanato-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4035-89-6</ENT>
              <ENT>Imidodicarbonic diamide,N,N’,2-tris(6-isocyanatohexyl)-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4098-71-9</ENT>
              <ENT>Cyclohexane, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethyl-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4151-51-3</ENT>
              <ENT>Phenol, 4-isocyanato-, phosphorothioate (3:1) (ester)</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">5124-30-1</ENT>
              <ENT>Cyclohexane, 1,1’-methylenebis(4-isocyanato-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">5873-54-1</ENT>
              <ENT>Benzene, 1-isocyanato-2-((4-isocyanatophenyl)methyl)-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">10031-75-1</ENT>
              <ENT>Benzene, 1,1’-(diisocyanatomethylene)bis-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">15646-96-5</ENT>
              <ENT>Hexane, 1,6-diisocyanato-2,4,4-trimethyl-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">16938-22-0</ENT>
              <ENT>Hexane, 1,6-diisocyanato-2,2,4-trimethyl-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">25854-16-4</ENT>
              <ENT>Benzene, bis(isocyanatomethyl)-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">26447-40-5</ENT>
              <ENT>Benzene, 1,1’-methylenebis(isocyanato-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">26603-40-7</ENT>
              <ENT>1,3,5,-Triazine-2,4,6(1H.3H,5H-trione, 1,3,5-tris(3-isocyanatomethylphenyl)-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">26747-90-0</ENT>
              <ENT>1,3-Diazetidine-2,4-dione, 1,3-bis(3-isocyanatomethylphenyl)-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">28178-42-9</ENT>
              <ENT>Benzene, 2-isocyanato-1,3-bis(1-methylethyl)-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">28556-81-2</ENT>
              <ENT>Benzene, 2-isocyanato-1,3-dimethyl-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">30674-80-7</ENT>
              <ENT>2-Propenoic acid, 2-methyl-,2-isocyanatoethyl ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">34893-92-0</ENT>
              <ENT>Benzene, 1,3-dichloro-5-isocyanato-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">68239-06-5</ENT>
              <ENT>Cyclohexane, 2-heptyl-3,4-bis(9-isocyanatononyl)-1-pentyl-</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="02">73597-26-9</ENT>
              <ENT>2-Propenoic acid, 2-methyl-, 2-(((((5-isocyanato-1,3,3-trimethylcyclohexyl) methyl)amino)carbonyl)oxy)ethyl ester</ENT>
              <ENT>10/29/90</ENT>
              <ENT>12/27/90</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">Methyl ethylene glycol ethers and esters:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3121-61-7</ENT>
              <ENT O="xl">Ethylene glycol monomethyl ether acrylate</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">23783-42-8 </ENT>
              <ENT O="xl">Tetraethylene glycol monomethyl ether</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">Nonylphenol ethoxylates</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="50"/>
              <ENT I="02">7311-27-5</ENT>
              <ENT>Ethanol, 2-[2-[2-[2-(p-nonylphenoxy)ethoxy]ethoxy]ethoxy]-</ENT>
              <ENT>2/10/00</ENT>
              <ENT>4/10/00</ENT>
            </ROW>
            <ROW>
              <ENT I="02">9016-45-9</ENT>
              <ENT>Poly(oxy-1,2-ethanediyl), alpha-(nonylphenyl)-omega-hydroxy-</ENT>
              <ENT>2/10/00</ENT>
              <ENT>4/10/00</ENT>
            </ROW>
            <ROW>
              <ENT I="02">20427-84-3</ENT>
              <ENT>Ethanol, 2-[2-(p-nonylphenoxy)ethoxy]-</ENT>
              <ENT>2/10/00</ENT>
              <ENT>4/10/00</ENT>
            </ROW>
            <ROW>
              <ENT I="02">20636-48-0</ENT>
              <ENT>3,6,9,12-Tetraoxatetradecan-1-ol, 14-(4-nonylphenoxy)-</ENT>
              <ENT>2/10/00</ENT>
              <ENT>4/10/00</ENT>
            </ROW>
            <ROW>
              <ENT I="02">26027-38-3</ENT>
              <ENT>Poly(oxy-1,2-ethanediyl), alpha-(4-nonylphenyl)-omega-hydroxy-</ENT>
              <ENT>2/10/00</ENT>
              <ENT>4/10/00</ENT>
            </ROW>
            <ROW>
              <ENT I="02">26264-02-8</ENT>
              <ENT>3,6,9,12-Tetraoxatetradecan-1-ol, 14-(nonylphenoxy)-</ENT>
              <ENT>2/10/00</ENT>
              <ENT>4/10/00</ENT>
            </ROW>
            <ROW>
              <ENT I="02">26571-11-9</ENT>
              <ENT>3,6,9,12,15,18,21,24-Octaoxahexacosan-1-ol, 26-(nonylphenoxy)-</ENT>
              <ENT>2/10/00</ENT>
              <ENT>4/10/00</ENT>
            </ROW>
            <ROW>
              <ENT I="02">27176-93-8</ENT>
              <ENT>Ethanol, 2-[2-(nonylphenoxy)ethoxy]-</ENT>
              <ENT>2/10/00</ENT>
              <ENT>4/10/00</ENT>
            </ROW>
            <ROW>
              <ENT I="02">27177-01-1</ENT>
              <ENT>3,6,9,12,15-Pentaoxaheptadecan-1-ol, 17-(nonylphenoxy)-</ENT>
              <ENT>2/10/00</ENT>
              <ENT>4/10/00</ENT>
            </ROW>
            <ROW>
              <ENT I="02">27177-05-5</ENT>
              <ENT>3,6,9,12,15,18,21-Heptaoxatricosan-1-ol, 23-(nonylphenoxy)-</ENT>
              <ENT>2/10/00</ENT>
              <ENT>4/10/00</ENT>
            </ROW>
            <ROW>
              <ENT I="02">27177-08-8</ENT>
              <ENT>3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-(nonylphenoxy)-</ENT>
              <ENT>2/10/00</ENT>
              <ENT>4/10/00</ENT>
            </ROW>
            <ROW>
              <ENT I="02">27986-36-3</ENT>
              <ENT>Ethanol, 2-(nonylphenoxy)-</ENT>
              <ENT>2/10/00</ENT>
              <ENT>4/10/00</ENT>
            </ROW>
            <ROW>
              <ENT I="02">37205-87-1</ENT>
              <ENT>Poly(oxy-1,2-ethanediyl), alpha-(isononylphenyl)-omega-hydroxy-</ENT>
              <ENT>2/10/00</ENT>
              <ENT>4/10/00</ENT>
            </ROW>
            <ROW>
              <ENT I="02">51938-25-1</ENT>
              <ENT>Poly(oxy-1,2-ethanediyl), alpha-(2-nonylphenyl)-omega-hydroxy-</ENT>
              <ENT>2/10/00</ENT>
              <ENT>4/10/00</ENT>
            </ROW>
            <ROW>
              <ENT I="02">65455-72-3</ENT>
              <ENT>3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-(isononylphenoxy)- </ENT>
              <ENT>2/10/00</ENT>
              <ENT>4/10/00</ENT>
            </ROW>
            <ROW>
              <ENT I="02">68412-54-4</ENT>
              <ENT>Poly(oxy-1,2-ethanediyl), alpha-(nonylphenyl)-omega-hydroxy-, branched </ENT>
              <ENT>2/10/00</ENT>
              <ENT>4/10/00</ENT>
            </ROW>
            <ROW>
              <ENT I="02">98113-10-1</ENT>
              <ENT>NP9</ENT>
              <ENT>2/10/00</ENT>
              <ENT>4/10/00</ENT>
            </ROW>
            <ROW>
              <ENT I="02">127087-87-0</ENT>
              <ENT>Poly(oxy-1,2-ethanediyl), alpha-(4-nonylphenyl)-omega-hydroxy-, branched</ENT>
              <ENT>2/10/00</ENT>
              <ENT>4/10/00</ENT>
            </ROW>
            <ROW>
              <ENT I="02">152143-22-1</ENT>
              <ENT>Poly(oxy-1,2-ethanediyl), alpha-(4-nonylphenyl)-omega-hydroxy-, branched, phosphates</ENT>
              <ENT>2/10/00</ENT>
              <ENT>4/10/00</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">OSHA Chemicals in Need of Dermal Absorption Testing:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">60-29-7</ENT>
              <ENT>Ethyl ether</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">61-82-5</ENT>
              <ENT>Amitrole</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">74-96-4</ENT>
              <ENT>Ethyl bromide</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">75-05-8</ENT>
              <ENT>Acetonitrile</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">75-12-7</ENT>
              <ENT>Formamide</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">75-15-0</ENT>
              <ENT>Carbon disulfide</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">75-25-2</ENT>
              <ENT>Bromoform</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">75-34-3</ENT>
              <ENT>1,1-Dichloroethane</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">75-35-4</ENT>
              <ENT>Vinylidene chloride</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">75-65-0</ENT>
              <ENT>
                <E T="03">tert</E>-Butyl alcohol</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">76-22-2</ENT>
              <ENT>Camphor</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">77-73-6</ENT>
              <ENT>Dicyclopentadiene</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">77-78-1</ENT>
              <ENT>Dimethyl sulfate</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">78-59-1</ENT>
              <ENT>Isophorone</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">78-87-5</ENT>
              <ENT>Propylene dichloride</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">78-92-2</ENT>
              <ENT>
                <E T="03">sec</E>-Butyl alcohol</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">79-20-9</ENT>
              <ENT>Methyl acetate</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">79-46-9</ENT>
              <ENT>2-Nitropropane</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">88-72-2</ENT>
              <ENT>o-Nitrotoluene</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">89-72-5</ENT>
              <ENT>o-sec-Butylphenol</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">90-04-0</ENT>
              <ENT>o-Anisidine</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">91-20-3</ENT>
              <ENT>Naphthalene</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">92-52-4</ENT>
              <ENT>Biphenyl</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">95-13-6</ENT>
              <ENT>Indene</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">95-49-8</ENT>
              <ENT>o-Chlorotoluene</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">95-50-1</ENT>
              <ENT>o-Dichlorobenzene</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">96-18-4</ENT>
              <ENT>1,2,3-Trichloropropane</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">97-77-8</ENT>
              <ENT>Disulfiram</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">98-29-3</ENT>
              <ENT>t-Butylcatechol</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">99-08-1</ENT>
              <ENT>m-Nitrotoluene</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">99-65-0</ENT>
              <ENT>m-Dinitrobenzene</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">99-99-0</ENT>
              <ENT>p-Nitrotoluene</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">100-00-5</ENT>
              <ENT>p-Nitrochlorobenzene</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">100-01-6</ENT>
              <ENT>p-Nitroaniline</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">100-44-7</ENT>
              <ENT>Benzyl chloride</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">100-25-4</ENT>
              <ENT>
                <E T="03">p</E>-Dinitrobenzene</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">100-63-0</ENT>
              <ENT>Phenylhydrazine</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">105-46-4</ENT>
              <ENT>
                <E T="03">sec</E>-Butyl acetate</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">106-42-3</ENT>
              <ENT>
                <E T="03">p</E>-Xylene</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">106-46-7</ENT>
              <ENT>p-Dichlorobenzene</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">106-49-0</ENT>
              <ENT>p-Toluidine</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">107-06-2</ENT>
              <ENT>Ethylene dichloride</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">107-31-3</ENT>
              <ENT>Methyl formate</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">107-66-4</ENT>
              <ENT>Dibutyl phosphate</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">108-03-2</ENT>
              <ENT>1-Nitropropane</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">108-44-1</ENT>
              <ENT>m-Toluidine</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">108-87-2</ENT>
              <ENT>Methylcyclohexane</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">108-90-7</ENT>
              <ENT>Chlorobenzene</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">108-93-0</ENT>
              <ENT>Cyclohexanol</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="51"/>
              <ENT I="02">109-66-0</ENT>
              <ENT>Pentane</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">109-99-9</ENT>
              <ENT>Tetrahydrofuran</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">110-12-3</ENT>
              <ENT>Methyl isoamyl ketone</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">110-83-8</ENT>
              <ENT>Cyclohexene</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">111-84-2</ENT>
              <ENT>Nonane</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">120-80-9</ENT>
              <ENT>Catechol</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">121-14-2</ENT>
              <ENT>2,4-Dinitrotoluene</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">121-69-7</ENT>
              <ENT>Dimethylaniline</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">122-39-4</ENT>
              <ENT>Diphenylamine</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">123-42-2</ENT>
              <ENT>Diacetone alcohol</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">123-92-2</ENT>
              <ENT>Isoamyl acetate</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">126-99-8</ENT>
              <ENT>beta-Chloroprene</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">127-19-5</ENT>
              <ENT>Dimethyl acetamide</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">142-82-5</ENT>
              <ENT>Heptane (<E T="03">n</E>-Heptane)</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">150-76-5</ENT>
              <ENT>p-Methoxyphenol</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">287-92-3</ENT>
              <ENT>Cyclopentane</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">528-29-0</ENT>
              <ENT>o-Dinitrobenzene</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">532-27-4</ENT>
              <ENT>
                <E T="03">a</E>-Chloroacetophenone</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">540-59-0</ENT>
              <ENT>1,2-Dichloroethylene</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">540-88-5</ENT>
              <ENT>
                <E T="03">tert</E>-Butyl acetate</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">542-92-7</ENT>
              <ENT>Cyclopentadiene</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">626-17-5</ENT>
              <ENT>m-Phthalodinitrile</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">628-63-7</ENT>
              <ENT>
                <E T="03">n</E>-Amyl acetate</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">768-52-5</ENT>
              <ENT>N-Isopropylaniline</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1300-73-8</ENT>
              <ENT>Xylidine</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">6423-43-4</ENT>
              <ENT>Propylene glycol dinitrate</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">7631-90-5</ENT>
              <ENT>Sodium bisulfite</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">7681-57-4</ENT>
              <ENT>Sodium metabisulfite</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">25013-15-4</ENT>
              <ENT>Vinyl toluene</ENT>
              <ENT>3/11/94</ENT>
              <ENT>5/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">34590-94-8</ENT>
              <ENT>Dipropylene glycol methyl ether</ENT>
              <ENT>8/4/95</ENT>
              <ENT>10/3/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">Propylene glycol ethers and esters:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">108-65-6</ENT>
              <ENT>Propylene glycol monomethyl ether acetate</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">110-98-5</ENT>
              <ENT>Dipropylene glycol</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">770-35-4</ENT>
              <ENT>1-Phenoxy-2-propanol</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">20324-32-7</ENT>
              <ENT>1-(2-Methoxy-1-methylethoxy)-2-propanol</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">20324-33-8</ENT>
              <ENT>Tripropylene glycol methyl ether</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">28677-93-2</ENT>
              <ENT>Methoxy-1-propanol</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">29387-86-8</ENT>
              <ENT>Propylene glycol monobutyl ether</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">29911-28-2</ENT>
              <ENT>Dipropylene glycol butyl ether</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">42978-66-5</ENT>
              <ENT>Tripropylene glycol diacrylate</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">57018-52-7</ENT>
              <ENT>Propylene glycol mono-<E T="03">tert</E>-butyl ether</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">88917-22-0</ENT>
              <ENT>Dipropylene glycol monomethyl ether acetate</ENT>
              <ENT>1/26/94</ENT>
              <ENT>3/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">Siloxanes:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">107-46-0</ENT>
              <ENT>Hexamethyldisiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">107-50-6</ENT>
              <ENT>Tetradecamethylcycloheptasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">107-51-7</ENT>
              <ENT>Octamethyltrisiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">107-52-8</ENT>
              <ENT>Tetradecamethylhexasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">107-53-9</ENT>
              <ENT>Tetracosamethylundecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">141-62-8</ENT>
              <ENT>Decamethyltetrasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">141-63-9</ENT>
              <ENT>Dodecamethylpentasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">540-97-6</ENT>
              <ENT>Dodecamethylcyclohexasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">541-01-5</ENT>
              <ENT>Hexadecamethylheptasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">541-02-6</ENT>
              <ENT>Decamethylcyclopentasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">541-05-9</ENT>
              <ENT>Hexamethylcyclotrisiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">546-56-5</ENT>
              <ENT>Octaphenylcyclotetrasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">556-67-2</ENT>
              <ENT>Octamethylcyclotetrasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">556-68-3</ENT>
              <ENT>Hexadecamethylcyclooctasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">556-69-4</ENT>
              <ENT>Octadecamethyloctasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">556-70-7</ENT>
              <ENT>Docosamethyldecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">556-71-8</ENT>
              <ENT>Octadecamethylcyclononasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">999-97-3</ENT>
              <ENT>Hexamethyldisilazane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2370-88-9</ENT>
              <ENT>Tetramethylcyclotetrasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2374-14-3</ENT>
              <ENT>Trifluoropropylmethylcyclotrisiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2471-08-1</ENT>
              <ENT>Hexacosamethyldodecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2471-09-2</ENT>
              <ENT>Octacosamethyltridecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2471-10-5</ENT>
              <ENT>Triacontamethyltetradecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2471-11-6</ENT>
              <ENT>Dotriacontamethylpentadecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2554-06-5</ENT>
              <ENT>Methylvinylcyclosiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2627-95-4</ENT>
              <ENT>Tetramethyldivinyldisiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2652-13-3</ENT>
              <ENT>Eicosamethylnonasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">70131-67-8</ENT>
              <ENT>Siloxanes and silicones, di-Me, hydroxy-terminated</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="52"/>
              <ENT I="02">9004-73-3</ENT>
              <ENT>Methylpolysiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">18766-38-6</ENT>
              <ENT>Docosamethylcycloundecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">18772-36-6</ENT>
              <ENT>Eicosamethylcyclodecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">18844-04-7</ENT>
              <ENT>Hexatriacontamethylheptadecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">18919-94-3</ENT>
              <ENT>Tetracosamethylcyclododecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">23523-12-8</ENT>
              <ENT>Hexatriacontamethylcyclooctadecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">23523-14-0</ENT>
              <ENT>Triacontamethylcyclopentadecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">23732-94-7</ENT>
              <ENT>Hexacosamethylcyclotridecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">36938-50-8</ENT>
              <ENT>Tetratriacontamethyl hexadecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">36938-52-0</ENT>
              <ENT>Octatriacontamethyl octadecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">63148-62-9</ENT>
              <ENT>Dimethyl silicones and siloxanes</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">67762-90-7</ENT>
              <ENT>Dimethyl silicones and siloxane, reaction products with silica</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">67762-94-1</ENT>
              <ENT>Dimethylmethylvinylsiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">68037-59-2</ENT>
              <ENT>Dimethylhydropolylsiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">68037-74-1</ENT>
              <ENT>Dimethylpolysiloxanes</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">68083-14-7</ENT>
              <ENT>Dimethyldiphenylsiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">69430-24-6</ENT>
              <ENT>Cyclopolydimethylsiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">115361-68-7</ENT>
              <ENT>Dimethylmethyl 3,3,3-trifluoropropyl siloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">149050-40-8</ENT>
              <ENT>Octacosamethylcyclotetradecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">150026-95-2</ENT>
              <ENT>Dotriacontamethylcyclohexadecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">150026-96-3</ENT>
              <ENT>Tetratriacontamethylcycloheptadecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">150026-97-4</ENT>
              <ENT>Octatriacontamethylcyclononadecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">150026-98-5</ENT>
              <ENT>Tetracontamethylcycloeicosasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">150026-99-6</ENT>
              <ENT>Tetracontamethylnonadecasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">150027-00-2</ENT>
              <ENT>Dotetracontamethyleicosasiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">not available</ENT>
              <ENT>Polymethyloctadecylsiloxane</ENT>
              <ENT>10/12/93</ENT>
              <ENT>2/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">Substantially produced chemicals in need of subchronic tests:</ENT>
              <ENT O="xl"/>
              <ENT O="xl"/>
              <ENT O="xl"/>
            </ROW>
            <ROW>
              <ENT I="02">80-51-3</ENT>
              <ENT>p,p’-Oxybis(benzenesulfonylhydrazide)</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">81-84-5</ENT>
              <ENT>Naphthalenedicarboxylic anhydride</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">84-51-5</ENT>
              <ENT>2-Ethylanthraquinone</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">87-02-5</ENT>
              <ENT>7-Amino-4-hydroxy-2-naphthalenesulfonic acid</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">90-15-3</ENT>
              <ENT>1-Naphthol</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">92-70-6</ENT>
              <ENT>3-Hydroxy-2-naphthoic acid</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">94-28-0</ENT>
              <ENT>Triethylene glycol bis(2-ethylhexanoate)</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">95-32-9</ENT>
              <ENT>2-(4-Morpholinyldithio)-benzothiazole</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">97-88-1</ENT>
              <ENT>N-Butyl methacrylate</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">98-48-6</ENT>
              <ENT>1,3-Benzenedisulfonic Acid</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">99-54-7</ENT>
              <ENT>3,4-Dichloronitrobenzene</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">99-63-8</ENT>
              <ENT>Isophthaloyl chloride</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">100-20-9</ENT>
              <ENT>Terephthaloyl chloride</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">100-29-8</ENT>
              <ENT>4-Ethoxynitrobenzene</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">102-01-2</ENT>
              <ENT>Acetoacetanilide</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">106-31-0</ENT>
              <ENT>Butyric anhydride</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">106-63-8</ENT>
              <ENT>Isobutyl acrylate</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">111-96-6</ENT>
              <ENT>Diethylene glycol dimethyl ether</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">112-15-2</ENT>
              <ENT>Ethanol, 2-(2-ethoxyethoxy)-, acetate</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">116-81-4</ENT>
              <ENT>Bromamine acid</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">119-33-5</ENT>
              <ENT>4-Methyl-2-nitro-phenol</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">121-60-8</ENT>
              <ENT>4-(Acetylamino)benzenesulfonyl chloride</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">123-54-6</ENT>
              <ENT>2,4-Pentanedione</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">123-62-6</ENT>
              <ENT>Propanoic anhydride</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">142-16-5</ENT>
              <ENT>Bis(2-ethylhexyl)-2-butenedioate</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">311-89-7</ENT>
              <ENT>Perfluorotributylamine</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">355-42-0</ENT>
              <ENT>Perfluoro-N-hexane</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">594-42-3</ENT>
              <ENT>Trichloromethanesulfenyl chloride</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">616-21-7</ENT>
              <ENT>1,2-Dichlorobutane</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">626-17-5</ENT>
              <ENT>1,3-Dicyanobenzene</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">760-23-6</ENT>
              <ENT>3,4-Dichlorobutene</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">929-06-6</ENT>
              <ENT>2-(2-Aminoethoxy)-ethanol</ENT>
              <ENT>6/30/92</ENT>
              <ENT>9/28/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1047-16-1</ENT>
              <ENT>Quinacridone</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1111-78-0</ENT>
              <ENT>Ammonium carbamate</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3089-11-0</ENT>
              <ENT>Hexa(methoxymethyl) melamine</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="01" O="xl">Sulphones:</ENT>
              <ENT O="xl"/>
              <ENT O="xl"/>
              <ENT O="xl"/>
            </ROW>
            <ROW>
              <ENT I="02">67-71-0</ENT>
              <ENT>Dimethylsulfone</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">77-79-2</ENT>
              <ENT>3-Sulfolene</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">80-07-9</ENT>
              <ENT>Sulfonyl bis-(4-chlorobenzene)</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">80-08-0</ENT>
              <ENT>4,4’-Diaminodiphenyl sulfone</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">80-09-1</ENT>
              <ENT>Bisphenol S</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">98-30-6</ENT>
              <ENT>2-Amino-4-(methylsulfonyl)phenol</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="53"/>
              <ENT I="02">126-33-0</ENT>
              <ENT>Sulfolane</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">127-63-9</ENT>
              <ENT>Diphenylsulfone</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2580-77-0</ENT>
              <ENT>2,2’-Sulfonyl bis-ethanol</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3278-22-6</ENT>
              <ENT>1,1’-[Methylene bis(sulfonyl)]bisethene</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">5246-57-1</ENT>
              <ENT>2-[(3-Aminophenyl)sulfonyl]ethanol</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">16588-67-3</ENT>
              <ENT>3-[N-Ethyl-4-[[6-(methylsulfonyl)-2-benzothiazolyl] azo]-m-toluidino]- propionitrile</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">17557-67-4</ENT>
              <ENT>6-(Methylsulfonyl)-2-benzothiazolamine</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">17601-96-6</ENT>
              <ENT>2-Amino-4-[(2-hydroxyethyl) sulfonyl]phenol</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">17688-68-5</ENT>
              <ENT>4-Phenylthiomorpholine, 1,1-dioxide</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">17741-62-7</ENT>
              <ENT>4-[4-[(2,6-Dichloro-4-nitrophenyl) azo]phenyl]thiomorpholine, 1,1-dioxide-</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">18760-44-6</ENT>
              <ENT>3-(Decyloxy)tetrahydrothiophene 1,1-dioxide</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">20018-09-1</ENT>
              <ENT>1-(Diiodomethyl) sulfonyl-4-methyl benzene</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">26750-50-5</ENT>
              <ENT>1,1’-[Oxybis(methylenesulfonyl)] bisethene</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">36724-43-3</ENT>
              <ENT>2,2’-[Oxybis(methylenesulfonyl)]bisethanol</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">41123-59-5</ENT>
              <ENT>1,1’-[Methylenebis(sulfonyl)]bis-2-chloroethane</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">41123-69-7</ENT>
              <ENT>2,2’-[Methylenebis(sulfonyl)]bisethanol</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">41687-30-3</ENT>
              <ENT>2-[(3-Nitrophenyl)sulfonyl]ethanol</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">52218-35-6</ENT>
              <ENT>2-[(6-Amino-2-naphthalenyl)sulfonyl]ethanol</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">53061-10-2</ENT>
              <ENT>1,1’-[Oxybis(methylenesulfonyl)]bis-2-chloroethane</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
            <ROW>
              <ENT I="02">63134-33-8</ENT>
              <ENT>4-[[4-(Phenylmethoxy)phenyl]sulfonyl]phenol</ENT>
              <ENT>9/30/91</ENT>
              <ENT>11/27/91</ENT>
            </ROW>
          </GPOTABLE>
          <CITA TYPE="W">(Secs 8(a) and 8(d), 90 Stat. 2027, 2029; 15 U.S.C. 2607 (a) and (d))</CITA>
          
          <CITA TYPE="W">[47 FR 26998, June 22, 1982]</CITA>
          <WEDNOTE>
            <HD SOURCE="HED">Editorial Note:</HD>
            <P>For <E T="04">Federal Register</E> citations affecting § 712.30, see the List of CFR Sections Affected in the Finding Aids section of this volume.</P>
          </WEDNOTE>
          <WEFFDNO>
            <HD SOURCE="HED">Effective Date Note</HD>
            <P>1: At 59 FR 14115, Mar. 25, 1994, in § 712.30 paragraph (x), the chemical substances under the category “propylene glycol ethers esters” and all related dates were stayed, effective March 25, 1994.</P>
          </WEFFDNO>
        </SECTION>
      </SUBPART>
    </PART>
    <PART>
      <EAR>Pt. 716</EAR>
      <HD SOURCE="HED">PART 716—HEALTH AND SAFETY DATA REPORTING</HD>
      <CONTENTS>
        <SUBPART>
          <HD SOURCE="HED">Subpart A—General Provisions</HD>
          <SECHD>Sec.</SECHD>
          <SECTNO>716.1</SECTNO>
          <SUBJECT>Scope and compliance.</SUBJECT>
          <SECTNO>716.3</SECTNO>
          <SUBJECT>Definitions.</SUBJECT>
          <SECTNO>716.5</SECTNO>
          <SUBJECT>Persons who must report.</SUBJECT>
          <SECTNO>716.10</SECTNO>
          <SUBJECT>Studies to be reported.</SUBJECT>
          <SECTNO>716.20</SECTNO>
          <SUBJECT>Studies not subject to the reporting requirements.</SUBJECT>
          <SECTNO>716.25</SECTNO>
          <SUBJECT>Adequate file search.</SUBJECT>
          <SECTNO>716.30</SECTNO>
          <SUBJECT>Submission of copies of studies.</SUBJECT>
          <SECTNO>716.35</SECTNO>
          <SUBJECT>Submission of lists of studies.</SUBJECT>
          <SECTNO>716.40</SECTNO>
          <SUBJECT>EPA requests for submission of further information.</SUBJECT>
          <SECTNO>716.45</SECTNO>
          <SUBJECT>How to report on substances and mixtures.</SUBJECT>
          <SECTNO>716.50</SECTNO>
          <SUBJECT>Reporting physical and chemical properties.</SUBJECT>
          <SECTNO>716.55</SECTNO>
          <SUBJECT>Confidentiality claims.</SUBJECT>
          <SECTNO>716.60</SECTNO>
          <SUBJECT>Reporting schedule.</SUBJECT>
          <SECTNO>716.65</SECTNO>
          <SUBJECT>Reporting period.</SUBJECT>
        </SUBPART>
        <SUBPART>
          <HD SOURCE="HED">Subpart B—Specific Chemical Listings</HD>
          <SECTNO>716.105</SECTNO>
          <SUBJECT>Additions of substances and mixtures to which this subpart applies.</SUBJECT>
          <SECTNO>716.120</SECTNO>
          <SUBJECT>Substances and listed mixtures to which this subpart applies.</SUBJECT>
        </SUBPART>
      </CONTENTS>
      <AUTH>
        <HD SOURCE="HED">Authority:</HD>
        <P>15 U.S.C. 2607(d).</P>
      </AUTH>
      <SOURCE>
        <HD SOURCE="HED">Source:</HD>
        <P>51 FR 32726, Sept. 15, 1986, unless otherwise noted.</P>
      </SOURCE>
      <SUBPART>
        <HD SOURCE="HED">Subpart—General Provisions</HD>
        <SECTION>
          <SECTNO>§ 716.1</SECTNO>
          <SUBJECT>Scope and compliance.</SUBJECT>
          <P>(a) This subpart sets forth requirements for the submission of lists and copies of health and safety studies on chemical substances and mixtures selected for priority consideration for testing rules under section 4(a) of the Toxic Substances Control Act (TSCA) and on other chemical substances and mixtures for which EPA requires health and safety information in fulfilling the purposes of TSCA.</P>

          <P>(b) Section 15(3) of TSCA makes it unlawful for any person to fail or refuse to submit information required under this subpart. Section 16 provides that a violation of section 15 renders a person liable to the United States for a civil penalty and possible criminal prosecution. Under section 17, the district courts of the United States have <PRTPAGE P="54"/>jurisdiction to restrain any violation of section 15.</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 716.3</SECTNO>
          <SUBJECT>Definitions.</SUBJECT>
          <P>The definitions in section 3 of TSCA apply to this subpart. In addition, the following definitions are provided for the purposes of this subpart:</P>
          <P>
            <E T="03">Byproduct</E> means a chemical substance produced without a separate commercial intent during the manufacture, processing, use, or disposal of another chemical substance(s) or mixture(s).</P>
          <P>
            <E T="03">Co-product</E> means a chemical substance produced for a commercial purpose during the manufacture, processing, use, or disposal of another chemical substance(s) or mixture(s).</P>
          <P>
            <E T="03">Copy of study</E> means the written presentation of the purpose and methodology of a study and its results.</P>
          <P>
            <E T="03">EPA</E> means the United States Environmental Protection Agency.</P>
          <P>
            <E T="03">Health and safety study</E> or <E T="03">study</E> means any study of any effect of a chemical substance or mixture on health or the environment or on both, including underlying data and epidemiological studies, studies of occupational exposure to a chemical substance or mixture, toxicological, clinical, and ecological or other studies of a chemical substance or mixture, and any test performed under TSCA.</P>
          <P>(1) It is intended that the term <E T="03">health and safety study</E> be interpreted broadly. Not only is information which arises as a result of a formal, disciplined study included, but other information relating to the effects of a chemical substance or mixture on health or the environment is also included. Any data that bear on the effects of a chemical substance on health or the environment would be included. Chemical identity is part of, or underlying data to, a health and safety study.</P>
          <P>(2) Examples are:</P>
          <P>(i) Long- and short-term tests of mutagenicity, carcinogenicity, or tera-togen-i-city; data on behavioral disorders; dermatoxicity; pharmacological effects; mammalian absorption, distribution, metabolism, and excretion; cumulative, additive, and synergistic effects; and acute, subchronic, and chronic effects.</P>
          <P>(ii) Tests for ecological or other environmental effects on invertebrates, fish, or other animals, and plants, including: Acute toxicity tests, chronic toxicity tests, critical life-stage tests, behavioral tests, algal growth tests, seed germination tests, plant growth or damage tests, microbial function tests, bioconcentration or bioaccumulation tests, and model ecosystem (microcosm) studies.</P>
          <P>(iii) Assessments of human and environmental exposure, including workplace exposure, and impacts of a particular chemical substance or mixture on the environment, including surveys, tests, and studies of: Biological, photochemical, and chemical degradation; structure/activity relationships; air, water, and soil transport; bio-mag-ni-fi-ca-tion and bio-con-cen-tra-tion; and chemical and physical properties, e.g., boiling point, vapor pressure, evaporation rates from soil and water, octanol/water partition coefficient, and water solubility.</P>
          <P>(iv) Monitoring data, when they have been aggregated and analyzed to measure the exposure of humans or the environment to a chemical substance or mixture.</P>
          <P>
            <E T="03">Import</E> means to import for commercial purposes.</P>
          <P>
            <E T="03">Import for commercial purposes</E> means to import with the purpose of obtaining an immediate or eventual commercial advantage for the importer, and includes the importation of any amount of a chemical substance or mixture. If a chemical substance or mixture containing impurities is imported for commercial purposes, then those impurities are also imported for commercial purposes.</P>
          <P>
            <E T="03">Importer</E> means any person who imports a chemical substance, including a chemical substance as a part of a mixture or article, into the customs territory of the United States and includes the person primarily liable for the payment of any duties on the merchandise or an authorized agent acting on his behalf (as defined in 19 CFR 1.11). Importer also includes, as appropriate:</P>
          <P>(1) The consignee.</P>
          <P>(2) The importer of record.</P>

          <P>(3) The actual owner, if an actual owner's declaration and superseding <PRTPAGE P="55"/>bond has been filed in accordance with 19 CFR 141.20.</P>
          <P>(4) The transferee, if the right to draw merchandise in a bonded warehouse has been transferred in accordance with subpart C of 19 CFR part 144. For the purpose of this definition, the customs territory of the United States consists of the 50 States, Puerto Rico, and the District of Columbia.</P>
          <P>
            <E T="03">Impurity</E> means a chemical substance which is unintentionally present with another chemical substance.</P>
          <P>
            <E T="03">Listed mixture</E> means any mixture listed in § 716.120.</P>
          <P>
            <E T="03">Manufacture</E> means to manufacture for commercial purposes.</P>
          <P>
            <E T="03">Manufacture for commercial purposes</E> means: (1) To produce, with the purpose of obtaining an immediate or eventual commercial advantage for the manufacturer, and includes among other things such “manufacture” of any amount of a chemical substance or mixture:</P>
          <P>(i) For commercial distribution, including for test marketing.</P>
          <P>(ii) For use by the manufacturer, including use for product research and development, or as an intermediate.</P>
          <P>(2) Manufacture for commercial purposes also applies to substances that are produced coincidentally during the manufacture, processing, use, or disposal of another substance or mixture, including byproducts and impurities. Such byproducts and impurities may, or may not, in themselves have commercial value. They are nonetheless produced for the purpose of obtaining a commercial advantage since they are part of the manufacture of a chemical product for a commercial purpose.</P>
          <P>
            <E T="03">Manufacturer</E> means a person who produces or manufactures a chemical substance. A person who extracts a component chemical substance from a previously existing chemical substance or a complex combination of substances is a manufacturer of that component chemical substance.</P>
          <P>
            <E T="03">Person</E> includes any individual, firm, company, corporation, joint-venture, partnership, sole proprietorship, association, or any other business entity, any State or political subdivision thereof, any municipality, any interstate body, and any department, agency, or instrumentality of the Federal government.</P>
          <P>
            <E T="03">Process</E> means to process for commercial purposes.</P>
          <P>
            <E T="03">Process for commercial purposes</E> means the preparation of a chemical substance or mixture, after its manufacture, for distribution in commerce with the purpose of obtaining an immediate or eventual commercial advantage for the processor. Processing of any amount of a chemical substance or mixture is included. If a chemical substance or mixture containing impurities is processed for commercial purposes, then those impurities are also processed for commercial purposes.</P>
          <P>
            <E T="03">Propose to manufacture, import, or process</E> means that a person has made a management decision to commit financial resources toward the manufacture, importation, or processing of a substance or mixture.</P>
          <P>
            <E T="03">Substance</E> means <E T="03">chemical substance</E> as defined at section 3(2)(A) of TSCA, 15 U.S.C. 2602(2)(A).</P>
          <P>
            <E T="03">TSCA</E> means the Toxic Substances Control Act (15 U.S.C. 2601 <E T="03">et seq.</E>).</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 716.5</SECTNO>
          <SUBJECT> Persons who must report.</SUBJECT>
          <P>(a) Except as provided in paragraphs (b) and (c) of this section, only those persons described in this section are required to report under this part. Persons who must report include manufacturers (including importers) who fall within the North American Industry Classification System (NAICS) (in effect as of January 1, 1997) Subsector 325 (chemical manufacturing and allied products) or Industry Group 32411 (petroleum refineries), who:</P>
          <P>(1) In the 10 years preceding the effective date on which a substance or mixture is added to § 716.120, either had proposed to manufacture (including import), or had manufactured (including imported) the listed substance or listed mixture (including as a known byproduct), are required to report during the reporting period specified in § 716.65.</P>

          <P>(2) As of the effective date on which a substance or mixture is added to § 716.120, and who propose to manufacture (including import), or who are manufacturing (including importing) the listed substance or listed mixture (including as a known byproduct), are <PRTPAGE P="56"/>required to report during the reporting period specified in § 716.65.</P>
          <P>(3) After the effective date on which a substance or mixture is added to § 716.120, and who propose to manufacture (including import) the listed substance or listed mixture (including as a known byproduct), are required to report during the reporting period specified in § 716.65.</P>
          <P>(b) A rule promulgated under the authority of 15 U.S.C. 2607(d) may require that any person who does not fall within NAICS (in effect as of January 1, 1997) Subsector 325 or Industry Group 32411, and who had proposed to manufacture (including import) or process, had manufactured (including imported) or processed, proposes to manufacture (including import) or process, or is manufacturing (including importing) or processing a substance or mixture listed in § 716.120 must report under this part.</P>
          <P>(c) Processors and persons who propose to process a substance or mixture otherwise subject to the reporting requirements imposed by this part are not subject to this part unless EPA specifically states otherwise in a particular notice or rule promulgated under the authority of 15 U.S.C. 2607(d).</P>
          <CITA>[63 FR 15773, Apr. 1, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 716.10</SECTNO>
          <SUBJECT>Studies to be reported.</SUBJECT>
          <P>(a) In general, health and safety studies, as defined in § 716.3, on any substance or listed mixture listed in § 716.120, that are unpublished are reportable, i.e., must be submitted or listed. However, this requirement has limitations according to the nature of the material studied, so that:</P>
          <P>(1) All studies of substances and listed mixtures are reportable. However, in the case of physical and chemical properties, only those studies listed in § 716.50 must be submitted.</P>
          <P>(2) Studies of mixtures known to contain substances or listed mixtures listed in § 716.120 are reportable except for studies of physical and chemical properties and the studies exempted at § 716.20(a)(6) (i) through (vi).</P>
          <P>(3) Studies of substances or listed mixtures that a person who is reporting has manufactured, imported, or processed or proposed to manufacture, import, or process only as impurities are not generally reportable under § 716.20(a)(9).</P>
          <P>(4) Underlying data, such as medical or health records, individual files, lab notebooks, and daily monitoring records supporting studies do not have to be submitted initially. EPA may request underlying data later under § 716.40.</P>
          <P>(b) [Reserved]</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 716.20</SECTNO>
          <SUBJECT>Studies not subject to the reporting requirements.</SUBJECT>
          <P>(a) Excluding paragraph (a)(3) of this section, the following types of studies are exempt from the copy and list submission requirements of §§ 716.30 and 716.35.</P>
          <P>(1) Studies which have been published in the scientific literature.</P>
          <P>(2) Studies previously submitted to the EPA Office of Pollution Prevention and Toxics. These studies are limited to section 8(e) submissions, studies submitted during section 4 proceedings, studies submitted with premanufacture notices or significant new use notices, and studies submitted “for your information” (FYI submissions) in support of EPA's TSCA Existing Chemicals Program. Studies which have been initiated pursuant to a TSCA section 4(a) test rule, for which the person has submitted a letter of intent to conduct testing in accordance with the provisions of § 790.25 of part 790 of this chapter, are exempt from the list submission requirements of § 716.35.</P>
          <P>(3) Except for those studies described in paragraph (a)(2) of this section, studies previously submitted to any Federal agency with no claims of confidentiality are exempt only from the copy submission requirements of § 716.30, and must be listed in accordance with the provisions of § 716.35.</P>
          <P>(4) Studies conducted or initiated by or for another person who is subject to, and who will report the studies under §§ 716.30 and 716.35.</P>
          <P>(5) Studies of chemical substances which are not on the TSCA Chemical Substances Inventory. This exemption applies only to those substances within categories listed under § 716.120(c).</P>

          <P>(6) The following types of studies when the subject of the study is a mixture known to contain a substance or listed mixture listed under § 716.120.<PRTPAGE P="57"/>
          </P>
          <P>(i) Acute oral toxicity studies.</P>
          <P>(ii) Acute dermal toxicity studies.</P>
          <P>(iii) Acute inhalation toxicity studies.</P>
          <P>(iv) Primary eye irritation studies.</P>
          <P>(v) Primary dermal irritation studies.</P>
          <P>(vi) Dermal sensitization studies.</P>
          <P>(vii) Physical and chemical properties.</P>
          <FP>If the substance or listed mixture is an impurity, no reporting is required (see paragraph (a)(9) of this section).</FP>
          <P>(7) Analyzed aggregations of monitoring data based on monitoring data acquired more than 5 years preceding the date the substance or listed mixture was added to the list under § 716.120.</P>
          <P>(8) Analyzed aggregations of monitoring data on mixtures known to contain one or more substances or listed mixtures listed in § 716.120, when the monitoring data are not analyzed to determine the exposure or concentration levels of the substances or listed mixture listed under § 716.120.</P>

          <P>(9) Studies on a substance or listed mixture listed under § 716.120 that the person who is reporting has manufactured, imported, or processed or proposed to manufacture, import, or process only as an impurity. When reporting of such studies is to be required, that reporting will be separately proposed in the <E T="04">Federal Register.</E>
          </P>
          <P>(10) Studies of chemical substances or listed mixtures previously submitted by trade associations in accordance with the provisions of § 716.30.</P>
          <P>(b) The following types of studies on substances or listed mixtures listed under § 716.120 are exempt from the copy and list submission requirements of §§ 716.30 and 716.35.</P>
          <P>(1) For the listed ureaformaldehyde resins (CAS Nos. 9011-05-6 and 68611-64-3), studies on agronomic plant growth or damage which demonstrate only that the resins stimulate plant growth or cause plant damage when applied as a fertilizer.</P>
          <P>(2) For the specified chemicals in § 716.120(d) under the category “Siloxanes,” acute oral, dermal, and inhalation toxicity studies and primary eye and dermal irritation studies.</P>
          <P>(3) For the listed chemicals under § 716.120(d) in the category “OSHA Chemicals in Need of Dermal Absorption Testing,” studies on ecological effects.</P>
          <P>(4) For the chemicals listed at § 716.120 with a special exemption referencing this paragraph, studies on mixtures containing the listed substance at levels below 1 percent of the mixture, except when a purpose of the study includes the investigation of the effects of the listed substance at levels below 1 percent.</P>
          <P>(5) Rulemaking proceedings that add substances and mixtures to § 716.120 will specify the types of health and/or environmental effects studies that must be reported and will specify the chemical grade/purity requirements that must be met or exceeded in individual studies. Chemical grade/purity requirements will be specified on a per chemical basis or for a category of chemicals for which reporting is required.</P>
          <CITA>[51 FR 32726, Sept. 15, 1986, as amended at 58 FR 47649, Sept. 10, 1993; 58 FR 68315, Dec. 27, 1993; 60 FR 34884, July 5, 1995; 63 FR 15773, Apr. 1, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 716.25</SECTNO>
          <SUBJECT> Adequate file search.</SUBJECT>
          <P>The scope of a person's responsibility to search records is limited to records in the location(s) where the required information is typically kept, and to records kept by the person or the person's individual employee(s) who is/are responsible for keeping such records or advising the person on the health and environmental effects of chemicals. Persons are not required to search for reportable information dated before January 1, 1977, to comply with this subpart unless specifically required to do so in a rule.</P>
          <CITA>[63 FR 15773, Apr. 1, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 716.30</SECTNO>
          <SUBJECT>Submission of copies of studies.</SUBJECT>

          <P>(a)(1) Except as provided in §§ 716.5, 716.20, and 716.50, persons must send to EPA copies of any health and safety studies in their possession for the substances or mixtures listed in § 716.120. Persons are responsible for submitting copies on only the substances or listed mixtures which they: Have manufactured, imported, or processed or proposed to manufacture, import, or process (including as known byproducts) <PRTPAGE P="58"/>within the 10 years preceding the effective date for reporting on the substances or listed mixtures; manufacture, import, or process on the effective date for reporting on the substances or listed mixtures; and propose to manufacture, import, or process following the effective date for reporting on the substances or listed mixtures. Persons who list studies as ongoing or initiated under § 716.35(a) (1) and (2) must submit them when they are completed.</P>
          <P>(2) [Reserved]</P>
          <P>(b) Submissions under paragraph (a) of this section must be identified either on the face of the study or otherwise by the applicable chemical name and CAS number (if any) listed in § 716.120(a) (1) and (2), and must be accompanied by a cover letter containing the name, job title, address and telephone number of the submitting official, and the name and address of the manufacturing or processing establishment on whose behalf the submission is made. In the cover letter, submitters must identify any impurity or additive known to have been present in the substance or listed mixtures as studied unless its presence is specifically noted in the study itself. The cover letter accompanying a study submitted by a trade association must also state that the submission is to satisfy reporting requirements under this part.</P>
          <P>(c) Copies of health and safety studies and the accompanying cover letters must be submitted, preferably by certified mail, to the Document Control Office (7407), Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Room G-099, 401 M St., SW., Washington, DC., 20460, ATTN: 8(d) Health and Safety Reporting Rule (Notification/Reporting).</P>
          <CITA>[51 FR 32726, Sept. 15, 1986, as amended at 52 FR 20084, May 29, 1987; 52 FR 44828, Nov. 20, 1987; 53 FR 12523, Apr. 15, 1988; 60 FR 34463, July 3, 1995; 63 FR 15773, Apr. 1, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 716.35</SECTNO>
          <SUBJECT>Submission of lists of studies.</SUBJECT>
          <P>(a) Except as provided in §§ 716.5, 716.20, and 716.50, persons subject to this rule must send lists of studies to EPA for each of the listed substances or listed mixtures (including as a known byproduct) in § 716.120 which they are manufacturing, importing, or processing, or which they propose to manufacture (including import) or process.</P>
          <P>(1) <E T="03">Ongoing studies.</E> As of the date a person becomes subject to this part, a list of ongoing health and safety studies being conducted by or initiated for them, noting for each entry: The beginning date of the study, the purpose of the study, the types of data to be collected, the anticipated date of completion, and the name and address of the laboratory conducting the study.</P>
          <P>(2) <E T="03">Initiated studies.</E> After the date a person becomes subject to this part, a list of studies initiated by or for them, noting for each entry: The beginning date of the study, the purpose of the study, the types of data to be collected, the anticipated date of completion, and the name and address of the laboratory conducting the study.</P>
          <P>(3) <E T="03">Studies which are known but without possession of copies.</E> As of the date a person becomes subject to this part, a list of unpublished health and safety studies known to them of which they do not have copies. The name and address of any person known to them to possess a copy of the unpublished study must accompany each entry on the list. For purposes of this section only, an unpublished study will be considered to be “known to” a person, if the study can be discovered by a file search in accordance with § 716.25.</P>
          <P>(4) <E T="03">Studies previously sent to Federal agencies without confidentiality claims.</E> A list of unpublished studies which have been sent to a Federal Agency with no claims of confidentiality. The submission must for each study: Identify the study by title, state the name and address to whom the study was sent, and the month and year in which the study was submitted. Any study identified will be treated as if it were submitted under section 8(d) and will be available for public disclosure under section 14(b) of TSCA. Persons subject to this requirement may submit either a list of unpublished health and safety studies previously submitted to any Federal agency without claims of confidentiality in accordance with § 716.35(a)(4), or copies of each such study in accordance with § 716.30.<PRTPAGE P="59"/>
          </P>
          <P>(b) Submission under paragraph (a) of this section must be identified either on the face of the study or otherwise by the applicable chemical name and CAS number (if any) listed in § 716.120(a) (1) and (2), and must be accompanied by a cover letter containing the name, job title, address and telephone numbers of the submitting official, and the name and address of the manufacturing or processing establishment on whose behalf the submission is made.</P>
          <P>(c) Lists of health and safety studies should be submitted, preferably by certified mail, to the Document Control Office (7407), Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Room G-099, 401 M St., SW., Washington, DC., 20460, ATTN: 8(d) Health and Safety Reporting Rule (Notification Reporting).</P>
          <CITA>[51 FR 32726, Sept. 15, 1986, as amended at 52 FR 20084, May 29, 1987; 52 FR 44828, Nov. 20, 1987; 53 FR 12523, Apr. 15, 1988; 53 FR 46746, Nov. 18, 1988; 60 FR 34463, July 3, 1995; 63 FR 15774, Apr. 1, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 716.40</SECTNO>
          <SUBJECT>EPA requests for submission of further information.</SUBJECT>
          <P>EPA may, by letter, request a person to submit or make available for review the following information after the initial reporting under §§ 716.30 and 716.35. If the requested submissions are not made, EPA may subpoena them under section 11 of TSCA, 15 U.S.C. 2610.</P>
          <P>(a) Submission of underlying data of the kind described in § 716.10(a)(4) by persons who submit copies of studies under § 716.30 or list studies under § 716.35(a)(1) or § 716.35(a)(2).</P>
          <P>(b) Submission of preliminary reports of ongoing studies by persons who list the studies under § 716.35(a)(1) or § 716.35(a)(2).</P>
          <P>(c) Submission of copies of studies by persons listed under § 716.35(a)(3) as possessing them.</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 716.45</SECTNO>
          <SUBJECT>How to report on substances and mixtures.</SUBJECT>
          <P>Section 716.120 lists substances and mixtures, in order by Chemical Abstract Service Registry Number and by alphabetical order. Studies of listed substances and listed mixtures shall be reported as follows:</P>
          <P>(a) When a substance is individually listed under § 716.120(a), studies of the substance and studies of mixtures known to contain the substance must be reported as studies of that substance.</P>
          <P>(b) When two or more substances are listed as a mixture under § 716.120(b), studies of the listed mixture and studies of any mixture known to contain the listed mixture must be reported as studies of the listed mixture.</P>
          <P>(c) Studies of the following preparations of a substance must be reported as studies of the substance itself, not as studies of mixtures known to contain the substance.</P>
          <P>(1) The substance in aqueous solution.</P>
          <P>(2) The substance containing a small amount of an additive, such as a stabilizer, emulsifier, or other chemical added for purposes of maintaining the integrity or physical form of the substance.</P>
          <P>(3) The substance of the grade/purity specified in each rule promulgated under 15 U.S.C. 2607(d).</P>
          <CITA>[51 FR 32726, Sept. 15, 1986, as amended at 63 FR 15774, Apr. 1, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 716.50</SECTNO>
          <SUBJECT>Reporting physical and chemical properties.</SUBJECT>
          <P>Studies of physical and chemical properties must be reported under this subpart if performed for the purpose of determining the environmental or biological fate of a substance, and only if they investigated one or more of the following properties:</P>
          <P>(a) Water solubility.</P>
          <P>(b) Adsorption/desorption on particulate surfaces, e.g., soil.</P>
          <P>(c) Vapor pressure.</P>
          <P>(d) Octanol/water partition coefficient.</P>
          <P>(e) Density/relative density (specific gravity).</P>
          <P>(f) Particle size distribution for insoluble solids.</P>
          <P>(g) Dissociation constant.</P>
          <P>(h) Degradation by photochemical mechanisms—aquatic and atmospheric.</P>
          <P>(i) Degradation by chemical mechanisms—hydrolytic, reductive, and oxidative.</P>
          <P>(j) Degradation by biological mechanisms—aerobic and anaerobic.</P>
        </SECTION>
        <SECTION>
          <PRTPAGE P="60"/>
          <SECTNO>§ 716.55</SECTNO>
          <SUBJECT>Confidentiality claims.</SUBJECT>
          <P>(a)(1) Section 14(b) of TSCA provides that EPA may not withhold from disclosure, on the grounds that they are confidential business information, health and safety studies of any substance or mixture that has been offered for commercial distribution (including for test marketing purposes and for use in research and development), any substance or mixture for which testinq is required under TSCA section 4, or any substance for which notice is required under TSCA section 5, except to the extent that disclosure of data from such studies would reveal—</P>
          <P>(i) Processes used in the manufacturing, importing, or processing of the substance or mixture, or</P>
          <P>(ii) The portion of a mixture comprised by any of the substances in the mixture.</P>
          <P>(2) Any respondent who wishes to assert a claim that part of a study should be withheld from disclosure because disclosure would reveal a confidential process or quantitative mixture composition should briefly state the basis of the claim, e.g., by saying “reveals confidential mixture proportion data,” and clearly identify the material subject to the claim.</P>
          <P>(3) Any respondent may assert a confidentiality claim for company name or address, financial statistics, and product codes used by a company. This information will not be subject to the disclosure requirements of section 14(b) of TSCA.</P>
          <P>(4) Information other than company name or address, financial statistics, and product codes used by a company, which is contained in a study, the disclosure of which would clearly be an unwarranted invasion of personal privacy (such as individual medical records), will be considered confidential by EPA as provided in Title 5, United States Code, section 552(b)(6).</P>
          <P>(b) To assert a claim of confidentiality for data contained in a submitted document, the respondent must submit two copies of the document:</P>
          <P>(1) One copy must be complete. In that copy, the respondent must indicate what data, if any, are claimed as confidential by bracketing or underlining the specific information. Each page containing data claimed as confidential must also contain a brief statement for the basis of the claim as well as a label such as “confidential,” “proprietary,” or “trade secret.”</P>
          <P>(2) The second copy must be complete, except that all information claimed as confidential in the first copy must be deleted. The second copy will be immediately subject to public disclosure.</P>
          <P>(3) Failure to furnish a second copy when information is claimed as confidential in the first copy will be considered a presumptive waiver of the claim of confidentiality. EPA will notify the respondent by certified mail that a finding of a presumptive waiver of the claim of confidentiality has been made. The respondent will be given 30 days from the date of his or her receipt of this notification to submit the required second copy. If the respondent fails to submit the second copy within the 30 days, EPA will place the first copy in the public file.</P>
          <P>(c) If no claim of confidentiality accompanies a document at the time it is submitted to EPA, the document will be placed in an open file available to the public without further notice to the respondent.</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 716.60</SECTNO>
          <SUBJECT>Reporting schedule.</SUBJECT>
          <P>(a) <E T="03">General requirements</E>. Except as provided in § 716.5 and paragraphs (b) and (c) of this section, submissions under §§ 716.30 and 716.35 must be postmarked on or before 60 days after the effective date of the listing of a substance or mixture in § 716.120 or within 60 days of proposing to manufacture (including import) or process a listed substance or listed mixture (including as a known byproduct) if first done after the effective date of the substance or mixture being listed in § 716.120.</P>
          <P>(b)(1) <E T="03">Submission of lists of initiated studies.</E> Persons subject to the listing requirements of § 716.35(a)(2) must inform EPA of the initiated study within 30 days of its initiation.</P>
          <P>(2) <E T="03">Submission of copies of completed studies.</E> Persons must submit copies of studies listed as ongoing or initiated under § 716.35(a) (1) and (2) within 30 days of completing the study.</P>
          <P>(c) <E T="03">Requests for extensions of time.</E> Respondents who cannot meet a deadline <PRTPAGE P="61"/>under this section may apply for a reasonable extension of time. Requests for extensions must be in writing and addressed to the Director, Office of Pollution Prevention and Toxics (7401), U.S. Environmental Protection Agency, Room E-539, 401 M St., SW., Washington, DC, 20460, ATTN: Section 8(d) extension. Extension requests must be postmarked on or before 40 days after the effective date of the listing of a substance or mixture in § 716.120. The Director of EPA's Office of Pollution Prevention and Toxics will grant or deny extension requests.</P>
          <CITA>[51 FR 32726, Sept. 15, 1986, as amended at 60 FR 34464, July 3, 1995; 63 FR 15774, Apr. 1, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 716.65</SECTNO>
          <SUBJECT> Reporting period.</SUBJECT>
          <P>Unless otherwise required in a rule promulgated under 15 U.S.C. 2607(d) relating to a listed chemical substance or listed mixture [hereinafter “rule”], the reporting period for a listed chemical substance or listed mixture will terminate 60 days after the effective date on which the listed chemical substance or listed mixture is added to 40 CFR 716.120. EPA may require reporting for a listed chemical substance or listed mixture beyond the 60 day period in a rule promulgated under 15 U.S.C. 2607(d), however EPA will not extend any reporting period later than 2 years after the effective date on which a listed chemical substance or listed mixture is added to 40 CFR 716.120. After the applicable reporting period terminates, any person subject to the rule under 40 CFR 716.5 (a)(2) or (a)(3) and who has submitted to EPA lists of ongoing or initiated studies under 40 CFR 716.35 (a)(1) or (a)(2) must submit a copy of any such study within 30 days after its completion, regardless of the study's completion date.</P>
          <CITA>[63 FR 15774, Apr. 1, 1998]</CITA>
        </SECTION>
      </SUBPART>
      <SUBPART>
        <HD SOURCE="HED">Subpart B—Specific Chemical Listings</HD>
        <SECTION>
          <SECTNO>§ 716.105</SECTNO>
          <SUBJECT>Additions of substances and mixtures to which this subpart applies.</SUBJECT>
          <P>The requirements of this subpart will be extended periodically to cover additional substances and mixtures. Two procedures will be used to add substances and mixtures.</P>

          <P>(a) Except as provided in paragraph (b) of this section, substances and mixtures will be added to § 716.120 after publication in the <E T="04">Federal Register</E> of a notice of proposed amendment to this subpart. There will be at least a 30-day public comment period on the notice. After consideration of the comments, EPA will amend § 716.120 by final rule to add the substances and listed mixtures.</P>

          <P>(b) Except as provided in paragraph (c) of this section, chemical substances, mixtures, and categories of chemical substances that have been added to the TSCA section 4(e) Priority List by the Interagency Testing Committee, established under section 4 of TSCA, will be added to § 716.120 but only to the extent that the total number of designated and recommended substances, mixtures and categories of chemical substances has not exceeded 50 in any 1 year. The addition of such chemical substances, mixtures, and categories of chemical substances to § 716.120 will be effective 30 days after publication of a notice to that effect in the <E T="04">Federal Register.</E>
          </P>

          <P>(c) Prior to the effective date of an amendment under paragraph (b) of this section, the Assistant Administrator for Prevention, Pesticides and Toxic Substances may for good cause withdraw a chemical substance, mixture, or category of chemical substances from § 716.120. Any information submitted showing why a chemical substance, mixture, or category of chemical substances should be withdrawn from the amendment must be received by EPA within 14 days after the date of publication of the notice under paragraph (b) of this section. If a chemical substance, mixture, or category of chemical substances is withdrawn, a <E T="04">Federal Register</E> notice announcing this decision will be published no later than the effective date of the amendment under paragraph (b) of this section. Persons who wish to submit information that shows why a chemical should be withdrawn must address their comments, in writing to the Document Control Office (7407), Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Room <PRTPAGE P="62"/>G-099, 401 M St., SW., Washington, DC., 20460, ATTN: 8(d) Auto-ITC.</P>
          <CITA>[51 FR 32726, Sept. 15, 1986, as amended at 60 FR 34464, July 3, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 716.120</SECTNO>
          <SUBJECT>Substances and listed mixtures to which this subpart applies.</SUBJECT>
          <P>Substances listed in this section appear in order by Chemical Abstract Service Registry Number. Chemical mixtures and categories are listed separately and by alphabetical order. Chemical substances listed within a category are provided only as examples of the category, and are not included on the list of substances. When a chemical substance in the substance or category list had been listed previously by a trivial (or common) name, it appears first, followed by the Chemical Abstract Service (CAS) name appearing in the TSCA Chemical Substance Inventory.</P>
          <P>(a) <E T="03">List of substances.</E> The following chemical substances are subject to all the provisions of part 716. Manufacturers, importers, and processors of a listed substance are subject to the reporting requirements of subpart A for that substance.</P>
          <GPOTABLE CDEF="10,r100,xs74,10,10" COLS="5" OPTS="L2,i1">
            <BOXHD>
              <CHED H="1">CAS No.</CHED>
              <CHED H="1">Substance</CHED>
              <CHED H="1">Special exemptions</CHED>
              <CHED H="1">Effective date</CHED>
              <CHED H="1">Sunset date</CHED>
            </BOXHD>
            <ROW>
              <ENT I="01">62-74-8</ENT>
              <ENT>Acetic acid, fluoro-, sodium salt</ENT>
              <ENT/>
              <ENT>03/07/86</ENT>
              <ENT>03/07/96</ENT>
            </ROW>
            <ROW>
              <ENT I="01">67-63-0</ENT>
              <ENT>2-Propanol</ENT>
              <ENT/>
              <ENT>12/15/86</ENT>
              <ENT>12/15/96</ENT>
            </ROW>
            <ROW>
              <ENT I="01">67-66-3</ENT>
              <ENT>Methane, trichloro-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">67-72-1</ENT>
              <ENT>Ethane, hexachloro-</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>01/13/86</ENT>
            </ROW>
            <ROW>
              <ENT I="01">68-12-2</ENT>
              <ENT>Dimethyl formamide-Formamide, N,N-dimethyl-</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">71-55-6</ENT>
              <ENT>1,1,1-Trichloroethane—Ethane, 1,1,1-trichloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">74-83-9</ENT>
              <ENT>Methane, bromo-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">74-87-3</ENT>
              <ENT>Chloromethane—Methane, chloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">74-95-3</ENT>
              <ENT>Methane, dibromo-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">74-97-5</ENT>
              <ENT>Methane, bromochloro-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-00-3</ENT>
              <ENT>Ethane, chloro-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-02-5</ENT>
              <ENT>Vinyl fluoride—Ethene, fluoro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-04-7</ENT>
              <ENT>Ethanamine</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-05-8</ENT>
              <ENT>Acetonitrile</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-09-2</ENT>
              <ENT>Methylene chloride—Methane, dichloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-12-7</ENT>
              <ENT>Formamide</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-21-8</ENT>
              <ENT>Oxirane</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-25-2</ENT>
              <ENT>Methane, tribromo-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-27-4</ENT>
              <ENT>Methane, bromodichloro-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-29-6</ENT>
              <ENT>Propane, 2-chloro-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-34-3</ENT>
              <ENT>Ethane, 1,1-dichloro-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-37-6</ENT>
              <ENT>1,1-Difluoroethane-Ethane, 1,1-difluoro-</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-38-7</ENT>
              <ENT>Vinylidene fluoride—Ethene, 1,1-difluoro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-43-4</ENT>
              <ENT>Dichloromonofluoromethane-Methane, dichlorofluoro-</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-45-6</ENT>
              <ENT>Chlorodifluoromethane—Methane, chlorodifluoro-</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-52-5</ENT>
              <ENT>Nitromethane-Methane, nitro-</ENT>
              <ENT/>
              <ENT O="xl">4/13/89</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-56-9</ENT>
              <ENT>Oxirane, methyl-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-68-3</ENT>
              <ENT>1-Chloro-1,1-difluoroethane-Ethane, 1-chloro-1,1-difluoro</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-86-5</ENT>
              <ENT>Propanenitrile, 2-hydroxy-2-methyl-</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75-88-7</ENT>
              <ENT>Ethane, 2-chloro- 1,1,1-trifluoro</ENT>
              <ENT/>
              <ENT>10/15/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">76-13-1</ENT>
              <ENT>1,1,2-Trichloro-1,2,2-trifluoroethane-Ethane, 1,1,2-trichloro-1,2,2-trifluoro-1</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">77-47-4</ENT>
              <ENT>Hexachlorocyclopentadiene—1,3-Cyclopentadiene, 1,2,3,4,5,5-hexachloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">77-58-7</ENT>
              <ENT>Dibutyltin dilaurate—Stannane, dibutylbis[(1-oxododecyl)oxy]-</ENT>
              <ENT/>
              <ENT>01/03/83</ENT>
              <ENT>01/03/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">78-59-1</ENT>
              <ENT>Isophorone—2-Cyclohexen-1-one, 3,5,5-trimethyl-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">78-83-1</ENT>
              <ENT>1-Propanol, 2-methyl-</ENT>
              <ENT/>
              <ENT>03/07/86</ENT>
              <ENT>03/07/96</ENT>
            </ROW>
            <ROW>
              <ENT I="01">78-87-5</ENT>
              <ENT>1,2-Dichloropropane—Propane, 1,2-dichloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">78-88-6</ENT>
              <ENT>1-Propene, 2,3-dichloro-</ENT>
              <ENT/>
              <ENT O="xl">6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">78-93-3</ENT>
              <ENT>Methyl ethyl ketone—2-Butanone</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">78-97-7</ENT>
              <ENT>Propanenitrile, 2-hydroxy-</ENT>
              <ENT/>
              <ENT O="xl">6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">78-99-9</ENT>
              <ENT>Propane, 1,1-dichloro-</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">79-00-5</ENT>
              <ENT>Ethane, 1,1,2-trichloro-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">79-06-1</ENT>
              <ENT>Acrylamide—2-Propenamide</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">79-24-3</ENT>
              <ENT>Nitroethane-Ethane, nitro-</ENT>
              <ENT/>
              <ENT O="xl">4/13/89</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">79-94-7</ENT>
              <ENT>Tetrabromobisphenol A—Phenol, 4,4′-(methylethylidene)bis[2,6-dibromo-</ENT>
              <ENT/>
              <ENT>06/20/85</ENT>
              <ENT>06/20/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">80-05-7</ENT>
              <ENT>Bisphenol A—Phenol, 4,4′-(1-methylethylidene)bis-</ENT>
              <ENT/>
              <ENT>06/28/84</ENT>
              <ENT>06/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01">80-15-9</ENT>
              <ENT>Hydroperoxide, 1-methyl-1-phenylethyl</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">80-62-6</ENT>
              <ENT>Methyl methacrylate—2-Propenoic acid, 2-methyl-, methyl ester</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="63"/>
              <ENT I="01">84-65-1</ENT>
              <ENT>Anthraquinone—9,10-Anthracenedione</ENT>
              <ENT/>
              <ENT>12/28/84</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">85-22-3</ENT>
              <ENT>Pentabromoethylbenzene—Benzene, pentabromoethyl-</ENT>
              <ENT/>
              <ENT>12/28/84</ENT>
              <ENT>12/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01">85-68-7</ENT>
              <ENT>Benzyl butyl phthalate—1,2-Benzenedicarboxylic acid, butyl phenylmethyl ester</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">86-74-8</ENT>
              <ENT>9<E T="03">H</E>-Carbazole</ENT>
              <ENT/>
              <ENT>03/07/86</ENT>
              <ENT>03/07/96</ENT>
            </ROW>
            <ROW>
              <ENT I="01">87-68-3</ENT>
              <ENT>Hexachloro-1,3-butadiene—1,3-Butadiene, 1,1,2,3,4,4-hexachloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">88-04-0</ENT>
              <ENT>p-Chloro-m-xylenol-Phenol, 4-chloro-3,5-dimethyl-</ENT>
              <ENT/>
              <ENT>l4/13/89</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">90-30-2</ENT>
              <ENT>N-Phenyl-1-naphthylamine</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">90-42-6</ENT>
              <ENT>[1,1′-Bicyclohexyl]-2-one</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">91-08-7</ENT>
              <ENT>Benzene, 1,3-diisocyanato-2-methyl-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">91-20-3</ENT>
              <ENT>Naphthalene</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">91-58-7</ENT>
              <ENT>Naphthalene, 2-chloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">92-52-4</ENT>
              <ENT>1,1′-Biphenyl</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">92-69-3</ENT>
              <ENT>[1,1’-Biphenyl]-4-ol</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">92-84-2</ENT>
              <ENT>10<E T="03">H</E>-Phenothiazine</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">92-87-5</ENT>
              <ENT>[1,1′-Biphenyl]-4,4′-diamine</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">95-14-7</ENT>
              <ENT>1,2,3-Benzotriazole-1H-Benzotriazole</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">95-47-6</ENT>
              <ENT>
                <E T="03">o</E>-Xylene—Benzene, 1,2-dimethyl-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">95-48-7</ENT>
              <ENT>
                <E T="03">o</E>-Cresol—Phenol, 2-methyl-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">95-49-8</ENT>
              <ENT>2/Chlorotoluene—Benzene, 1-chloro-2-methyl-</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">95-53-4</ENT>
              <ENT>Benzenamine, 2-methyl-</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">95-63-6</ENT>
              <ENT>1,2,4-Trimethylbenzene—Benzene, 1,2,4-trimethyl-</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">96-18-4</ENT>
              <ENT>Propane, 1,2,3-trichloro-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">96-29-7</ENT>
              <ENT>2-Butanone, oxime</ENT>
              <ENT/>
              <ENT>12/15/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">96-37-7</ENT>
              <ENT>Methylcyclopentane—Cyclopentane, methyl-</ENT>
              <ENT/>
              <ENT>06/20/85</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">97-18-7</ENT>
              <ENT>Phenol, 2,2’-thiobis[4,6-dichloro-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">97-23-4</ENT>
              <ENT>Phenol, 2,2’-methylenebis[4-chloro-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">97-88-1</ENT>
              <ENT>Butyl methacrylate-2-Propenoic acid, 2-methyl-,butyl ester</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">98-01-1</ENT>
              <ENT>2-Furancarboxaldehyde</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">98-06-6</ENT>
              <ENT>Benzene, (1,1-dimethylethyl)-</ENT>
              <ENT/>
              <ENT O="xl">6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">98-09-9</ENT>
              <ENT>Benzenesulfonyl chloride</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">98-51-1</ENT>
              <ENT>
                <E T="03">p</E>-<E T="03">tert</E>-Butyltoluene—Benzene, 1-(1,1-dimethylethyl)-4-methyl-</ENT>
              <ENT/>
              <ENT>06/25/86</ENT>
              <ENT>06/25/96</ENT>
            </ROW>
            <ROW>
              <ENT I="01">98-56-6</ENT>
              <ENT>4-Chlorobenzotrifluoride—Benzene, 1-chloro-4-(trifluoromethyl)-</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">98-73-7</ENT>
              <ENT>p-tert-Butylbenzoic acid-Benzoic acid, 4-(1,1-dimethylethyl)-</ENT>
              <ENT/>
              <ENT>6/25/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">98-82-8</ENT>
              <ENT>Cumene—Benzene, (1-methylethyl)-</ENT>
              <ENT/>
              <ENT>12/28/84</ENT>
              <ENT>12/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01">98-83-9</ENT>
              <ENT>Benzene, (1-methylethenyl)-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">98-95-3</ENT>
              <ENT>Nitrobenzene—Benzene, nitro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">100-02-7</ENT>
              <ENT>
                <E T="03">p</E>-Nitrophenol—Phenol, 4-nitro-</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">100-40-3</ENT>
              <ENT>4-Vinylcyclohexene</ENT>
              <ENT/>
              <ENT>1/11/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">100-41-4</ENT>
              <ENT>Benzene, ethyl-</ENT>
              <ENT/>
              <ENT>06/19/87</ENT>
              <ENT>06/19/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">100-48-1</ENT>
              <ENT>4-Pyridinecarbonitrile</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/87</ENT>
            </ROW>
            <ROW>
              <ENT I="01">100-54-9</ENT>
              <ENT>3-Pyridinecarbonitrile</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="01">100-70-9</ENT>
              <ENT>2-Pyridinecarbonitrile</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">101-68-8</ENT>
              <ENT>Benzene, 1,1<E T="61">′</E>-methylenebis[4-isocyanato-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">101-77-9</ENT>
              <ENT>Benzenamine, 4,4<E T="61">′</E>-methylenebis-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">101-84-8</ENT>
              <ENT>Diphenyl oxide—Benzene, 1,1′-oxybis-</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">102-71-6</ENT>
              <ENT>Triethanolamine-Ethanol, 2,2’,2”-nitrilotris-</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">104-49-4</ENT>
              <ENT>Benzene, 1,4-diisocyanato-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">104-51-8</ENT>
              <ENT>Benzene, butyl-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">104-76-7</ENT>
              <ENT>1-Hexanol, 2-ethyl-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">105-60-2</ENT>
              <ENT>2<E T="03">H</E>-Azepin-2-one, hexahydro-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">106-42-3</ENT>
              <ENT>
                <E T="03">p</E>-Xylene—Benzene, 1,4-dimethyl-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">106-43-4</ENT>
              <ENT>Benzene, 1-chloro-4-methyl-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">106-44-5</ENT>
              <ENT>
                <E T="03">p</E>-Cresol—Phenol, 4-methyl-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">106-49-0</ENT>
              <ENT>Benzenamine, 4-methyl-</ENT>
              <ENT/>
              <ENT>03/07/86</ENT>
              <ENT>03/07/96</ENT>
            </ROW>
            <ROW>
              <ENT I="01">106-50-3</ENT>
              <ENT>
                <E T="03">p</E>-Phenylenediamine—1,4-Benzenediamine</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">106-51-4</ENT>
              <ENT>Quinone—2,5-Cyclohexadiene-1,4-dione</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">106-88-7</ENT>
              <ENT>Oxirane, ethyl-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">106-89-8</ENT>
              <ENT>Oxirane, (chloromethyl)-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">107-06-2</ENT>
              <ENT>Ethane, 1,2-dichloro-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">107-10-8</ENT>
              <ENT>1-Propanamine</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">107-19-7</ENT>
              <ENT>2-Propyn-1-ol</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">107-98-2</ENT>
              <ENT>1-Methoxy-2-propanol—2-Propanol, 1-methoxy-</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">108-05-4</ENT>
              <ENT>Vinyl acetate—Acetic acid ethenyl ester</ENT>
              <ENT/>
              <ENT>02/10/86</ENT>
              <ENT>02/10/96</ENT>
            </ROW>
            <ROW>
              <ENT I="01">108-10-1</ENT>
              <ENT>Methyl isobutyl ketone—2-Pentanone, 4-methyl-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">108-31-6</ENT>
              <ENT>Maleic anhydride—2,5-Furandione</ENT>
              <ENT/>
              <ENT>09/10/84</ENT>
              <ENT>09/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01">108-38-3</ENT>
              <ENT>
                <E T="03">m</E>-Xylene—Benzene, 1,3-dimethyl-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="64"/>
              <ENT I="01">108-39-4</ENT>
              <ENT>
                <E T="03">m</E>-Cresol—Phenol, 3-methyl-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">108-60-1</ENT>
              <ENT>Propane, 2,2’-oxybis[1-chloro-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">108-67-8</ENT>
              <ENT>1,3,5-Trimethylbenezene—Benzene, 1,3,5-trimethyl-</ENT>
              <ENT/>
              <ENT>02/13/84</ENT>
              <ENT>02/13/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01">108-86-1</ENT>
              <ENT>Benzene, bromo-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">108-88-3</ENT>
              <ENT>Toluene—Benzene, methyl-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">108-89-4</ENT>
              <ENT>4-Methylpyridine—Pyridine, 4-methyl-</ENT>
              <ENT/>
              <ENT>09/10/84</ENT>
              <ENT>09/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01">108-94-1</ENT>
              <ENT>Cyclohexanone</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">108-95-2</ENT>
              <ENT>Phenol</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">108-95-5</ENT>
              <ENT>Thiophenol</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">108-98-5</ENT>
              <ENT>Benzenethiol</ENT>
              <ENT/>
              <ENT>03/07/86</ENT>
              <ENT>03/07/96</ENT>
            </ROW>
            <ROW>
              <ENT I="01">108-99-6</ENT>
              <ENT>3-Methylpyridine—Pyridine, 3-methyl-</ENT>
              <ENT/>
              <ENT>09/10/84</ENT>
              <ENT>09/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01">109-06-8</ENT>
              <ENT>2-Methylpyridine—Pyridine, 2-methyl-</ENT>
              <ENT/>
              <ENT>09/10/84</ENT>
              <ENT>09/10/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01">109-77-3</ENT>
              <ENT>Propanedinitrile</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">109-87-5</ENT>
              <ENT>Methane, Dimethoxy-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">109-89-7</ENT>
              <ENT>Ethanamine, <E T="03">N</E>-ethyl-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">110-75-8</ENT>
              <ENT>Ethene, (2-chloroethoxy)-</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">110-82-7</ENT>
              <ENT>Cyclohexane</ENT>
              <ENT/>
              <ENT>12/19/85</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">110-86-1</ENT>
              <ENT>Pyridine</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">111-21-7</ENT>
              <ENT>Ethylene bisoxyethylene diacetate—Ethanol, 2,2′]-[1,2-ethanediylbis(oxy)]bis-, diacetate</ENT>
              <ENT/>
              <ENT>01/13/84</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="01">111-40-0</ENT>
              <ENT>Diethylenetriamine—1,2-Ethanediamine, <E T="03">N</E>-(2-amino-ethyl)-</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">111-42-2</ENT>
              <ENT>Diethanolamine—Ethanol, 2,2′-iminobis-</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">111-69-3</ENT>
              <ENT>Hexanedinitrile</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">111-76-2</ENT>
              <ENT>2-Butoxyethanol—Ethanol, 2-butoxy-</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">111-77-3</ENT>
              <ENT>Diethylene glycol monomethyl ether-Ethanol, 2-(2-methoxyethoxy)-</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">111-90-0</ENT>
              <ENT>Diethylene glycol monoethyl ether-Ethanol, 2-(2-ethoxyethoxy)-</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">111-91-1</ENT>
              <ENT>Ethane, 1,1’-[methylenebis(oxy)]bis[2-chloro-</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">111-92-2</ENT>
              <ENT>1-Butanamine, N-butyl-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">112-35-6</ENT>
              <ENT>Triethyleneglycol monomethyl ether—Ethanol, 2-[2-(2-methoxyethoxy)ethoxy]-</ENT>
              <ENT/>
              <ENT>06/20/85</ENT>
              <ENT>06/20/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">112-50-5</ENT>
              <ENT>Triethyleneglycol monoethyl ether—Ethanol, 2-[2-(2-ethoxyethoxy)ethoxy]-</ENT>
              <ENT/>
              <ENT>06/20/85</ENT>
              <ENT>06/20/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">112-90-3</ENT>
              <ENT>Oleylamine—9-Octadecen-1-amine, (<E T="03">Z</E>)-</ENT>
              <ENT/>
              <ENT>01/13/84</ENT>
              <ENT>01/13/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01">115-28-6</ENT>
              <ENT>Chlorendic acid—Bicyclo[2.2.1] hept-5-ene-2,3-dicarboxylic acid, 1,4,5,6,7,7-hexachloro-</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>01/13/86</ENT>
            </ROW>
            <ROW>
              <ENT I="01">115-96-8</ENT>
              <ENT>Ethanol, 2-chloro-, phosphate (3:1)</ENT>
              <ENT/>
              <ENT>12/16/88</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">118-79-6</ENT>
              <ENT>2,4,6-Tribromophenol</ENT>
              <ENT/>
              <ENT>1/11/90</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">120-20-7</ENT>
              <ENT>Anthracene</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">120-32-1</ENT>
              <ENT>2-Benzyl-4-chlorophenol-Phenol, 4-chloro-2-chlorophenol(phenyl methyl)-</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">121-44-8</ENT>
              <ENT>Ethanamine, <E T="03">N,N</E>-diethyl-</ENT>
              <ENT/>
              <ENT>01/13/84</ENT>
              <ENT>01/13/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01">121-47-1</ENT>
              <ENT>Benzenesulfonic acid, 3-amino-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="01">122-09-8</ENT>
              <ENT>Benzeneethanamine, alpha,alpha-dimethyl-</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">122-66-7</ENT>
              <ENT>Hydrazine, 1,2-diphenyl-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">122-99-6</ENT>
              <ENT>2-Phenoxyethanol—Ethanol, 2-phenoxy-</ENT>
              <ENT/>
              <ENT>07/01/83</ENT>
              <ENT>07/01/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">123-31-9</ENT>
              <ENT>Hydroquinone—1,4-Benzenediol</ENT>
              <ENT/>
              <ENT>10/04/84</ENT>
              <ENT>10/04/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01">123-61-5</ENT>
              <ENT>Benzene, 1,3-diisocyanato-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">123-72-8</ENT>
              <ENT>Butanal</ENT>
              <ENT/>
              <ENT>12/16/88</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">124-16-3</ENT>
              <ENT>1-Butoxyethoxy-2-propanol-2-Propanol, 1-(2-butoxyethoxy)-</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">124-17-4</ENT>
              <ENT>2-(2-Butoxyethoxy)ethyl acetate—Ethanol, 2-(2-butoxyethoxy)-, acetate</ENT>
              <ENT/>
              <ENT>01/13/82</ENT>
              <ENT>01/13/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">124-48-1</ENT>
              <ENT>Methane, dibromochloro-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">126-73-8</ENT>
              <ENT>Phosphoric acid, tributyl ester</ENT>
              <ENT/>
              <ENT>06/18/86</ENT>
              <ENT>06/18/96</ENT>
            </ROW>
            <ROW>
              <ENT I="01">126-99-8</ENT>
              <ENT>Chloroprene—1,3-Butadiene, 2-chloro-</ENT>
              <ENT/>
              <ENT>12/28/84</ENT>
              <ENT>12/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01">127-18-4</ENT>
              <ENT>Ethene, tetrachloro-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">128-39-2</ENT>
              <ENT>Phenol, 2,6-bis(1,1-dimethylethyl)-</ENT>
              <ENT/>
              <ENT>12/19/85</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">128-86-9</ENT>
              <ENT>2,6-Anthracenedisulfonic acid, 4,8-diamino-9,10-dihydro-1,5-dihydroxy-9,10-dioxo-</ENT>
              <ENT/>
              <ENT>12/21/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">129-00-0</ENT>
              <ENT>Pyrene</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">131-17-9</ENT>
              <ENT>Diallyl phthalate-1,2-Benzenedicarboxylic acid, di-2-propenyl ester</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">135-98-8</ENT>
              <ENT>Benzene, (1-methylpropyl)-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">137-20-2</ENT>
              <ENT>Soldium <E T="03">N</E>-methyl-<E T="03">N</E>-oleoyltaurine—Ethanesulfonic acid, 2-[methyl (1-oxo-9-octadecenyl)amino]-, sodium salt, (<E T="03">Z</E>)-</ENT>
              <ENT/>
              <ENT>12/28/84</ENT>
              <ENT>12/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01">137-26-8</ENT>
              <ENT>Thioperoxydicarbonic diamide, tetramethyl-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">139-25-3</ENT>
              <ENT>Benzene, 1,1 <SU>1</SU>-methylenebis[4-isocyanato-3-methyl-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">140-08-9</ENT>
              <ENT>Tris(2-chloroethyl)phosphite—Ethanol, 2-chloro-, phos-phite (3:1)</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>01/13/86</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="65"/>
              <ENT I="01">140-66-9</ENT>
              <ENT>4-(1,1,3,3-Tetramethylbutyl) phenol—Phenol, 4-(1,1,3,3-tetramethylbutyl)-</ENT>
              <ENT/>
              <ENT>01/30/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="01">140-88-5</ENT>
              <ENT>Ethyl acrylate—2-Propenoic acid, ethyl ester</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">141-79-7</ENT>
              <ENT>Mesityl oxide—3-Penten-2-one, 4-methyl-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">142-28-9</ENT>
              <ENT>Propane, 1,3,-dichloro-</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">142-84-7</ENT>
              <ENT>1-Propanamine, <E T="03">N</E>-propyl-</ENT>
              <ENT/>
              <ENT>03/07/86</ENT>
              <ENT>12/5/90</ENT>
            </ROW>
            <ROW>
              <ENT I="01">143-22-6</ENT>
              <ENT>Triethyleneglycol monobutyl ether—Ethanol, 2-[-2-(2-butoxyethoxy)ethoxy]-</ENT>
              <ENT/>
              <ENT>06/20/85</ENT>
              <ENT>06/20/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">143-33-9</ENT>
              <ENT>Sodium cyanide</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">149-30-4</ENT>
              <ENT>Mercaptobenzothiazole—2(3<E T="03">H</E>-Benzothiazolethione</ENT>
              <ENT/>
              <ENT>12/28/84</ENT>
              <ENT>12/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01">149-57-5</ENT>
              <ENT>2-Ethylhexanoic acid—Hexanoic acid, 2-ethyl-</ENT>
              <ENT/>
              <ENT>06/28/84</ENT>
              <ENT>06/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01">306-83-2</ENT>
              <ENT>Ethane, 2,2-dichloro-1,1,1-trifluoro</ENT>
              <ENT/>
              <ENT>10/15/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">328-84-7</ENT>
              <ENT>3,4-Dichlorobenzotrifluoride—Benzene, 1,2-dichloro-4-(trifluoromethyl)-</ENT>
              <ENT/>
              <ENT>05/08/85</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">354-33-6</ENT>
              <ENT>Ethane, pentafluoro</ENT>
              <ENT/>
              <ENT>10/15/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">357-57-3</ENT>
              <ENT>Strychnidin-10-one, 2,3-dimethoxy-</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">428-59-1</ENT>
              <ENT>Oxirane, trifluoro(trifluoromethyl)-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">472-41-3</ENT>
              <ENT>Phenol, 4-(3,4-dihydro-2,2,4-trimethyl-2<E T="03">H</E>-1-ben-zo-pyran-4-yl)-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="01">506-96-7</ENT>
              <ENT>Acetyl bromide</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">526-73-8</ENT>
              <ENT>1,2,3-Trimethylbenzene—Benzene, 1,2,3-trimethyl-</ENT>
              <ENT/>
              <ENT>02/13/84</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">530-50-7</ENT>
              <ENT>Hydrazine, 1,1-diphenyl-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">534-07-6</ENT>
              <ENT>2-Propanone, 1,3-dichloro-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">540-54-5</ENT>
              <ENT>Propane, 1-chloro-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">540-84-1</ENT>
              <ENT>Pentane, 2,2,4-trimethyl-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">542-75-6</ENT>
              <ENT>1-Propene, 1,3-dichloro-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">556-67-2</ENT>
              <ENT>Octamethylcyclotetrasiloxane—Cyclotetrasiloxane, octamethyl-</ENT>
              <ENT/>
              <ENT>12/28/84</ENT>
              <ENT>12/28/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01">563-54-2</ENT>
              <ENT>1-Propene, 1,2-dichloro-</ENT>
              <ENT/>
              <ENT>03/07/86</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="01">563-58-6</ENT>
              <ENT>1-Propene, 1,1-dichloro-</ENT>
              <ENT/>
              <ENT>03/07/86</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="01">580-51-8</ENT>
              <ENT>[1,1<E T="61">′</E>-Biphenyl]-3-ol</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">584-84-9</ENT>
              <ENT>Benzene, 2,4-diisocyanato-1-methyl-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">591-08-2</ENT>
              <ENT>Acetamide, N-(aminothioxomethyl)-</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">594-20-7</ENT>
              <ENT>Propane, 2,2-dichloro-</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">598-21-0</ENT>
              <ENT>Acetyl bromide, bromo-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">598-31-2</ENT>
              <ENT>2-Propanone, 1-bromo-</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">616-23-9</ENT>
              <ENT>1-Propanol, 2,3-dichloro-</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">620-14-4</ENT>
              <ENT>
                <E T="03">m</E>-Ethyltoluene—Benzene, 1-ethyl-3-methyl-</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">622-96-8</ENT>
              <ENT>
                <E T="03">p</E>-Ethyltoluene—Benzene, 1-ethyl-4-methyl-</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">630-20-6</ENT>
              <ENT>Ethane, 1,1,1,2-tetrachloro-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">632-79-1</ENT>
              <ENT>Tetrabromophthalic anhydride</ENT>
              <ENT/>
              <ENT>1/11/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">637-92-3 </ENT>
              <ENT O="xl">Ethyl-tert-butyl ether</ENT>
              <ENT O="xl">§ 716.20(b)(3) applies</ENT>
              <ENT O="xl">12/28/94</ENT>
              <ENT O="xl">6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">646-06-0</ENT>
              <ENT>1,3-Dioxolane</ENT>
              <ENT/>
              <ENT>01/03/83</ENT>
              <ENT>01/03/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">677-21-4</ENT>
              <ENT>Trifluoromethylethene—1-Propene, 3,3,3-trifluoro-</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>01/13/86</ENT>
            </ROW>
            <ROW>
              <ENT I="01">685-91-6</ENT>
              <ENT>Acetamide, <E T="03">N</E>,<E T="03">N</E>-diethyl-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">692-42-2</ENT>
              <ENT>Arsine, diethyl-</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">696-28-6</ENT>
              <ENT>Arsonous dichloride, phenyl-</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">757-58-4</ENT>
              <ENT>Tetraphosphoric acid, hexaethyl ester</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">811-97-2</ENT>
              <ENT>Ethane, 1,1,2-tetrafluoro-</ENT>
              <ENT/>
              <ENT>10/15/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">812-03-3</ENT>
              <ENT>Propane, 1,1,1,2-tetrachloro-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">822-06-0</ENT>
              <ENT>Hexane, 1,6-diisocyanato-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">828-00-2</ENT>
              <ENT>1,3-Dioxan-4-ol, 2,6-dimethyl-, acetate</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">930-22-3</ENT>
              <ENT>Oxirane, ethenyl-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">939-97-9</ENT>
              <ENT>
                <E T="03">p</E>-<E T="03">tert</E>-Butylbenzaldehyde—Benzaldehyde, 4-(1,1-di-methyl-ethyl)-</ENT>
              <ENT/>
              <ENT>06/25/86</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">994-05-8 </ENT>
              <ENT O="xl">Tert-amyl methyl ether</ENT>
              <ENT O="xl">§ 716.20(b)(3) applies</ENT>
              <ENT O="xl">12/28/94</ENT>
              <ENT O="xl">06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1000-82-4</ENT>
              <ENT>Methylolurea—Urea, (hydroxymethyl)-</ENT>
              <ENT/>
              <ENT>07/01/83</ENT>
              <ENT>07/01/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1070-78-6</ENT>
              <ENT>Propane, 1,1,1,3-tetrachloro-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1163-19-5</ENT>
              <ENT>Decabromodiphenyl ether</ENT>
              <ENT/>
              <ENT>1/11/90</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1185-81-5</ENT>
              <ENT>Dibutyltin bis(lauryl mercaptide)—Stannane, di-butyl-bis(dodecylthio)</ENT>
              <ENT/>
              <ENT>01/03/83</ENT>
              <ENT>01/03/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1208-52-2</ENT>
              <ENT>Benzenamine, 2-[(4-aminophenyl)methyl]-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1300-71-6</ENT>
              <ENT>Phenol, dimethyl-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1309-64-4</ENT>
              <ENT>Antimony trioxide</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1321-38-6</ENT>
              <ENT>Benzene, diisocyanatomethyl-(unspecified isomer)</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1321-64-8</ENT>
              <ENT>Naphthalene, pentachloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1321-65-9</ENT>
              <ENT>Naphthalene, trichloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1331-47-1</ENT>
              <ENT>[1,1<E T="61">′</E>-Biphenyl]-4,4<E T="61">′</E>-diamino, dichloro-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1333-41-1</ENT>
              <ENT>Methyl pyridine—Pyridine, methyl-</ENT>
              <ENT/>
              <ENT>09/10/84</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1335-87-1</ENT>
              <ENT>Naphthalene, hexachloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1335-88-2</ENT>
              <ENT>Naphthalene, tetrachloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1345-04-6</ENT>
              <ENT>Antimony trisulfide</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1464-53-5</ENT>
              <ENT>2,2<E T="61">′</E>-Bioxirane</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="66"/>
              <ENT I="01">1634-04-4</ENT>
              <ENT>Propane, 2-methoxy-2-methyl-</ENT>
              <ENT/>
              <ENT>12/15/86</ENT>
              <ENT>12/15/96</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1649-08-7</ENT>
              <ENT>Ethane, 1,2-dichloro-1,1-difluoro</ENT>
              <ENT/>
              <ENT>10/15/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1717-00-6</ENT>
              <ENT>Ethane, 1,1-dichloro-1-fluoro-</ENT>
              <ENT/>
              <ENT>10/15/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1825-30-5</ENT>
              <ENT>Naphthalene, 1,5-dichloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1825-31-6</ENT>
              <ENT>Naphthalene, 1,4-dichloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">1888-71-7</ENT>
              <ENT>1-Propene, 1,1,2,3,3,3-hexachloro-</ENT>
              <ENT/>
              <ENT>3/7/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">2050-69-3</ENT>
              <ENT>Naphthalene, 1,2-dichloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">2050-72-8</ENT>
              <ENT>Naphthalene, 1,6-dichloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">2050-73-9</ENT>
              <ENT>Naphthalene, 1,7-dichloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">2050-74-0</ENT>
              <ENT>Naphthalene, 1,8-dichloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">2050-75-1</ENT>
              <ENT>Naphthalene, 2,3-dichloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">2065-70-5</ENT>
              <ENT>Naphthalene, 2,6-dichloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">2198-75-6</ENT>
              <ENT>Naphthalene, 1,3-dichloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">2198-77-8</ENT>
              <ENT>Naphthalene, 2,7-dichloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">2234-13-1</ENT>
              <ENT>Naphthalene, octachloro-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">2536-05-2</ENT>
              <ENT>Benzene, 1,1<E T="61">′</E>-methylenebis[2-isocyanato-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">2556-36-7</ENT>
              <ENT>Cyclohexane, 1,4-diisocyanato</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">2763-96-4</ENT>
              <ENT>3(2H)-Isoxazolone, 5-(aminomethyl)-</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>2/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">2778-42-9</ENT>
              <ENT>Benzene, 1,3-bis(1-isocyanato-1-methylethyl-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">2861-02-1</ENT>
              <ENT O="xl">2,6-Anthracenedisulfonic acid, 4,8-diamino-9,10-dihydro-1,5-dihydroxy-9,10-dioxo-, disodium salt</ENT>
              <ENT/>
              <ENT>12/21/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">2873-89-0</ENT>
              <ENT>Ethane, 2-chloro-1,1,1,2-tetrafluoro-</ENT>
              <ENT/>
              <ENT>10/15/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">3083-25-8</ENT>
              <ENT>Oxirane, (2,2,2-trichloroethyl)-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">3173-72-6</ENT>
              <ENT>Naphthalene, 1,5,-diisocyanato-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">3194-55-6</ENT>
              <ENT>Hexabromocyclododecane</ENT>
              <ENT/>
              <ENT>1/11/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">3288-58-2</ENT>
              <ENT>Phosphorodithioic acid, O,O-diethyl-S-methyl ester</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">3296-90-0</ENT>
              <ENT>1,3-Propanediol, 2,2-bis(bromomethyl)-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">3319-31-1</ENT>
              <ENT>Tris(2-ethylhexyl) trimellitate—1,2,4-Ben-zen-e-tri-car-boxylic acid, tris(2-ethylhexyl)ester</ENT>
              <ENT/>
              <ENT>01/03/83</ENT>
              <ENT>01/03/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">3322-93-8</ENT>
              <ENT>1,2-Dibromo-4-(1,2-dibromoethyl) cyclohexane—Cyclohexane, 1,2-dibromo-4-(1,2-dibromo-ethyl)-</ENT>
              <ENT/>
              <ENT>06/28/84</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="01">3389-71-7</ENT>
              <ENT>1,2,3,4,7,7-Hexachloronorbornadiene—Bi-cyclo[2.2.1]hepta-2,5-diene, 1,2,3,4,7,7-hex-a-chloro-</ENT>
              <ENT/>
              <ENT>01/13/84</ENT>
              <ENT>01/13/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01">3618-72-2</ENT>
              <ENT>Acetamide, <E T="03">N</E>-[5-[bis[2-(acetyloxy)ethyl]amino]-2-[(2-bromo-4,6-dinitrophenyl)azo]-4- meth-oxyphenyl]-</ENT>
              <ENT/>
              <ENT>06/19/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">3618-73-3</ENT>
              <ENT>Acetamide, <E T="03">N</E>-[5-[bis[2-(acetyloxy)ethyl]amino]-2-[(2-chloro-4,6-dinitrophenyl)azo]-4-methoxyphenyl]-</ENT>
              <ENT/>
              <ENT>06/19/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">3956-55-6</ENT>
              <ENT>Acetamide, <E T="03">N</E>-[5-[bis[2-(acetyloxy)ethyl]-amino]-2-[(2-bromo-4,6-dinitrophenyl)azo]-4-ethoxypheny-l</ENT>
              <ENT/>
              <ENT>12/15/86</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">4098-71-9</ENT>
              <ENT>Cyclohexane, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethyl-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">4170-30-3</ENT>
              <ENT>2-Butenal</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">5124-30-1</ENT>
              <ENT>Cyclohexane, 1,1<E T="61">′</E>-methylenebis[4-isocyanato-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">5131-66-8</ENT>
              <ENT>1-Butoxy-2-propanol-2-Propanol, 1-butoxy-</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">5344-82-1</ENT>
              <ENT>Thiourea, (2-chlorophenyl)-</ENT>
              <ENT/>
              <ENT>3/7/86</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">5873-54-1</ENT>
              <ENT>Benzene, 1-iso-cy-a-nato-2-[4-isocyanatophenyl)methyl]-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">6145-73-9</ENT>
              <ENT>1-Propanol, 2-chloro-, phosphate (3:1)</ENT>
              <ENT/>
              <ENT>12/16/88</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">6247-34-3</ENT>
              <ENT>2-Anthracenesulfonic acid, 4-[[4-(acetyl-a-mino)phenyl]amino]-1-amino-9,10-dihydro-9,10-dioxo-</ENT>
              <ENT/>
              <ENT>12/21/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">6422-86-2</ENT>
              <ENT>Bis(2-ethylhexyl) terephthalate—1,4-Ben-zen-e-di-car-boxylic acid, bis(2-ethylhexyl) ester</ENT>
              <ENT/>
              <ENT>01/03/83</ENT>
              <ENT>01/03/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">6424-85-7</ENT>
              <ENT>2-Anthracenesulfonic acid, 4-[[4- (acetylamino)phenyl]amino]- 1-amino-9,10-dihydro-9,10-dioxo-, monosodium salt</ENT>
              <ENT/>
              <ENT>12/21/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">7320-37-8</ENT>
              <ENT>Oxirane, tetradecyl-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">7440-28-0</ENT>
              <ENT>Thallium</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">7440-36-0</ENT>
              <ENT>Antimony</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">7440-48-4</ENT>
              <ENT>Cobalt</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">7723-14-0</ENT>
              <ENT>White phosphorus</ENT>
              <ENT/>
              <ENT>04/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">9011-05-6</ENT>
              <ENT>Urea, polymer with formaldehyde</ENT>
              <ENT>§ 716.20(b)(1) applies</ENT>
              <ENT>06/03/85</ENT>
              <ENT>06/03/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">9016-87-9</ENT>
              <ENT>Isocyanic acid, polymethylenepolyphenylene ester</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">10347-54-3</ENT>
              <ENT>Cyclohexane, 1,4-bis(isocyanatomethyl)-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/87</ENT>
            </ROW>
            <ROW>
              <ENT I="01">10436-39-2</ENT>
              <ENT>1-Propene, 1,1,2,3-tetrachloro-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">12001-85-3</ENT>
              <ENT>Naphthenic acids, zinc salts</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">12185-10-3</ENT>
              <ENT>White phosphorus</ENT>
              <ENT/>
              <ENT>01/26/94</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">12217-79-7</ENT>
              <ENT>9,10-Anthracenedione, 1,5-diamino-chloro-4,8-di-hy-droxy-</ENT>
              <ENT/>
              <ENT>12/21/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">13414-54-5</ENT>
              <ENT>Methallyl 2-nitrophenyl ether—Benzene, 1-[(2-methyl-2-propenyl)oxy]-2-nitro-</ENT>
              <ENT/>
              <ENT>02/13/84</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">13414-55-6</ENT>
              <ENT>7-Nitro-2,2-dimethyl-2,3-dihydro-benzofuran—Benzofuran, 2,3-dihydro-2,2-dimethyl-7-nitro-</ENT>
              <ENT/>
              <ENT>02/13/84</ENT>
              <ENT>02/13/94</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="67"/>
              <ENT I="01">13674-84-5</ENT>
              <ENT>2-Propanol, 1-chloro-, phosphate (3:1)</ENT>
              <ENT/>
              <ENT>12/16/88</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">13674-87-8</ENT>
              <ENT>2-Propanol, 1,3-dichloro-, phosphate (3:1)</ENT>
              <ENT/>
              <ENT>12/16/88</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">15646-96-5</ENT>
              <ENT>Hexane, 1,6-diisocyanato-2,4,4-trimethyl-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">16938-22-0</ENT>
              <ENT>Hexane, 1,6-diisocyanato-2,2,4-trimethyl-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">17418-58-5</ENT>
              <ENT>9,10-Anthracenedione, 1-amino-4-hydroxy-2-phenoxy-</ENT>
              <ENT/>
              <ENT>12/21/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">18495-30-2</ENT>
              <ENT>Propane, 1,1,2,3-tetrachloro-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="01">18633-25-5</ENT>
              <ENT>Oxirane, tridecyl-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">19660-16-3</ENT>
              <ENT>2-Propenoic acid, 2,3-dibromopropyl ester</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="01">21429-43-6</ENT>
              <ENT>Acetamide, <E T="03">N</E>-[5-[bis[2-(acetyloxy)ethyl]amino]-2-[(2-chloro-4,6-dinitrophenyl)azo]-4-methoxyphenyl]-</ENT>
              <ENT/>
              <ENT>06/19/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">25168-06-3</ENT>
              <ENT>Isopropyl phenol—Phenol, (1-methylethyl)-</ENT>
              <ENT/>
              <ENT>04/13/89</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">25168-21-2</ENT>

              <ENT>Dibutyltin bis (isooctyl maleate)—2-Butenoic acid, 4,4<E T="61">′</E>-[(dibutylstannylene)bis(oxy)]bis-[4-oxo-, diisoctyl ester, (<E T="03">Z</E>,<E T="03">Z</E>)-</ENT>
              <ENT/>
              <ENT>01/03/83</ENT>
              <ENT>01/03/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">25498-49-1</ENT>
              <ENT>Tripropylene glycol monomethyl ether-Propanol, [2-(2-methoxy methylethoxy)methylethoxy]-</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">25550-14-5</ENT>
              <ENT>Benzene, ethylmethyl- (mixed isomers)</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">25550-98-5</ENT>
              <ENT>Phosphorous acid, diisodecyl phenyl ester</ENT>
              <ENT/>
              <ENT>12/19/85</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">25551-13-7</ENT>
              <ENT>Trimethylbenzene—Benzene, trimethyl- (mixed isomers)</ENT>
              <ENT/>
              <ENT>02/13/84</ENT>
              <ENT>02/13/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01">25640-78-2</ENT>
              <ENT>Isopropyl biphenyl—1,1<E T="61">′</E>-Biphenyl, (1-methylethyl)-</ENT>
              <ENT/>
              <ENT>06/28/84</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">25852-70-4</ENT>

              <ENT>Monobutyltin tris (isooctyl) mercapto-acetate—Acetic acid, 2,2<E T="61">′</E>,2<E T="61">′</E>
                <E T="61">′</E>-[(butylstannylidyne)tris(thio)]tris-, tri-iso-oc-tyl es-ter</ENT>
              <ENT/>
              <ENT>01/03/83</ENT>
              <ENT>01/03/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">26447-40-5</ENT>
              <ENT>Benzene, 1,1<E T="61">′</E>-methylenebis[isocyanato-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">26471-62-5</ENT>
              <ENT>Benzene, 1,3-diisocyanatomethyl-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>06/01/97</ENT>
            </ROW>
            <ROW>
              <ENT I="01">26530-20-1</ENT>
              <ENT>3(2<E T="03">H</E>)-Isothiazolone, 2-octyl-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="01">26952-23-8</ENT>
              <ENT>1-Propene, dichloro-</ENT>
              <ENT/>
              <ENT>6/1/87</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">29385-43-1</ENT>
              <ENT>Tolyl triazole-1H-Benzotriazole, methyl-</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">32052-51-0</ENT>
              <ENT>Isocyanic acid, trimethylcyclohexyl ester</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">32534-81-9</ENT>
              <ENT>Pentabromodiphenyl ether</ENT>
              <ENT/>
              <ENT>1/11/90</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">32536-52-0</ENT>
              <ENT>Octabromodiphenyl ether</ENT>
              <ENT/>
              <ENT>1/11/90</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">32588-76-4</ENT>
              <ENT>Ethylene Bis-(tetrabromophthalimide)</ENT>
              <ENT/>
              <ENT>1/11/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">33125-86-9</ENT>
              <ENT>Phosphoric acid, 1,2-ethanediyl tetrakis (2-chloroethyl) ester</ENT>
              <ENT/>
              <ENT>12/16/88</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">34590-94-8</ENT>
              <ENT>Dipropylene glycol monomethyl ether—Propanol, (2-methoxymethylethoxy)-</ENT>
              <ENT/>
              <ENT>4/13/89</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">37853-59-1</ENT>
              <ENT>1,2-Bis(tribromophenoxy) ethane</ENT>
              <ENT/>
              <ENT>1/11/90</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">38661-72-2</ENT>
              <ENT>Cyclohexane, 1,3-bis(isocyanatomethyl)-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">41291-34-3</ENT>
              <ENT>Ethylene(5,6-dibromonorbornane-2,3-dicarboximide)</ENT>
              <ENT/>
              <ENT>1/11/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">52907-07-0</ENT>
              <ENT>Ethylene bis(5,6-dibromonorbornane-2,3-dicarboximide</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">57137-10-7</ENT>
              <ENT>Tribrominated polystyrene</ENT>
              <ENT/>
              <ENT>1/11/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">61262-53-1</ENT>
              <ENT>Ethylene bis(pentabromophenoxide)</ENT>
              <ENT/>
              <ENT>1/11/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">61788-33-8</ENT>
              <ENT>Terphenyl, chlorinated</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="01">61789-36-4</ENT>
              <ENT>Calcium naphthenate—Naphthenic acids, calcium salts</ENT>
              <ENT/>
              <ENT>07/01/83</ENT>
              <ENT>07/01/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">61789-51-3</ENT>
              <ENT>Cobalt naphthenate—Naphthenic acids, cobalt salts</ENT>
              <ENT/>
              <ENT>07/01/83</ENT>
              <ENT>07/01/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">61790-14-5</ENT>
              <ENT>Lead naphthenate—Naphthenic acids, lead salts</ENT>
              <ENT/>
              <ENT>07/01/83</ENT>
              <ENT>07/01/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">64742-95-6</ENT>
              <ENT>Solvent naphtha (petroleum), light arom</ENT>
              <ENT/>
              <ENT>2/13/84</ENT>
              <ENT>2/13/94</ENT>
            </ROW>
            <ROW>
              <ENT I="01">68081-84-5</ENT>
              <ENT>Oxirane, mono[(C<E T="52">10-16</E>-alkyloxy) methyl] derivatives</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">68122-86-1</ENT>
              <ENT>Imidazolium compounds, 4,5-dihydro-1-methyl-2-nortallow alkyl-1-(2-tallow amidoethyl), methyl sulfates</ENT>
              <ENT/>
              <ENT>6/20/88</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">68153-35-5</ENT>
              <ENT>Ethanaminium, 2-amino-<E T="03">N</E>-(2-aminoethyl-<E T="03">N</E>-(2-hy-droxy-ethyl)-<E T="03">N</E>-methyl-, <E T="03">N</E>,<E T="03">N</E>  ′-ditallow acyl derivatives, methyl sulfates (salts)</ENT>
              <ENT/>
              <ENT>06/20/88</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">68298-46-4</ENT>
              <ENT>7-Amino-2,2-dimethyl-2,3-dihydrobenzofuran—7-Benzofuranamine,2,3-dihydro-2,2-dimethyl-</ENT>
              <ENT/>
              <ENT>02/13/84</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="01">68389-88-8</ENT>
              <ENT>Poly(oxy-1,2-ethanediyl), <E T="61">a</E>-[2-[bis(2-amino-ethyl)methylammonio]ethyl]-<E T="61">v</E>-hydroxy-, <E T="03">N</E>,<E T="03">N</E>  ′-dicoco acyl derivatives, methyl sulfates (salts)</ENT>
              <ENT/>
              <ENT>06/20/88</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">68389-89-9</ENT>
              <ENT>Poly(oxy-1,2-ethanediyl), <E T="61">a</E>-[2-[bis(2-amino-ethyl)methylammonio]ethyl]-<E T="61">v</E>-hydroxy-,<E T="03">N</E>,<E T="03">N</E>  ′-bis(hydrogenated tallow acyl) derivatives, methyl sulfates (salts)</ENT>
              <ENT/>
              <ENT>06/20/88</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">68410-69-5</ENT>
              <ENT>Poly(oxy-1,2-ethanediyl), alpha-[2-[bis(2-aminoethyl) methylammonio]ethyl]-w-hydroxy,- N,N’-ditallow acyl derivatives, methyl sulfates (salts)</ENT>
              <ENT/>
              <ENT>6/20/88</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">68413-04-7</ENT>
              <ENT>Poly[oxy(methyl-1,2-ethanediyl)], <E T="61">a</E>-[2-[bis(2-amino-ethyl)methylammonio] methylethyl]-<E T="61">v</E>-hydroxy-, <E T="03">N</E>,<E T="03">N</E>  ′-ditallow acyl derivatives, methyl sulfates (salts)</ENT>
              <ENT/>
              <ENT>06/20/88</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="68"/>
              <ENT I="01">68554-06-3</ENT>
              <ENT>Poly(oxy-1,2-ethanediyl), <E T="61">a</E>-[3-[bis(2-amino-ethyl)methylammonio]-2-hydroxy-propyl]-<E T="61">v</E>-hydroxy-, <E T="03">N</E>-coco acyl derivatives, methyl sulfates (salts)</ENT>
              <ENT/>
              <ENT>06/20/88</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">68611-64-3</ENT>
              <ENT>Urea, reaction products with formaldehyde</ENT>
              <ENT>§ 716.20(b)(1) applies</ENT>
              <ENT>06/03/85</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">69009-90-1</ENT>
              <ENT>Diisopropyl biphenyl—1,1′-Biphenyl, bis(1-meth-yl-eth-yl)-</ENT>
              <ENT/>
              <ENT>06/28/84</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="01">70914-09-9</ENT>
              <ENT>Poly(oxy-1,2-ethanediyl), <E T="61">a</E>-[2-[bis(2-amino-ethyl)methylammonio]ethyl]-<E T="61">v</E>-hydroxy-, <E T="03">N</E>,<E T="03">N</E>  ′-di[C<E T="52">14-18</E> acyl] derivatives, methyl sulfates (salts)</ENT>
              <ENT/>
              <ENT>06/20/88</ENT>
              <ENT>06/20/88</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75790-84-0</ENT>
              <ENT>Benzene, 2-isocyanato-4-[(4-isocyanato-   phenyl)methyl]-1-methyl-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">75790-87-3</ENT>
              <ENT>Benzene, 1-isocyanato-2-[(4-isocyanato-phenyl)thio]-</ENT>
              <ENT/>
              <ENT>06/01/87</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
          </GPOTABLE>
          <P>(b) [Reserved]</P>
          <P>(c) <E T="03">By category.</E> The following categories are listed in alphabetical order. Chemical substances listed within a category are provided only as examples of the category. All chemical substances within a category are subject to all the provisions of part 716 for the time period from the effective date of the category until the sunset date. Manufacturers, importers, and processors of any chemical substance within a category are subject to the reporting requirements of subpart A for that category, except when the sunset date for the particular substance predates the sunset date for the category, or when the exemption of § 716.20(b) of this part applies.</P>
          <GPOTABLE CDEF="s30,12,10,10,11" COLS="5" OPTS="L2,i1">
            <BOXHD>
              <CHED H="1">Category</CHED>
              <CHED H="1">CAS No. (examples for category)</CHED>
              <CHED H="1">Special exemptions</CHED>
              <CHED H="1">Effective date</CHED>
              <CHED H="1">Sunset date</CHED>
            </BOXHD>
            <ROW>
              <ENT I="01">Alkyl epoxides—including all noncyclic aliphatic hydrocarbons with one or more epoxy functional groups.</ENT>
              <ENT/>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
          </GPOTABLE>
          
          <GPH DEEP="143" SPAN="2">
            <GID>716-106a.eps</GID>
          </GPH>
          <GPOTABLE CDEF="s30,12,10,10,11" COLS="5" OPTS="L2,i1">
            <BOXHD>
              <CHED H="1">Category</CHED>
              <CHED H="1">CAS No. (examples for category)</CHED>
              <CHED H="1">Special exemptions</CHED>
              <CHED H="1">Effective date</CHED>
              <CHED H="1">Sunset date</CHED>
            </BOXHD>
            <ROW>
              <ENT I="11">R<E T="52">1</E>=R<E T="52">2</E>=R<E T="52">3</E>=R<E T="52">4</E>=H or alkyl. Groups R<E T="52">1</E>-R<E T="52">4</E> may contain one or more epoxide functions.</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, decyl-</ENT>
              <ENT>2855-19-8</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2-dimethyl-</ENT>
              <ENT>558-30-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,3-dimethyl-</ENT>
              <ENT>3266-23-7</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, dodecyl</ENT>
              <ENT>3234-28-4</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, heptadecyl-</ENT>
              <ENT>67860-04-2</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, octyl-</ENT>
              <ENT>2404-44-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, pentadecyl-</ENT>
              <ENT>22092-38-2</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="69"/>
              <ENT I="01">Alkyl phthalates—all alkyl esters of 1,2-benzenedicarboxylic acid (<E T="03">ortho</E>-phthalic acid).</ENT>
              <ENT/>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
          </GPOTABLE>
          <GPH DEEP="130" SPAN="2">
            <GID>716-106b.eps</GID>
          </GPH>
          <GPOTABLE CDEF="s30,12,10,10,11" COLS="5" OPTS="L2,i1">
            <BOXHD>
              <CHED H="1">Category</CHED>
              <CHED H="1">CAS No. (examples for category)</CHED>
              <CHED H="1">Special exemptions</CHED>
              <CHED H="1">Effective date</CHED>
              <CHED H="1">Sunset date</CHED>
            </BOXHD>
            <ROW>
              <ENT I="11">R<E T="52">1</E>=R<E T="52">2</E>=alkyl.</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester</ENT>
              <ENT>117-81-7</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, bis(1-methylheptyl) ester</ENT>
              <ENT>131-15-7</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, bis(2-methylpropyl) ester</ENT>
              <ENT>84-69-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, 2-butoxy-2-oxyethyl butyl ester</ENT>
              <ENT>85-70-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>01/13/86</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, butyl cyclohexyl ester</ENT>
              <ENT>84-64-0</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, butyl 2-ethylhexyl ester</ENT>
              <ENT>85-69-8</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, butyl octyl ester</ENT>
              <ENT>84-78-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, decyl hexyl ester</ENT>
              <ENT>25724-58-7</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, decyl octyl ester</ENT>
              <ENT>119-07-3</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, dibutyl ester</ENT>
              <ENT>84-74-2</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, dicyclohexyl ester</ENT>
              <ENT>84-61-7</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, diethyl ester</ENT>
              <ENT>84-66-2</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, dihexyl ester</ENT>
              <ENT>84-75-3</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, diisodecyl ester</ENT>
              <ENT>26761-40-0</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, diisononyl ester</ENT>
              <ENT>28553-12-0</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, diisooctyl ester</ENT>
              <ENT>27554-26-3</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, demethyl ester</ENT>
              <ENT>131-11-3</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, dinonyl ester</ENT>
              <ENT>84-76-4</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, dioctyl ester</ENT>
              <ENT>117-84-0</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, diundecyl ester</ENT>
              <ENT>119-06-2</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, isodecyl tridecyl ester</ENT>
              <ENT>3648-20-2</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, 2-ethylhexyl-8-methylnonyl ester</ENT>
              <ENT>89-13-4</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, hexyl isodecyl ester</ENT>
              <ENT>61702-81-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenedicarboxylic acid, isodecyl tridecyl ester</ENT>
              <ENT>61886-60-0</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Alkyltin compounds.</ENT>
              <ENT/>
              <ENT/>
              <ENT>01/03/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dibutyltin <E T="03">S,S</E>’-bis(isooctyl mercaptoacetate)—Acetic acid, 2,2’-[(dibutylstannylene)bis(thio)]bis-, diisooctyl ester</ENT>
              <ENT>25168-24-5</ENT>
              <ENT/>
              <ENT>01/03/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dibutyltin <E T="03">S,S</E>’-bis(isooctyl mercaptoacetate)—Acetic acid, 2,2’-[(dimethylstannylene)bis(thio)]bis-, diisooctyl ester</ENT>
              <ENT>26636-01-1</ENT>
              <ENT/>
              <ENT>01/03/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Mono methyltin tris(isooctylmercaptoacetate) Acetic acid, 2,2’,2”-[(methylstannylidyne)tris(thio)]tris-triisoacetyl ester</ENT>
              <ENT>54849-38-6</ENT>
              <ENT/>
              <ENT>01/03/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Aniline and chloro-, bromo-, and/or nitroanilines.</ENT>
              <ENT/>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine</ENT>
              <ENT>62-53-3</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 4-bromo-</ENT>
              <ENT>106-40-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 2-bromo-6-chloro-4-nitro-</ENT>
              <ENT>99-29-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 2-bromo-,4,6-dinitro-</ENT>
              <ENT>1817-73-8</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 2-chloro-</ENT>
              <ENT>95-51-2</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 3-chloro-</ENT>
              <ENT>108-42-9</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 4-chloro-</ENT>
              <ENT>106-47-8</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 2-chloro-4,6-dinitro-</ENT>
              <ENT>3531-19-9</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 4-chloro-2,6-dinitro-</ENT>
              <ENT>5388-62-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 3-chloro-, hydrochloride</ENT>
              <ENT>141-85-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 2-chloro-4-nitro-</ENT>
              <ENT>121-87-9</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="70"/>
              <ENT I="02">Benzenamine, 2-chloro-5-nitro-</ENT>
              <ENT>6283-25-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 4-chloro-2-nitro-</ENT>
              <ENT>89-63-4</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 4-chloro-3-nitro-</ENT>
              <ENT>635-22-3</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 2,6-dibromo-4-nitro-</ENT>
              <ENT>827-94-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 2,3-dichloro-</ENT>
              <ENT>608-27-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 2,4-dichloro-</ENT>
              <ENT>554-00-7</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 2,5-dichloro-</ENT>
              <ENT>95-82-9</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 3,4-dichloro-</ENT>
              <ENT>95-76-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 3,5-dichloro-</ENT>
              <ENT>626-43-7</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 2,6-dichloro-4-nitro-</ENT>
              <ENT>99-30-9</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 2,4-dinitro-</ENT>
              <ENT>97-02-9</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 2-nitro-</ENT>
              <ENT>88-74-4</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 3-nitro-</ENT>
              <ENT>99-09-2</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 4-nitro-</ENT>
              <ENT>100-01-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 2,4,6-tribromo-</ENT>
              <ENT>147-82-0</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenamine, 2,4,6-trichloro-</ENT>
              <ENT>634-93-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Aryl phosphates—phosphate esters of phenol or of alkyl-substituted phenols. Triaryl and mixed alkyl and aryl esters are included but trialkyl esters are excluded</ENT>
              <ENT/>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
          </GPOTABLE>
          <GPH DEEP="125" SPAN="2">
            <GID>716-108.eps</GID>
          </GPH>
          <GPOTABLE CDEF="s30,12,10,10,11" COLS="5" OPTS="L2,i1">
            <BOXHD>
              <CHED H="1">Category</CHED>
              <CHED H="1">CAS No. (examples for category)</CHED>
              <CHED H="1">Special exemptions</CHED>
              <CHED H="1">Effective date</CHED>
              <CHED H="1">Sunset date</CHED>
            </BOXHD>
            <ROW>
              <ENT I="11">R<E T="52">1</E>=phenyl, either unsubstituted or substituted with one or more alkyl or aralkyl groups R<E T="52">2</E>=R<E T="52">3</E> alkyl; or phenyl, either unsubstituted or substituted with one or more alkyl or aralkyl groups</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phenol, dimethyl-, phosphate (3:1)</ENT>
              <ENT>25155-23-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phenol, 4-(1,1-dimethylethyl)-, phosphate (3:1)</ENT>
              <ENT>78-33-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, dibutyl phenyl ester</ENT>
              <ENT>2528-36-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, diisodecyl phenyl ester</ENT>
              <ENT>51363-64-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, (1,1-dimethylethyl) phenyl diphenyl ester</ENT>
              <ENT>56803-37-3</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, 2-ethylhexyl diphenyl ester</ENT>
              <ENT>1241-94-7</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, isodecyl diphenyl ester</ENT>
              <ENT>29761-21-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, (1-methylethyl)phenyl diphenyl ester</ENT>
              <ENT>28108-99-8</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, methylphenyl diphenyl ester</ENT>
              <ENT>25444-49-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, (1-methyl-l-phenylethyl)phenyl diphenyl ester</ENT>
              <ENT>34364-42-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, triphenyl ester</ENT>
              <ENT>115-86-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, tris(methylphenyl) ester</ENT>
              <ENT>1330-78-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, tris(2-methylphenyl) ester</ENT>
              <ENT>78-30-8</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, tris(3-methylphenyl) ester</ENT>
              <ENT>563-04-2</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, tris(4-methylphenyl) ester</ENT>
              <ENT>78-32-0</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Asbestos—asbestiform varieties of chrysolite (serpentine); crocidolite (riebeckite); amosite (cummingtonite—grunerite); anthophyllite; tremolite; and actinolite.</ENT>
              <ENT/>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Asbestos</ENT>
              <ENT>1332-21-4</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Asbestiform minerals</ENT>
              <ENT>12001-29-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Asbestiform minerals</ENT>
              <ENT>17068-78-9</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Asbestiform minerals</ENT>
              <ENT>12172-73-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="71"/>
              <ENT I="01">Bisazobiphenyl dyes derived from benzidine and its congeners, <E T="03">ortho</E>-toluidine (dimethylbenzidine) and dianisidine (dimethoxybenzidine).</ENT>
              <ENT/>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benoic acid, 2-[[2-amino-6-[[4<E T="61">′</E>-[(-carboxy-4-hydroxphenyl) azo[-3,3<E T="61">′</E>-dimethoxy[1,1<E T="61">′</E>-biphenyl]-4-yl]azo]-5-hydroxy-7-sulfo-1-naphthalenylazo]-5-nitro-, trisodium salt</ENT>
              <ENT>6739-62-4</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzoic acid, 5-[[4<E T="61">′</E>-[2-amino-8-hydroxy-6-sulfo-1-naphthalenyl) azo] [1,1<E T="61">′</E>-biphenyl]-4-yl]-azo]-2-hydroxy-, disodium salt</ENT>
              <ENT>2429-84-7</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzoic acid, 5-[[4<E T="61">′</E>-[7-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo] [1,1<E T="61">′</E>-biphenyl]-4-yl]azo]-2-hydroxy-, disodium salt</ENT>
              <ENT>2429-82-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzoic acid, 5-[[4<E T="61">′</E>-[(1-amino-4-sulfo-2-naphthalenyl)azo] [1,1<E T="61">′</E>-biphenyl]-4-yl]azo]-2-hydroxy-, disodium salt</ENT>
              <ENT>2429-79-0</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzoic acid, 5-[[4<E T="61">′</E>-[[2,6-diamino-3-[[8-hydroxy-3,6-disulfo-7-[(4-sulfo-1-naphthalenyl)azo]-2-naphthalenyl]azo]-5-methylphenyl]azo] [1,1<E T="61">′</E>-biphenyl]-4-yl]azo]-2-hydroxy-, tetrasodium salt</ENT>
              <ENT>2429-81-4</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzoic acid, 5-[[4<E T="61">′</E>-[(2,6-diamino-3-methyl-5-sulfophenyl)azo]-3,3<E T="61">′</E>-dimethyl[1,1<E T="61">′</E>-biphenyl]-4-yl]azo]-2-hydroxy-, disodium salt</ENT>
              <ENT>6637-88-3</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzoic acid, 5-[[4<E T="61">′</E>-[[2,6-diamino-3-methyl-5-[(4-sulfophenyl)azo]phenyl]azo][1,1<E T="61">′</E>-biphenyl]-4-yl]azo]-2-hydroxy-, disodium salt</ENT>
              <ENT>2586-58-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzoic acid, 5-[[4<E T="61">′</E>-[[2,6-diamino-3-methyl-5-[(4-sulfophenyl)azo]phenyl]azo]1,1<E T="61">′</E>-biphenyl]-4-yl]azo]-2-hydroxy-3-methly-, disodium salt</ENT>
              <ENT>6360-54-9</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzoic acid, 5-[[4<E T="61">′</E>-[[2,4-dihydroxy-3-[(4-sulfophenyl)azo]phenyl]azo] [1,1<E T="61">′</E>-biphenyl]-4-yl]azo]-2-hydroxy-, disodium salt</ENT>
              <ENT>2893-80-3</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzoic acid, 3,3<E T="61">′</E>-[(3,7-disulfo-1,5-naphthalene-diyl)bis[azo(6-hydroxy-3,1-phenylene)azo[6(or 7)-sulfo-4,1-naphthalenediyl]azo[1,1<E T="61">′</E>-biphenyl]-4,4<E T="61">′</E>-diylazo]]bis[6-hydroxy-, hexasodium salt</ENT>
              <ENT>8014-91-3</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">[1,1<E T="61">′</E>-Biphenyl]-4,1<E T="61">′</E>-bis diazonium), 3,3<E T="61">′</E>-dimethoxy-</ENT>
              <ENT>20282-70-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Butanamide, <E T="03">N</E>,<E T="03">N</E>
                <E T="61">′</E>-(3,3<E T="61">′</E>-dimethyl [1,1<E T="61">′</E>-biphenyl]-4,4<E T="61">′</E>-diyl)bis[3-oxo-</ENT>
              <ENT>91-96-3</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">C.I. Direct Blue 218</ENT>
              <ENT>10401-50-0</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Cuprate(2-), [5-[[4<E T="61">′</E>-[[2,6-dihydroxy-3-[(2-hydroxy-5-sulfophenyl)azo]phenyl]azo][1,1<E T="61">′</E>-biphenyl]-4-yl]azo]-2-hydroxybenzoato(4-)]-, disodium</ENT>
              <ENT>16071-86-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Cuprate(3-), [μ-[7-[[3,3<E T="61">′</E>-dihydroxy-4<E T="61">′</E>-[[1-hydroxy-6-(phenylamino)-3-sulfo-2-naphthalenyl]azo] [1,1<E T="61">′</E>-biphenyl]-4-yl]azo]-8-hydroxy-1,6-naphthalenedisulfonato(7-)]]di-, trisodium</ENT>
              <ENT>6656-03-7</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Cuprate(4-), [μ-[[6,6<E T="61">′</E>-[3,3<E T="61">′</E>-dihydroxy[1,1<E T="61">′</E>-biphenyl]-4-4<E T="61">′</E>-diyl)bis(azo)]bis[4-amino-5-hydroxy-1,3-naphthalendisulfonato]](8-)]]di-, tetrasodium</ENT>
              <ENT>16143-79-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Naphthalenecarboxamide, <E T="03">N</E>,<E T="03">N</E>
                <E T="61">′</E>-(3,3<E T="61">′</E>-dimethoxy[1,1<E T="61">′</E>-biphenyl]-4,4<E T="61">′</E>-diyl)bis[3-hydroxy-</ENT>
              <ENT>91-92-9</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-6-[[4<E T="61">′</E>-[(2hydroxy-1-naphthalenyl)azo]-3,3<E T="61">′</E>-dimethoxy[1,1<E T="61">′</E>-biphenyl]-4-yl]azo]-, disodium salt</ENT>
              <ENT>2586-57-4</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Naphthalenedisulfonic acid, 6,6<E T="61">′</E>-[(3,3<E T="61">′</E>-dimethoxy[1,1<E T="61">′</E>-biphenyl]-4,4<E T="61">′</E>diyl)bis(azo)]bis[4-amino-5-hydroxy-, tetrasodium salt</ENT>
              <ENT>2610-05-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Naphthalenedisulfonic acid, 8-[[4′-[(4-ethoxyphenyl)azo] [1,1′-biphenyl]-4-yl]azo]-7-hydroxy-, di-sodium salt</ENT>
              <ENT>3530-19-6-</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Naphthalenedisulfonic acid, 8-[[4′-[4-ethoxyphenyl)azo]-3,3′-dimethyl] [1,1′-biphenyl]-4-yl]azo]-7-hydroxy-, disodium salt</ENT>
              <ENT>6358-29-8</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Naphthalenedisulfonic acid, 7-hydroxy-8-[[4′-[[4-[[(4-methylphenyl) sulfonyl]oxy]phenyl]-azo] [1,1′-biphenyl]-4-yl]azo]-, disodium salt</ENT>
              <ENT>3567-65-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2,7-Naphthalenedisulfonic acid, 5-amino-3-[[4′-(7-amino-1-hydroxy-3-sulfo-2-naphthalenyl)-azo] [1,1′-biphenyl]-4-yl]azo]-4-hydroxy-, trisodium salt</ENT>
              <ENT>2429-73-4</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2,7-Naphthalenedisulfonic acid, 4-amino-3-[[4′-[(2,4-diamino-5-methylphenyl)azo] [1,1′-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)-, disodium salt</ENT>
              <ENT>2429-83-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2,7-Naphthalenedisulfonic acid, 4-amino-3-[[4′-[(2,4-diaminophenyl)azo] [1,1′-biphenyl]-4-yl]azo] 5-hydroxy-6-(phenylazo)-, disodium salt</ENT>
              <ENT>1937-37-7</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="72"/>
              <ENT I="02">2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-6[[4′-[(4-hydroxyphenyl)azo] [1,1′-biphenyl]-4-yl]-azo]-3-[(4-nitrophenyl)azo]-, disodium salt</ENT>
              <ENT>4335-09-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3-[[4′-[(4-hydroxyphenyl)azo] [1,1′-biphenyl]-4-yl]azo)-6-(phenylazo)-, disodium salt</ENT>
              <ENT>3626-28-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2,7-Naphthalenedisulfonic acid, 3,3′-[[1,1′-biphenyl]-4,4′-diylbis(azo)]bis[5-amino-4-hydroxy-, tetrasodium salt</ENT>
              <ENT>2602-46-2</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2,7-Naphthalenedisulfonic acid, 3,3′-[(3,3′-dimethoxy[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[5-amino-4-hydroxy-, tetrasodium salt</ENT>
              <ENT>2429-74-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2,7-Naphthalenedisulfonic acid, 3,3′-[(3,3′-dimethyl-[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[5-amino-4-hydroxy-, tetrasodium salt</ENT>
              <ENT>72-57-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2,7-Naphthalenedisulfonic acid, 3,3′-[(3,3′-dimethyl-[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis-[4,5-dihydroxy-, tetrasodium salt</ENT>
              <ENT>2150-54-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1-Naphthalenesulfonic acid, 3-[[4′[(6-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo]-3,3′-dimethoxy[1,1′-biphenyl]-4-yl]azo]-4-hydroxy-, disodium salt</ENT>
              <ENT>6449-35-0</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1-Naphthalenesulfonic acid, 3,3′-[[1,1′-biphenyl]-4,4′-diyl-4,4′-diyl)bis(azo)]bis[(4-amino-,disodium salt</ENT>
              <ENT>573-58-0</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1-Naphthalenesulfonic acid, 3,3′-[3,3′-dimethoxy-[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[4-hydroxy-, disodium salt</ENT>
              <ENT>2429-71-2</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1-Naphthalenesulfonic acid, 3,3′-[(3,3′dimethyl[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[4-amino-,disodium salt</ENT>
              <ENT>992-59-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Chlorinated benzenes, mono-, di-, tri-, tetra-, and penta-</ENT>
              <ENT/>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, chloro-</ENT>
              <ENT>108-90-7</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1,2-dichloro-</ENT>
              <ENT>95-50-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1,3-dichloro-</ENT>
              <ENT>541-73-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1,4-dichloro-</ENT>
              <ENT>106-46-7</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, pentachloro-</ENT>
              <ENT>608-93-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1,2,3,4-tetrachloro-</ENT>
              <ENT>634-66-2</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1,2,3,5-tetrachloro-</ENT>
              <ENT>634-90-2</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1,2,4,5-tetrachloro-</ENT>
              <ENT>95-94-3</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1,2,3-trichloro-</ENT>
              <ENT>87-61-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1,2,4-trichloro-</ENT>
              <ENT>120-82-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1,3,5-trichloro-</ENT>
              <ENT>108-70-3</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Chlorinated naphthalenes—chlorinated derivatives of naphthalene (empirical formula) C<E T="52">10</E>H<E T="52">x</E>Cl<E T="52">y </E>where x=y=8.</ENT>
              <ENT/>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Naphthalene, chloro-</ENT>
              <ENT>25586-43-0</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Naphthalene, chloro derivatives</ENT>
              <ENT>70776-03-3</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Naphthalene, 1-chloro-</ENT>
              <ENT>90-13-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Naphthalene, heptachloro-</ENT>
              <ENT>32241-08-0</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Chlorinated paraffins—chlorinated paraffin oils and chlorinated paraffin waxes, with chlorine content of 35 percent through 70 percent by weight.</ENT>
              <ENT/>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Alkanes, chloro-</ENT>
              <ENT>61788-76-9</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Alkanes, C<E T="52">6-18, </E>chloro-</ENT>
              <ENT>68920-70-7</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Paraffin waxes and hydrocarbon waxes, chlorinated</ENT>
              <ENT>63449-39-8</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Ethyltoluenes—This category consists of ethyltoluene (mixed isomers) and the ortho (1,2-), meta (1,3-)   and para (1,4-) isomers</ENT>
              <ENT/>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1-ethyl-2-methyl-</ENT>
              <ENT>611-14-3</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Fluoroalkenes—This category is defined as fluroalkenes of the general formula: C<E T="52">n</E>H<E T="52">2n-x</E>F<E T="52">x</E> where n   equals 2 to 3 and X equals 1 to 6.</ENT>
              <ENT/>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Ethene, tetrafluoro-</ENT>
              <ENT>116-14-3</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Ethene, trifluoro-</ENT>
              <ENT>359-11-5</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>01/13/86</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1-Propene, 1,1,2,3,3,3-hexafluoro-</ENT>
              <ENT>116-15-4</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Glycidol (oxiranemethanol) and its derivatives</ENT>
              <ENT/>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
          </GPOTABLE>
          <GPH DEEP="146" SPAN="2">
            <PRTPAGE P="73"/>
            <GID>716-106a.eps</GID>
          </GPH>
          <GPOTABLE CDEF="s30,12,10,10,11" COLS="5" OPTS="L2,i1">
            <BOXHD>
              <CHED H="1">Category</CHED>
              <CHED H="1">CAS No. (examples for category)</CHED>
              <CHED H="1">Special exemptions</CHED>
              <CHED H="1">Effective date</CHED>
              <CHED H="1">Sunset date</CHED>
            </BOXHD>
            <ROW>
              <ENT I="11">R=H; alkyl, alkenyl or alkynyl; aryl; acyl. where R=alkyl, alkenyl, alkynyl, aryl, or acyl; any substituents   or functional groups may be present with the alkyl, etc., groups</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Cyclohexanedicarboxylic acid, bis(oxiranylmethyl) ester</ENT>
              <ENT>5493-45-8</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Disiloxane, 1,1,3,3-tetramethyl-1,3-bis[3-oxiranylmethoxy)propyl]-</ENT>
              <ENT>126-80-7</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2,4-Imidazolidinedione, 5,5-dimethyl-3-[2-(oxiranylmethoxy)propyl]-1-(oxiranylmethyl)-</ENT>
              <ENT>32568-89-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2,4-Imidazolidenedione, 3,3′-[2-(oxiranylmethoxy)-1,3-propanediyl]bis[5,5-dimethyl-1-(oxiranyl-methyl)-</ENT>
              <ENT>38304-52-8</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Neodecanoic acid, oxiranylmethyl ester</ENT>
              <ENT>26761-45-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2′-[1,4-butanediylbis(oxymethylene)]bis</ENT>
              <ENT>2425-79-8</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, (butoxymethyl)-</ENT>
              <ENT>2426-08-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2′-[1,4-cyclohexanedilbis (methyleneoxymethylene)]bis-</ENT>
              <ENT>14228-73-0</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, [(2,4-dibromophenoxy)methyl]-</ENT>
              <ENT>20217-01-0</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, [(1,2-dibromopropoxy)methyl]-</ENT>
              <ENT>35243-89-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, [(1,1-dimethylethoxy)methyl]-</ENT>
              <ENT>7665-72-7</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, [[4-(1,1-dimethylethyl)phenoxy]methyl]-</ENT>
              <ENT>3101-60-8</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2′-[(2,2-dimethyl-1,3-propanediyl)bis(oxymethylene)]bis-</ENT>
              <ENT>17557-23-2</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, [(dodecyloxy)methyl]-</ENT>
              <ENT>2461-18-9</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2′-[1,2-ethanediylbis (oxymethylene)]bis-</ENT>
              <ENT>2224-15-9</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2′,2′′,2′′′-[1,2-ethanediylidenetetrakis-(4,1-phenyleneoxymethylene)]tetrakis-</ENT>
              <ENT>7328-97-4</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, (ethoxymethyl)-</ENT>
              <ENT>4016-11-9</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, [[(2-ethylhexyl)oxy]methyl]-</ENT>
              <ENT>2461-15-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, [(hexadecyloxy)methyl]-</ENT>
              <ENT>15965-99-8</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2′,2′′-[1,2,6-hexanetriyltris-(oxymethylene)]tris-</ENT>
              <ENT>68959-23-9</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, (methoxymethyl)-</ENT>
              <ENT>930-37-0</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2′-[methylenebis(phenyleneoxymethylene)]bis-</ENT>
              <ENT>39817-09-9</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2′-[methylenebis(2,1-phenyleneoxymethylene)]bis-</ENT>
              <ENT>54208-63-8</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, [(1-methylethoxy)methyl]-</ENT>
              <ENT>4016-14-2</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2′-[(1-methylethylidene)bis[4,1-phenyl-eneoxy[1-(butoxymethyl)-2,1-ethanediyl]oxymethylene]]bis-</ENT>
              <ENT>71033-08-4</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2′-[1-methylethylidene) bis(4,1-phenyl-eneoxymethylene)]bis-</ENT>
              <ENT>1675-54-3</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2′-[(1-methylethylidene)bis(4,1-phenyl-eneoxymethylene)[bis-, homopolymer</ENT>
              <ENT>25085-99-8</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2′-[(1-methylethylidene)bis[4,1-phenyleneoxy-3,1-propanediyloxy-4,1-phenylene(1-methylethylidene)-4,1-phenyleneoxymethylene]]bis-</ENT>
              <ENT>72319-24-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, [(methylphenoxy)methyl]-</ENT>
              <ENT>26447-14-3</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, [(2-methylphenoxy)methyl]-</ENT>
              <ENT>2210-79-9</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, [[4-(1-methyl-1-phenylethyl)phenoxy]-methyl]-</ENT>
              <ENT>61578-04-9</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, mono[C<E T="52">6</E>-C<E T="52">12</E>-alkyloxy)methyl]derivatives</ENT>
              <ENT>68987-80-4</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, mono[(C<E T="52">8</E>-C<E T="52">12</E>-alkyloxy)methyl]derivatives</ENT>
              <ENT>68609-96-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, mono[C<E T="52">10</E>-C<E T="52">16</E>-alkyloxy)methyl]derivatives</ENT>
              <ENT>68081-84-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, mono[(C<E T="52">10</E>-C<E T="52">14</E>-alkyloxy)methyl]derivatives</ENT>
              <ENT>68609-97-2</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, [(4-nitrophenoxy)methyl]-</ENT>
              <ENT>5255-75-4</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="74"/>
              <ENT I="02">Oxirane, [(4-nonylphenoxy)methyl]-</ENT>
              <ENT>6178-32-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, [(9-octadecenyloxy)methyl]-, (<E T="03">Z</E>)-</ENT>
              <ENT>60501-41-9</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, [(octadecyloxy)methyl]-</ENT>
              <ENT>16245-97-9</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2′-(oxiranylmethoxy)-1,3-phenylene]bis(methylene)]bis-</ENT>
              <ENT>13561-08-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2<E T="61">′</E>-[[[2-oxiranylmethyoxy) phenyl]methylene]bis(4,1-phenyl-eneoxymethylene)]bis-</ENT>
              <ENT>67786-03-2</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2<E T="61">′</E>-[oxybis(methylene)]bis-</ENT>
              <ENT>2238-07-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, (phenoxymethyl)-</ENT>
              <ENT>122-60-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2<E T="61">′</E>-[1,3-phenylenebis (oxymethylene)]bis-</ENT>
              <ENT>2425-01-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2<E T="61">′</E>-[1,4-phenylenebis (oxymethylene)]bis-</ENT>
              <ENT>101-90-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2<E T="61">′</E>,2<E T="71">¼</E>-[1,2,3-propanetriyl tris(oxymethylene)]tris-</ENT>
              <ENT>13236-02-7</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, [(2-propenyloxy)methyl]-</ENT>
              <ENT>106-92-3</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, 2,2<E T="61">′</E>,2<E T="71">¼</E>-[propylidynetris (4,1-phenyleneoxymethylene)]tris-</ENT>
              <ENT>68517-02-2</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, [(tetradecyloxy)methyl]-</ENT>
              <ENT>38954-75-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxiranecarboxylic acid, 3-methyl-3-phenyl-, ethyl ester</ENT>
              <ENT>77-83-8</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Poly(oxy-1,2-ethanediyl),-<E T="02">α</E>-[4-oxiranylmethyoxy)benzoyl]-<E T="61">v</E>-[[4-oxiranylmethoxy)benzoyl]oxy]-</ENT>
              <ENT>69943-75-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenoic acid, 2-methyl-, oxiranylmethyl ester</ENT>
              <ENT>106-91-2</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenoic acid, oxiranylmethyl ester</ENT>
              <ENT>106-90-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Silane, [(3-chloropropyl)(dimethoxy)[3-(oxiranylmethoxy)propyl]-</ENT>
              <ENT>71808-64-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Silane, diethoxymethyl[3-(oxiranyl-methoxy)propyl]-</ENT>
              <ENT>2897-60-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Silane, ethoxydimethyl[3-(oxiranyl-methoxy)propyl]-</ENT>
              <ENT>17963-04-1</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Silane, trimethyoxy[3-(oxiranyl-methoxy)propyl]-</ENT>
              <ENT>2530-83-8</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Tetrasiloxane, 1,1,1,3,5,7,7,7-octamethyl-3,5-bis[3-(oxiranylmethoxy)propyl]-</ENT>
              <ENT>69155-42-6</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Trisiloxane, 1,1,1,3,5,5,5-heptamethyl-3-[3-(oxiranyl-methoxy)propyl]-</ENT>
              <ENT>7422-52-8</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>10/04/92</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Halogenated alkyl epoxides—halogenated noncyclic aliphatic hydrocarbons with one or more epoxy functional groups.</ENT>
              <ENT/>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
          </GPOTABLE>
          <GPH DEEP="143" SPAN="2">
            <GID>716-106a.eps</GID>
          </GPH>
          <GPOTABLE CDEF="s30,12,10,10,11" COLS="5" OPTS="L2,i1">
            <BOXHD>
              <CHED H="1">Category</CHED>
              <CHED H="1">CAS No. (examples for category)</CHED>
              <CHED H="1">Special exemptions</CHED>
              <CHED H="1">Effective date</CHED>
              <CHED H="1">Sunset date</CHED>
            </BOXHD>
            <ROW>
              <ENT I="11">R<E T="52">1</E>=X or C<E T="52">n</E>H<E T="52">2n=1−y</E>X<E T="52">y</E>(y=1 to 1n=1)</ENT>
              <ENT/>
              <ENT/>
              <ENT/>
              <ENT/>
            </ROW>
            <ROW>
              <ENT I="11">R<E T="52">2</E>=H or X or C<E T="52">n</E>H<E T="52">2n=1−y</E>X<E T="52">y</E>(y=0 to 2n=1)</ENT>
              <ENT/>
              <ENT/>
              <ENT/>
              <ENT/>
            </ROW>
            <ROW>
              <ENT I="11">R<E T="52">3</E>=H or X or C<E T="52">n</E>H<E T="52">2n=1−y</E>X<E T="52">y</E>(y=0 to 2n=1)</ENT>
              <ENT/>
              <ENT/>
              <ENT/>
              <ENT/>
            </ROW>
            <ROW>
              <ENT I="11">R<E T="52">4</E>=H or X or C<E T="52">n</E>H<E T="52">2n=1−y</E>X<E T="52">y</E>(y=0 to 2n=1)</ENT>
              <ENT/>
              <ENT/>
              <ENT/>
              <ENT/>
            </ROW>
            <ROW>
              <ENT I="11">X=halogen. Groups R<E T="52">1</E>-R<E T="52">4 </E>may contain one or more expoxide functions.</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, (bromomethyl)-</ENT>
              <ENT>3132-463-7</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxirane, (2,2,3,3,4,4,5,5,6,6,7,7,7-tridecafluoroheptyl)-</ENT>
              <ENT>38565-52-5</ENT>
              <ENT/>
              <ENT>10/04/82</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="75"/>
              <ENT I="01">Phenylenediamines (Benzenediamines). This category is defined as all nitrogen unsubstituted phenylenediamines and their salts with zero to two substitutents on the ring selected from the same of different members of the group of halo, nitro, hydroxy, hydroxy-lower alkoxy, lower-alkyl, and lower alkoxy. For this purpose, the term “lower” is defined as a group containing between one and four carbons.</ENT>
              <ENT/>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenediamine</ENT>
              <ENT>95-54-5</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Benzenediamine</ENT>
              <ENT>108-45-2</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenediamine, 4-butyl-</ENT>
              <ENT>3663-23-8</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenediamine, 4-butyl-</ENT>
              <ENT>95-83-0</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/83</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Benzenediamine, 4-chloro-</ENT>
              <ENT>5131-60-2</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,4-Benzenediamine, 2-chloro-, dihydrochloride</ENT>
              <ENT>615-46-3</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenediamine, 5-chloro-3-nitro-</ENT>
              <ENT>42389-30-0</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenediamine, 4-chloro-, sulfate (1:1)</ENT>
              <ENT>68459-98-3</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Benzenediamine, 4-chloro-, sulfate (1:1)</ENT>
              <ENT>68239-80-5</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,4-Benzenediamine, 2-chloro-, sulfate</ENT>
              <ENT>6219-71-2</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,4-Benzenediamine, 2,5-dichloro-</ENT>
              <ENT>20103-09-7</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenediamine, dihydrochloride</ENT>
              <ENT>615-28-1</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Benzenediamine, dihydrochloride</ENT>
              <ENT>541-69-5</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,4-Benzenediamine, dihydrochloride</ENT>
              <ENT>624-18-0</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,4-Benzenediamine, ethanedioate (1:1)</ENT>
              <ENT>62654-17-5</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenediamine, 4-ethoxy-</ENT>
              <ENT>1197-37-1</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Benzenediamine, 4-ethoxy-dihydrochloride</ENT>
              <ENT>67801-06-3</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Benzenediamine, 4-ethoxy-, sulfate (1:1)</ENT>
              <ENT>68015-98-5</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Benzenediamine, <E T="03">ar</E>-ethyl-<E T="03">ar-</E>methyl-</ENT>
              <ENT>68966-84-7</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,4-Benzenediamine, 2-methoxy</ENT>
              <ENT>5307-02-8</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenediamine, 4-methoxy-, dihydrochloride</ENT>
              <ENT>614-94-8</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Benzenediamine, 4-methoxy-, sulfate</ENT>
              <ENT>6219-67-6</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Benzenediamine, 4-methoxy-, sulfate (1:1)</ENT>
              <ENT>39156-41-7</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenediamine, <E T="03">ar</E>-methyl-</ENT>
              <ENT>25376-45-8</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenediamine, 3-methyl-</ENT>
              <ENT>2687-25-4</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenediamine, 4-methyl-</ENT>
              <ENT>496-72-0</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Benzenediamine, 2-methyl-</ENT>
              <ENT>823-40-5</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Benzenediamine, 4-methyl-</ENT>
              <ENT>95-80-7</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Benzenediamine, 5-methyl-</ENT>
              <ENT>108-71-4</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,4-Benzenediamine, 2-methyl-</ENT>
              <ENT>95-70-5</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,4-Benzenediamine, 2-methyl-, dihydrochloride-</ENT>
              <ENT>615-45-2</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,4-Benzenediamine, 2-methyl-, sulfate</ENT>
              <ENT>6369-59-1</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,4-Benzenediamine, 2-methyl-, sulfate (1:1)</ENT>
              <ENT>615-50-9</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenediamine, 4-nitro-</ENT>
              <ENT>99-56-9</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Benzenediamine, 4-nitro-,</ENT>
              <ENT>5131-58-8</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Benzenediamine, 5-nitro-,</ENT>
              <ENT>5042-55-7</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,4-Benzenediamine, 2-nitro-,</ENT>
              <ENT>5307-14-2</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenediamine, 4-nitro-, dihydrochloride</ENT>
              <ENT>6219-77-8</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,4-Benzenediamine, 2-nitro-, dihydrochloride</ENT>
              <ENT>18266-52-9</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Benzenediamine, 4-nitro-, sulfate (1:1)</ENT>
              <ENT>68239-82-7</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,4-Benzenediamine, 2-nitro-, sulfate (1:1)</ENT>
              <ENT>68239-83-8</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Benzenediamine, sulfate (1:1)</ENT>
              <ENT>541-70-8</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,4-Benzenediamine, sulfate (1:1)</ENT>
              <ENT>16245-77-5</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Ethanol, 2-(2,4-diaminophenoxy)-, dihydrochloride</ENT>
              <ENT>66422-95-5</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phenol, 2,4-diamino-, dihydrochloride</ENT>
              <ENT>137-09-7</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>04/29/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phenol, 2,4-diamino-6-methyl-</ENT>
              <ENT>15872-73-8</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phenol, 2,4-diamino-6-methyl-, hydrochloride</ENT>
              <ENT>65879-44-9</ENT>
              <ENT/>
              <ENT>04/29/83</ENT>
              <ENT>12/29/88</ENT>
            </ROW>
          </GPOTABLE>
          <P>(d) <E T="03">Listed members of categories</E>. The following categories are listed in alphabetical order with the chemical substances identified in each category also listed alphabetically. Only those chemical substances specifically listed within a category are subject to all provisions of part 716 for the time period from the effective date of the rule until the sunset date.<PRTPAGE P="76"/>
          </P>
          <GPOTABLE CDEF="s100,xs80,15,15,15" COLS="5" OPTS="L2,i1">
            <BOXHD>
              <CHED H="1">Category</CHED>
              <CHED H="1">CAS No.</CHED>
              <CHED H="1">Special Exemptions</CHED>
              <CHED H="1">Effective Date</CHED>
              <CHED H="1">Sunset Date</CHED>
            </BOXHD>
            <ROW>
              <ENT I="01">Aldehydes:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Acetaldehyde</ENT>
              <ENT>75-07-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Acetaldehyde, chloro-</ENT>
              <ENT>107-20-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Acetaldehyde, (1,3-dihydro-1,3,3-trimethyl-2<E T="03">H</E>-indol-2-ylidene)</ENT>
              <ENT>84-83-3</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Acetaldehyde, trichloro-</ENT>
              <ENT>75-87-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde</ENT>
              <ENT>100-52-7</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 3-bromo-</ENT>
              <ENT>3132-99-8</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 4-butyl-</ENT>
              <ENT>1200-14-2</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 2-chloro-</ENT>
              <ENT>89-98-5</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 4-chloro-</ENT>
              <ENT>104-88-1</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 4-(diethylamino)-</ENT>
              <ENT>120-21-8</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 4-(diethylamino)-2-hydroxy-</ENT>
              <ENT>17754-90-4</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 2,4-dihydroxy-</ENT>
              <ENT>95-01-2</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 2,5-dimethoxy-</ENT>
              <ENT>93-02-7</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 3,4-dimethoxy-</ENT>
              <ENT>120-14-9</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, (dimethylamino)-</ENT>
              <ENT>28602-27-9</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 4-(dimethylamino)-</ENT>
              <ENT>100-10-7</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 4-ethoxy-</ENT>
              <ENT>10031-82-0</ENT>
              <ENT/>
              <ENT>l9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 3-ethoxy-4-hydroxy-</ENT>
              <ENT>121-32-4</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 2-hydroxy-</ENT>
              <ENT>90-02-8</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 4-hydroxy-</ENT>
              <ENT>123-08-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 4-hydroxy-3-methoxy-</ENT>
              <ENT>121-33-5</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 2-hydroxy-5-nitro-</ENT>
              <ENT>97-51-8</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 2-methoxy-</ENT>
              <ENT>135-02-4</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 4-methoxy-</ENT>
              <ENT>123-11-5</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, methyl-</ENT>
              <ENT>1334-78-7</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 4-methyl-</ENT>
              <ENT>104-87-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 2-nitro-</ENT>
              <ENT>552-89-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 3-phenoxy-</ENT>
              <ENT>39515-51-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzaldehyde, 4-(trifluoromethyl)-</ENT>
              <ENT>455-19-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzeneacetaldehyde</ENT>
              <ENT>122-78-1</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzeneacetaldehyde, alpha-methyl-</ENT>
              <ENT>93-53-8</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzeneacetaldehyde, 4-methyl-</ENT>
              <ENT>104-09-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenepropanal, 4-(1,1-dimethylethyl)-.<E T="61">a</E>.-methyl-</ENT>
              <ENT>80-54-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenepropanal, .<E T="61">a</E>.-methyl-4-(1-methylethyl)-</ENT>
              <ENT>103-95-7</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Benzodioxole-5-carboxaldehyde</ENT>
              <ENT>120-57-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Benzodioxole-5-carboxaldehyde, 7-methoxy-</ENT>
              <ENT>5780-07-4</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Butanal, 3-methyl-</ENT>
              <ENT>590-86-3</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3-Cyclohexene-1-carboxaldehyde</ENT>
              <ENT>100-50-5</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3-Cyclohexene-1-carboxaldehyde, dimethyl-</ENT>
              <ENT>27939-60-2</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3-Cyclohexene-1-carboxaldehyde, 4-(4-hydroxy-4-methylpentyl)-</ENT>
              <ENT>31906-04-4</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3-Cyclohexene-1-carboxaldehyde, 1-methyl-4-(4-methyl-3-pentenyl)-</ENT>
              <ENT>52475-86-2</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3-Cyclohexene-1-carboxaldehyde, 1-methyl-4-(4-methylpentyl)-</ENT>
              <ENT>66327-54-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3-Cyclohexene-1-carboxaldehyde, 4-(4-methyl-3-pentenyl)-</ENT>
              <ENT>37677-14-8</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3-Cyclohexene-1-carboxaldehyde, 2,4,6-trimethyl-</ENT>
              <ENT>1423-46-7</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3-Cyclopentene-1-acetaldehyde, 2,2,3-trimethyl-</ENT>
              <ENT>4501-58-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Decanal</ENT>
              <ENT>112-31-2</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="77"/>
              <ENT I="02">4a(4<E T="03">H</E>)-Dibenzofurancarboxaldehyde, 1,5a,6,9,9a,9b-hexahydro-</ENT>
              <ENT>126-15-8</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dodecanal</ENT>
              <ENT>112-54-9</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Ethanedial</ENT>
              <ENT>107-22-2</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Heptanal</ENT>
              <ENT>111-71-7</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Heptanal, 2-(phenylmethylene)-</ENT>
              <ENT>122-40-7</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">5-Heptenal, 2,6-dimethyl-</ENT>
              <ENT>106-72-9</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Hexanal, 2-ethyl-</ENT>
              <ENT>123-05-7</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Hexanal, 3,5,5-trimethyl-</ENT>
              <ENT>5435-64-3</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Hexenal</ENT>
              <ENT>505-57-7</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Hexenal, 2-ethyl-</ENT>
              <ENT>26266-68-2</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1-Naphthalene carboxaldehyde</ENT>
              <ENT>66-77-3</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Nonanal</ENT>
              <ENT>124-19-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2,6-Octadienal, 3,7-dimethyl-, (E)</ENT>
              <ENT>141-27-5</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2,6-Octadienal, 3,7-dimethyl-, (Z)</ENT>
              <ENT>106-26-3</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Octanal</ENT>
              <ENT>124-13-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Octanal, 3,7-dimethyl-</ENT>
              <ENT>5988-91-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Octanal, 7-hydroxy-3,7-dimethyl-</ENT>
              <ENT>107-75-5</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Octanal, 7-methoxy-3,7-dimethyl-</ENT>
              <ENT>3613-30-7</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Octanal, 2-(phenylmethylene)-</ENT>
              <ENT>101-86-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">6-Octenal, 3,7-dimethyl-</ENT>
              <ENT>106-23-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">6-Octenal, 3,7-dimethyl-, (S)-</ENT>
              <ENT>5949-05-3</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Pentanal</ENT>
              <ENT>110-62-3</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Pentanedial</ENT>
              <ENT>111-30-8</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1-Piperidinecarboxaldehyde</ENT>
              <ENT>2591-86-8</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Propanal</ENT>
              <ENT>123-38-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Propanal, 3-hydroxy-2,2-dimethyl-</ENT>
              <ENT>597-31-9</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenal, 2-methyl-</ENT>
              <ENT>78-85-3</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Propanal, 3-(methylthio)-</ENT>
              <ENT>3268-49-3</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenal</ENT>
              <ENT>107-02-8</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenal, 3- 4-(1,1-dimethylethyl)phenyl -2-methyl-</ENT>
              <ENT>13586-68-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenal, 3-(2-methoxyphenyl)-</ENT>
              <ENT>1504-74-1</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenal, 2-methyl-</ENT>
              <ENT>78-85-3</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenal, 2-methyl-3-phenyl-</ENT>
              <ENT>101-39-3</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenal, 3-phenyl-</ENT>
              <ENT>104-55-2</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenal, 3-phenyl-, monopentyl deriv.</ENT>
              <ENT>1331-92-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Pyridinecarboxaldehyde</ENT>
              <ENT>1121-60-4</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Thiophene carboxaldehyde</ENT>
              <ENT>98-03-3</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Undecanal</ENT>
              <ENT>112-44-7</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Undecanal, 2-methyl-</ENT>
              <ENT>110-41-8</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">9-Undecenal</ENT>
              <ENT>143-14-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">10-Undecenal</ENT>
              <ENT>112-45-8</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Alkyl-, Chloro-, and Hydroxymethyl Diaryl Ethers:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1-(bromomethyl)-3-phenoxy-</ENT>
              <ENT>51632-16-7</ENT>
              <ENT/>
              <ENT>04/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenemethanol, 3-phenoxy-,</ENT>
              <ENT>13826-35-2</ENT>
              <ENT/>
              <ENT>04/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzenemethanol, 3-phenoxy-, acetate</ENT>
              <ENT>50789-44-1</ENT>
              <ENT/>
              <ENT>4/12/93</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1-methyl-3-phenoxy-</ENT>
              <ENT>3586-14-9</ENT>
              <ENT/>
              <ENT>04/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1,1’-oxybis[dodecyl-</ENT>
              <ENT>69834-19-1</ENT>
              <ENT/>
              <ENT>4/12/93</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1,1,<E T="61">′</E>-oxybis[methyl-</ENT>
              <ENT>28299-41-4</ENT>
              <ENT/>
              <ENT>04/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1,1’-oxybis[(1,1,3,3-tetramethylbutyl)-</ENT>
              <ENT>61702-88-3</ENT>
              <ENT/>
              <ENT>4/12/93</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzoic acid, 3-[2-chloro-4-(tri-fluor-o-methyl)phenoxy]-,</ENT>
              <ENT>63734-62-3</ENT>
              <ENT/>
              <ENT>04/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="78"/>
              <ENT I="02">Benzoic acid, 3-[2-chloro-4-(trifluoromethyl)phenoxy], potassium salt</ENT>
              <ENT>72242-48-3</ENT>
              <ENT/>
              <ENT>04/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,1<E T="61">′</E>-Biphenyl, phenoxy-</ENT>
              <ENT>28984-89-6</ENT>
              <ENT/>
              <ENT>04/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Chloro-1-(3-methylphenoxy)-4-(trifluoromethyl)benzene</ENT>
              <ENT>42874-96-4</ENT>
              <ENT/>
              <ENT>04/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,4-Diphenoxybenzene</ENT>
              <ENT>3061-36-7</ENT>
              <ENT/>
              <ENT>4/12/93</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phenol, 3-[2-chloro-4-(trifluoromethyl)phenoxy]-, acetate</ENT>
              <ENT>50594-77-9</ENT>
              <ENT/>
              <ENT>04/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Alkyl Phosphates:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Ethanol, 2-butoxy-, phosphate (3:1)</ENT>
              <ENT>78-51-3</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Ethanol, 2-(2-butoxyethoxy)-, phosphate (3:1)</ENT>
              <ENT>7332-46-9</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, bis(2-ethylhexyl) ester</ENT>
              <ENT>298-07-7</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, dibutyl ester</ENT>
              <ENT>107-66-4</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, didodecyl ester</ENT>
              <ENT>7057-92-3</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, diisooctyl ester</ENT>
              <ENT>27215-10-7</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, dodecyl ester</ENT>
              <ENT>12751-23-4</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, 2-ethylhexyl ester</ENT>
              <ENT>12645-31-7</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, monobutyl ester</ENT>
              <ENT>1623-15-0</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, mono(2-ethylhexyl)ester</ENT>
              <ENT>1070-03-7</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, monohexyl ester</ENT>
              <ENT>3900-04-7</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, monomethyl ester</ENT>
              <ENT>812-00-0</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, mono(1-methylethyl)ester</ENT>
              <ENT>1623-24-1</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, monooctyl ester</ENT>
              <ENT>3991-73-9</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, monooctadecyl ester</ENT>
              <ENT>2958-09-0</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, triethyl ester</ENT>
              <ENT>78-40-0</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, tris(2-ethylhexyl) ester</ENT>
              <ENT>78-42-2</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphoric acid, tris(2-methylpropyl) ester</ENT>
              <ENT>126-71-6</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phosphorodichloridic acid, ethyl ester</ENT>
              <ENT>1498-51-7</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Alkylphenols and Alkylphenol Ethoxyates:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">tert-Butylphenol (mixed isomers)</ENT>
              <ENT>27178-34-3</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Butylphenol</ENT>
              <ENT>3180-09-4</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-tert-Butylphenol</ENT>
              <ENT>88-18-6</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4-n-Butylphenol</ENT>
              <ENT>1638-22-8</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4-sec-Butylphenol</ENT>
              <ENT>99-71-8</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4-tert-Butylphenol</ENT>
              <ENT>98-54-4</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Decaethylene glycol 4-isoctylphenyl ether</ENT>
              <ENT>2315-66-4</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4-Dodecylphenol</ENT>
              <ENT>104-43-8</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dodecylphenol (mixed isomers)</ENT>
              <ENT>1331-57-3</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dedecylphenol (mixed isomers)</ENT>
              <ENT>27193-86-8</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="79"/>
              <ENT I="02">Hexaethylene glycol 4-isoctylphenyl ether</ENT>
              <ENT>2497-58-7</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Isobutylphenol (mixed isomers)</ENT>
              <ENT>31195-95-6</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Isononylphenol (mixed isomers)</ENT>
              <ENT>11066-49-2</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4-(1-Methylbutyl)phenol</ENT>
              <ENT>94-06-4</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">(1-Methylheptyl)phenol (mixed isomers)</ENT>
              <ENT>27985-70-2</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4-(1-Methyloctyl)phenol</ENT>
              <ENT>17404-66-9</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Nonylphenol (mixed isomers)</ENT>
              <ENT>1300-16-9</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="22"/>
              <ENT>25154-52-3</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4-Nonylphenol</ENT>
              <ENT>104-40-5</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Branched 4-nonylphenol (mixed isomers)</ENT>
              <ENT>84852-15-3</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Octylphenol</ENT>
              <ENT>949-13-3</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4-Octylphenol</ENT>
              <ENT>1806-26-4</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4-Pentylphenol</ENT>
              <ENT>14938-35-3</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4-tert-Pentylphenol</ENT>
              <ENT>80-46-6</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Polyethylene glycol mono(octyl)phenyl ether</ENT>
              <ENT>9036-19-5</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Polyethylene glycol 4-(tert-octyl)phenyl ether</ENT>
              <ENT>9002-93-1</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Poly(oxy-1,2-ethanediyl), <E T="02">α</E>-(octylphenyl)-<E T="61">v</E>-hydroxy-, branched</ENT>
              <ENT>68987-90-6</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-(1,1,3,3-Tetramethylbutyl)phenol</ENT>
              <ENT>3884-95-5</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">(1,1,3,3-Tetramethylbutyl)phenol (mixed isomers)</ENT>
              <ENT>1322-69-6</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="22"/>
              <ENT>27193-28-8</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="22"/>
              <ENT>29932-96-5</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="22"/>
              <ENT>30105-54-5</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="22"/>
              <ENT>62744-41-6</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4-(2,2,3,3-Tetramethylbutyl)phenol</ENT>
              <ENT>54932-78-4</ENT>
              <ENT>§ 716.20(b)(4) applies</ENT>
              <ENT>3/29/96</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Brominated flame retardants:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Alkanes, C10-18, bromochloro-</ENT>
              <ENT>68955-41-9</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="80"/>
              <ENT I="02">Benzamide, 3,5-dibromo-N-(4-bromophenyl)-2-hydroxy-</ENT>
              <ENT>87-10-5</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, ethenyl-, homopolymer, brominated</ENT>
              <ENT>88497-56-7</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1,1’-(1-methylethylidene)bis (3,5-dibromo-4-(2-propenyloxy)-</ENT>
              <ENT>25327-89-3</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, pentabromomethyl-</ENT>
              <ENT>87-83-2</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Cyclohexane, 1,2,3,4,5-pentabromo-6-chloro-</ENT>
              <ENT>87-84-3</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Cyclohexane, tetrabromodichloro-</ENT>
              <ENT>30554-72-4</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Cyclohexane, tribromotrichloro-</ENT>
              <ENT>30554-73-5</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Ethanol, 2,2’-((1-methylethylidene)bis ((2,6-dibromo-4,1-phenylene)oxy)) bis-</ENT>
              <ENT>4162-45-2</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Ethene, bromo-</ENT>
              <ENT>593-60-2</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phenol, 2,4-dibromo-</ENT>
              <ENT>615-58-7</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phenol, 2,4(or 2,6)-dibromo-,homopolymer</ENT>
              <ENT>69882-11-7</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1-Propanol, 2,3-dibromo-</ENT>
              <ENT>96-13-9</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1-Propanol, 2,2-dimethyl-,tribromo deriv</ENT>
              <ENT>36483-57-5</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenoic acid,(1-methylethylidene)bis (2,6-dibromo-4,1-phenylene) ester</ENT>
              <ENT>55205-38-4</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Chloroalkyl phosphates:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2,2-Bis(chloromethyl)-1,3-propanediyltetrakis(2-chloroethyl) phosphate</ENT>
              <ENT>38051-10-4</ENT>
              <ENT/>
              <ENT>6/14/93</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Chloro-1-methylethylbis(2-chloropropyl) phosphate-</ENT>
              <ENT>76649-15-5</ENT>
              <ENT/>
              <ENT>6/14/93</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Ethanediyl tetrakis(2-chloro-1-methylethylene) phosphate</ENT>
              <ENT>34621-99-3</ENT>
              <ENT/>
              <ENT>6/14/93</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Oxydi-2,1-ethanediyltetrakis(2-choloroethyl) phosphate</ENT>
              <ENT>53461-82-8</ENT>
              <ENT/>
              <ENT>6/14/93</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Cyanoacrylates:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenoic acid, 2-cyano-, methyl ester</ENT>
              <ENT>137-05-3</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenoic acid, 2-cyano-, isobutyl ester</ENT>
              <ENT>1069-55-2</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenoic acid, 2-cyano-3,3-diphenyl-, 2-ethylhexyl ester</ENT>
              <ENT>6197-30-4</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenoic acid, 2-cyano-, butyl ester</ENT>
              <ENT>6606-65-1</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenoic acid, 2-cyano-, ethyl ester</ENT>
              <ENT>7085-85-0</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenoic acid, 2-cyano-, 2-propenyl ester</ENT>
              <ENT>7324-02-9</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenoic acid, 2-cyano-, 1-methylethyl ester</ENT>
              <ENT>10586-17-1</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenoic acid, 2-cyano-, ethoxy ethyl ester</ENT>
              <ENT>21982-43-4</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenoic acid, 2-cyano-, 2,2,2-trifluoromethyl ester</ENT>
              <ENT>23023-91-8</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenoic acid, 2-cyano-, 2-methoxyethyl ester</ENT>
              <ENT>27816-23-5</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Ethanaminium, 2-[[2-cyano-3-[4-(diethylamino)phenyl]-1-oxo-2-propenyl]oxy]-N,N,N-trimethyl-, chloride</ENT>
              <ENT>64992-16-1</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">IRIS Chemicals:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3,4-Dimethylphenol</ENT>
              <ENT>95-65-8</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2,4-Dinitrophenol</ENT>
              <ENT>51-28-5</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Isocyanates:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Acetic acid, isocyanato-, ethyl ester</ENT>
              <ENT>2949-22-6</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, bis(isocyanatomethyl)-</ENT>
              <ENT>25854-16-4</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1-bromo-4-isocyanato-</ENT>
              <ENT>2493-02-9</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1-chloro-3-isocyanato-</ENT>
              <ENT>2909-38-8</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1-chloro-4-isocyanato-</ENT>
              <ENT>104-12-1</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1,2-dichloro-4-isocyanato-</ENT>
              <ENT>102-36-3</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1,3-dichloro-5-isocyanato-</ENT>
              <ENT>34893-92-0</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1,1’-(diisocyanatomethylene)bis-</ENT>
              <ENT>10031-75-1</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, isocyanato-</ENT>
              <ENT>103-71-9</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 2-isocyanato-1,3-bis(1-methylethyl)-</ENT>
              <ENT>28178-42-9</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 2-isocyanato-1,3-dimethyl-, ester</ENT>
              <ENT>28556-81-2</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="81"/>
              <ENT I="02">Benzene, 1-isocyanato-2-methyl-</ENT>
              <ENT>614-68-6</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1-isocyanato-4-methyl-</ENT>
              <ENT>622-58-2</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1-isocyanato-4-nitro-</ENT>
              <ENT>100-28-7</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1-isocyanato-3-(trifluoromethyl)-</ENT>
              <ENT>329-01-1</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzene, 1,1’,1”-methylidynetris(4-isocyanato-</ENT>
              <ENT>2422-91-5</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Butane, 1-isocyanato-</ENT>
              <ENT>111-36-4</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Cyclohexane, 2-heptyl-3,4-bis (9-iso-cy-anat-o-nonyl)-1-pentyl-</ENT>
              <ENT>68239-06-5</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Cyclohexane, isocyanato-</ENT>
              <ENT>3173-53-3</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Diazetidine-2,4-dione, 1,3-bis(3-isocyanato methylphenyl)-</ENT>
              <ENT>26747-90-0</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Ethane, isocyanato-</ENT>
              <ENT>109-90-0</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Imidodicarbonic diamide, N,N’-2-tris(6-iso-cyan-a-tohexyl)-</ENT>
              <ENT>4035-89-6</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Methane, isocyanato-</ENT>
              <ENT>624-83-9</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Octadecane, 1-isocyanato-</ENT>
              <ENT>112-96-9</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phenol, 4-isocyanato-, phosphorothioate (3:1) (ester)</ENT>
              <ENT>4151-51-3</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Propane, 1-isocyanato-</ENT>
              <ENT>110-78-1</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1-Propene, 3-isocyanato-</ENT>
              <ENT>1476-23-9</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenoic acid, 2-methyl-, 2- isocyanatoethyl ester</ENT>
              <ENT>30674-80-7</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Propenoic acid, 2-methyl-2-(((((5-isocyanato-1,3,3-trimethylcyclohexyl)methyl)amino) carbonyl)oxy)ethyl ester</ENT>
              <ENT>73597-26-9</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3,5,-Triazine-2,4,6(1H.3H.5H-trione, 1,3,5-  tris(3-isocyanatomethylphenyl)-</ENT>
              <ENT>26603-40-7</ENT>
              <ENT/>
              <ENT>10/29/90</ENT>
              <ENT>11/09/93</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Methyl ethylene glycol ethers and esters:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Ethylene glycol monomethy ether acrylate</ENT>
              <ENT>3121-61-7</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Tetraethylene glycol monomethyl ether</ENT>
              <ENT>23783-42-8</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">OSHA Chemicals in Need of Dermal Absorption Testing:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Amitrole</ENT>
              <ENT>61-82-5</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">
                <E T="03">n</E>-Amyl acetate</ENT>
              <ENT>628-63-7</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">o-Anisidine</ENT>
              <ENT>90-04-0</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Benzyl chloride</ENT>
              <ENT>100-44-7</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">
                <E T="03">sec</E>-Butyl acetate</ENT>
              <ENT>105-46-4</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">
                <E T="03">tert</E>-Butyl acetate</ENT>
              <ENT>540-88-5</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">
                <E T="03">sec</E>-Butyl alcohol</ENT>
              <ENT>78-92-2</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">
                <E T="03">tert</E>-Butyl alcohol</ENT>
              <ENT>75-65-0</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">t-Butylcatechol</ENT>
              <ENT>98-29-3</ENT>
              <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT>
              <ENT>8/4/95</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">o-sec-butylphenol</ENT>
              <ENT>89-72-5</ENT>
              <ENT/>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Camphor</ENT>
              <ENT>76-22-2</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Carbon disulfide</ENT>
              <ENT>75-15-0</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Catechol</ENT>
              <ENT>120-80-9</ENT>
              <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT>
              <ENT>8/4/95</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="82"/>
              <ENT I="02">
                <E T="03">a</E>-Chloroacetophenone</ENT>
              <ENT>532-27-4</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Chlorobenzene</ENT>
              <ENT>108-90-7</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">o-Chlorotoluene</ENT>
              <ENT>95-49-8</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Cyclohexene</ENT>
              <ENT>110-83-8</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Cyclohexanol</ENT>
              <ENT>108-93-0</ENT>
              <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT>
              <ENT>8/4/95</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Cyclopentadiene</ENT>
              <ENT>542-92-7</ENT>
              <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT>
              <ENT>8/4/95</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Cyclopentane</ENT>
              <ENT>287-92-3</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Diacetone alcohol</ENT>
              <ENT>123-42-2</ENT>
              <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT>
              <ENT>8/4/95</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dibutyl phosphate</ENT>
              <ENT>107-66-4</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Dichloroethylene</ENT>
              <ENT>540-59-0</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dicylcopentadiene</ENT>
              <ENT>77-73-6</ENT>
              <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT>
              <ENT>8/4/95</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dimethyl acetamide</ENT>
              <ENT>127-19-5</ENT>
              <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT>
              <ENT>8/4/95</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dimethylaniline</ENT>
              <ENT>121-69-7</ENT>
              <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT>
              <ENT>8/4/95</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dimethyl sulfate</ENT>
              <ENT>77-78-1</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">m-Dinitrobenzene</ENT>
              <ENT>99-65-0</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">o-Dinitrobenzene</ENT>
              <ENT>528-29-0</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">
                <E T="03">p</E>-Dinitrobenzene</ENT>
              <ENT>100-25-4</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2,4-Dinitrotoluene</ENT>
              <ENT>121-14-2</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Diphenylamine</ENT>
              <ENT>122-39-4</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Disulfiram</ENT>
              <ENT>97-77-8</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>1/26/94</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Ethyl bromide</ENT>
              <ENT>74-96-4</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Ethyl ether</ENT>
              <ENT>60-29-7</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Heptane (<E T="03">n</E>-Heptane)</ENT>
              <ENT>142-82-5</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="83"/>
              <ENT I="02">Indene</ENT>
              <ENT>95-13-6</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Isoamyl acetate</ENT>
              <ENT>123-92-2</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">N-Isopropylaniline</ENT>
              <ENT>768-52-5</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">p-Methoxyphenol</ENT>
              <ENT>150-76-5</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Methyl acetate</ENT>
              <ENT>79-20-9</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Methylcyclohexane</ENT>
              <ENT>108-87-2</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Methyl formate</ENT>
              <ENT>107-31-3</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Methyl isoamyl ketone</ENT>
              <ENT>110-12-3</ENT>
              <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT>
              <ENT>8/4/95</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">p-Nitroaniline</ENT>
              <ENT>100-01-6</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">p-Nitrochlorobenzene</ENT>
              <ENT>100-00-5</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1-Nitropropane</ENT>
              <ENT>108-03-2</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Nitropropane</ENT>
              <ENT>79-46-9</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">m-Nitrotoluene</ENT>
              <ENT>99-08-1</ENT>
              <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT>
              <ENT>8/4/95</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">o-Nitrotoluene</ENT>
              <ENT>88-72-2</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">p-Nitrotoluene</ENT>
              <ENT>99-99-0</ENT>
              <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT>
              <ENT>8/4/95</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Nonane</ENT>
              <ENT>111-84-2</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Pentane</ENT>
              <ENT>109-66-0</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Phenylhydrazine</ENT>
              <ENT>100-63-0</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Propylene glycol dinitrate</ENT>
              <ENT>6423-43-4</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Sodium bisulfite</ENT>
              <ENT>7631-90-5</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Sodium metabisulfite</ENT>
              <ENT>7681-57-4</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Tetrahydrofuran</ENT>
              <ENT>109-99-9</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">m-Toluidine</ENT>
              <ENT>108-44-1</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Vinylidene chloride</ENT>
              <ENT>75-35-4</ENT>
              <ENT>§ 716.20(b)(3) and (b)(4) apply</ENT>
              <ENT>8/4/95</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Vinyl toluene</ENT>
              <ENT>25013-15-4</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="84"/>
              <ENT I="02">
                <E T="03">p</E>-Xylene</ENT>
              <ENT>106-42-3</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>1/26/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Xylidine</ENT>
              <ENT>1300-73-8</ENT>
              <ENT>§ 716.20(b)(3) applies</ENT>
              <ENT>3/11/94</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Propylene glycol ethers and esters:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dipropylene glycol</ENT>
              <ENT>110-96-5</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dipropylene glycol butyl ether</ENT>
              <ENT>29911-28-2</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dipropylene glycol monomethyl ether acetate</ENT>
              <ENT>88917-22-0</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1-(2-Methoxy-1-methylethoxy)-2-propanol</ENT>
              <ENT>20324-32-7</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Methoxy-1-propanol</ENT>
              <ENT>28677-93-2</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1-Phenoxy-2-propanol</ENT>
              <ENT>770-35-4</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Propylene glycol monobutyl ether</ENT>
              <ENT>29387-86-8</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Propylene glycol monomethyl ether acetate</ENT>
              <ENT>108-65-6</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Propylene glycol mono-tert-butyl ether</ENT>
              <ENT>57018-52-7</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Tripropylene glycol diacrylate</ENT>
              <ENT>42978-66-5</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Tripropylene glycol methyl ether</ENT>
              <ENT>20324-33-8</ENT>
              <ENT/>
              <ENT>1/26/94</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Siloxanes:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Cyclopolydimethylsiloxane</ENT>
              <ENT>69430-24-6</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Decamethylcyclopentasiloxane</ENT>
              <ENT>541-02-6</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Decamethyltetrasiloxane</ENT>
              <ENT>141-62-8</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dimethyldiphenylsiloxane</ENT>
              <ENT>68083-14-7</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dimethylhydropolylsiloxane</ENT>
              <ENT>68037-59-2</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dimethylmethyl 3,3,3-trifluoropropyl siloxane</ENT>
              <ENT>115361-68-7</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dimethylmethylvinylsiloxane</ENT>
              <ENT>67762-94-1</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dimethylpolysiloxanes</ENT>
              <ENT>68037-74-1</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dimethyl silicones and siloxanes</ENT>
              <ENT>63148-62-9</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dimethyl silicones and siloxane, reaction products with silica</ENT>
              <ENT>67762-90-7</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Docosamethylcycloundecasiloxane</ENT>
              <ENT>18766-38-6</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Docosamethyldecasiloxane</ENT>
              <ENT>556-70-7</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dodecamethylcyclohexasiloxane</ENT>
              <ENT>540-97-6</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dodecamethylpentasiloxane</ENT>
              <ENT>141-63-9</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dotetracontamethyleicosasiloxane</ENT>
              <ENT>150027-00-2</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dotriacontamethylcyclohexadecasiloxane</ENT>
              <ENT>150026-95-2</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dotriacontamethylpentadecasiloxane</ENT>
              <ENT>2471-11-6</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Eicosamethylcyclodecasiloxane</ENT>
              <ENT>18772-36-6</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Eicosamethylnonasiloxane</ENT>
              <ENT>2652-13-3</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Hexacosamethylcyclotridecasiloxane</ENT>
              <ENT>23732-94-7</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="85"/>
              <ENT I="02">Hexacosamethyldodecasiloxane</ENT>
              <ENT>2471-08-1</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Hexadecamethylcyclooctasiloxane</ENT>
              <ENT>556-68-3</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Hexadecamethylheptasiloxane</ENT>
              <ENT>541-01-5</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Hexamethylcyclotrisiloxane</ENT>
              <ENT>541-05-9</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Hexamethyldisilazane</ENT>
              <ENT>999-97-3</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Hexamethyldisiloxane</ENT>
              <ENT>107-46-0</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Hexatriacontamethylcyclooctadecasiloxane</ENT>
              <ENT>23523-12-8</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Hexatriacontamethylheptadecasiloxane</ENT>
              <ENT>18844-04-7</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Methylpolysiloxane</ENT>
              <ENT>9004-73-3</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Methylvinylcyclosiloxane</ENT>
              <ENT>2554-06-5</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Siloxanes and silicones, di-Me, hydroxy-terminated</ENT>
              <ENT>70131-67-8</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Octacosamethylcyclotetradecasiloxane</ENT>
              <ENT>149050-40-8</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Octacosamethyltridecasiloxane</ENT>
              <ENT>2471-09-2</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Octadecamethylcyclononasiloxane</ENT>
              <ENT>556-71-8</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Octadecamethyloctasiloxane</ENT>
              <ENT>556-69-4</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Octamethyltrisiloxane</ENT>
              <ENT>107-51-7</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Octaphenylcyclotetrasiloxane</ENT>
              <ENT>546-56-5</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Octatriacontamethylcyclononadecasiloxane</ENT>
              <ENT>150026-97-4</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Octatriacontamethyloctadecasiloxane</ENT>
              <ENT>36938-52-0</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Polymethyloctadecylsiloxane</ENT>
              <ENT>not available</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Tetracontamethylcycloeicosasiloxane</ENT>
              <ENT>150026-98-5</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Tetracontamethylnonadecasiloxane</ENT>
              <ENT>150026-99-6</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Tetracosamethylcyclododecasiloxane</ENT>
              <ENT>18919-94-3</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Tetracosamethylundecasiloxane</ENT>
              <ENT>107-53-9</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Tetradecamethylcycloheptasiloxane</ENT>
              <ENT>107-50-6</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Tetradecamethylhexasiloxane</ENT>
              <ENT>107-52-8</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Tetramethylcyclotetrasiloxane</ENT>
              <ENT>2370-88-9</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Tetramethyldivinyldisiloxane</ENT>
              <ENT>2627-95-4</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Tetratriacontamethylcycloheptadecasiloxane</ENT>
              <ENT>150026-96-3</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Tetratriacontamethylhexadecasiloxane</ENT>
              <ENT>36938-50-8</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="86"/>
              <ENT I="02">Triacontamethylcyclopentadecasiloxane</ENT>
              <ENT>23523-14-0</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Triacontamethyltetradecasiloxane</ENT>
              <ENT>2471-10-5</ENT>
              <ENT>§ 716.20(b)(2) applies</ENT>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Trifluoropropylmethylcyclotrisiloxane</ENT>
              <ENT>2374-14-3</ENT>
              <ENT/>
              <ENT>10/12/93</ENT>
              <ENT>06/30/98
              </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Substantially produced chemicals in need of subchronic tests:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Acetoacetanilide</ENT>
              <ENT>102-01-2</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4-(Acetylamino)benzenesulfonyl chloride</ENT>
              <ENT>121-60-8</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-(2-Aminoethoxy)-ethanol</ENT>
              <ENT>929-06-6</ENT>
              <ENT/>
              <ENT>6/30/92</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">7-Amino-4-hydroxy-2-naphthalenesulfonic acid</ENT>
              <ENT>87-02-5</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Ammonium carbamate</ENT>
              <ENT>1111-78-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Benzenedisulfonic acid</ENT>
              <ENT>98-48-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Bis(2-ethylhexyl)-2-butenedioate</ENT>
              <ENT>142-16-5</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Bromamine acid</ENT>
              <ENT>116-81-4</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Butyric anhydride</ENT>
              <ENT>106-31-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Ethanol, 2-(2-ethoxyethoxy)-, acetate</ENT>
              <ENT>112-15-2</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,2-Dichlorobutane</ENT>
              <ENT>616-21-7</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3,4-Dichlorobutene</ENT>
              <ENT>760-23-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3,4-Dichloronitrobenzene</ENT>
              <ENT>99-54-7</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,3-Dicyanobenzene</ENT>
              <ENT>626-17-5</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Diethylene glycol dimethyl ether</ENT>
              <ENT>111-96-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4-Ethoxynitrobenzene</ENT>
              <ENT>100-29-8</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Ethylanthraquinone</ENT>
              <ENT>84-51-5</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Hexa(methoxymethyl) melamine</ENT>
              <ENT>3089-11-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3-Hydroxy-2-naphthoic acid</ENT>
              <ENT>92-70-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Isobutyl acrylate</ENT>
              <ENT>106-63-8</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Isophthaloyl chloride</ENT>
              <ENT>9-63-8</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4-Methyl-2-nitro-phenol</ENT>
              <ENT>119-33-5</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-(4-Morpholinyldithio)-benzothiazole</ENT>
              <ENT>95-32-9</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Naphthalenedicarboxylic anhydride</ENT>
              <ENT>81-84-5</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1-Naphthol</ENT>
              <ENT>90-15-3</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">
                <E T="03">p</E>,<E T="03">p</E>’-Oxybis(benzenesulfonylhydrazide)</ENT>
              <ENT>80-51-3</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2,4-Pentanedione</ENT>
              <ENT>123-54-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Perfluoro-N-hexane</ENT>
              <ENT>355-42-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Perfluorotributylamine</ENT>
              <ENT>311-89-7</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Propanoic anhydride</ENT>
              <ENT>123-62-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Quinacridone</ENT>
              <ENT>1047-16-1</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Terephthaloyl chloride</ENT>
              <ENT>100-20-9</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT/>
            </ROW>
            <ROW>
              <ENT I="02">Trichloromethanesulfenyl chloride</ENT>
              <ENT>594-42-3</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>6/30/98</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Triethylene glycol bis(2-ethylhexanoate)</ENT>
              <ENT>94-28-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="01">Sulphones:</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Amino-4-[(2-hydroxyethyl) sulfonyl]phenol</ENT>
              <ENT>17601-96-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-Amino-4-(methylsulfonyl)phenol</ENT>
              <ENT>98-30-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-[(6-Amino-2-naphthalenyl) sulfonyl]ethanol</ENT>
              <ENT>52218-35-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-[(3-Aminophenyl)sulfonyl]ethanol</ENT>
              <ENT>5246-57-1</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Bisphenol S</ENT>
              <ENT>80-09-1</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="87"/>
              <ENT I="02">3-(Decyloxy)tetrahydrothiophene 1,1-dioxide</ENT>
              <ENT>18760-44-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4,4’-Diaminodiphenyl sulfone</ENT>
              <ENT>80-08-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4-[4-[(2,6-Dichloro-4-nitrophenyl)azo]phenyl] thiomorpholine, 11,1-dioxide</ENT>
              <ENT>17741-62-7</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1-(Diiodomethyl)sulfonyl-4-methyl benzene</ENT>
              <ENT>20018-09-1</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Dimethylsulfone</ENT>
              <ENT>67-71-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Diphenylsulfone</ENT>
              <ENT>127-63-9</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3-[N-Ethyl-4-[[6-(methylsulfonyl)-2-benzothiazolyl]azo]-m-toluidino]propionitrile</ENT>
              <ENT>16588-67-3</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,1’-[Methylenebis(sulfonyl)]bis-2-chloroethane</ENT>
              <ENT>41123-59-5</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2,2’-[Methylenebis(sulfonyl)]bisethanol</ENT>
              <ENT>41123-69-7</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,1’-[Methylenebis(sulfonyl)]bisethene</ENT>
              <ENT>3278-22-6</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">6-Methylsulfonyl)-2-benzothiazolamine</ENT>
              <ENT>17557-67-4</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2-[(3-Nitrophenyl)sulfonyl]ethanol</ENT>
              <ENT>41687-30-3</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,1’-[Oxybis(methylenesulfonyl)]bis-2-chloroethane</ENT>
              <ENT>53061-10-2</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2,2’-[Oxybis(methylenesulfonyl)] bisethanol</ENT>
              <ENT>36724-43-3</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">1,1’-[Oxybis(methylenesulfonyl)] bisethene</ENT>
              <ENT>26750-50-5</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4-[[4-(Phenylmethoxy)phenyl]sulfonyl] phenol</ENT>
              <ENT>63134-33-8</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">4-Phenylthiomorpholine, 1,1-dioxide</ENT>
              <ENT>17688-68-5</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Sulfolane</ENT>
              <ENT>126-33-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">3-Sulfolene</ENT>
              <ENT>77-79-2</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">Sulfonyl bis(4-chlorobenzene)</ENT>
              <ENT>80-07-9</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
            <ROW>
              <ENT I="02">2,2’-Sulfonyl bisethanol</ENT>
              <ENT O="xl">2580-77-0</ENT>
              <ENT/>
              <ENT>9/30/91</ENT>
              <ENT>12/19/95</ENT>
            </ROW>
          </GPOTABLE>
          <CITA TYPE="T">[53 FR 38645, Sept. 30, 1988; 53 FR 45656, Nov. 10, 1988, as amended at 53 FR 46281, Nov. 16, 1988; 53 FR 49966, Dec. 12, 1988; 54 FR 617, Jan. 9, 1989; 54 FR 8488, Feb. 28, 1989; 54 FR 51134, Dec. 12, 1989; 55 FR 35631, Aug. 31, 1990; 55 FR 36640, Sept. 6, 1990; 55 FR 39774, Sept. 28, 1990; 55 FR 39784, Sept. 28, 1990; 56 FR 42693, Aug. 29, 1991; 56 FR 49146, Sept. 27, 1991; 57 FR 29034, June 30, 1992; 58 FR 13559, Mar. 12, 1993; 58 FR 28515, May 14, 1993; 58 FR 42678, Aug. 11, 1993; 58 FR 47649, Sept. 10, 1993; 58 FR 68315, 68321, Dec. 27, 1993; 59 FR 5960, Feb. 9, 1994; 59 FR 22519, May 2, 1994; 59 FR 60719, Nov. 28, 1994; 60 FR 34884, July 5, 1995; 60 FR 48662, Sept. 20, 1995; 61 FR 7425, Feb. 28, 1996; 61 FR 14596, Apr. 2, 1996; 61 FR 55875, Oct. 29, 1996; 63 FR 15774, Apr. 1, 1998; 65 FR 1554, Jan. 11, 2000]</CITA>
          <TEFFDNO>
            <HD SOURCE="HED">Effective Date Note:</HD>
            <P>At 59 FR 14115, Mar. 25, 1994, in § 716.120 paragraph (d), the chemical substances under the category “propylene glycol ethers and esters” and all related dates, was stayed effective March 25, 1994. </P>
          </TEFFDNO>
        </SECTION>
      </SUBPART>
    </PART>
    <PART>
      <PRTPAGE P="88"/>
      <EAR>Pt. 717</EAR>
      <HD SOURCE="HED">PART 717—RECORDS AND REPORTS OF ALLEGATIONS THAT CHEMICAL SUBSTANCES CAUSE SIGNIFICANT ADVERSE REACTIONS TO HEALTH OR THE ENVIRONMENT</HD>
      <CONTENTS>
        <SUBPART>
          <HD SOURCE="HED">Subpart A—General Provisions</HD>
          <SECHD>Sec.</SECHD>
          <SECTNO>717.1</SECTNO>
          <SUBJECT>Scope and compliance.</SUBJECT>
          <SECTNO>717.3</SECTNO>
          <SUBJECT>Definitions.</SUBJECT>
          <SECTNO>717.5</SECTNO>
          <SUBJECT>Persons subject to this part.</SUBJECT>
          <SECTNO>717.7</SECTNO>
          <SUBJECT>Persons not subject to this part.</SUBJECT>
          <SECTNO>717.10</SECTNO>
          <SUBJECT>Allegations subject to this part.</SUBJECT>
          <SECTNO>717.12</SECTNO>
          <SUBJECT>Significant adverse reactions that must be recorded.</SUBJECT>
          <SECTNO>717.15</SECTNO>
          <SUBJECT>Recordkeeping requirements.</SUBJECT>
          <SECTNO>717.17</SECTNO>
          <SUBJECT>Inspection and reporting requirements.</SUBJECT>
          <SECTNO>717.19</SECTNO>
          <SUBJECT>Confidentiality.</SUBJECT>
        </SUBPART>
      </CONTENTS>
      <AUTH>
        <HD SOURCE="HED">Authority:</HD>
        <P>15 U.S.C. 2607(c).</P>
      </AUTH>
      <SOURCE>
        <HD SOURCE="HED">Source:</HD>
        <P>48 FR 38187, Aug. 22, 1983, unless otherwise noted.</P>
      </SOURCE>
      <SUBPART>
        <HD SOURCE="HED">Subpart A—General Provisions</HD>
        <SECTION>
          <SECTNO>§ 717.1</SECTNO>
          <SUBJECT>Scope and compliance.</SUBJECT>
          <P>Section 8 (c) of the Toxic Substances Control Act (TSCA) requires manufacturers, processors, and distributors of chemical substances and mixtures:</P>
          <P>(a) To keep “records of significant adverse reactions to health or the environment, as determined by the Administrator by rule, alleged to have been caused by the substance or mixture.”</P>
          <P>(b) To “permit inspection and submit copies of such records”, upon request of any designated representative of the Administrator. This rule implements section 8(c) of TSCA. It describes the records to be kept and prescribes the conditions under which certain firms must submit or make the records available to a duly designated representative of the Administrator.</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 717.3</SECTNO>
          <SUBJECT>Definitions.</SUBJECT>
          <P>The definitions set forth in section 3 of TSCA and the following definitions apply to this part:</P>
          <P>(a) <E T="03">Allegation</E> means a statement, made without formal proof or regard for evidence, that a chemical substance or mixture has caused a significant adverse reaction to health or the environment.</P>
          <P>(b) <E T="03">Firm</E> or <E T="03">company</E> means any person, that is subject to this part, as defined in § 717.5.</P>
          <P>(c)(1) <E T="03">Known human effects</E> means a commonly recognized human health effect of a particular substance or mixture as described either in:</P>
          <P>(i) Scientific articles or publications abstracted in standard reference sources.</P>
          <P>(ii) The firm's product labeling or material safety data sheets (MSDS).</P>
          <P>(2) However, an effect is not a “known human effect” if it:</P>
          <P>(i) Was a significantly more severe toxic effect than previously described.</P>
          <P>(ii) Was a manifestation of a toxic effect after a significantly shorter exposure period or lower exposure level than described.</P>
          <P>(iii) Was a manifestation of a toxic effect by an exposure route different from that described.</P>
          <P>(d) <E T="03">Manufacture</E> or <E T="03">process</E> means to manufacture or process for commercial purposes.</P>
          <P>(e)(1) <E T="03">Manufacture for commercial purposes</E> means to import, produce, or manufacture with the purpose of obtaining an immediate or eventual commercial advantage for the manufacturer, and includes, among other things, such “manufacture” of any amount of a chemical substance or mixture:</P>
          <P>(i) For distribution in commerce, including for test marketing.</P>
          <P>(ii) For use by the manufacturer, including use for product research and development, or as an intermediate.</P>
          <P>(2) <E T="03">Manufacture for commercial purposes</E> also applies to substances that are produced coincidentally during the manufacture, processing, use, or disposal of another substance or mixture, including both byproducts that are separated from that other substances or mixture and impurities that remain in that substance or mixture. Such byproducts and impurities may, or may not, in themselves have commercial value. They are nonetheless produced for the purpose of obtaining a commercial advantage since they are part of the manufacture of a chemical product for a commercial purpose.</P>
          <P>(f) <E T="03">Person</E> includes any individual, firm, company, corporation, joint venture, partnership, sole proprietorship, <PRTPAGE P="89"/>association, or any other business entity, any State or political subdivision thereof, and any department, agency, or instrumentally of the Federal Government.</P>
          <P>(g) <E T="03">Process for commercial purposes</E> means the preparation of a chemical substance or mixture, after its manufacture, for distribution in commerce with the purpose of obtaining an immediate or eventual commercial advantage for the processor. Processing of any amount of a chemical substance or mixture is included. If a chemical substance or mixture containing impurities is processed for commercial purposes, then those impurities are also processed for commercial purposes.</P>
          <P>(h) <E T="03">Retailer</E> means a person who distributes in commerce a chemical substance, mixture, or article to ultimate purchasers who are not commercial entities.</P>
          <P>(i) <E T="03">Significant adverse reactions</E> are reactions that may indicate a substantial impairment of normal activities, or long-lasting or irreversible damage to health or the environment.</P>
          <P>(j) <E T="03">Site</E> means a contiguous property unit. Property divided only by a public right-of-way is considered one site. There may be multiple manufacturing, processing, or distribution activities occurring within a single site.</P>
          <P>(k) <E T="03">Substance</E> means a chemical substance or mixture unless otherwise indicated.</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 717.5</SECTNO>
          <SUBJECT>Persons subject to this part.</SUBJECT>
          <P>(a) <E T="03">Manufacturers.</E> (1) All manufacturers of chemical substances are subject to this part except as provided in § 717.7(a). If manufacture of a chemcial substance occurs at any site owned or controlled by a firm then that firm is subject to this part.</P>
          <P>(2) A manufacturer must collect:</P>
          <P>(i) Any allegation identifying a chemical substance it manufactures and any allegation identifying the operations in the manufacture of any chemical substance it manufactures.</P>
          <P>(ii) Any allegation identifying any of its own processing or distribution in commerce activities with respect to any chemical substance it manufactures.</P>
          <P>(iii) Any allegation identifying emissions, effluents, or other discharges from activities described in this paragraph.</P>
          <P>(iv) Any allegation identifying a substance produced coincidentally during processing, use, storage or disposal of a chemical substance it manufactures.</P>
          <P>(3) For the purpose of this part, owned or controlled means ownership of 50 percent or more of a firm's voting stock or other equity rights, or the power to control the management and policies of that firm.</P>
          <P>(b) <E T="03">Processors.</E> (1) A person who processes chemical substances, who is not also a manufacturer of those chemical substances, is subject to this part if (i) the person processes chemical substances to produce mixtures, or (ii) the person repackages chemical substances or mixtures.</P>
          <P>(2) As a processor subject to this part such person must collect:</P>
          <P>(i) Any allegation identifying any mixture it produces and distributes in commerce and any allegation identifying any chemical substance or mixture it repackages and distributes in commerce.</P>
          <P>(ii) Any allegation identifying any of its own further processing or distribution in commerce activities of the products described in paragraph -(b)(2)(i) of this section.</P>
          <P>(iii) Any allegation identifying emissions, effluents, or other discharges from activities described in this paragraph.</P>
          <P>(iv) Any allegation identifying a substance produced coincidentally during the processing, use, storage or disposal of the products described in paragraph (b)(2)(i) of this section.</P>
          <P>(c) <E T="03">SIC code.</E> SIC codes applicable to this part are published in Standard Industrial Classification Manual—1972 and the 1977 Supplement. This manual and supplement may be obtained from the U.S. Government Printing Office, Washington, D.C. 20402—stock number 4101-0006 and stock number 003-005-0170-0 respectively. Where there is a conflict between the SIC code use of a term and the definition of that term in this part, the definition in this part applies.</P>
          <CITA>[48 FR 38187, Aug 22, 1983, as amended at 50 FR 46769, Nov. 13, 1985]</CITA>
        </SECTION>
        <SECTION>
          <PRTPAGE P="90"/>
          <SECTNO>§ 717.7</SECTNO>
          <SUBJECT>Persons not subject to this part.</SUBJECT>
          <P>(a) <E T="03">Manufacturers.</E> (1) Persons or site activities are exempt from this part if the means by which they manufacture a chemical substance solely involves mining or other solely extractive functions, e.g., those companies or sites within a company whose sole function is to mine mineral ores, extract petroleum or natural gas, quarry non-metallic minerals (including extraction of salts from seawater or brines), mine or otherwise extract coal, or separate gases from the atmosphere. This exemption may include, but is not necessarily limited to, firms engaged in activities as described in SIC Division B—Mining and SIC Code 2813—Industrial Gases.</P>
          <P>(2) A person is not subject to this part if the chemical substances that person causes to be produced are limited to:</P>
          <P>(i) Chemical substances that result from chemical reactions that occur incidental to exposure of another chemical substance, mixture, or article to environmental factors such as air, moisture, microbial organisms, or sunlight.</P>
          <P>(ii) Chemical substances that result from chemical reactions that occur incidental to storage or disposal of other chemical substances, mixtures, or articles.</P>
          <P>(iii) Chemical substances that result from chemical reactions that occur upon end use of other chemical substances, mixtures, or articles such as adhesives, paints, miscellaneous cleaners or other housekeeping products, fuel additives, water softening and treatment agents, photographic films, batteries, matches, or safety flares, and that are not themselves manufactured or imported for distribution in commerce for use as chemical intermediates.</P>
          <P>(iv) Chemical substances that result from chemical reactions that occur upon use of curable plastic or rubber molding compounds, inks, drying oils, metal finishing compounds, adhesives, or paints, or other chemical substance formed during the manufacture of an article destined for the marketplace without further chemical change of the chemical substance.</P>
          <P>(v) Chemical substances that result from chemical reactions that occur when (A) a stabilizer, colorant, odorant, antioxidant, filler, solvent, carrier, surfactant, plasticizer, corrosion inhibitor, antifoamer or defoamer, dispersant, precipitation-inhibitor, binder, emulsifier, deemulsifier, dewatering agent, agglomerating agent, adhesion promoter, flow modifier, pH adjuster, sequestrant, coagulant, flocculant, fire retardant, lubricant, chelating agent, or quality control reagent functions as intended, or (B) a chemical substance, which is intended solely to impart a specific physicochemical characteristic, functions as intended.</P>
          <P>(b) [Reserved]</P>
          <P>(c) <E T="03">Sole distributors.</E> A person solely engaged in the distribution of chemical substances is exempt from this part, unless such person is also a manufacturer or processor subject to this part. For example, a “distributor” who repackages chemical substances or mixtures is considered to be a processor and, thus, is not a sole distributor. Sole distributors may include, but are not limited to, those firms that distribute chemical substances as described in the wholesale trade SIC codes 5161—Chemicals and Allied Products, 5171—Petroleum Bulk Stations and Terminals, and 5172—Petroleum and Petroleum Products Wholesalers, Except Bulk Stations and Terminals.</P>
          <P>(d) <E T="03">Retailers.</E> A person who is a retailer is exempt from this part unless such person is also a manufacturer or a processor subject to this part.</P>
          <CITA>[48 FR 38187, Aug 22, 1983, as amended at 50 FR 46770, Nov. 13, 1985]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 717.10</SECTNO>
          <SUBJECT>Allegations subject to this part.</SUBJECT>
          <P>(a) Allegations subject to this part are those allegations received on or after November 21, 1983 by persons subject to this part.</P>
          <P>(b) Allegations subject to this part are those that:</P>

          <P>(1) Are submitted either in writing and are signed by the alleger, or are submitted orally. In the case of an oral allegation, the firm must transcribe the allegation into written form, or it must inform the alleger that such allegation may be subject to this part and request that the alleger submit such <PRTPAGE P="91"/>allegation to the firm in writing and signed.</P>
          <P>(2) Implicate a substance that caused the stated significant adverse reaction by one of the following:</P>
          <P>(i) Naming the specific substance.</P>
          <P>(ii) Naming a mixture that contains a specific substance.</P>
          <P>(iii) Naming an article that contains a specific substance.</P>
          <P>(iv) Naming a company process or operation in which substances are involved.</P>
          <P>(v) Identifying an effluent, emission, or other discharge from a site of manufacturing, processing or distribution of a substance.</P>
          <P>(c) Allegations subject to this part may be made to a firm by any person, such as an employee of the firm, individual consumer, a neighbor of the firm's plant, another firm on behalf of its employees or an organization on behalf of its members.</P>
          <P>(d) EPA intends that firms should, to the maximum practical extent, provide allegers with information regarding the ultimate disposition of their allegations. For example, firms could provide a brief notice to the alleger stating that a record was created under this part based upon their allegation, or that a record was not created and briefly explain the reasons why not.</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 717.12</SECTNO>
          <SUBJECT>Significant adverse reactions that must be recorded.</SUBJECT>
          <P>(a) Except as provided in paragraph (b) of this section, significant adverse reactions to human health that must be recorded include but are not limited to:</P>
          <P>(1) Long-lasting or irreversible damage, such as cancer or birth defects.</P>
          <P>(2) Partial or complete impairment of bodily functions, such as reproductive disorders, neurological disorders or blood disorders.</P>
          <P>(3) An impairment of normal activities experienced by all or most of the persons exposed at one time.</P>
          <P>(4) An impairment of normal activities which is experienced each time an individual is exposed.</P>
          <P>(b) Firms are not required to record significant adverse reactions that are known human effects as defined in § 717.3(c).</P>
          <P>(c) Except as provided in paragraph (d) of this section, significant adverse reactions to the environment that must be recorded, even if restricted to the environs of a plant or disposal site, include but are not limited to:</P>
          <P>(1) Gradual or sudden changes in the composition of animal life or plant life, including fungal or microbial organisms, in an area.</P>
          <P>(2) Abnormal number of deaths of organisms (e.g., fish kills).</P>
          <P>(3) Reduction of the reproductive success or the vigor of a species.</P>
          <P>(4) Reduction in agricultural productivity, whether crops or livestock.</P>
          <P>(5) Alterations in the behavior or distribution of a species.</P>
          <P>(6) Long lasting or irreversible contamination of components of the physical environment, especially in the case of ground water, and surface water and soil resources that have limited self-cleansing capability.</P>
          <P>(d) Firms are not required to record a significant adverse reaction to the environment if the alleged cause of that significant adverse reaction can be directly attributable to an accidental spill or other accidental discharge, emission exceeding permitted limits, or other incident of environmental contamination that has been reported to the Federal Government under any applicable authority.</P>
          <CITA>[48 FR 38187, Aug. 22, 1983, as amended at 49 FR 23183, June 5, 1984; 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 717.15</SECTNO>
          <SUBJECT>Recordkeeping requirements.</SUBJECT>
          <P>(a) <E T="03">Establishment and location of records.</E> A firm subject to this part shall establish and maintain records of significant adverse reactions alleged to have been caused by chemical substances or mixtures manufactured or processed by the firm. Such records shall be kept at the firm's headquarters or at any other appropriate location central to the firm's chemical operations.</P>
          <P>(b) <E T="03">Content of records.</E> The record shall consist of the following:</P>
          <P>(1) The original allegation as received.</P>
          <P>(2) An abstract of the allegation and other pertinent information as follows:</P>

          <P>(i) The name and address of the plant site which received the allegation.<PRTPAGE P="92"/>
          </P>
          <P>(ii) The date the allegation was received at that site.</P>
          <P>(iii) The implicated substance, mixture, article, company process or operation, or site discharge.</P>
          <P>(iv) A description of the alleger (e.g., “company employee,” “individual consumer,” “plant neighbor”). If the allegation involves a health effect, the sex and year of birth of the individual should be recorded, if ascertainable.</P>
          <P>(v) A description of the alleged health effect(s). The description must relate how the effect(s) became known and the route of exposure, if explained in the allegation.</P>
          <P>(vi) A description of the nature of the alleged environmental effect(s), identifying the affected plant and/or animal species, or contaminated portion of the physical environment.</P>
          <P>(3) The results of any self-initiated investigation with respect to an allegation. (EPA does not require persons subject to this part to investigate allegations received, and no provision of this part shall be construed to imply that EPA recommends, encourages or requires such investigation.)</P>
          <P>(4) Copies of any further required records or reports relating to the allegation. For example, if an employee allegation results in a requirement for the firm to record the case on Occupational Safety and Health Form 101 or appropriate substitute (see 29 CFR part 1904 for requirements under the Occupational Safety and Health Act of 1970), a copy of that OSHA record must be included in the allegation record.</P>
          <P>(c) <E T="03">File structure.</E> Records must be retrievable by the alleged cause of the significant adverse reaction, which cause may be one of the following:</P>
          <P>(1) A specific chemical identity.</P>
          <P>(2) A mixture.</P>
          <P>(3) An article.</P>
          <P>(4) A company process or operation.</P>
          <P>(5) A site emission, effluent or other discharge.</P>
          <P>(d) <E T="03">Retention period.</E> Records of significant adverse reactions to the health of employees shall be retained for a period of 30 years from the date such reactions were first reported to or known by the person maintaining such records. This provision requires persons subject to this part to retain for 30 years an employee health related allegation, arising from any employment related exposure, whether or not such allegation was submitted by or on the behalf of that recordkeeper's own employee. Any other record of significant adverse reactions shall be maintained for a period of five years from the date the information contained in the record was first reported to or known by the person maintaining the record.</P>
          <P>(e) <E T="03">Transfer of records.</E> (1) If a firm ceases to do business, the successor must receive and keep all the records that must be kept under this part.</P>
          <P>(2) If a firm ceases to do business and there is no successor to receive and keep the records for the prescribed period, these records must be transmitted to EPA. See § 717.17(c) for the address to which such records must be sent.</P>
          <CITA>[48 FR 38187, Aug. 22, 1983, as amended at 49 FR 23183, June 5, 1984; 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 717.17</SECTNO>
          <SUBJECT>Inspection and reporting requirements.</SUBJECT>
          <P>(a) <E T="03">Inspection.</E> Firms must make records of allegations available for inspection by any duly designated representative of the Administrator.</P>
          <P>(b) <E T="03">Reporting.</E> Each person who is required to keep records under this part must submit copies of those records to the Agency as required by the EPA Administrator or appropriate designee. EPA will notify those responsible for reporting by letter or will announce any such requirements for submitting copies of records by a notice in the <E T="04">Federal Register.</E> Such letter or notice will be signed by the Administrator or appropriate designee, and will specify which records or portion of records must be submitted. The reporting period will be specified by the letter or notice but in no case will such reporting period be less than 45 days from the date of the letter or the effective date of the notice.</P>
          <P>(c) <E T="03">How to report.</E> When required to report, firms must submit copies of records (preferably by certified mail) to the Document Control Office (7407), Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Room G-099, 401 M St., SW., <PRTPAGE P="93"/>Washington, DC., 20460, ATTN: 8(c) Allegations.</P>
          <CITA>[48 FR 38187, Aug. 22, 1983, as amended at 49 FR 23183, June 5, 1984; 52 FR 20084, May 29, 1987; 53 FR 12523, Apr. 15, 1988; 58 FR 34204, June 23, 1993; 60 FR 34464, July 3, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 717.19</SECTNO>
          <SUBJECT>Confidentiality.</SUBJECT>
          <P>(a) Any person submitting copies of records may assert a business confidentiality claim covering all or part of the submitted information. Any information covered by a claim will be disclosed by EPA only as provided in procedures set forth at part 2 of this title.</P>
          <P>(b) If no claim accompanies a document at the time it is submitted to EPA, the document will be placed in an open file available to the public without further notice to the respondent.</P>
          <P>(c) To asset a claim of confidentiality for information contained in a submitted record, the respondent must submit two copies of the document.</P>
          <P>(1) One copy must be complete. In that copy, the respondent must indicate what information, if any, is claimed as confidential by marking the specific information on each page with a label such as “confidential”, “proprietary”, or “trade secret” and briefly state the basis of the claim.</P>
          <P>(2) If some information is claimed as confidential, the respondent must submit a second copy of the record. The second copy must be complete, except that all information claimed as confidential in the first copy must be deleted.</P>
          <P>(3) The first copy will be for internal use by EPA. The second copy will be placed in an open file to be available to the public.</P>
          <P>(4) Failure to furnish a second copy when information is claimed as confidential in the first copy will be considered a presumptive waiver of the claim of confidentiality. EPA will notify the respondent by certified mail that a finding of a presumptive waiver of the claim of confidentiality has been made. The respondent will be given 30 days from the date of receipt of notification to submit the required second copy. If the respondent fails to submit the second copy within the 30 days, EPA will place the first copy in the public file.</P>
        </SECTION>
      </SUBPART>
    </PART>
    <PART>
      <EAR>Pt. 720</EAR>
      <HD SOURCE="HED">PART 720—PREMANUFACTURE NOTIFICATION</HD>
      <CONTENTS>
        <SUBPART>
          <HD SOURCE="HED">Subpart A—General Provisions</HD>
          <SECHD>Sec.</SECHD>
          <SECTNO>720.1</SECTNO>
          <SUBJECT>Scope.</SUBJECT>
          <SECTNO>720.3</SECTNO>
          <SUBJECT>Definitions.</SUBJECT>
        </SUBPART>
        <SUBPART>
          <HD SOURCE="HED">Subpart B—Applicability</HD>
          <SECTNO>720.22</SECTNO>
          <SUBJECT>Persons who must report.</SUBJECT>
          <SECTNO>720.25</SECTNO>
          <SUBJECT>Determining whether a chemical substance is on the Inventory.</SUBJECT>
          <SECTNO>720.30</SECTNO>
          <SUBJECT>Chemicals not subject to notification requirements.</SUBJECT>
          <SECTNO>720.36</SECTNO>
          <SUBJECT>Exemption for research and development.</SUBJECT>
          <SECTNO>720.38</SECTNO>
          <SUBJECT>Exemptions for test marketing.</SUBJECT>
        </SUBPART>
        <SUBPART>
          <HD SOURCE="HED">Subpart C—Notice Form</HD>
          <SECTNO>720.40</SECTNO>
          <SUBJECT>General.</SUBJECT>
          <SECTNO>720.45</SECTNO>
          <SUBJECT>Information that must be included in the notice form.</SUBJECT>
          <SECTNO>720.50</SECTNO>
          <SUBJECT>Submission of test data and other data concerning the health and environmental effects of a substance.</SUBJECT>
          <SECTNO>720.57</SECTNO>
          <SUBJECT>Imports.</SUBJECT>
        </SUBPART>
        <SUBPART>
          <HD SOURCE="HED">Subpart D—Disposition of Notices</HD>
          <SECTNO>720.60</SECTNO>
          <SUBJECT>General.</SUBJECT>
          <SECTNO>720.62</SECTNO>
          <SUBJECT>Notice that notification is not required.</SUBJECT>
          <SECTNO>720.65</SECTNO>
          <SUBJECT>Acknowledgment of receipt of a notice; errors in the notice; incomplete submissions; false and misleading statements.</SUBJECT>
          <SECTNO>720.70</SECTNO>
          <SUBJECT>Notice in the <E T="04">Federal Register.</E>
          </SUBJECT>
          <SECTNO>720.75</SECTNO>
          <SUBJECT>Notice review period.</SUBJECT>
          <SECTNO>720.78</SECTNO>
          <SUBJECT>Recordkeeping.</SUBJECT>
        </SUBPART>
        <SUBPART>
          <HD SOURCE="HED">Subpart E—Confidentiality and Public Access to Information</HD>
          <SECTNO>720.80</SECTNO>
          <SUBJECT>General provisions.</SUBJECT>
          <SECTNO>720.85</SECTNO>
          <SUBJECT>Chemical identity.</SUBJECT>
          <SECTNO>720.87</SECTNO>
          <SUBJECT>Categories or proposed categories of uses of a new chemical substance.</SUBJECT>
          <SECTNO>720.90</SECTNO>
          <SUBJECT>Data from health and safety studies.</SUBJECT>
          <SECTNO>720.95</SECTNO>
          <SUBJECT>Public file.</SUBJECT>
        </SUBPART>
        <SUBPART>
          <HD SOURCE="HED">Subpart F—Commencement of Manufacture or Import</HD>
          <SECTNO>720.102</SECTNO>
          <SUBJECT>Notice of commencement of manufacture or import.</SUBJECT>
        </SUBPART>
        <SUBPART>
          <HD SOURCE="HED">Subpart G—Compliance and Inspections</HD>
          <SECTNO>720.120</SECTNO>
          <SUBJECT>Compliance.</SUBJECT>
          <SECTNO>720.122</SECTNO>
          <SUBJECT>Inspections.</SUBJECT>
        </SUBPART>
      </CONTENTS>
      <AUTH>
        <HD SOURCE="HED">Authority:</HD>
        <P>15 U.S.C. 2604, 2607, and 2613.</P>
      </AUTH>
      <SOURCE>
        <HD SOURCE="HED">Source:</HD>
        <P>48 FR 21742, May 13, 1983, unless otherwise noted.</P>
      </SOURCE>
      <SUBPART>
        <PRTPAGE P="94"/>
        <HD SOURCE="HED">Subpart A—General Provisions</HD>
        <SECTION>
          <SECTNO>§ 720.1</SECTNO>
          <SUBJECT>Scope.</SUBJECT>
          <P>This part establishes procedures for the reporting of new chemical substances by manufacturers and importers under section 5 of the Toxic Substances Control Act, 15 U.S.C. 2604. This part applies to microorganisms only to the extent provided by part 725 of this chapter. The rule defines the persons and chemical substances subject to the reporting requirements, prescribes the contents of section 5 notices, and establishes procedures for submitting notices. The rule also establishes EPA policy regarding claims of confidentiality for, and public disclosure of, various categories of information submitted in connection with section 5 notices.</P>
          <CITA>[48 FR 21742, May 13, 1983, as amended at 58 FR 34204, June 23, 1993; 62 FR 17932, April 11, 1997]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 720.3</SECTNO>
          <SUBJECT>Definitions.</SUBJECT>
          <P>(a)(1) For the purposes of this part, the terms <E T="03">cosmetic, device, drug, food,</E> and <E T="03">food additive</E> have the meanings contained in the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 321 <E T="03">et seq.,</E> and the regulations issued under it. In addition, the term “food” includes poultry and poultry products, as defined in the Poultry Products Inspection Act, 21 U.S.C. 453 <E T="03">et seq.;</E> meats and meat food products, as defined in the Federal Meat Inspection Act, 21 U.S.C. 60 <E T="03">et seq.;</E> and eggs and egg products, as defined in the Egg Products Inspection Act, 21 U.S.C. 1033 <E T="03">et seq.</E>
          </P>
          <P>(2) The term <E T="03">pesticide</E> has the meaning contained in the Federal Insecticide, Fungicide, and Rodenticide Act, 7 U.S.C. 136 <E T="03">et seq.</E> and the regulations issued under it.</P>
          <P>(3) The terms <E T="03">byproduct material, source material,</E> and <E T="03">special nuclear material</E> have the meanings contained in the Atomic Energy Act of 1954, 42 U.S.C 2014 <E T="03">et seq.</E> and the regulations issued under it.</P>
          <P>(b) <E T="03">Act</E> means the Toxic Substances Control Act, 15 U.S.C. 2601 <E T="03">et seq.</E>
          </P>
          <P>(c) <E T="03">Article</E> means a manufactured item (1) which is formed to a specific shape or design during manufacture, (2) which has end use function(s) dependent in whole or in part upon its shape or design during end use, and (3) which has either no change of chemical composition during its end use or only those changes of composition which have no commercial purpose separate from that of the article and that may occur as described in § 720.36(g)(5), except that fluids and particles are not considered articles regardless of shape or design.</P>
          <P>(d) <E T="03">Byproduct</E> means a chemical substance produced without a separate commercial intent during the manufacture, processing, use, or disposal of another chemical substance or mixture.</P>
          <P>(e) <E T="03">Chemical substance</E> means any organic or inorganic substance of a particular molecular identity, including any combination of such substances occurring in whole or in part as a result of a chemical reaction or occurring in nature, and any chemical element or uncombined radical, except that “chemical substance” does not include:</P>
          <P>(1) Any mixture.</P>
          <P>(2) Any pesticide when manufactured, processed, or distributed in commerce for use as a pesticide.</P>
          <P>(3) Tobacco or any tobacco product.</P>
          <P>(4) Any source material, special nuclear material, or byproduct material.</P>
          <P>(5) Any pistol, firearm, revolver, shells, or cartridges.</P>
          <P>(6) Any food, food additive, drug, cosmetic, or device, when manufactured, processed, or distributed in commerce for use as a food, food additive, drug, cosmetic, or device.</P>
          <P>(f) <E T="03">Commerce</E> means trade, traffic, transportation, or other commerce (1) between a place in a State and any place outside of such State, or (2) which affects trade, traffic, transportation, or commerce between a place in a State and any place outside of such State.</P>
          <P>(g) <E T="03">Customs territory of the United States</E> means the 50 States, Puerto Rico, and the District of Columbia.</P>
          <P>(h) <E T="03">Director</E> means the Director of the EPA Office of Pollution Prevention and Toxics.</P>
          <P>(i) <E T="03">Distribute in commerce</E> means to sell in commerce, to introduce or deliver for introduction into commerce, or to hold after introduction into commerce.</P>
          <P>(j) <E T="03">EPA</E> means the U.S. Environmental Protection Agency.<PRTPAGE P="95"/>
          </P>
          <P>(k) <E T="03">Health and safety study</E> or <E T="03">study</E> means any study of any effect of a chemical substance or mixture on health or the environment or on both, including underlying data and epidemiological studies, studies of occupational exposure to a chemical substance or mixture, toxicological, clinical, and ecological, or other studies of a chemical substance or mixture, and any test performed under the Act. Chemical identity is always part of a health and safety study.</P>
          <P>(1) Not only is information which arises as a result of a formal, disciplined study included, but other information relating to the effects of a chemical substance or mixture on health or the environment is also included. Any data that bear on the effects of a chemical substance on health or the environment would be included.</P>
          <P>(2) Examples include:</P>
          <P>(i) Long- and short-term tests of mutagenicity, carcinogenicity, or ter-a-to-gen-i-city; data on behavioral disorders; dermatoxicity; pharmacological effects; mammalian absorption, distribution, metabolism, and excretion; cumulative, additive, and synergistic effects; acute, subchronic, and chronic effects; and structure/activity analyses.</P>
          <P>(ii) Tests for ecological or other environmental effects on invertebrates, fish, or other animals, and plants, including: Acute toxicity tests, chronic toxicity tests, critical life stage tests, behavioral tests, algal growth tests, seed germination tests, plant growth or damage tests, microbial function tests, bioconcentration or bioaccumulation tests, and model ecosystem (microcosm) studies.</P>
          <P>(iii) Assessments of human and environmental exposure, including workplace exposure, and impacts of a particular chemical substance or mixture on the environment, including surveys, tests, and studies of: Biological, photochemical, and chemical degradation; air, water, and soil transport; bio-mag-ni-fi-ca-tion and bio-con-cen-tra-tion; and chemical and physical properties, e.g., boiling point, vapor pressure, evaporation rates from soil and water, octanol/water partition coefficient, and water solubility.</P>
          <P>(iv) Monitoring data, when they have been aggregated and analyzed to measure the exposure of humans or the environment to a chemical substance or mixture.</P>
          <P>(v) Any assessments of risk to health and the environment resulting from the manufacture, processing, distribution in commerce, use, or disposal of the chemical substance.</P>
          <P>(l) <E T="03">Importer</E> means any person who imports a chemical substance, including a chemical substance as part of a mixture or article, into the customs territory of the United States. “Importer” includes the person primarily liable for the payment of any duties on the merchandise or an authorized agent acting on his or her behalf. The term also includes, as appropriate:</P>
          <P>(1) The consignee.</P>
          <P>(2) The importer of record.</P>
          <P>(3) The actual owner if an actual owner's declaration and superseding bond has been filed in accordance with 19 CFR 141.20; or</P>
          <P>(4) The transferee, if the right to draw merchandise in a bonded warehouse has been transferred in accordance with subpart C of 19 CFR part 144. (See “principal importer.”)</P>
          <P>(m) <E T="03">Impurity</E> means a chemical substance which is unintentionally pres-ent with another chemical substance.</P>
          <P>(n) <E T="03">Intermediate</E> means any chemical substance that is consumed, in whole or in part, in chemical reactions used for the intentional manufacture of another chemical substance(s) or mixture(s), or that is intentionally present for the purpose of altering the rates of such chemical reactions.</P>
          <P>(o) <E T="03">Inventory</E> means the list of chemical substances manufactured or processed in the United States that EPA compiled and keeps current under section 8(b) of the Act.</P>
          <P>(p) <E T="03">Known to or reasonably ascertainable by</E> means all information in a person's possession or control, plus all information that a reasonable person similarly situated might be expected to possess, control, or know.</P>
          <P>(q) <E T="03">Manufacture</E> means to produce or manufacture in the United States or import into the customs territory of the United States.</P>
          <P>(r) <E T="03">Manufacture or import for commercial purposes</E> means:</P>

          <P>(1) To import, produce, or manufacture with the purpose of obtaining an <PRTPAGE P="96"/>immediate or eventual commercial advantage for the manufacturer or importer, and includes, among other things, “manufacture” of any amount of a chemical substance or mixture:</P>
          <P>(i) For commercial distribution, including for test marketing.</P>
          <P>(ii) For use by the manufacturer, including use for product research and development or as an intermediate.</P>
          <P>(2) The term also applies to substances that are produced coincidentally during the manufacture, processing, use, or disposal of another substance or mixture, including byproducts that are separated from that other substance or mixture and impurities that remain in that substance or mixture. Byproducts and impurities without separate commercial value are nonetheless produced for the purpose of obtaining a commercial advantage, since they are part of the manufacture of a chemical substance for commercial purposes.</P>
          <P>(s) <E T="03">Manufacture solely for export</E> means to manufacture or import for commercial purposes a chemical substance solely for export from the United States under the following restrictions on activities in the United States:</P>
          <P>(1) Distribution in commerce is limited to purposes of export or processing solely for export as defined in § 721.3 of this chapter.</P>
          <P>(2) The manufacturer or importer, and any person to whom the substance is distributed for purposes of export or processing solely for export (as defined in § 721.3 of this chapter), may not use the substance except in small quantities solely for research and development in accordance with § 720.36.</P>
          <P>(t) <E T="03">Manufacturer</E> means a person who imports, produces, or manufactures a chemical substance. A person who extracts a component chemical substance from a previously existing chemical substance or a complex combination of substances is a manufacturer of that component chemical substance. A person who contracts with a manufacturer to manufacture or produce a chemical substance is also a manufacturer if (1) the manufacturer manufactures or produces the substance exclusively for that person, and (2) that person specifies the identity of the substance and controls the total amount produced and the basic technology for the plant process.</P>
          <P>(u) <E T="03">Mixture</E> means any combination of two or more chemical substances if the combination does not occur in nature and is not, in whole or in part, the result of a chemical reaction; except “mixture” does include (1) any combination which occurs, in whole or in part, as a result of a chemical reaction if the combination could have been manufactured for commercial purposes without a chemical reaction at the time the chemical substances comprising the combination were combined, and if all of the chemical substances comprising the combination are not new chemical substances, and (2) hydrates of a chemical substance or hydrated ions formed by association of a chemical substance with water, so long as the nonhydrated form is itself not a new chemical substance.</P>
          <P>(v) <E T="03">New chemical substance</E> means any chemical substance which is not included on the Inventory.</P>
          <P>(w) <E T="03">Nonisolated intermediate</E> means any intermediate that is not intentionally removed from the equipment in which it is manufactured, including the reaction vessel in which it is manufactured, equipment which is ancillary to the reaction vessel, and any equipment through which the chemical substance passes during a continuous flow process, but not including tanks or other vessels in which the substance is stored after its manufacture.</P>
          <P>(x) <E T="03">Person</E> means any natural person, firm, company, corporation, joint-venture, partnership, sole proprietorship, association, or any other business entity, any State or political subdivision thereof, any municipality, any interstate body, and any department, agency or instrumentality of the Federal Government.</P>
          <P>(y) <E T="03">Possession or control</E> means in possession or control of the submitter, or of any subsidiary, partnership in which the submitter is a general partner, parent company, or any company or partnership which the parent company owns or controls, if the subsidiary, parent company, or other company or partnership is associated with the submitter in the research, development, <PRTPAGE P="97"/>test marketing, or commercial marketing of the chemical substance in question. (A parent company owns or controls another company if the parent owns or controls 50 percent or more of the other company's voting stock. A parent company owns or controls any partnership in which it is a general partner). Information is included within this definition if it is:</P>
          <P>(1) In files maintained by submitter's employees who are:</P>
          <P>(i) Associated with research, development, test marketing, or commercial marketing of the chemical substance in question.</P>
          <P>(ii) Reasonably likely to have such data.</P>
          <P>(2) Maintained in the files of other agents of the submitter who are associated with research, development, test marketing, or commercial marketing of the chemical substance in question in the course of their employment as such agents.</P>
          <P>(z) <E T="03">Principal importer</E> means the first importer who, knowing that a new chemical substance will be imported rather than manufactured domestically, specifies the identity of the chemical substance and the total amount to be imported. Only persons who are incorporated, licensed, or doing business in the United States may be principal importers.</P>
          <P>(aa) <E T="03">Process</E> means the preparation of a chemical substance or mixture, after its manufacture, for distribution in commerce (1) in the same form or physical state as, or in a different form or physical state from, that in which it was received by the person so preparing such substance or mixture, or (2) as part of a mixture or article containing the chemical substance or mixture.</P>
          <P>(bb) <E T="03">Processor</E> means any person who processes a chemical substance or mixture.</P>
          <P>(cc) <E T="03">Small quantities solely for research and development</E> (or “small quantities solely for purposes of scientific experimentation or analysis or chemical research on, or analysis of, such substance or another substance, including such research or analysis for the development of a product”) means quantities of a chemical substance manufactured, imported, or processed or proposed to be manufactured, imported, or processed solely for research and development that are not greater than reasonably necessary for such purposes.</P>
          <P>(dd) <E T="03">State</E> means any State of the United States and the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam, the Canal Zone, American Samoa, the Northern Mariana Islands, and any other territory or possession of the United States.</P>
          <P>(ee) <E T="03">Technically qualified individual</E> means a person or persons (1) who, because of education, training, or experience, or a combination of these factors, is capable of understanding the health and environmental risks associated with the chemical substance which is used under his or her supervision, (2) who is responsible for enforcing appropriate methods of conducting scientific experimentation, analysis, or chemical research to minimize such risks, and (3) who is responsible for the safety assessments and clearances related to the procurement, storage, use, and disposal of the chemical substance as may be appropriate or required within the scope of conducting a research and development activity.</P>
          <P>(ff) <E T="03">Test data</E> means data from a formal or informal test or experiment, including information concerning the objectives, experimental methods and materials, protocols, results, data analyses, recorded observations, monitoring data, measurements, and conclusions from a test or experiment.</P>
          <P>(gg) <E T="03">Test marketing</E> means the distribution in commerce of no more than a predetermined amount of a chemical substance, mixture, or article containing that chemical substance or mixture, by a manufacturer or processor, to no more than a defined number of potential customers to explore market capability in a competitive situation during a predetermined testing period prior to the broader distribution of that chemical substance, mixture, or article in commerce.</P>
          <P>(hh) <E T="03">United States,</E> when used in the geographic sense, means all of the States.</P>
          <CITA>[48 FR 21742, May 13, 1983, as amended at 51 FR 15101, Apr. 22, 1986]</CITA>
        </SECTION>
      </SUBPART>
      <SUBPART>
        <PRTPAGE P="98"/>
        <HD SOURCE="HED">Subpart B—Applicability</HD>
        <SECTION>
          <SECTNO>§ 720.22</SECTNO>
          <SUBJECT>Persons who must report.</SUBJECT>
          <P>(a)(1) Any person who intends to manufacture a new chemical substance in the United States for commercial purposes must submit a notice unless the substance is excluded under § 720.30.</P>
          <P>(2) If a person contracts with a manufacturer to manufacture or produce a new chemical substance, and (i) the manufacturer manufactures or produces the substance exclusively for that person, and (ii) that person specifies the identity of the substance, and controls the total amount produced and the basic technology for the plant process, that person must submit the notice. If it is unclear who must report, EPA should be contacted to determine who must submit the notice.</P>
          <P>(3) Only manufacturers that are incorporated, licensed, or doing business in the United States may submit a notice.</P>
          <P>(b)(1) Any person who intends to import a new chemical substance into the United States for commercial purposes must submit a notice, unless the substance is excluded under § 720.30 or unless the substance is imported as part of an article.</P>
          <P>(2) When several persons are involved in an import transaction, the notice must be submitted by the principal importer. If no one person fits the principal importer definition in a particular transaction, the importer should contact EPA to determine who must submit the notice for that transaction.</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 720.25</SECTNO>
          <SUBJECT>Determining whether a chemical substance is on the Inventory.</SUBJECT>
          <P>(a) A new chemical substance is any chemical substance that is not currently listed on the Inventory.</P>

          <P>(b)(1) A chemical substance is listed in the public portion of the Inventory by a specific chemical name (either a Chemical Abstracts (CA) Index Name or a CA Preferred Name) and a Chemical Abstracts Service (CAS) Registry Number if its identity is not confidential. If its identity is confidential, it is listed in the public portion of the Inventory by a TSCA Accession Number and a generic chemical name that masks the specific substance identity. The confidential substance is listed by its specific chemical name only in the confidential portion of the Inventory, which is not available to the public. A person who intends to manufacture or import a chemical substance not listed by specific chemical name in the public portion of the Inventory may ask EPA whether the substance is included in the confidential Inventory. EPA will answer such an inquiry only if EPA determines that the person has a <E T="03">bona fide</E> intent to manufacture or import the chemical substance for commercial purposes.</P>
          <P>(2) To establish a <E T="03">bona fide</E> intent to manufacture or import a chemical substance, the person who proposes to manufacture or import the substance must submit to EPA:</P>
          <P>(i) Except as provided in paragraphs (b)(3) (i) and (ii) of this section, the specific chemical identity of the substance that the person intends to manufacture or import, using the currently, correct CA name for the substance and the other correct chemical identity information in accordance with §§ 720.45(a) (1), (2), and (3).</P>
          <P>(ii) A signed statement that the person intends to manufacture or import that chemical substance for commercial purposes.</P>
          <P>(iii)(A) A brief description of the research and development activities conducted to date related to the substance, including the year in which the person first started to conduct research or development activity on the substance, and the general types of research and development activities conducted thus far (e.g., synthesis, substance isolation/purification, formulating, product development, process development, end-use application, toxicity testing, etc.). The person must also indicate whether any pilot plant or production-scale plant evaluations have been conducted involving the manufacture or processing of the substance.</P>

          <P>(B) If an importer is unable to provide the information requested in paragraph (b)(2)(iii)(A) of this section from the foreign manufacturer or supplier, the following information shall be submitted:<PRTPAGE P="99"/>
          </P>
          <P>(<E T="03">1</E>) A brief statement indicating how long the substance has been in commercial use outside of the United States.</P>
          <P>(<E T="03">2</E>) The name of a country in which it has been commercially used.</P>
          <P>(<E T="03">3</E>) Whether the importer believes that the substance has already been used commercially, in any country, for the same purpose or application that the importer is intending.</P>
          <P>(iv) A specific description of the major intended application or use of the substance.</P>
          <P>(v) An infrared spectrum of the substance, or alternative spectra or other data which identify the substance if infrared analysis is not suitable for the substance or does not yield a reasonable amount of structural information. When using alternative spectra or instrumental analysis, the person must submit a spectrum or instrumental readout for the substance.</P>
          <P>(vi) The estimated date (month/year) in which the person intends to submit a Premanufacture Notice (PMN) for this substance if EPA informs the notice submitter that the substance is not on the Inventory.</P>
          <P>(vii) The address of the facility under the control of the submitter at which the manufacture or processing of the substance would most likely occur. For an imported substance, the facility under the control of the importer at which processing of the substance would likely occur, if any.</P>
          <P>(viii)(A) For substances intended to be manufactured in the United States, a description of the most probable manufacturing process that would be used by the submitter to produce the substance for non-exempt commercial purposes.</P>
          <P>(B) For substances intended to be imported, a brief description of how the submitter is most likely to process or use the substance for a commercial purpose. If the substance is not expected to be processed or used at any facility under the importer's control, a statement to this effect must be included along with a description of how the substance will be processed or used at sites controlled by others, if this information is known or reasonably ascertainable.</P>
          <P>(3)(i) If an importer cannot provide the chemical identity information required by paragraph (b)(2) (i) and (v) of this section because it is claimed confidential by its foreign manufacturer or supplier, the foreign manufacturer or supplier must supply the required information directly to EPA in accordance with § 720.45(a) (1), (2), and (3) and reference the importer's notice. If the appropriate supporting document from the foreign party is not received within 30 days after EPA receives the importer's notice, the notice will be considered incomplete.</P>
          <P>(ii) If a manufacturer cannot provide all of the required information in accordance with § 720.45(a) (1), (2), and (3) because the new chemical substance is manufactured using a reactant that has a specific chemical identity claimed as confidential by its supplier, the notice must contain chemical identity information that is as complete as known by the manufacturer. In addition, a letter of support for the notice must then be sent to EPA by the chemical supplier of the confidential reactant, providing the specific chemical identity of the proprietary reactant. The letter of support must reference the manufacturer's notice. If the appropriate supporting document from the supplier is not received within 30 days after EPA receives the manufacturer's notice, the notice will be considered incomplete.</P>

          <P>(4) EPA will review the information submitted by the proposed manufacturer or importer under this paragraph to determine whether it has a <E T="03">bona fide</E> intent to manufacture or import the chemical substance. If necessary, EPA will compare this information either to the information requested for the confidential chemical substance under § 710.7(e)(2)(v) of this chapter or the information requested under § 720.85(b)(3)(iii).</P>
          <P>(5) If the proposed manufacturer or importer has shown a <E T="03">bona fide</E> intent to manufacture or import the substance, and provide sufficient unambiguous chemical identity information so <PRTPAGE P="100"/>EPA can make a conclusive determination of the chemical substance's Inventory status, EPA will search the confidential Inventory and inform the proposed manufacturer or importer whether the chemical substance is on the confidential Inventory.</P>

          <P>(6) If the chemical substance is found on the confidential Inventory, EPA will notify the person(s) who originally reported the chemical substance that another person has demonstrated a <E T="03">bona fide</E> intent to manufacture or import the substance and therefore was told that the chemical substance is on the Inventory.</P>

          <P>(7) A disclosure of a confidential chemical identity to a person with a <E T="03">bona fide</E> intent to manufacture or import the particular chemical substance will not be considered a public disclosure of confidential business information under section 14 of the Act.</P>
          <P>(8) EPA will answer an inquiry on whether a particular chemical substance is on the confidential Inventory within 30 days after receipt of a complete submission under paragraph (b)(2) of this section.</P>

          <P>(9) If the required chemical identity information has not been reported correctly or completely in the notice (except as provided under paragraph (b)(3)(ii) of this section) or if any other required data or information has been omitted or is incomplete, EPA will consider the whole notice to be incomplete. As soon as an incomplete notice is identified as such by EPA, the Agency will immediately return the notice directly to the submitter. The submitter must then resubmit the whole, completed <E T="03">bona fide</E> notice to EPA in order to have the Agency perform the desired Inventory search and respond to the notice.</P>
          <CITA>[48 FR 21742, May 13, 1983, as amended at 58 FR 34204, June 23, 1993; 60 FR 16309, Mar. 29, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 720.30</SECTNO>
          <SUBJECT>Chemicals not subject to notification requirements.</SUBJECT>
          <P>The following substances are not subject to the notification requirements of this part:</P>
          <P>(a) Any substance which is not a “chemical substance” as defined in § 720.3(e).</P>
          <P>(b) Any mixture as defined in § 720.3(u).<E T="51">1</E>
            <FTREF/>
          </P>
          <FTNT>
            <P>
              <E T="51">1</E> A new chemical substance that is manufactured or imported as part of a mixture is subject to the requirements of this part. This exclusion applies only to a mixture as a whole and not to any chemical substances which are part of the mixture.</P>
          </FTNT>
          <P>(c) Any new chemical substance which will be manufactured or imported in small quantities solely for research and development under § 720.36.</P>
          <P>(d) Any new chemical substance which will be manufactured or imported solely for test-marketing purposes under an exemption granted under § 720.38.</P>
          <P>(e) Any new chemical substance manufactured solely for export if, when the substance is distributed in commerce:</P>
          <P>(1) The substance is labeled in accordance with section 12(a)(1)(B) of the Act.</P>
          <P>(2) The manufacturer knows that the person to whom the substance is being distributed intends to export it or process it solely for export as defined in § 721.3 of this chapter.</P>
          <P>(f) Any new chemical substance which is manufactured or imported under the terms of a rule promulgated under section 5(h)(4) of the Act.</P>
          <P>(g) Any byproduct if its only commercial purpose is for use by public or private organizations that (1) burn it as a fuel, (2) dispose of it as a waste, including in a landfill or for enriching soil, or (3) extract component chemical substances from it for commercial purposes. (This exclusion only applies to the byproduct; it does not apply to the component substances extracted from the byproduct.)</P>
          <P>(h) The chemical substances described below: (Although they are manufactured for commercial purposes under the Act, they are not manufactured for distribution in commerce as chemical substances per se and have no commercial purpose separate from the substance, mixture, or article of which they are a part.)</P>
          <P>(1) Any impurity.</P>
          <P>(2) Any byproduct which is not used for commercial purposes.</P>

          <P>(3) Any chemical substance which results from a chemical reaction that occurs incidental to exposure of another chemical substance, mixture, or article <PRTPAGE P="101"/>to environmental factors such as air, moisture, microbial organisms, or sunlight.</P>
          <P>(4) Any chemical substance which results from a chemical reaction that occurs incidental to storage or disposal of another chemical substance, mixture, or article.</P>
          <P>(5) Any chemical substance which results from a chemical reaction that occurs upon end use of another chemical substance, mixture, or article such as an adhesive, paint, miscellaneous cleanser or other housekeeping product, fuel additive, water softening and treatment agent, photographic film, battery, match, or safety flare, and which is not itself manufactured or imported for distribution in commerce or for use as an intermediate.</P>
          <P>(6) Any chemical substance which results from a chemical reaction that occurs upon use of curable plastic or rubber molding compounds, inks, drying oils, metal finishing compounds, adhesives, or paints, or any other chemical substance formed during the manufacture of an article destined for the marketplace without further chemical change of the chemical substance except for those chemical changes that occur as described elsewhere in this paragraph.</P>
          <P>(7) Any chemical substance which results from a chemical reaction that occurs when (i) a stabilizer, colorant, odorant, antioxidant, filler, solvent, carrier, surfactant, plasticizer, corrosion inhibitor, antifoamer or defoamer, dispersant, precipitation inhibitor, bind-er, emulsifier, deemulsifier, de-water-ing agent, agglomerating agent, adhesion promoter, flow modifier, pH neutralizer, sequesterant, coagulant, flocculant, fire retardant, lubricant, chelating agent, or quality control reagent functions as intented, or (ii) a chemical substance, which is intended solely to impart a specific physiochemical characteristic, functions as intended.</P>
          <P>(8) Any nonisolated intermediate.</P>
          <P>(i) Any chemical substance which is manufactured solely for non-commercial research and development purposes. Non-commercial research and development purposes include scientific experimentation, research, or analysis conducted by academic, government, or independent not-for-profit research organizations (e.g., universities, colleges, teaching hospitals, and research institutes), unless the activity is for eventual commercial purposes.</P>
          <CITA>[48 FR 21742, May 13, 1983, as amended at 51 FR 15101, Apr. 22, 1986]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 720.36</SECTNO>
          <SUBJECT>Exemption for research and development.</SUBJECT>
          <P>(a) This part does not apply to a chemical substance if the following conditions are met:</P>
          <P>(1) The chemical substance is manufactured or imported only in small quantities solely for research and development.</P>
          <P>(2) The manufacturer or importer notifies all persons in its employ or to whom it directly distributes the chemical substance, who are engaged in experimentation, research, or analysis on the chemical substance, including the manufacture, processing, use, transport, storage, and disposal of the substance associated with research and development activities, of any risk to health, identified under paragraph (b) of this section, which may be associated with the substance. The notification must be made in accordance with paragraph (c) of this section.</P>
          <P>(3) The chemical substance is used by, or directly under the supervision of, a technically qualified individual.</P>
          <P>(b)(1) To determine whether notification under paragraph (a)(2) of this section is required, the manufacturer or importer must review and evaluate the following information to determine whether there is reason to believe there is any potential risk to health which may be associated with the chemical substance:</P>
          <P>(i) Information in its possession or control concerning any significant adverse reaction by persons exposed to the chemical substance which may reasonably be associated with such exposure.</P>
          <P>(ii) Information provided to the manufacturer or importer by a supplier or any other person concerning a health risk believed to be associated with the substance.</P>

          <P>(iii) Health and environmental effects data in its possession or control concerning the substance.<PRTPAGE P="102"/>
          </P>
          <P>(iv) Information on health effects which accompanies any EPA rule or order issued under sections 4, 5, or 6 of the Act that applies to the substance and of which the manufacturer or importer has knowledge.</P>
          <P>(2) When the research and development activity is conducted solely in a laboratory and exposure to the chemical substance is controlled through the implementation of prudent laboratory practices for handling chemical substances of unknown toxicity, and any distribution, except for purposes of disposal, is to other such laboratories for further research and development activity, the information specified in paragraph (b)(1) of this section need not be reviewed and evaluated. (For purposes of this paragraph, a laboratory is a contained research facility where relatively small quantities of chemical substances are used on a non-production basis, and where activities involve the use of containers for reactions, transfers, and other handling of substances designed to be easily manipulated by a single individual.)</P>
          <P>(c)(1) The manufacturer or importer must notify the persons identified in paragraph (a)(2) of this section by means of a container labeling system, conspicuous placement of notices in areas where exposure may occur, written notification to each person potentially exposed, or any other method of notification which adequately informs persons of health risks which the manufacturer or importer has reason to believe may be associated with the substance, as determined under paragraph (b)(1) of this section.</P>
          <P>(2) If the manufacturer or importer distributes a chemical substance manufactured or imported under this section to persons not in its employ, the manufacturer or importer must in written form:</P>
          <P>(i) Notify those persons that the substance is to be used only for research and development purposes.</P>
          <P>(ii) Provide the notice of health risks specified in paragraph (c)(1) of this section.</P>
          <P>(3) The adequacy of any notification under this section is the responsibility of the manufacturer or importer.</P>
          <P>(d) A chemical substance is not exempt from reporting under this part if any amount of the substance, including as part of a mixture, is processed, distributed in commerce, or used, for any commercial purpose other than research and development, except where the chemical substance is processed, distributed in commerce, or used only as an impurity or as part of an article.</P>
          <P>(e) Quantities of the chemical substance, or of mixtures or articles containing the chemical substance, remaining after completion of research and development activities may be:</P>
          <P>(1) Disposed of as a waste in accordance with applicable Federal, state, and local regulations, or</P>
          <P>(2) Used for the following commercial purposes:</P>
          <P>(i) Burning it as a fuel.</P>
          <P>(ii) Reacting or otherwise processing it to form other chemical substances for commercial purposes, including extracting component chemical substances.</P>
          <P>(f) Quantities of research and development substances existing solely as impurities in a product or incorporated into an article, in accordance with paragraph (d) of this section, and quantities of research and development substances used solely for commercial purposes listed in paragraph (e) of this section, are not subject to the requirements of paragraphs (a), (b), and (c) of this section, once research and development activities have been completed.</P>
          <P>(g) A person who manufactures or imports a chemical substance in small quantities solely for research and development is not required to comply with the requirements of this section if the person's exclusive intention is to perform research and development activities solely for the purpose of determining whether the substance can be used as a pesticide.</P>
          <CITA>[51 FR 15102, Apr. 22, 1986]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 720.38</SECTNO>
          <SUBJECT>Exemptions for test marketing.</SUBJECT>

          <P>(a) Any person may apply for an exemption to manufacture or import a new chemical substance for test marketing. EPA may grant the exemption if the person demonstrates that the chemical substance will not present an unreasonable risk to injury to health or the environment as a result of the test marketing.<PRTPAGE P="103"/>
          </P>
          <P>(b) Persons applying for a test-marketing exemption should provide the following information:</P>
          <P>(1) All existing data regarding health and environmental effects of the chemical substance, including physical/chemical properties or, in the absence of such data, a discussion of toxicity based on structure-activity relationships (SAR) and relevant data on chemical analogues.</P>
          <P>(2) The maximum quantity of the chemical substance which the applicant will manufacture or import for test marketing.</P>
          <P>(3) The maximum number of persons who may be provided the chemical substance during test marketing.</P>
          <P>(4) The maximum number of persons who may be exposed to the chemical substance as a result of test marketing, including information regarding duration and route of such exposures.</P>
          <P>(5) A description of the test-marketing activity, including its length and how it can be distinguished from full-scale commercial production and research and development.</P>
          <P>(c) In accordance with section 5(h)(6) of the Act, after EPA receives an application for exemption under this section, the Agency will file with the Office of the Federal Register a notice containing a summary of the information provided in the application, to the extent it has not been claimed confidential.</P>

          <P>(d) No later than 45 days after EPA receives an application, the Agency will either approve or deny the application. Thereafter, EPA will publish a notice in the <E T="04">Federal Register</E> explaining the reasons for approval or denial.</P>
          <P>(e) In approving an application for exemption, EPA may impose any restrictions necessary to ensure that the substance will not present an unreasonable risk of injury to health and the environment as a result of test marketing.</P>
          <CITA>[48 FR 21742, May 13, 1983, as amended at 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
      </SUBPART>
      <SUBPART>
        <HD SOURCE="HED">Subpart C—Notice Form</HD>
        <SECTION>
          <SECTNO>§ 720.40</SECTNO>
          <SUBJECT>General.</SUBJECT>
          <P>(a) <E T="03">Use of the notice form; electronic submissions.</E> (1) Each person who is required by subpart B of this part to submit a notice must complete, sign, and submit a notice containing the information in the form and manner specified in this paragraph. The information submitted and all attachments (unless the attachment appears in the open scientific literature) must be in English. All information submitted must be true and correct.</P>
          <P>(2) Information may be submitted on paper, or electronically, as follows:</P>
          <P>(i) Information submitted on paper must be submitted in the form and manner set forth in EPA Form No. 7710-25, which is available from the Environmental Assistance Division (7408), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 401 M St., SW., Washington, DC 20460. Information which is not submitted on the EPA Form No. 7710-25 or a photocopy thereof (e.g., on a form created by commercial form-making software) must be in a format pre-approved by the Agency.</P>
          <P>(ii) Information may be submitted electronically (on magnetic or other media) pursuant to an EPA published format for electronic submissions. Such submissions must comply with this format and all other media specifications published by EPA. Persons submitting electronically must still complete and submit on paper the Certification and Submitter Identification sections of Form 7710-25.</P>
          <P>(b) <E T="03">When to submit a notice.</E> Each person who is required to submit a notice must submit the notice at least 90 calendar days before manufacture or import of the new chemical substance for commercial purposes begins.</P>
          <P>(c) <E T="03">Where to submit a notice.</E> Each person who submits a notice must submit it to the address listed on the notice form.</P>
          <P>(d) <E T="03">General notice requirements.</E>  (1) Each person who submits a notice must provide the information described in § 720.45 and specified on the notice form, to the extent such information is <PRTPAGE P="104"/>known to or reasonably ascertainable by the person. In accordance with § 720.50, the notice must also include any test data in the person's possession or control, and descriptions of other data which are known to or reasonably ascertainable by the person and which concern the health and environmental effects of the new chemical substance.</P>
          <P>(2) A person who submits a notice to EPA under this part must provide EPA with an original and two complete copies of the notice, including all test data and any other information attached to the notice form. If information is claimed as confidential pursuant to § 720.80, a sanitized copy must also be provided.</P>
          <P>(e) <E T="03">Agency or joint submissions.</E> (1) A manufacturer or importer may designate an agent to submit the notice. Both the manufacturer or importer and the agent must sign the certification on the form.</P>
          <P>(2) A manufacturer or importer may authorize another person, (e.g., a foreign manufacturer or supplier, or a toll manufacturer) to report some of the information required in the notice to EPA on its behalf. If separate portions of a joint notice are not submitted together, the submitter should indicate which information will be supplied by another person and identify that person. The other person must submit the information on the appropriate part of the notice form. The manufacturer or importer and any other person supplying the information must sign the certification provided on their respective notice forms.</P>
          <P>(3) If EPA receives a submission which does not include information required by this rule, which the submitter indicates that it has authorized another person to provide, the notice review period will not begin until EPA receives that information.</P>
          <P>(f) <E T="03">New information.</E> During the notice review period, if the submitter possesses, controls, or knows of new information that materially adds to, changes, or otherwise makes significantly more complete the information included in the notice, the submitter must that information to the address listed on the notice form within ten days of receiving the new information, but no later than five days before the end of the notice review period. The new submission must clearly identify the submitter and the notice to which the new information is related. If the new information becomes available during the last five days of the notice review period, the submitter must immediately inform its EPA contract for that notice by telephone.</P>
          <P>(g) <E T="03">Chemical substances subject to a section 4 test rule.</E> (1) Except as provided in paragraph (g)(3) of this section, if (i) A person intends to manufacture or import a new chemical substance which is subject to the notification requirements of this part, and (ii) The chemical substance is subject to a test rule promulgated under section 4 of the Act before the notice is submitted, section 5(b)(1) of the Act requires the person to submit the test data required by the testing rule with the notice. The person must submit the data in the form and manner specified in the test rule and in accordance with § 720.50. If the person does not submit the test data, the submission is incomplete and EPA will follow the procedures in § 720.65.</P>
          <P>(2) If EPA has granted the submitter an exemption under section 4(c) of the Act from the requirement to conduct tests and submit data, the submitter may not submit a notice until EPA receives the test data.</P>
          <P>(3) If EPA has granted the submitter an exemption under section 4(c) of the Act and if another person previously has submitted the test data to EPA, the exempted person may either submit the test data or provide the following information as part of the notice:</P>
          <P>(i) The name, title, and address of the person who submitted the test data to EPA.</P>
          <P>(ii) The date the test data were submitted to EPA.</P>
          <P>(iii) A citation for the test rule.</P>
          <P>(iv) A description of the exemption and a reference identifying it.</P>
          <P>(h) <E T="03">Chemical substances subject to a section 5(b)(4) rule.</E> (1) If a person (i) intends to manufacture or import a new chemical substance which is subject to the notification requirements of this part and which is subject to a rule issued under section 5(b)(4) of the Act; and (ii) is not required by a rule issued under section 4 of the Act to submit <PRTPAGE P="105"/>test data for the substance before the submission of a notice, the person must submit to EPA data described in paragraph (h)(2) of this section at the time the notice is submitted.</P>
          <P>(2) Data submitted under paragraph (h)(1) of this section must be data which the person submitting the notice believes show that the manufacture, processing, distribution in commerce, use and disposal of the substance, or any combination of such activities, will not present an unreasonable risk of injury to health or the environment.</P>
          <CITA>[48 FR 21742, May 13, 1983, as amended at 58 FR 34204, June 23, 1993; 60 FR 16309, Mar. 29, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 720.45</SECTNO>
          <SUBJECT>Information that must be included in the notice form.</SUBJECT>
          <P>Each person who submits a notice must include the information specified in the notice form to the extent it is known to or reasonably ascertainable by the submitter. However, no person is required to include information which relates solely to exposure of human or ecological populations outside of the United States. The notice form requires the following information relating to the manufacture, processing, distribution in commerce, use, and disposal of the new chemical substance:</P>
          <P>(a)(1) The specific chemical identity of the substance that the person intends to manufacture or import, which includes the following:</P>
          <P>(i) The currently correct Chemical Abstracts (CA) name for the substance, based on the Ninth Collective Index (9CI) of CA nomenclature rules and conventions, and consistent with listings for similar substances in the Inventory. For each substance having a chemical composition that can be represented by a specific, complete chemical structure diagram (a Class 1 substance), a CA Index Name must be provided. For each chemical substance that cannot be fully represented by a complete, specific chemical structure diagram (a Class 2 substance), or if the substance is a polymer, a CA Index Name or CA Preferred Name must be provided (whichever is appropriate based on CA 9CI nomenclature rules and conventions). In addition, for a Class 2 substance, the notice must identify the immediate chemical precursors and reactants by specific chemical name and Chemical Abstracts Service Registry Number (CASRN), if the number is available. Tradenames or generic names of chemical precursors or reactants are not acceptable as substitutes for specific chemical names.</P>
          <P>(ii) The currently correct CASRN for the substance if a CASRN already exists for the substance.</P>
          <P>(iii) For a Class 1 substance and for any Class 2 substance for which a definite molecular formula is known or reasonably ascertainable, the correct molecular formula.</P>
          <P>(iv) For a Class 1 substance, a complete, correct chemical structure diagram; for a Class 2 substance or polymer, a correct representative or partial chemical structure diagram, as complete as can be known, if one can be reasonably ascertained.</P>
          <P>(2) For a polymer, the submitter must also report the following:</P>
          <P>(i) The specific chemical name and CASRN, if the number is available, of each monomer and other reactant used, at any weight percent, to manufacture the polymer. Tradenames or generic names of chemical reactants or monomers are not acceptable as substitutes for specific chemical names.</P>
          <P>(ii) The typical percent by weight of each monomer and other reactant in the polymer (weight of the monomer or other reactant expressed as a percentage of the weight of the polymeric chemical substance manufactured), and the maximum residual amount of each monomer present in the polymer.</P>

          <P>(iii) For monomers and other reactants used at 2 weight percent or less (based on the dry weight of the polymer manufactured), indicate on the PMN form any such monomers and other reactants that should be included as part of the polymer description on the Inventory, where the weight percent is based on either (A) the weight of monomer or other reactant actually charged to the reaction vessel, or (B) the minimum weight of monomer or other reactant required in theory to account for the actual weight of monomer or other reactant molecules or fragments chemically incorporated (chemically combined) in the polymeric substance manufactured.<PRTPAGE P="106"/>
          </P>
          <P>(iv) For a determination that 2 weight percent or less of a monomer or other reactant is incorporated (chemically combined) in a polymeric substance manufactured, as specified in paragraphs (a)(2)(iii)(B) of this section, analytical data or appropriate theoretical calculations (if it can be documented that analytical measurement is not feasible or not necessary) to support this determination must be maintained at the site of manufacture or import of the polymer.</P>
          <P>(v) Measured or estimated values of the minimum number-average molecular weight of the polymer and the amount of low molecular weight species below 500 and below 1,000 molecular weight, with a description of how the measured or estimated values were obtained.</P>
          <P>(3) The person must use one of the following two methods to develop or obtain the specified chemical identity information reported under paragraphs (a) (1) and (2) of this section and must identify the method used in the notice:</P>
          <P>(i) <E T="03">Method 1</E>. Obtain the correct chemical identity information required by paragraphs (a) (1) and (2) of this section directly from the Chemical Abstracts Service (CAS), specifically from the CAS Registry Services Inventory Expert Service, prior to submitting a notice to EPA. A copy of the chemical identification report obtained from CAS must be submitted with the notice.</P>
          <P>(ii) <E T="03">Method 2.</E> Obtain the correct chemical identity information required by paragraphs (a) (1) and (2) from any source. The notice will be incomplete according to § 720.65(c)(1)(vi) if the person uses Method 2 and any chemical identity information is determined to be incorrect by EPA.</P>
          <P>(4) If an importer submitting the notice cannot provide all the information specified in paragraphs (a) (1) and (2) of this section because it is claimed as confidential by the foreign supplier of the substance, the importer must have the foreign supplier follow the procedures in paragraph (a)(3) of this section and provide the correct chemical identity information specified in paragraphs (a) (1) and (2) of this section directly to EPA in a joint submission or as a letter of support to the notice, which clearly references the importer's notice and PMN User Fee Identification Number. The statutory review process will commence upon receipt of both the notice and the complete, correct information.</P>
          <P>(5) If a manufacturer cannot provide all the information specified in paragraphs (a) (1) and (2) of this section because the new chemical substance is manufactured using a reactant having a specific chemical identity claimed as confidential by its supplier, the manufacturer must submit a notice directly to EPA containing all the information known by the manufacturer about the chemical identity of the reported substance and its proprietary reactant. In addition, the manufacturer must ensure that the supplier of the confidential reactant submit a letter of support directly to EPA providing the specific chemical identity of the confidential reactant, including the CAS number, if available, and the appropriate PMN or exemption number, if applicable. The letter of support must reference the manufacturer's name and PMN User Fee Identification Number under § 700.45(c)(3) of this chapter. The statutory review period will commence upon receipt of both the notice and the letter of support.</P>
          <P>(b) The impurities anticipated to be present in the substance by name, CAS Registry number, and weight percent of the total substance.</P>
          <P>(c) Known synonyms or trade names of the new chemical substance.</P>
          <P>(d) A description of the byproducts resulting from the manufacture, processing, use, and disposal of the new chemical substance.</P>
          <P>(e) The estimated maximum amount to be manufactured or imported during the first year of production and the estimated maximum amount to be manufactured or imported during any 12-month period during the first three years of production.</P>
          <P>(f) A description of intended categories of use by function and application, the estimated percent of production volume devoted to each category of use, and the percent of the new substance in the formulation for each commercial or consumer use.</P>
          <P>(g) For sites controlled by the submitter:<PRTPAGE P="107"/>
          </P>
          <P>(1) The identity of sites where the new substance will be manufactured, processed, or used.</P>
          <P>(2) A process description of each manufacture, processing, and use operation which includes a diagram of the major unit operations and chemical conversions, the identity and entry point of all feedstocks, and the points of release of the new chemical substance.</P>
          <P>(3) Worker exposure information, including worker activities, physical form of the new substance to which workers may be exposed, the number of workers, and the duration of activities.</P>
          <P>(4) Information on release of the new substance to the environment, including the quantity and media of release and type of control technology used.</P>
          <P>(h) For sites not controlled by the submitter, a description of each type of processing and use operation involving the new chemical substance, including identification of the estimated number of processing or use sites, situations in which worker exposure to and/or environmental release of the new chemical substance will occur, the number of workers exposed and the duration of exposure, and controls which limit worker exposure and environmental release.</P>
          <CITA>[48 FR 21742, May 13, 1983, as ameneded at 60 FR 16310, Mar. 29, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 720.50</SECTNO>
          <SUBJECT>Submission of test data and other data concerning the health and environmental effects of a substance.</SUBJECT>
          <P>(a) <E T="03">Test data on the new chemical substance in the possession or control of the submitter.</E> (1) Except as provided in paragraph (d) of this section, each notice must contain all test data in the submitter's possession or control which are related to the effects on health or the environment of any manufacture, processing, distribution in commerce, use, or disposal of the new chemical substance or any mixture or article containing the new chemical substance, or any combination of such activities. This includes test data concerning the new chemical substance in a pure, technical grade, or formulated form.</P>
          <P>(2) A full report or standard literature citation must be submitted for the following types of test data:</P>
          <P>(i) Health effects data.</P>
          <P>(ii) Ecological effects data.</P>
          <P>(iii) Physical and chemical properties data.</P>
          <P>(iv) Environmental fate characteristics.</P>
          <P>(v) Monitoring data and other test data related to human exposure to or environmental release of the chemical substance.</P>
          <P>(3)(i) If the data do not appear in the open scientific literature, the submitter must provide a full report. A full report includes the experimental methods and materials, results, discussion and data analysis, conclusions, references, and the name and address of the laboratory that developed the data.</P>
          <P>(ii) If the data appear in the open scientific literature, the submitter need only provide a standard literature citation. A standard literature citation includes author, title, periodical name, date of publication, volume, and page numbers.</P>
          <P>(4)(i) If a study, report, or test is incomplete when a person submits a notice, the submitter must identify the nature and purpose of the study; name and address of the laboratory developing the data; progress to date; types of data collected; significant preliminary results; and anticipated completion date.</P>
          <P>(ii) If a test or experiment is completed before the notice review period ends, the person must submit the study, report, or test to the address listed on the notice form, as specified in paragraph (a)(3)(i) of this section, within ten days of receiving it, but no later than five days before the end of the review period. If the test or experiment is completed during the last five days of the review period, the submitter must immediately inform its EPA contact for that notice by telephone.</P>

          <P>(5) For test data in the submitter's possession or control which are not listed in paragraph (a)(2) of this section, a person is not required to submit a complete report. The person must submit a summary of the data. If EPA so requests, the person must submit a full report within ten days of the request, but no later than five days before the end of the review period.<PRTPAGE P="108"/>
          </P>
          <P>(6) All test data described by paragraph (a) are subject to these requirements, regardless of their age, quality, or results.</P>
          <P>(b) <E T="03">Other data concerning the health and environmental effects of the new chemical substance that are known to or reasonably ascertainable by the submitter. </E>(1) Except as provided in paragraph (d) of this section, any person who submits a notice must describe the following data, including any data from a health and safety study, if the data are related to the effects on health or the environment of any manufacture, processing, distribution in commerce, use, or disposal of the new chemical substance, of any mixture or article containing the new chemical substance, or of any combination of such activities:</P>
          <P>(i) Any data, other than test data, in the submitter's possession or control.</P>
          <P>(ii) Any data, including test data, which are not in the submitter's possession or control, but which are known to or reasonably ascertainable by the submitter. For the purposes of this section, data are known to or reasonably ascertainable by the submitter if the data are known to any of its employees or other agents who are associated with the research and development, test marketing, or commercial marketing of the substance.</P>
          <P>(2) Data that must be described include data concerning the new chemical substance in a pure, technical grade, or formulated form.</P>
          <P>(3) The description of data reported under this paragraph must include:</P>
          <P>(i) If the data appear in the open scientific literature, a standard literature citation, which includes the author, title, periodical name, date of publication, volume, and pages.</P>
          <P>(ii) If the data are not contained in the open scientific literature, a description of the type of data and summary of the results, if available, and the names and addresses of persons the submitter believes may have possession or control of the data.</P>
          <P>(4) All data described by this paragraph are subject to these requirements, regardless of their age, quality, or results; and regardless of whether they are complete at the time the notice is submitted.</P>
          <P>(c) [Reserved]</P>
          <P>(d) <E T="03">Data that need not be submitted</E>—(1) <E T="03">Data previously submitted to EPA.</E> (i) A person need not submit any data previously submitted to EPA with no claims of confidentiality if the notice includes the office or person to whom the data were submitted, the date of submission, and, if appropriate, a standard literature citation as specified in paragraph (a)(3)(ii) of this section.</P>
          <P>(ii) For data previously submitted to EPA with a claim of confidentiality, the person must resubmit the data with the notice and any claim of confidentiality, under § 720.80.</P>
          <P>(2) <E T="03">Efficacy data.</E> This part does not require submission of any data related solely to product efficacy. This does not exempt a person from submitting any of the data specified in paragraph (a), (b), or (c) of this section.</P>
          <P>(3) <E T="03">Non-U.S. exposure data.</E> This part does not require submission of any data which relates only to exposure of humans or the environment outside the United States. This does not exclude nonexposure data such as data on health effects (including epidemiological studies), ecological effects, physical and chemical properties, or environmental fate characteristics.</P>
          <CITA>[48 FR 21742, May 13, 1983, as amended at 51 FR 15102, Apr. 22, 1986]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 720.57</SECTNO>
          <SUBJECT>Imports.</SUBJECT>
          <P>(a) Except as otherwise provided in this section, the provisions of this subpart C apply to each person who submits a notice for a new chemcial substance which he or she intends to import for a commercial purpose. In addition, each importer must comply with this section.</P>
          <P>(b) EPA will hold the principal importer, or the importer that EPA determines must submit the notice when there is no principal importer under § 720.22(b)(2), liable for complying with this part, for completing the notice form and for the completeness and truthfulness of all information which it submits.</P>
        </SECTION>
      </SUBPART>
      <SUBPART>
        <PRTPAGE P="109"/>
        <HD SOURCE="HED">Subpart D—Disposition of Notices</HD>
        <SECTION>
          <SECTNO>§ 720.60</SECTNO>
          <SUBJECT>General.</SUBJECT>
          <P>This subpart establishes procedures that EPA will follow in reviewing notices.</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 720.62</SECTNO>
          <SUBJECT>Notice that notification is not required.</SUBJECT>
          <P>When EPA receives a notice, EPA will review it to determine whether the chemical substance is subject to the requirements of this part. If EPA determines that the chemical substance is not subject to these requirements, EPA will notify the submitter that section 5 of the Act does not prevent the manufacture or import of the substance and that the submission is not a notice under this part.</P>
          <CITA>[48 FR 21742, May 13, 1983, as amended at 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 720.65</SECTNO>
          <SUBJECT>Acknowledgment of receipt of a notice; errors in the notice; incomplete submissions; false and misleading statements.</SUBJECT>
          <P>(a) <E T="03">Notification to submitter.</E> EPA will acknowledge receipt of each notice by sending the submitter a letter that identifies the premanufacture notice number assigned to the new chemical substance and the date on which the review period begins. The review period will begin on the date the notice is received by the Office of Pollution Prevention and Toxics Document Control Officer. The acknowledgment does not constitute a finding by EPA that the notice, as submitted, is in compliance with this part.</P>
          <P>(b) <E T="03">Errors in the notice.</E> (1) Within 30 days of receipt of the notice, EPA may request that the submitter remedy errors in the notice. The following are examples of such errors:</P>
          <P>(i) Failure to date the notice form.</P>
          <P>(ii) Typographical errors that cause data to be misleading or answers to any questions to be unclear.</P>
          <P>(iii) Contradictory information.</P>
          <P>(iv) Ambiguous statements or information.</P>
          <P>(2) In the request to correct the notice, EPA will explain the action which the submitter must take to correct the notice.</P>
          <P>(3) If the submitter fails to correct the notice within 15 days of receipt of the request, EPA may extend the notice period under section (5)(c) of the Act, in accordance with § 720.75(c).</P>
          <P>(c) <E T="03">Incomplete submissions.</E> (1) A submission is not complete, and the notification period does not begin, if:</P>
          <P>(i) The wrong person submits the notice form.</P>
          <P>(ii) The submitter does not sign the notice form.</P>
          <P>(iii) Some or all of the information in the notice or the attachments are not in English, except for published scientific literature.</P>
          <P>(iv) The submitter does not use the notice form.</P>
          <P>(v) The submitter does not provide information that is required by section 5(d)(1) (B) and (C) of the Act and § 720.50.</P>
          <P>(vi) The submitter does not provide information required on the notice form and by § 720.45 or indicate that it is not known to or reasonably ascertainable by the submitter.</P>
          <P>(vii) The submitter does not submit a second copy of the submission with all confidential information deleted for the public file, as required by § 720.80(b)(2).</P>
          <P>(viii) The submitter does not include any information required by section 5(b)(1) of the Act and pursuant to a rule promulgated under section 4 of the Act, as required by § 720.40(g).</P>
          <P>(ix) The submitter does not submit data which the submitter believes show that the chemical substance will not present an unreasonable risk of injury to health or the environment, if EPA has listed the chemical substance under section 5(b)(4) of the Act, as required in § 720.40(h).</P>
          <P>(2)(i) If EPA receives an incomplete submission, the Director, or his or her delegate, will notify the submitter within 30 days of receipt that the submission is incomplete and that the notice review period will not begin until EPA receives a complete notice.</P>

          <P>(ii) If EPA obtains additional information during the notice review period that indicates the original submission was incomplete, the Director, or his or her delegate, may declare the submission incomplete within 30 days after EPA obtains the additional information and so notify the submitter.<PRTPAGE P="110"/>
          </P>
          <P>(3) The notification that a submission is incomplete under paragraph (c)(2) (i) or (ii) of this section will include:</P>
          <P>(i) A statement of the basis of EPA's determination that the submission is incomplete.</P>
          <P>(ii) The requirements for correcting the incomplete submission.</P>
          <P>(iii) Information on procedures under paragraph (c)(4) of this section for filing objections to the determination or requesting modification of the requirements for completing the submission.</P>
          <P>(4) Within ten days after receipt of notification by EPA that a submission is incomplete, the submitter may file written objections requesting that EPA accept the submission as a complete notice or modify the requirements necessary to complete the submission.</P>
          <P>(5)(i) EPA will consider the objections filed by the submitter. The Director, or his or her delegate, will determine whether the submission was complete or incomplete, or whether to modify the requirements for completing the submission. EPA will notify the submitter in writing of EPA's response within ten days of receiving the objections.</P>
          <P>(ii) If the Director, or his or her delegate, determines, in response to the objection, that the submission was complete, the notice review period will be deemed suspended on the date EPA declared the notice incomplete, and will resume on the date that the notice is declared complete. The submitter need not correct the notice as EPA originally requested. If EPA can complete its review within 90 days from the date of the original submission, the Director, or his or her delegate, may inform the submitter that the running of the review period will resume on the date EPA originally declared it incomplete.</P>
          <P>(iii) If the Director, or his or her delegate, modifies the requirements for completing the submission or concurs with EPA's original determination, the notice review period will begin when EPA receives a complete notice.</P>
          <P>(d) <E T="03">Materially false or misleading statements.</E> If EPA discovers at any time that person submitted materially false or misleading statements in the notice, EPA may find that the notice was incomplete from the date it was submitted, and take any other appropriate action.</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 720.70</SECTNO>
          <SUBJECT>Notice in the Federal Register.</SUBJECT>
          <P>(a) <E T="03">Filing of</E>
            <E T="04">Federal Register</E>
            <E T="03">notice.</E> In accordance with section 5(d)(2) of the Act, after EPA receives a notice, EPA will file with the Office of the Federal Register a notice including the information specified in paragraph (b) of this section.</P>
          <P>(b) <E T="03">Contents of notice.</E> (1) In the public interest, the specific chemical identity listed in the notice will be published in the <E T="04">Federal Register</E> unless the submitter has claimed chemical identity confidential. If the submitter claims confidentiality, a generic name will be published in accordance with § 720.85(a)(3).</P>
          <P>(2) The categories of use of the new chemical substance will be published as reported in the notice unless this information is claimed confidential. If confidentiality is claimed, the generic information which is submitted under § 720.87(b) will be published.</P>
          <P>(3) A list of data submitted in accordance with § 720.50(a) will be published. In addition, for test data submitted in accordance with § 720.40(g), a summary of the data will be published.</P>
          <P>(4) The submitter's identity will be published, unless the submitter has claimed it confidential.</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 720.75</SECTNO>
          <SUBJECT>Notice review period.</SUBJECT>
          <P>(a) <E T="03">Length of notice review period.</E> The notice review period specified in section 5(a) of the Act runs for 90 days from the date the Document Control Officer for the Office of Pollution Prevention and Toxics receives a complete notice, or the date EPA determines the notice is complete under § 720.65(c), unless the Agency extends the period under section 5(c) of TSCA and paragraph (c) of this section.</P>
          <P>(b) <E T="03">Suspension of the running of the notice review period.</E> (1) A submitter may voluntarily suspend the running of the notice review period if the Director or his or her delegate agrees. If the Director does not agree, the review period will continue to run, and EPA will notify the submitter. A submitter may <PRTPAGE P="111"/>request a suspension at any time during the notice review period. The suspension must be for a specified period of time.</P>
          <P>(2) A request for suspension may be made in writing to the Document Control Office (7407), Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Room G-099, 401 M St., SW., Washington, DC., 20460. The suspension also may be made orally, including by telephone, to the submitter's EPA contact for that notice. EPA will send the submitter a written confirmation that the suspension has been granted.</P>
          <P>(i) An oral request may be granted for 15 days only. To obtain a longer suspension, the Document Control Officer for the Office of Pollution Prevention and Toxics must receive written confirmation of the oral request. The notice review period is suspended as of the date of the oral request.</P>
          <P>(ii) If the submitter has not made a previous oral request, the running of the notice review period is suspended as of the date of receipt of the written request by the Document Control Officer for the Office of Pollution Prevention and Toxics.</P>
          <P>(c) <E T="03">Extension of notice review period.</E> (1) At any time during the notice review period, EPA may determine that good cause exists to extend the notice review period specified in paragraph (a) of this section.</P>
          <P>(2) If EPA makes such a determination, EPA will:</P>
          <P>(i) Notify the submitter that EPA is extending the notice review period for a specified length of time, and state the reasons for the extension.</P>
          <P>(ii) Issue a notice for publication in the <E T="04">Federal Register</E> which states that EPA is extending the notice review period and gives the reasons for the extension.</P>
          <P>(3) The initial extension may be for a period of up to 90 days. If the initial extension is for less than 90 days, EPA may make additional extensions. However, the total period of extensions may not exceed 90 days for any notice.</P>
          <P>(4) The following are examples of situations in which EPA may find that good cause exists for extending the notice review period:</P>
          <P>(i) EPA has reviewed the notice and determined that there is a significant possibility that the chemical substance will be regulated under section 5(e) or section 5(f) of the Act, but EPA is unable to initiate regulatory action within the initial 90-day period.</P>
          <P>(ii) EPA has reviewed the submission and is seeking additional information.</P>
          <P>(iii) EPA has received significant additional information during the notice review period.</P>
          <P>(iv) The submitter has failed to correct a notice after receiving EPA's request under § 720.65(b).</P>
          <P>(d) <E T="03">Notice of expiration of notice review period.</E> EPA will notify the submitter that the notice review period has expired or that EPA has completed its review of the notice. Expiration of the review period does not constitute EPA approval or certification of the new chemical substance, and does not mean that EPA may not take regulatory action against the substance in the future. After expiration of the statutory notice review period, in the absence of regulatory action by EPA under section 5(e), 5(f), or 6(a) of the Act, the submitter may manufacture or import the chemical substance even if the submitter has not received notice of expiration.</P>
          <P>(e) <E T="03">Withdrawal of a notice by the submitter.</E> (1) A submitter may withdraw a notice during the notice review period. A statement of withdrawal must be made in writing to the Document Control Office (7407), Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Room G-099, 401 M St., SW., Washington, DC., 20460. The withdrawal is effective upon receipt of the statement by the Document Control Officer.</P>
          <P>(2) If a manufacturer or importer which withdrew a notice later resubmits a notice for the same chemical substance, a new notice review period begins.</P>
          <CITA>[48 FR 21742, May 13, 1983, as amended at 53 FR 12523, Apr. 15, 1988; 58 FR 34204, June 23, 1993; 60 FR 34464, July 3, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 720.78</SECTNO>
          <SUBJECT>Recordkeeping.</SUBJECT>

          <P>(a) Any person who submits a notice under this part must retain documentation of information in the notice, including (1) other data, as defined in <PRTPAGE P="112"/>§ 720.50(b), in the submitter's possession or control; and (2) records of production volume for the first three years of production or import, the date of commencement of manufacture or import, and documentation of this information. This information must be retained for five years from the date of commencement of manufacture of import.</P>
          <P>(b)(1) Persons who manufacture or import a chemical substance under § 720.36 must retain the following records:</P>
          <P>(i) Copies of, or citations to, information reviewed and evaluated under § 720.36(b)(1) to determine the need to make any notification of risk.</P>
          <P>(ii) Documentation of the nature and method of notification under § 720.36(c)(1) including copies of any labels or written notices used.</P>
          <P>(iii) Documentation of prudent laboratory practices used instead of notification and evaluation under § 720.36(b)(2).</P>
          <P>(iv) The names and addresses of any persons other than the manfacturer or importer to whom the substance is distributed, the identity of the substance to the extent known, the amount distributed, and copies of the notifications required under § 720.36(c)(2). These records are not required when substances are distributed as impurities or incorporated into an article, in accordance with paragraph (d) of this section.</P>
          <P>(2) A person who manufactures or imports a chemical substance under § 720.36 and who manufactures or imports the substance in quantities greater than 100 kilograms per year must retain records of the identity of the substance to the extent known, the production volume of the substance, and the person's disposition of the substance. The person is not required to maintain records of the disposition of products containing the substance as an impurity or of articles incorporating the substances.</P>
          <P>(3) Records under this paragraph must be retained for 5 years after they are developed.</P>
          <P>(c) Any person who obtains a test-marketing exemption under this part must retain documentation of information in the application and documentation of compliance with any restrictions imposed by EPA when it granted the application. This information must be retained for five years from the final date of manufacture or import under the exemption.</P>
          <CITA>[48 FR 21742, May 13, 1983; 48 FR 33872, July 26, 1983, as amended at 51 FR 15102, Apr. 22, 1986; 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
      </SUBPART>
      <SUBPART>
        <HD SOURCE="HED">Subpart E—Confidentiality and Public Access to Information</HD>
        <SECTION>
          <SECTNO>§ 720.80</SECTNO>
          <SUBJECT>General provisions.</SUBJECT>
          <P>(a) A person may assert a claim of confidentiality for any information which he or she submits to EPA under this part.</P>
          <P>(b) Any claim of confidentiality must accompany the information when it is submitted to EPA.</P>
          <P>(1)(i) For information submitted on the notice form, the claim(s) must be asserted on the form in the manner prescribed on the notice form.</P>
          <P>(ii) When a person submits information in an attachment, the claim(s) must be asserted in the attachment as described on the notice form.</P>
          <P>(2) If any information is claimed as confidential, the person must submit, in addition to the copies specified by § 720.40, a sanitized copy of the notice form (or electronic submission) and any attachments.</P>
          <P>(i) The original and two copies of the notice, specified at § 720.40 (or electronic submission) and attachments must be complete. The submitter must designate that information which is claimed as confidential in the manner prescribed on the notice form (or in EPA's electronic submission instructions).</P>
          <P>(ii) The sanitized copy must be complete except that all information claimed as confidential in the original must be deleted. EPA will place this sanitized copy in the public file.</P>

          <P>(iii) If the person does not provide the sanitized copy, or information in a health and safety study (except information claimed as confidential in accordance with § 720.90), the submission will be deemed incomplete and the notice review period will not begin until EPA receives the sanitized copy or the health and safety study information is included, in accordance with § 720.65(c)(1)(vii).<PRTPAGE P="113"/>
          </P>
          <P>(c) EPA will disclose information that is subject to a claim of confidentiality asserted under this section only to the extent permitted by the Act, this subpart, and part 2 of this title.</P>
          <P>(d) If a notice submitter does not assert a claim of confidentiality for information at the time it is submitted to EPA, EPA may make the information public and place it in the public file without further notice to the submitter.</P>
          <CITA>[48 FR 21742, May 13, 1983, as amended at 58 FR 34204, June 23, 1993; 60 FR 16311, Mar. 29, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 720.85</SECTNO>
          <SUBJECT>Chemical identity.</SUBJECT>
          <P>(a) <E T="03">Claims applicable to the period prior to commencement of manufacture or import.</E> (1)(i) A person who submits information to EPA under this part may assert a claim of confidentiality for the chemical identity of the new chemical substance. This claim will apply only to the period prior to the commencement of manufacture or import for commercial purposes. A submitter may assert this claim only if the submitter believes that public disclosure prior to commencement of manufacture or import of the fact that anyone intends to manufacture or import the specific chemical substance for commercial purposes would reveal confidential business information.</P>
          <P>(ii) If the notice includes a health and safety study concerning the new chemical substance and if the claim for confidentiality with respect to the chemical identity is denied in accordance with § 720.90(c), EPA will deny a claim asserted under this paragraph.</P>
          <P>(2) Any person who asserts a claim of confidentiality for chemical identity under this paragraph must provide one of the following items at the time the notice is submitted:</P>
          <P>(i) The generic name which was accepted by EPA in the prenotice consultation conducted under paragraph (a)(3) of this section.</P>
          <P>(ii) One generic name that is only as generic as necessary to protect the confidential chemical identity of the particular chemical substance. The name should reveal the specific chemical identity to the maximum extent possible. The generic name will be subject to EPA review and approval at the time a notice of commencement is submitted.</P>
          <P>(3)(i) Any person who intends to assert a claim of confidentiality for the chemical identity of a new chemical substance may seek a determination by EPA of an appropriate generic name for the substance before submitting a notice. For this purpose, the person should submit to EPA:</P>
          <P>(A) The chemical identity of the substance.</P>
          <P>(B) A proposed generic name(s) which in only as generic as necessary to protect the confidential chemical identity of the new chemical substance. The name(s) should reveal the chemical identity of the substance to the maximum extent possible.</P>
          <P>(ii) Within 30 days, EPA will inform the submitter either that one of the proposed generic names is adequate or that none is adequate and further consultation is necessary.</P>

          <P>(4) If a submitter claims chemical identity to be confidential under this paragraph, and if the submitter complies with paragraph (a)(2) of this section, EPA will issue for publication in the <E T="04">Federal Register</E> notice described in § 720.70 the generic name proposed by the submitter or one agreed upon by EPA and the submitter.</P>
          <P>(b) <E T="03">Claims applicable to the period after commencement of manufacture or import.</E> (1) Any claim of confidentiality under paragraph (a) of this section is applicable only until the substance is manufactured or imported for commercial purposes and becomes eligible for inclusion on the Inventory. To maintain the confidential status of the chemical identity when the substance is added to the Inventory, a submitter must reassert the confidentiality claim and substantiate the claim in the notice of commencement of manufacture required uner § 720.102. A submitter may not claim the chemical indentity confidential for the period after commencement of manufacture or import unless the submitter claimed the chemical identity confidential for the period prior to commencement of manufacture or import under paragraph (a) of this section.</P>

          <P>(2)(i) A person who believes that public disclosure of the fact that anyone <PRTPAGE P="114"/>manfactures or imports the new chemical substance for commercial purposes would reveal confidential business information may assert a claim of confidentiality under this paragraph.</P>
          <P>(ii) If the notice includes a health and safety study concerning the new chemical substance, and if the claim for confidentiality with respect to the chemical identity is denied in accordance with § 720.90(c), EPA will deny a claim asserted under this paragraph.</P>
          <P>(3) Any person who asserts a confidentiality claim for chemical identity must:</P>
          <P>(i) Comply with the requirements of paragraph (a)(3) of this section regarding submission of a generic name.</P>
          <P>(ii) Agree that EPA may disclose to a person with a <E T="03">bona fide</E> intent to manufacture or import the chemical substance the fact that the particular chemical substance is included on the confidential Inventory for purposes of notification under section 5(a)(1)(A) of the Act.</P>
          <P>(iii) Have available for the particular chemical substance, and agree to furnish to EPA upon request:</P>
          <P>(A) An elemental analysis.</P>
          <P>(B) Either an X-ray diffraction pattern (for inorganic substances), a mass spectrum (for most other substances), or an infrared spectrum of the particular chemical substance, or if such data do not resolve uncertainties with respect to the identity of the chemical substance, additional or alternative spectra or other data to identify the chemical substance.</P>
          <P>(iv) Provide a detailed written substantiation of the claim, by answering the following questions:</P>
          <P>(A) What harmful effects to your competitive position, if any, do you think would result if EPA publishes on the Inventory the identity of the chemical substance? How could a competitor use such information given the fact that the identity of the substance otherwise would appear on the Inventory of chemical substances with no link between the substance and your company or industry? How substantial would the harmful effects of disclosure be? What is the casual relationship between the disclosure and the harmful effects?</P>
          <P>(B) For what period of time should confidential treatment be given? Until a specific date, the occurrence of a specific event, or permanently? Why?</P>
          <P>(C) Has the chemical substance been patented? If so, have you granted licenses to others with respect to the patent as it applies to the chemical substance? If the chemical substance has been patented and therefore disclosed through the patent, why should it be treated as confidential for purposes of the Inventory?</P>
          <P>(D) Has the identity of the chemical substance been kept confidential to the extent that your competitors do not know it is being manufactured on imported for a commercial purpose by anyone?</P>
          <P>(E) Is the fact that someone is manufacturing or importing this chemical substance for commercial purposes available to the public, e.g., in technical journals or other publications; in libraries; or in State, local, or Federal agency public files?</P>
          <P>(F) What measures have you taken to prevent undesired disclosure of the fact that you are manufacturing or importing this substance for a commercial purpose?</P>
          <P>(G) To what extent has the fact that you are manufacturing or importing this chemical substance for a commercial purpose been disclosed to others? What precautions have you taken in regard to these disclosures? Has this information been disclosed to the public or to competitors?</P>
          <P>(H) In what form does this particular chemical substance leave the site of manufacture, e.g., as part of a product; in an effluent or emission stream? If so, what measures have you taken to guard against discovery of its identity?</P>
          <P>(I) If the chemical substance leaves the site of manufacture in a product that is available to either the public or your competitors, can they identify the substance by analyzing the product?</P>
          <P>(J) For what purpose do you manufacture or import the substance?</P>
          <P>(K) Has EPA, another Federal agency, or any Federal court made any pertinent confidentiality determinations regarding this chemical substance? If so, copies of such determinations must be included in the substantiation.</P>

          <P>(L) If the notice includes a health and safety study concerning the new chemical substance, the submitter <PRTPAGE P="115"/>must also answer the questions in § 720.90(b)(2).</P>
          <P>(4) If the submitter does not meet the requirements of this paragraph, EPA will deny the claim of confidentiality.</P>
          <P>(5)(i) EPA will publish a generic name on the public Inventory if:</P>
          <P>(A) The submitter asserts a claim of confidentiality in accordance with this paragraph.</P>
          <P>(B) No claim for confidentiality of the specific chemical identity as part of a health and safety study has been denied in accordance with part 2 of this title or § 720.90.</P>

          <P>(ii) Publication of a generic name on the public Inventory does not create a category for purposes of the Inventory. Any person who has a <E T="03">bona fide</E> intent to manufacture or import a chemical substance which is described by a generic name on the public Inventory may submit an inquiry to EPA under § 720.25(b) to determine whether the particular chemical substance is included on the confidential Inventory.</P>
          <P>(iii) Upon receipt of a request described in § 720.25(b), EPA may require the submitter which originally asserted confidentiality for a chemical substance to submit to EPA the information listed in paragraph (b)(3)(iii) of this section.</P>
          <P>(iv) Failure to submit any of the information required under paragraph (b)(3)(iii) of this section within ten days of a request by EPA under this paragraph is a waiver of the original submitter's confidentiality claim. In this event, EPA may place the specific chemical identity on the public Inventory without further notice to the original submitter.</P>
          <P>(6) If a submitter asserts a claim of confidentiality under this paragraph, EPA will examine the generic chemical name proposed by the submitter.</P>
          <P>(i) If EPA determines that the generic name proposed by the submitter is only as generic as necessary to protect the confidential identity of the particular chemical substance, EPA will place that generic name on the public Inventory.</P>
          <P>(ii) If EPA determines that the generic name proposed by the submitter is more generic than necessary to protect the confidential identity, EPA will propose in writing, for review by the submitter, an alternative generic name that will reveal the chemical identity of the chemical substance to the maximum extent possible.</P>
          <P>(iii) If the generic name proposed by EPA is acceptable to the submitter, EPA will place that generic name on the public Inventory.</P>
          <P>(iv) If the generic name proposed by EPA is not acceptable to the submitter, the submitter must explain in detail why disclosure of that generic name would reveal confidential business information and propose another generic name which is only as generic as necessary to protect the confidential identity. If EPA does not receive a response from the submitter within 30 days after the submitter receives the proposed name, EPA will place EPA's chosen generic name on the public Inventory. If the submitter does provide the information requested, EPA will review the response. If the submitter's proposed generic name is acceptable, EPA will publish that generic name on the public Inventory. If the submitter's proposed generic name is not acceptable, EPA will notify the submitter of EPA's choice of a generic name. Thirty days after this notification, EPA will place the chosen generic name on the public Inventory.</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 720.87</SECTNO>
          <SUBJECT>Categories or proposed categories of uses of a new chemical substance.</SUBJECT>
          <P>(a) A person who submits information to EPA under this part on the categories or proposed categories of use of a new chemical substance may assert a claim of confidentiality for this information.</P>
          <P>(b) A submitter that asserts such a claim must:</P>
          <P>(1) Report the categories or proposed categories of use of the chemical substance.</P>

          <P>(2) Provide, in nonconfidential form, a description of the uses that is only as generic as necessary to protect the confidential business information. The generic use description will be included in the <E T="04">Federal Register</E> notice described in § 720.70.</P>
          <P>(c) The person must submit the information required by paragraph (b) of this section in the manner specified in the notice form.</P>
        </SECTION>
        <SECTION>
          <PRTPAGE P="116"/>
          <SECTNO>§ 720.90</SECTNO>
          <SUBJECT>Data from health and safety studies.</SUBJECT>
          <P>(a) <E T="03">Information other than specific chemical identity</E>. Except as provided in paragraph (b) of this section, EPA will deny any claim of confidentiality with respect to information included in a health and safety study, unless the information would disclose confidential business information concerning:</P>
          <P>(1) Processes used in the manufacture or processing of a chemical substance or mixture.</P>
          <P>(2) In the case of a mixture, the portion of the mixture comprised by any of the chemical substances in the mixture.</P>
          <P>(3) Information which is not in any way related to the effects of a substance on human health or the environment, such as the name of the submitting company, cost or other financial data, product development or marketing plans, and advertising plans, for which the person submits a claim of confidentiality in accordance with § 720.80.</P>
          <P>(b) <E T="03">Specific chemical identity</E>—(1) <E T="03">Claims applicable to period prior to commencement of manufacture</E>. A claim of confidentiality for the period prior to commencement of manufacture or import for the chemical identity of a chemical substance for which a health and safety study was submitted must be asserted in conjunction with a claim asserted under § 720.85(a).</P>
          <P>(2) <E T="03">Claims applicable to period after commencement of manufacture or import for commercial purposes</E>. To maintain the confidential status of the chemical identity of a chemical substance for which a health and safety study was submitted after commencement of manufacture or import, the claim must be reasserted and substantiated in conjunction with a claim under § 720.85(b). In addition to the questions set forth in § 720.85(b)(3)(iv) of this part, the submitter must answer the following questions:</P>
          <P>(i) Would disclosure of the chemical identity disclose processes used in the manufacture or processing of a chemical substance or mixture? Describe how this would occur. In responding to the question in § 720.85(b)(3)(iv)(A), explain what harmful competitive effects would occur from disclosure of this process information.</P>
          <P>(ii) Would disclosure of the chemical identity disclose the portion of a mixture comprised by any of the substances in the mixture? Describe how this would occur. In responding to the question in § 720.85(b)(3)(iv)(A), explain what harmful competitive effects would occur from disclosure of this information.</P>
          <P>(iii) Do you assert that disclosure of the chemical identity is not necessary to interpret any of the health and safety studies you have submitted? If so, explain how a less specific identity would be sufficient to interpret the studies.</P>
          <P>(c) <E T="03">Denial of confidentiality claim</E>. EPA will deny a claim of confidentiality for chemical identity under paragraph (b) of this section, unless:</P>
          <P>(1) The information would disclose processes used in the manufacture or processing of a chemical substance or mixture.</P>
          <P>(2) In the case of a mixture, the information would disclose the portion of the mixture comprised by any of the substances in the mixture.</P>
          <P>(3) The specific chemical identity is not necessary to interpret a health and safety study.</P>
          <P>(d) <E T="03">Use of generic names.</E> When EPA discloses a health and safety study containing a specific chemical identity, which the submitter has claimed confidential, and if the Agency has not denied the claim under paragraph (c) of this section, EPA will identify the chemical substance by the generic name selected under § 720.85.</P>
          <CITA>[48 FR 21742, May 13, 1983, as amended at 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 720.95</SECTNO>
          <SUBJECT>Public file.</SUBJECT>

          <P>All information submitted with a notice, including any health and safety study and other supporting documentation, will become part of the public file for that notice, unless such materials are claimed confidential. In addition, EPA may add materials to the public file, subject to subpart E of this part. Any of the nonconfidential material described in this subpart will be available for public inspection in the Non-Confidential Information Center <PRTPAGE P="117"/>(NCIC) (7407), Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Room B-607 NEM, 401 M Street, SW., Washington, DC, 20460, between the hours of 12 p.m. and 4 p.m. weekdays excluding legal holidays.</P>
          <CITA>[48 FR 21742, May 13, 1983, as amended at 53 FR 12523, Apr. 15, 1988; 60 FR 16311, Mar. 29, 1995; 60 FR 34464, July 3, 1995]</CITA>
        </SECTION>
      </SUBPART>
      <SUBPART>
        <HD SOURCE="HED">Subpart F—Commencement of Manufacture or Import</HD>
        <SECTION>
          <SECTNO>§ 720.102</SECTNO>
          <SUBJECT>Notice of commencement of manufacture or import.</SUBJECT>
          <P>(a) <E T="03">Applicability.</E> Any person who commences the manufacture or import of a new chemical substance for a nonexempt commercial purpose for which that person previously submitted a section 5(a) notice under this part must submit a notice of commencement of manufacture or import.</P>
          <P>(b) <E T="03">When to report.</E> (1) If manufacture or import for commercial purposes begins on or after the effective date of this rule, the submitter must submit the notice to EPA on, or no later than 30 calendar days, after the first day of such manufacture or import.</P>
          <P>(2) If manufacture or import for commercial purposes began or will begin before the effective date of this rule, the submitter must submit the notice by the effective date of this rule.</P>
          <P>(c) <E T="03">Information to be reported on form.</E> (1) The notice must be submitted on EPA (Form 7710-56), which is available from the Environmental Assistance Division (7408), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 401 M St., SW., Washington, DC 20460. The form must be signed and dated by an authorized official. All information specified on the form must be provided. The notice must contain the following information:</P>
          <P>(i) The specific chemical identity of the PMN substance.</P>
          <P>(ii) A generic chemical name (if the chemical identity is claimed as confidential by the submitter).</P>
          <P>(iii) The premanufacture notice (PMN) number assigned by EPA.</P>
          <P>(iv) The date of commencement for the submitter's manufacture or import for a non-exempt commercial purpose (indicating whether the substance was initially manufactured in the United States or imported). The date of commencement is the date of completion of non-exempt manufacture of the first amount (batch, drum, etc.) of new chemical substance identified in the submitter's PMN. For importers, the date of commencement is the date the new chemical substance clears United States customs.</P>
          <P>(v) The name and address of the submitter.</P>
          <P>(vi) The name of the authorized official.</P>
          <P>(vii) The name and telephone number of a technical contact in the United States.</P>
          <P>(viii) The address of the site where commencement of manufacture occurred.</P>
          <P>(ix) Clear indications of whether the chemical identity, submitter identity, and/or other information are claimed as confidential by the submitter.</P>
          <P>(2) If the submitter claims the chemical identity confidential, and wants the identity to be listed on the confidential portion of the Inventory, the claim must be reasserted and substantiated in accordance with § 720.85(b). Otherwise, EPA will list the specific chemical identity on the public Inventory. Submitters who did not claim the chemical identity, submitter identity, or other information to be confidential in the PMN cannot claim this information as confidential in the notice of commencement.</P>
          <P>(d) <E T="03">Where to submit.</E> Notices of commencement of manufacture or import should be submitted to the Document Control Office (7407), Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Room G-099, 401 M St., SW., Washington, DC., 20460.</P>
          <CITA>[48 FR 21742, May 13, 1983, as amended at 48 FR 41140, Sept. 13, 1983; 51 FR 15103, Apr. 22, 1986; 53 FR 12523, Apr. 15, 1988; 60 FR 16311, Mar. 29, 1995; 60 FR 34464, July 3, 1995; 65 FR 39304, June 26, 2000]</CITA>
        </SECTION>
      </SUBPART>
      <SUBPART>
        <PRTPAGE P="118"/>
        <HD SOURCE="HED">Subpart G—Compliance and Inspections</HD>
        <SECTION>
          <SECTNO>§ 720.120</SECTNO>
          <SUBJECT>Compliance.</SUBJECT>
          <P>(a) Failure to comply with any provision of this part is a violation of section 15 of the Act (15 U.S.C 2614).</P>
          <P>(b) A person who manufactures or imports a new chemical substance before a notice is submitted and the notice review period expires is in violation of section 15 of the Act even if that person was not requied to submit the notice under § 720.22.</P>
          <P>(c) Using for commercial purposes a chemical substance or mixture which a person knew or had reason to know was manufactured, processed, or distributed in commerce in violation of section 5 of this rule is a violation of section 15 of the Act (15 U.S.C. 2614).</P>
          <P>(d) Failure or refusal to establish and maintain records or to permit access to or copying of records, as required by the Act, is a violation of section 15 of the Act (15 U.S.C. 2614).</P>
          <P>(e) Failure or refusal to permit entry or inspection as required by section 11 is a violation of section 15 of the Act (15 U.S.C. 2614).</P>
          <P>(f) Violators may be subject to the civil and criminal penalties in section 16 of the Act (15 U.S.C. 2615) for each violation. Persons who submit materially misleading or false information in connection with the requirements of any provision of this rule may be subject to penalties calculated as if they never filed their notices.</P>
          <P>(g) EPA may seek to enjoin the manufacture or processing of a chemical substance in violation of this rule or act to seize any chemical substance manufactured or processed in violation of this rule or take other actions under the authority of section 7 of this Act (15 U.S.C. 2606) or section 17 or this Act (15 U.S.C. 2616).</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 720.122</SECTNO>
          <SUBJECT>Inspections.</SUBJECT>
          <P>EPA will conduct inspections under section 11 of the Act to assure compliance with section 5 of the Act and this rule, to verify that information submitted to EPA under this rule is true and correct, and to audit data submitted to EPA under this rule.</P>
        </SECTION>
      </SUBPART>
    </PART>
    <PART>
      <EAR>Pt. 721</EAR>
      <HD SOURCE="HED">PART 721—SIGNIFICANT NEW USES OF CHEMICAL SUBSTANCES</HD>
      <CONTENTS>
        <SUBPART>
          <HD SOURCE="HED">Subpart A—General Provisions</HD>
          <SECHD>Sec.</SECHD>
          <SECTNO>721.1</SECTNO>
          <SUBJECT>Scope and applicability.</SUBJECT>
          <SECTNO>721.3</SECTNO>
          <SUBJECT>Definitions.</SUBJECT>
          <SECTNO>721.5</SECTNO>
          <SUBJECT>Persons who must report.</SUBJECT>
          <SECTNO>721.11</SECTNO>
          <SUBJECT>Applicability determination when the specific chemical identity is confidential.</SUBJECT>
          <SECTNO>721.20</SECTNO>
          <SUBJECT>Exports and imports.</SUBJECT>
          <SECTNO>721.25</SECTNO>
          <SUBJECT>Notice requirements and procedures.</SUBJECT>
          <SECTNO>721.30</SECTNO>
          <SUBJECT>EPA approval of alternative control measures.</SUBJECT>
          <SECTNO>721.35</SECTNO>
          <SUBJECT>Compliance and enforcement.</SUBJECT>
          <SECTNO>721.40</SECTNO>
          <SUBJECT>Recordkeeping.</SUBJECT>
          <SECTNO>721.45</SECTNO>
          <SUBJECT>Exemptions.</SUBJECT>
          <SECTNO>721.47</SECTNO>
          <SUBJECT>Conditions for research and development exemption.</SUBJECT>
        </SUBPART>
        <SUBPART>
          <HD SOURCE="HED">Subpart B—Certain Significant New Uses</HD>
          <SECTNO>721.50</SECTNO>
          <SUBJECT>Applicability.</SUBJECT>
          <SECTNO>721.63</SECTNO>
          <SUBJECT>Protection in the workplace.</SUBJECT>
          <SECTNO>721.72</SECTNO>
          <SUBJECT>Hazard communication program.</SUBJECT>
          <SECTNO>721.80</SECTNO>
          <SUBJECT>Industrial, commercial, and consumer activities.</SUBJECT>
          <SECTNO>721.85</SECTNO>
          <SUBJECT>Disposal.</SUBJECT>
          <SECTNO>721.90</SECTNO>
          <SUBJECT>Release to water.</SUBJECT>
          <SECTNO>721.91</SECTNO>
          <SUBJECT>Computation of estimated surface water concentrations: Instructions.</SUBJECT>
        </SUBPART>
        <SUBPART>
          <HD SOURCE="HED">Subpart C—Recordkeeping Requirements</HD>
          <SECTNO>721.100</SECTNO>
          <SUBJECT>Applicability.</SUBJECT>
          <SECTNO>721.125</SECTNO>
          <SUBJECT>Recordkeeping requirements.</SUBJECT>
        </SUBPART>
        <SUBPART>
          <HD SOURCE="HED">Subpart D—Expedited Process for Issuing Significant New Use Rules for Selected Chemical Substances and Limitation or Revocation of Selected Significant New Use Rules</HD>
          <SECTNO>721.160</SECTNO>
          <SUBJECT>Notification requirements for new chemical substances subject to section 5(e) orders.</SUBJECT>
          <SECTNO>721.170</SECTNO>
          <SUBJECT>Notification requirements for selected new chemical substances that have completed premanufacture review.</SUBJECT>
          <SECTNO>721.185</SECTNO>
          <SUBJECT>Limitation or revocation of certain notification requirements.</SUBJECT>
        </SUBPART>
        <SUBPART>
          <HD SOURCE="HED">Subpart E—Significant New Uses for Specific Chemical Substances</HD>
          <SECTNO>721.225</SECTNO>
          <SUBJECT>2-Chloro-N-methyl-N-substituted acetamide (generic name).</SUBJECT>
          <SECTNO>721.267</SECTNO>
          <SUBJECT>N-[2-[(substituted dinitrophenyl)azo]diallylamino-4-substituted phenyl] acetamide (generic name).</SUBJECT>
          <SECTNO>721.275</SECTNO>
          <SUBJECT>Halogenated-N-(2-propenyl)-N-(substituted phenyl) acetamide.</SUBJECT>
          <SECTNO>721.285</SECTNO>
          <SUBJECT>Acetamide, <E T="03">N</E>-[4-(pentyloxy)phenyl]-, acetamide, <E T="03">N</E>-[2-nitro-4-<PRTPAGE P="119"/>(pentyloxy)phenyl]-, and acetamide, <E T="03">N</E>-[2-amino-4-(pentyloxy)phenyl]-.</SUBJECT>
          <SECTNO>721.305</SECTNO>
          <SUBJECT>Di-substituted acetophenone (generic).</SUBJECT>
          <SECTNO>721.320</SECTNO>
          <SUBJECT>Acrylamide-substituted epoxy.</SUBJECT>
          <SECTNO>721.323</SECTNO>
          <SUBJECT>Substituted acrylamide.</SUBJECT>
          <SECTNO>721.324</SECTNO>
          <SUBJECT>Alkoxylated acrylate polymer (generic).</SUBJECT>
          <SECTNO>721.329</SECTNO>
          <SUBJECT>Halogenated benzyl ester acrylate (generic).</SUBJECT>
          <SECTNO>721.336</SECTNO>
          <SUBJECT>Perfluoroalkylethyl acrylate copolymer (generic name).</SUBJECT>
          <SECTNO>721.405</SECTNO>
          <SUBJECT>Polyether acrylate.</SUBJECT>
          <SECTNO>721.430</SECTNO>
          <SUBJECT>Oxo-substituted aminoalkanoic acid derivative.</SUBJECT>
          <SECTNO>721.435</SECTNO>
          <SUBJECT>Alkylphenylpolyetheralkanolamines (generic).</SUBJECT>
          <SECTNO>721.445</SECTNO>
          <SUBJECT>Substituted ethyl alkenamide.</SUBJECT>
          <SECTNO>721.450</SECTNO>
          <SUBJECT>Hydrofluorochloroalkene (generic).</SUBJECT>
          <SECTNO>721.484</SECTNO>
          <SUBJECT>Fluorinated acrylic copolymer (generic name).</SUBJECT>
          <SECTNO>721.505</SECTNO>
          <SUBJECT>Halogenated acrylonitrile.</SUBJECT>
          <SECTNO>721.520</SECTNO>
          <SUBJECT>Alanine, N-(2-carboxyethyl)-N- alkyl-, salt.</SUBJECT>
          <SECTNO>721.524</SECTNO>
          <SUBJECT>Alcohols, C<E T="52">6-12</E>, ethoxylated, reaction product with maleic anhydride.</SUBJECT>
          <SECTNO>721.530</SECTNO>
          <SUBJECT>Substituted aliphatic acid halide (generic name).</SUBJECT>
          <SECTNO>721.536</SECTNO>
          <SUBJECT>Halogenated phenyl alkane.</SUBJECT>
          <SECTNO>721.537</SECTNO>
          <SUBJECT>Organosilane ester.</SUBJECT>
          <SECTNO>721.538</SECTNO>
          <SUBJECT>Phenol, 4-(1,1-dimethylethyl)-, homopolymer.</SUBJECT>
          <SECTNO>721.539</SECTNO>
          <SUBJECT>Poly(oxy-1,2-ethanediyl), <E T="61">a</E>-sulfo-<E T="61">v</E>-[1-[(4-nonylphenoxy)methyl]-2-(2-propenyloxy)ethoxy]-, branched, ammonium salts.</SUBJECT>
          <SECTNO>721.540</SECTNO>
          <SUBJECT>Alkylphenoxypolyalkoxy-amine (generic name).</SUBJECT>
          <SECTNO>721.550</SECTNO>
          <SUBJECT>Alkyl alkenoate, azobis-.</SUBJECT>
          <SECTNO>721.555</SECTNO>
          <SUBJECT>Alkyl amino nitriles (generic).</SUBJECT>
          <SECTNO>721.558</SECTNO>
          <SUBJECT>Salt of a fatty alkylamine derivative (generic).</SUBJECT>
          <SECTNO>721.562</SECTNO>
          <SUBJECT>Substituted alkylamine salt.</SUBJECT>
          <SECTNO>721.575</SECTNO>
          <SUBJECT>Substituted alkyl halide.</SUBJECT>
          <SECTNO>721.600</SECTNO>
          <SUBJECT>3-Alkyl-2-(2-anilino)vinyl thi-azo-lin-i-um salt (generic name).</SUBJECT>
          <SECTNO>721.625</SECTNO>
          <SUBJECT>Alkylated diarylamine, sul-furized (generic name).</SUBJECT>
          <SECTNO>721.630</SECTNO>
          <SUBJECT>Salt of a modified tallow alkylenediamine (generic).</SUBJECT>
          <SECTNO>721.639</SECTNO>
          <SUBJECT>Amine aldehyde condensate.</SUBJECT>
          <SECTNO>721.640</SECTNO>
          <SUBJECT>Amine substituted metal salts.</SUBJECT>
          <SECTNO>721.641</SECTNO>
          <SUBJECT>Alkylpoly(oxyalkylene)amine.</SUBJECT>
          <SECTNO>721.642</SECTNO>
          <SUBJECT>Amines, <E T="03">N</E>-(C<E T="52">14-18</E> and C<E T="52">16-18</E> unsaturated alkyl)] dipropylene-tri-, tripropylenetetra-, and tetrapropylenepenta-.</SUBJECT>
          <SECTNO>721.643</SECTNO>
          <SUBJECT>Ethoxylated alcohol, phosphated, amine salt.</SUBJECT>
          <SECTNO>721.644</SECTNO>
          <SUBJECT>Amines, C<E T="52">12-14</E>-tert-alkyl, sulfonates.</SUBJECT>
          <SECTNO>721.646</SECTNO>
          <SUBJECT>Aminofluoran derivative (generic name).</SUBJECT>
          <SECTNO>721.650</SECTNO>
          <SUBJECT>11-Aminoundecanoic acid.</SUBJECT>
          <SECTNO>721.655</SECTNO>
          <SUBJECT>Ethoxylated alkyl quaternary ammonium compound.</SUBJECT>
          <SECTNO>721.715</SECTNO>
          <SUBJECT>Trisubstituted anthracene.</SUBJECT>
          <SECTNO>721.720</SECTNO>
          <SUBJECT>Alkoxylated fatty acid amide, alkylsulfate salt.</SUBJECT>
          <SECTNO>721.750</SECTNO>
          <SUBJECT>Aromatic amine compound.</SUBJECT>
          <SECTNO>721.757</SECTNO>
          <SUBJECT>Polyoxyalkylene substituted aromatic azo colorant.</SUBJECT>
          <SECTNO>721.775</SECTNO>
          <SUBJECT>Brominated aromatic com-pound (generic name).</SUBJECT>
          <SECTNO>721.785</SECTNO>
          <SUBJECT>Halogenated alkane aromatic compound (generic name).</SUBJECT>
          <SECTNO>721.805</SECTNO>
          <SUBJECT>Benzenamine, 4,4<E T="61">′</E>-[1,3-phe-nyl-ene-bis(1-methylethyl idene)]bis[2,6-di-methyl-.</SUBJECT>
          <SECTNO>721.825</SECTNO>
          <SUBJECT>Certain aromatic ether diamines.</SUBJECT>
          <SECTNO>721.840</SECTNO>
          <SUBJECT>Alkyl substituted diaromatic hydrocarbons.</SUBJECT>
          <SECTNO>721.875</SECTNO>
          <SUBJECT>Aromatic nitro compound.</SUBJECT>
          <SECTNO>721.925</SECTNO>
          <SUBJECT>Substituted aromatic (generic).</SUBJECT>
          <SECTNO>721.950</SECTNO>
          <SUBJECT>Sodium salt of an alkylated, sulfonated aromatic (generic name).</SUBJECT>
          <SECTNO>721.977</SECTNO>
          <SUBJECT>Aryloxyarene.</SUBJECT>
          <SECTNO>721.980</SECTNO>
          <SUBJECT>Sodium salt of azo acid dye.</SUBJECT>
          <SECTNO>721.981</SECTNO>
          <SUBJECT>Substituted naphtholoazo-substituted naphthalenyl-substituted azonaphthol chromium complex.</SUBJECT>
          <SECTNO>721.982</SECTNO>
          <SUBJECT>Calcium, bis(2,4-pentanedionato-<E T="03">O,O</E>
            <E T="61">′</E>).</SUBJECT>
          <SECTNO>721.987</SECTNO>
          <SUBJECT>Dialkylaminophenyl imino pyrazole acid ester (generic).</SUBJECT>
          <SECTNO>721.988</SECTNO>
          <SUBJECT>Pyrazolone azomethine dye (generic).</SUBJECT>
          <SECTNO>721.1000</SECTNO>
          <SUBJECT>Benzenamine, 3-chloro-2,6-dinitro-N,N-dipropyl-4-(tri-fluoro-methyl)-.</SUBJECT>
          <SECTNO>721.1025</SECTNO>
          <SUBJECT>Benzenamine, 4-chloro-2-methyl-; benzenamine, 4-chloro-2-methyl-, hydrochloride; and ben-zenamine, 2-chloro-6-methyl-.</SUBJECT>
          <SECTNO>721.1050</SECTNO>
          <SUBJECT>Benzenamine, 2,5-dibutoxy-4-(4-mor-pho-linyl)-, sulfate.</SUBJECT>
          <SECTNO>721.1055</SECTNO>
          <SUBJECT>Benzeneamine, 3,5-difluoro-.</SUBJECT>
          <SECTNO>721.1068</SECTNO>
          <SUBJECT>Benzenamine, 4-isocyanato-<E T="03">N,N</E>-bis(4-isocyanatophenyl)-2,5-dimethoxy-.</SUBJECT>
          <SECTNO>721.1075</SECTNO>
          <SUBJECT>Benzenamine, 4-(1-methylbutoxy)-, hydrochloride.</SUBJECT>
          <SECTNO>721.1105</SECTNO>
          <SUBJECT>Benzenamine, 4,4′-methylenebis[2-methyl-6-(1-methylethyl)]-.</SUBJECT>
          <SECTNO>721.1120</SECTNO>
          <SUBJECT>Benzenamine, 4,4<E T="61">′</E>-[1,4-phe-nyl-ene-bis(1-methyle-thy-li-dene)]bis[2,6- dimethyl-.</SUBJECT>
          <SECTNO>721.1150</SECTNO>
          <SUBJECT>Substituted polyglycidyl ben-zena-mine.</SUBJECT>
          <SECTNO>721.1155</SECTNO>
          <SUBJECT>1,4-benzenediol, 2-(1,1,3,3-tetramethylbutyl)-and Bis(dimethylamino substituted)carbomonocycle.</SUBJECT>
          <SECTNO>721.1187</SECTNO>
          <SUBJECT>Bis(imidoethylene) benzene.</SUBJECT>
          <SECTNO>721.1193</SECTNO>
          <SUBJECT>Benzene, 2-bromo-1,4-dimethoxy-.</SUBJECT>
          <SECTNO>721.1210</SECTNO>
          <SUBJECT>Benzene, (2-chloroethoxy)-.</SUBJECT>
          <SECTNO>721.1225</SECTNO>
          <SUBJECT>Benzene, 1,2-dimethyl-, poly-propene derivatives, sulfonated, po-tas-sium salts.</SUBJECT>
          <SECTNO>721.1300</SECTNO>
          <SUBJECT>[(Dinitrophenyl)azo]-[2,4-dia-mino-5-methoxybenzene] derivatives.</SUBJECT>
          <SECTNO>721.1325</SECTNO>
          <SUBJECT>Benzene, 1-(1-methylbutoxy)-4-  nitro-.</SUBJECT>
          <SECTNO>721.1350</SECTNO>
          <SUBJECT>Benzene, (1-methylethyl)(2-  phenylethyl)-.</SUBJECT>
          <SECTNO>721.1372</SECTNO>
          <SUBJECT>Substituted nitrobenzene.<PRTPAGE P="120"/>
          </SUBJECT>
          <SECTNO>721.1375</SECTNO>
          <SUBJECT>Disubstituted nitrobenzene (generic name).</SUBJECT>
          <SECTNO>721.1425</SECTNO>
          <SUBJECT>Pentabromoethylbenzene.</SUBJECT>
          <SECTNO>721.1430</SECTNO>
          <SUBJECT>Pentachlorobenzene.</SUBJECT>
          <SECTNO>721.1435</SECTNO>
          <SUBJECT>1,2,4,5-Tetrachlorobenzene.</SUBJECT>
          <SECTNO>721.1440</SECTNO>
          <SUBJECT>1,3,5-Trinitrobenzene.</SUBJECT>
          <SECTNO>721.1450</SECTNO>
          <SUBJECT>1,3-Benzenediamine, 4-(1,1-di-methyl-ethyl)-ar-methyl.</SUBJECT>
          <SECTNO>721.1500</SECTNO>
          <SUBJECT>1,2-Benzenediamine, 4-ethoxy, sulfate.</SUBJECT>
          <SECTNO>721.1550</SECTNO>
          <SUBJECT>Benzenediazonium, 4-(di-methyl-amino)-, salt with 2-hy-droxy-5-sul-fo-benzoic acid (1:1).</SUBJECT>
          <SECTNO>721.1555</SECTNO>
          <SUBJECT>Substituted phenyl azo substituted benzenediazonium salt.</SUBJECT>
          <SECTNO>721.1568</SECTNO>
          <SUBJECT>Substituted benzenediazonium.</SUBJECT>
          <SECTNO>721.1576</SECTNO>
          <SUBJECT>1,3-Benzenedicarboxylic acid, bis[[4-[(ethenyloxy)methyl] cyclohexyl] methyl] ester.</SUBJECT>
          <SECTNO>721.1577</SECTNO>
          <SUBJECT>1,4-Benzenedicarboxylic acid, bis [4-(ethenyloxy) butyl] ester.</SUBJECT>
          <SECTNO>721.1578</SECTNO>
          <SUBJECT>1,4-Benzenedicarboxylic acid, bis[[4-[(ethenyloxy)methyl] cyclohexyl] methyl] ester.</SUBJECT>
          <SECTNO>721.1579</SECTNO>
          <SUBJECT>1,2,4-Benzenetricarboxylic acid, tris [4-(ethenyloxy) butyl] ester.</SUBJECT>
          <SECTNO>721.1580</SECTNO>
          <SUBJECT>Disubstituted benzene ether, polymer with substituted phenol (generic).</SUBJECT>
          <SECTNO>721.1612</SECTNO>
          <SUBJECT>Substituted 2-nitro- and 2-aminobenzesulfonamide.</SUBJECT>
          <SECTNO>721.1625</SECTNO>
          <SUBJECT>Alkylbenzene sulfonate, amine salt.</SUBJECT>
          <SECTNO>721.1630</SECTNO>

          <SUBJECT>1,2-Ethanediol bis(4-methylbenzenesulfonate); 2,2-oxybis-ethane bis(4-methylbenzenesulfonate); ethanol, 2,2<E T="61">′</E>-[oxybis(2,1-ethanediyl oxy)]bis-, bis(4-methylbenzenesulfonate); ethanol, 2,2<E T="61">′</E>-[oxybis (2,1-ethane diyloxy)] bis-, bis(4-methylbenzenesulfonate); ethanol, 2,2<E T="61">′</E>-[[1-[(2-propenyloxy) methyl]-1,2-ethanediyl] bis(oxy)]bis-, bis(4-methylbenzene sulfonate); and ethanol, 2-[1-[[2-[2-[[(4-methylphenyl)sulfonyl] oxy]ethoxy] ethoxy]methyl]-2-(2-propenyloxy)ethoxy]-, 4-methylbenzenesulfonate.</SUBJECT>
          <SECTNO>721.1637</SECTNO>
          <SUBJECT>1,2-Propanediol, 3-(2-propenyloxy)-, bis(4-methylbenzene sulfonate); 2-propanol, 1-[2-[[(4-methylphenyl)sulfonyl] oxy]ethoxy]-3-(2-propenyloxy)-4-methylbenzenesulfonate; and 2-propanol, 1-[2-[2-[[(4-methylphenyl)sulfonyl]oxy] ethoxy]ethoxy]-3-(2-propenyloxy)-, 4-methylbenzenesulfonate.</SUBJECT>
          <SECTNO>721.1640</SECTNO>
          <SUBJECT>3,6,9,12,-Tetraoxatetradecane-1,14-diol, bis(4-methylbenzenesulfonate; 3,6,9,13-tetraoxahexadec-15-ene-1,11-diol, bis(4-methylbenzenesulfonate); 3,6,9,12,16-pentaoxanonadec-18-ene-1,14-diol, bis(4-methyl benzenesulfonate); and 3,6,9,12-tetraoxatetradecane-1,14-diol, 7-[(2-propenyloxy)methyl]-, bis(4-methylbenzenesulfonate).</SUBJECT>
          <SECTNO>721.1643</SECTNO>
          <SUBJECT>Benzenesulfonic acid, amino substituted phenylazo-.</SUBJECT>
          <SECTNO>721.1645</SECTNO>

          <SUBJECT>Benzenesulfonic acid, 4-methyl-, reaction products with oxirane mono[(C<E T="52">10‐16</E>-alkyloxy)methyl] derivatives and 2,2,4(or 2,4,4)-trimethyl-1,6-hexanediamine.</SUBJECT>
          <SECTNO>721.1650</SECTNO>
          <SUBJECT>Alkylbenzenesulfonic acid and sodium salts.</SUBJECT>
          <SECTNO>721.1655</SECTNO>
          <SUBJECT>Alkylbenzenesulfonic acid (generic).</SUBJECT>
          <SECTNO>721.1660</SECTNO>
          <SUBJECT>Benzidine-based chemical substances.</SUBJECT>
          <SECTNO>721.1675</SECTNO>
          <SUBJECT>Disulfonic acid rosin amine salt of a benzidine derivative (generic name).</SUBJECT>
          <SECTNO>721.1700</SECTNO>
          <SUBJECT>Halonitrobenzoic acid, substituted (generic name).</SUBJECT>
          <SECTNO>721.1705</SECTNO>
          <SUBJECT>Benzoic acid, 3-amino-, diazotized, coupled with 6-amino-4-hydroxy-2-naphthalenesulfonic acid, diazotized, (3-aminophenyl)phosphonic acid and diazotized 2,5-diethoxybenzenamine.</SUBJECT>
          <SECTNO>721.1710</SECTNO>
          <SUBJECT>Methoxy benzoic acid derivative (generic).</SUBJECT>
          <SECTNO>721.1725</SECTNO>
          <SUBJECT>Benzoic acid, 3,3<E T="61">′</E>-methyl-enebis [6 amino-, di-2-propenyl ester.</SUBJECT>
          <SECTNO>721.1728</SECTNO>
          <SUBJECT>Benzoic acid, 2-(3-phenylbutylidene)amino-, methyl ester.</SUBJECT>
          <SECTNO>721.1729</SECTNO>
          <SUBJECT>Boric acid (H3BO3), mixed esters with polyethylene glycol mono-Bu ether and polyethylene glycol mono Me ether.</SUBJECT>
          <SECTNO>721.1730</SECTNO>
          <SUBJECT>Poly(oxy-1,2-ethanediyl), <E T="61">a</E>-butyl-<E T="61">v</E>-hydroxy, ester with boric acid (H3BO3).</SUBJECT>
          <SECTNO>721.1731</SECTNO>
          <SUBJECT>Poly(oxy-1,2-ethanediyl), <E T="61">a</E>-methyl-<E T="61">v</E>-hydroxy, ester with boric acid (H3BO3).</SUBJECT>
          <SECTNO>721.1732</SECTNO>
          <SUBJECT>Nitrobenzoic acid octyl ester.</SUBJECT>
          <SECTNO>721.1734</SECTNO>
          <SUBJECT>Substituted benzonitrile (generic).</SUBJECT>
          <SECTNO>721.1735</SECTNO>
          <SUBJECT>Alkylbisoxyalkyl (sub-sti-tut-ed-1,1-dimethylethylphenyl) ben-zo-tria-zole (generic name).</SUBJECT>
          <SECTNO>721.1738</SECTNO>
          <SUBJECT>Substituted benzotriazole (generic name).</SUBJECT>
          <SECTNO>721.1745</SECTNO>
          <SUBJECT>Ethoxybenzothiazole disulfide.</SUBJECT>
          <SECTNO>721.1750</SECTNO>
          <SUBJECT>1<E T="03">H</E>-Benzotriazole, 5-(pentyloxy)- and 1<E T="03">H</E>-benzotriazole, 5-(pentyloxy)-, sodium and potassium salts.</SUBJECT>
          <SECTNO>721.1755</SECTNO>
          <SUBJECT>Methylenebisbenzotriazole.</SUBJECT>
          <SECTNO>721.1760</SECTNO>
          <SUBJECT>Substituted benzotriazole derivatives.</SUBJECT>
          <SECTNO>721.1765</SECTNO>
          <SUBJECT>2-Substituted benzotriazole.</SUBJECT>
          <SECTNO>721.1775</SECTNO>
          <SUBJECT>6-Nitro-2(3H)-benzo-xazo-lone.</SUBJECT>
          <SECTNO>721.1790</SECTNO>
          <SUBJECT>Polybrominated biphenyls.</SUBJECT>
          <SECTNO>721.1800</SECTNO>
          <SUBJECT>3,3’,5,5’-Tetra-methyl-bi-phenyl-4,4’-diol.</SUBJECT>
          <SECTNO>721.1805</SECTNO>
          <SUBJECT>Substituted bisaniline.</SUBJECT>
          <SECTNO>721.1820</SECTNO>
          <SUBJECT>Bisphenol derivative.</SUBJECT>
          <SECTNO>721.1825</SECTNO>
          <SUBJECT>Bisphenol A, epichloro-hy-drin, poly-al-ky-lenepolyol and poly-iso-cyanato derivative.</SUBJECT>
          <SECTNO>721.1850</SECTNO>
          <SUBJECT>Toluene sulfonamide bisphe-nol A epoxy adduct.</SUBJECT>
          <SECTNO>721.1875</SECTNO>
          <SUBJECT>Boric acid, alkyl and substituted alkyl esters (generic name).</SUBJECT>
          <SECTNO>721.1900</SECTNO>
          <SUBJECT>Substituted bromothiophene.</SUBJECT>
          <SECTNO>721.1907</SECTNO>
          <SUBJECT> Butanamide, 2,2′-[3′dichloro[1,1′-biphenyl]-4,4′-diyl)bisazobis N-2,3-dihydro-2-oxo-1H-benximdazol-5-yl)-3-oxo-.</SUBJECT>
          <SECTNO>721.1920</SECTNO>
          <SUBJECT>1,4-Bis(3-hydroxy-4-benzoylphenoxy)butane.</SUBJECT>
          <SECTNO>721.1925</SECTNO>

          <SUBJECT>Substituted carbo-hetero-cyc-lic butane tetra-carboxy-late.<PRTPAGE P="121"/>
          </SUBJECT>
          <SECTNO>721.1930</SECTNO>
          <SUBJECT>Butanoic acid, antimony (3=) salt.</SUBJECT>
          <SECTNO>721.1950</SECTNO>
          <SUBJECT>2-Butenedioic acid (Z), mono(2-((1-oxopropenyloxy)ethyl) ester .</SUBJECT>
          <SECTNO>721.2025</SECTNO>
          <SUBJECT>Substituted phenylimino carbamate derivative.</SUBJECT>
          <SECTNO>721.2075</SECTNO>
          <SUBJECT>Carbamodithioic acid, methyl-, compound with methanamine (1:1).</SUBJECT>
          <SECTNO>721.2077</SECTNO>
          <SUBJECT>Substituted carbazate (generic).</SUBJECT>
          <SECTNO>721.2078</SECTNO>
          <SUBJECT>1-Piperidinecarboxylic acid, 2-[(dichloro-hydroxy-carbomonocycle)hydrazono]-, methyl ester (generic).</SUBJECT>
          <SECTNO>721.2079</SECTNO>
          <SUBJECT>Dichloro, hydroxy, hydrazino-carbomonocycle (generic).</SUBJECT>
          <SECTNO>721.2081</SECTNO>
          <SUBJECT>Dichloro, hydroxy, hydrazino-carbomonocycle-monohydrochloride (generic).</SUBJECT>
          <SECTNO>721.2083</SECTNO>
          <SUBJECT>Polysubstituted carbomonocyclic hydroxylamine (generic).</SUBJECT>
          <SECTNO>721.2084</SECTNO>
          <SUBJECT>Carbon oxyfluoride (Carbonic difluoride).</SUBJECT>
          <SECTNO>721.2085</SECTNO>
          <SUBJECT>Hydroxyalkylquinoline dioxoindandialkylcarboxamide.</SUBJECT>
          <SECTNO>721.2086</SECTNO>
          <SUBJECT>Coco acid triamine condensate, polycarboxylic acid salts.</SUBJECT>
          <SECTNO>721.2087</SECTNO>
          <SUBJECT>3-furancarboxaldehyde, tetrahydro-.</SUBJECT>
          <SECTNO>721.2088</SECTNO>
          <SUBJECT>Carboxylic acids, (C6-C9) branched and linear.</SUBJECT>
          <SECTNO>721.2089</SECTNO>
          <SUBJECT>Tetrasubstituted aminocarboxylic acid.</SUBJECT>
          <SECTNO>721.2091</SECTNO>
          <SUBJECT>Chloroalkane.</SUBJECT>
          <SECTNO>721.2092</SECTNO>
          <SUBJECT>3-Methylcholanthrene.</SUBJECT>
          <SECTNO>721.2094</SECTNO>
          <SUBJECT>N,N′-di(alkyl heteromonocycle)amino chlorotriazine.</SUBJECT>
          <SECTNO>721.2095</SECTNO>
          <SUBJECT>Chromate(3), bis 2-[[substituted-3-[(5-sulfo-1-napthalenyl)azo]phenyl]azo]substituted monocycle, trisodium (generic name).</SUBJECT>
          <SECTNO>721.2097</SECTNO>
          <SUBJECT>Azo chromium complex dyestuff preparation (generic name).</SUBJECT>
          <SECTNO>721.2120</SECTNO>
          <SUBJECT>Cyclic amide.</SUBJECT>
          <SECTNO>721.2122</SECTNO>
          <SUBJECT>Substituted phenyl azo substituted sulfo carbopolycycle.</SUBJECT>
          <SECTNO>721.2140</SECTNO>
          <SUBJECT>Carbo-poly-cycli-col azo-alkyl-amino-al-kyl-carbo-mono-cyclic ester, halogen acid salt.</SUBJECT>
          <SECTNO>721.2145</SECTNO>
          <SUBJECT>Ceteareth-25 sorbate.</SUBJECT>
          <SECTNO>721.2175</SECTNO>
          <SUBJECT>Salt of cyclodiamine and mineral acid.</SUBJECT>
          <SECTNO>721.2222</SECTNO>
          <SUBJECT>Cyclohexanamine, N,N-dimethyl-, compd. with alpha-isotridecyl-omega-hydroxypoly(oxy-1,2-ethanediyl) phosphate.</SUBJECT>
          <SECTNO>721.2250</SECTNO>
          <SUBJECT>1,4-Cyclohexanediamine, cis- and trans-.</SUBJECT>
          <SECTNO>721.2260</SECTNO>
          <SUBJECT>1,2-Cyclohexanedicarboxylic acid, 2,2-bis[[[[2-[(oxiranylmethoxy) carbonyl]cyclohexy]carbonyl]oxy]methyl]-1,3-propanediyl bis(oxiranylmethyl) ester.</SUBJECT>
          <SECTNO>721.2270</SECTNO>
          <SUBJECT>Aliphatic dicarboxylic acid salt.</SUBJECT>
          <SECTNO>721.2275</SECTNO>
          <SUBJECT>N,N,N’,N’-Tetrakis(oxi-ranyl methyl)-1,3-cyclohexane di-meth-anamine.</SUBJECT>
          <SECTNO>721.2280</SECTNO>
          <SUBJECT>Cyclopropanecarboxaldehyde.</SUBJECT>
          <SECTNO>721.2287</SECTNO>
          <SUBJECT>DDT (Dichlorodiphenyltrichloroethane).</SUBJECT>
          <SECTNO>721.2340</SECTNO>
          <SUBJECT>Dialkenylamide (generic name).</SUBJECT>
          <SECTNO>721.2345</SECTNO>
          <SUBJECT>Alkyletherpropyl dialkylamines.</SUBJECT>
          <SECTNO>721.2350</SECTNO>
          <SUBJECT>Alkyltri, tetra, and pentaamines.</SUBJECT>
          <SECTNO>721.2355</SECTNO>
          <SUBJECT>Diethylstilbestrol.</SUBJECT>
          <SECTNO>721.2380</SECTNO>
          <SUBJECT>Disubstituted diamino ani-sole.</SUBJECT>
          <SECTNO>721.2385</SECTNO>
          <SUBJECT>Fluoroalkyl diester (generic).</SUBJECT>
          <SECTNO>721.2410</SECTNO>
          <SUBJECT>Alkoxylated alkyldiethylenetriamine, alkyl sulfate salts.</SUBJECT>
          <SECTNO>721.2420</SECTNO>
          <SUBJECT>Alkoxylated di-al-kyl-die-thy-lene-tri-a-mine, alkyl sulfate salt.</SUBJECT>
          <SECTNO>721.2475</SECTNO>
          <SUBJECT>Dimetridazole.</SUBJECT>
          <SECTNO>721.2480</SECTNO>
          <SUBJECT>Isoalkyldimethylamine (generic).</SUBJECT>
          <SECTNO>721.2485</SECTNO>
          <SUBJECT>1,3-Dioxolane, 2-ethenyl-.</SUBJECT>
          <SECTNO>721.2520</SECTNO>
          <SUBJECT>Alkylated diphenyls.</SUBJECT>
          <SECTNO>721.2527</SECTNO>
          <SUBJECT>Substituted diphenylazo dye (generic name).</SUBJECT>
          <SECTNO>721.2532</SECTNO>
          <SUBJECT>Substituted diphenylmethane (generic).</SUBJECT>
          <SECTNO>721.2535</SECTNO>
          <SUBJECT>Benzene, 1,1′-methylanebis[4-isocyanato-, homopolymer, Bu alc.-blocked.</SUBJECT>
          <SECTNO>721.2540</SECTNO>
          <SUBJECT>Diphenylmethane diisocyanate   (MDI) modified.</SUBJECT>
          <SECTNO>721.2560</SECTNO>
          <SUBJECT>Alkylated diphenyl oxide (generic name).</SUBJECT>
          <SECTNO>721.2565</SECTNO>
          <SUBJECT>Alkylated sulfonated diphenyl oxide, alkali and amine salts.</SUBJECT>
          <SECTNO>721.2570</SECTNO>
          <SUBJECT>Alkylated diphenyls (generic).</SUBJECT>
          <SECTNO>721.2575</SECTNO>
          <SUBJECT>Disubstituted diphenylsulfone.</SUBJECT>
          <SECTNO>721.2580</SECTNO>
          <SUBJECT>C.I. Disperse Red 152 (generic).</SUBJECT>
          <SECTNO>721.2585</SECTNO>
          <SUBJECT>Sodium salts of dodecylphenol (generic).</SUBJECT>
          <SECTNO>721.2600</SECTNO>
          <SUBJECT>Epibromohydrin.</SUBJECT>
          <SECTNO>721.2625</SECTNO>
          <SUBJECT>Reaction product of alkane-diol and epichlorohydrin.</SUBJECT>
          <SECTNO>721.2675</SECTNO>
          <SUBJECT>Perfluoroalkyl epoxide (generic name).</SUBJECT>
          <SECTNO>721.2725</SECTNO>
          <SUBJECT>Trichlorobutylene oxide.</SUBJECT>
          <SECTNO>721.2755</SECTNO>
          <SUBJECT>Cycloaliphatic epoxy resin (generic).</SUBJECT>
          <SECTNO>721.2800</SECTNO>
          <SUBJECT>Erionite fiber.</SUBJECT>
          <SECTNO>721.2805</SECTNO>
          <SUBJECT>Acrylate ester.</SUBJECT>
          <SECTNO>721.2825</SECTNO>
          <SUBJECT>Alkyl ester (generic name).</SUBJECT>
          <SECTNO>721.2900</SECTNO>
          <SUBJECT>Substituted aminobenzoic acid ester (generic name).</SUBJECT>
          <SECTNO>721.2920</SECTNO>
          <SUBJECT>tert-Amyl peroxy alkylene ester (generic name).</SUBJECT>
          <SECTNO>721.2925</SECTNO>
          <SUBJECT>Brominated aromatic ester.</SUBJECT>
          <SECTNO>721.2950</SECTNO>
          <SUBJECT>Carboxylic acid glycidyl esters.</SUBJECT>
          <SECTNO>721.3000</SECTNO>
          <SUBJECT>Dicarboxylic acid monoester.</SUBJECT>
          <SECTNO>721.3020</SECTNO>
          <SUBJECT>1,1-Dimethylpropyl per-oxy-ester (generic name).</SUBJECT>
          <SECTNO>721.3025</SECTNO>
          <SUBJECT>Fatty acids C<E T="52">12-18</E>, C<E T="52">18</E> unsaturated, C<E T="52">12-18</E> alkyl esters (generic).</SUBJECT>
          <SECTNO>721.3031</SECTNO>
          <SUBJECT>Boric acid (H<E T="52">3</E>BO<E T="52">3</E>), zinc salt (2=3).</SUBJECT>
          <SECTNO>721.3032</SECTNO>
          <SUBJECT>Boric acid (H<E T="52">3</E>BO<E T="52">2</E>), zinc salt.</SUBJECT>
          <SECTNO>721.3034</SECTNO>
          <SUBJECT>Methylamine esters.</SUBJECT>
          <SECTNO>721.3063</SECTNO>
          <SUBJECT>Substituted phenyl azo substituted phenyl esters (generic name).</SUBJECT>
          <SECTNO>721.3080</SECTNO>
          <SUBJECT>Substituted phosphate ester (generic).</SUBJECT>
          <SECTNO>721.3085</SECTNO>
          <SUBJECT>Brominated phthalate ester.</SUBJECT>
          <SECTNO>721.3100</SECTNO>
          <SUBJECT>Oligomeric silicic acid ester compound with a hydroxylalkylamine.</SUBJECT>
          <SECTNO>721.3140</SECTNO>
          <SUBJECT>Vinyl epoxy ester.<PRTPAGE P="122"/>
          </SUBJECT>
          <SECTNO>721.3152</SECTNO>
          <SUBJECT>Ethanaminium, <E T="03">N</E>-ethyl-2-hydroxy-<E T="03">N,N</E>-bis(2-hydroxyethyl)-, diester with C<E T="52">12‐18</E> fatty acids, ethyl sulfates (salts).</SUBJECT>
          <SECTNO>721.3155</SECTNO>
          <SUBJECT>3,8-Dioxa-4,7-disiladecane, 4,4,7,7-tetraethoxy-.</SUBJECT>
          <SECTNO>721.3160</SECTNO>
          <SUBJECT>1-Chloro-2-bromoethane.</SUBJECT>
          <SECTNO>721.3220</SECTNO>
          <SUBJECT>Pentachloroethane.</SUBJECT>
          <SECTNO>721.3248</SECTNO>
          <SUBJECT>Ethane, 1,2,2-trichlorodifluoro-.</SUBJECT>
          <SECTNO>721.3260</SECTNO>
          <SUBJECT>Ethanediimidic acids.</SUBJECT>
          <SECTNO>721.3310</SECTNO>
          <SUBJECT>Poly[oxy(methyl-1,2-ethanediyl)],<E T="61">a</E>-(1-oxo-2-propenyl)-<E T="61">v</E>-[(tetrahydro-2-furanyl)methoxy]-.</SUBJECT>
          <SECTNO>721.3320</SECTNO>
          <SUBJECT>Ethanol, 2-amino-, com-pound with N-hydroxy-N-nitro-soben-zena-mine (1:1).</SUBJECT>
          <SECTNO>721.3340</SECTNO>
          <SUBJECT>Ethanol, 2,2’-(hexylamino)bis-.</SUBJECT>
          <SECTNO>721.3350</SECTNO>
          <SUBJECT>N-Nitrosodiethanolamine.</SUBJECT>
          <SECTNO>721.3360</SECTNO>
          <SUBJECT>Substituted ethanolamine.</SUBJECT>
          <SECTNO>721.3364</SECTNO>
          <SUBJECT>Aliphatic ether.</SUBJECT>
          <SECTNO>721.3374</SECTNO>
          <SUBJECT>Alkylenediolalkyl ether.</SUBJECT>
          <SECTNO>721.3380</SECTNO>
          <SUBJECT>Anilino ether.</SUBJECT>
          <SECTNO>721.3420</SECTNO>
          <SUBJECT>Brominated arylalkyl ether.</SUBJECT>
          <SECTNO>721.3430</SECTNO>
          <SUBJECT>4-Bromophenyl phenyl ether.</SUBJECT>
          <SECTNO>721.3435</SECTNO>
          <SUBJECT>Butoxy-substituted ether alkane.</SUBJECT>
          <SECTNO>721.3437</SECTNO>
          <SUBJECT>Dialkyl ether.</SUBJECT>
          <SECTNO>721.3440</SECTNO>
          <SUBJECT>Haloalkyl substituted cyclic ethers.</SUBJECT>
          <SECTNO>721.3460</SECTNO>
          <SUBJECT>Diglycidyl ether of disubstituted carbopolycyle (generic name).</SUBJECT>
          <SECTNO>721.3465</SECTNO>
          <SUBJECT>Stilbene diglycidyl ether.</SUBJECT>
          <SECTNO>721.3480</SECTNO>
          <SUBJECT>Halogenated biphenyl glycidyl ethers.</SUBJECT>
          <SECTNO>721.3485</SECTNO>
          <SUBJECT>Hydrofluorocarbon alkyl ether.</SUBJECT>
          <SECTNO>721.3486</SECTNO>
          <SUBJECT>Polyglycerin mono(4-nonylphenyl) ether.</SUBJECT>
          <SECTNO>721.3488</SECTNO>

          <SUBJECT>Poly(oxy-1,2-ethanediyl), alpha substituted-omega-hydroxy-, C<E T="52">16-20</E> alkyl ethers.</SUBJECT>
          <SECTNO>721.3500</SECTNO>
          <SUBJECT>Perhalo alkoxy ether.</SUBJECT>
          <SECTNO>721.3520</SECTNO>
          <SUBJECT>Aliphatic polyglycidyl ether.</SUBJECT>
          <SECTNO>721.3550</SECTNO>
          <SUBJECT>Dipropylene glycol dimethyl ether.</SUBJECT>
          <SECTNO>721.3560</SECTNO>
          <SUBJECT>Derivative of tetra-chloro-ethy-lene.</SUBJECT>
          <SECTNO>721.3565</SECTNO>
          <SUBJECT>Ethylenediamine, substituted, sodium salt.</SUBJECT>
          <SECTNO>721.3620</SECTNO>
          <SUBJECT>Fatty acid amine condensate, polycarboxylic acid salts.</SUBJECT>
          <SECTNO>721.3625</SECTNO>
          <SUBJECT>Fatty acid amine salt (generic name).</SUBJECT>
          <SECTNO>721.3627</SECTNO>
          <SUBJECT>Branched synthetic fatty acid.</SUBJECT>
          <SECTNO>721.3628</SECTNO>
          <SUBJECT>Fatty acids, C(14-18)- unsaturated, branched and linear, methyl and butyl esters.</SUBJECT>
          <SECTNO>721.3629</SECTNO>
          <SUBJECT>Triethanolamine salts of fatty acids.</SUBJECT>
          <SECTNO>721.3635</SECTNO>

          <SUBJECT>Octadecanoic acid, ester with 1,2-propanediol, phosphate, anhydride with silicic acid (H<E T="52">4</E>SiO<E T="52">4</E>).</SUBJECT>
          <SECTNO>721.3680</SECTNO>
          <SUBJECT>Ethylene oxide adduct of fatty acid ester with pentaerythritol.</SUBJECT>
          <SECTNO>721.3700</SECTNO>
          <SUBJECT>Fatty acid, ester with styrenated phenol, ethylene oxide adduct.</SUBJECT>
          <SECTNO>721.3720</SECTNO>
          <SUBJECT>Fatty amide.</SUBJECT>
          <SECTNO>721.3740</SECTNO>
          <SUBJECT>Bisalkylated fatty alkyl amine oxide</SUBJECT>
          <SECTNO>721.3760</SECTNO>
          <SUBJECT>Fluorene-containing diaromatic amines.</SUBJECT>
          <SECTNO>721.3764</SECTNO>
          <SUBJECT>Fluorene substituted aromatic amine.</SUBJECT>
          <SECTNO>721.3790</SECTNO>
          <SUBJECT>Polyfluorocarboxylates.</SUBJECT>
          <SECTNO>721.3800</SECTNO>
          <SUBJECT>Formaldehyde, condensated poly-ox-y-eth-y-lene fatty acid, ester with styrenated phenol, ethylene oxide adduct.</SUBJECT>
          <SECTNO>721.3815</SECTNO>
          <SUBJECT>Furan, 2-(ethoxymethyl)- tetrahydro-.</SUBJECT>
          <SECTNO>721.3840</SECTNO>
          <SUBJECT>Tetraglycidalamines (generic  name).</SUBJECT>
          <SECTNO>721.3845</SECTNO>
          <SUBJECT>Alkyl substituted aromatic glycidyl ether (generic).</SUBJECT>
          <SECTNO>721.3860</SECTNO>
          <SUBJECT>Glycol monobenzoate.</SUBJECT>
          <SECTNO>721.3880</SECTNO>
          <SUBJECT>Polyalkylene glycol substituted acetate.</SUBJECT>
          <SECTNO>721.3900</SECTNO>
          <SUBJECT>Alkyl polyethylene glycol phosphate, potassium salt.</SUBJECT>
          <SECTNO>721.4000</SECTNO>
          <SUBJECT>Polyoxy alkylene glycol amine.</SUBJECT>
          <SECTNO>721.4040</SECTNO>
          <SUBJECT>Glycols, polyethylene-, 3-sulfo-2-hy-drox-y-pro-pyl-p-(1,1,3,3-tetra-methylbutyl)phenyl ether, sodium salt.</SUBJECT>
          <SECTNO>721.4060</SECTNO>
          <SUBJECT>Alkylene glycol tereph-tha-late and substituted benzoate esters (generic name).</SUBJECT>
          <SECTNO>721.4080</SECTNO>
          <SUBJECT>MNNG (N-methyl-N’-nitro-N-nitrosoguanidine).</SUBJECT>
          <SECTNO>721.4085</SECTNO>
          <SUBJECT>Guanidine, pentaethyl-.</SUBJECT>
          <SECTNO>721.4090</SECTNO>
          <SUBJECT>Ethanaminium, N-[bis(diethylamino)-methylene]-N-ethyl-, bromide.</SUBJECT>
          <SECTNO>721.4095</SECTNO>
          <SUBJECT>Quaternary ammonium alkyltherpropyl trialkylamine halides.</SUBJECT>
          <SECTNO>721.4097</SECTNO>
          <SUBJECT>7-Oxabicyclo[4.1.0]heptane-3-carboxylic acid, methyl ester.</SUBJECT>
          <SECTNO>721.4098</SECTNO>
          <SUBJECT>Substituted heteroaromatic-2[[4-(dimethylamino) phenyl]azo]-3-methyl-, salts (generic).</SUBJECT>
          <SECTNO>721.4100</SECTNO>
          <SUBJECT>Tris(disubstituted alkyl) heter-o-cy-cle.</SUBJECT>
          <SECTNO>721.4105</SECTNO>
          <SUBJECT>Bicyclo[2.2.1]hept-2-ene, 5-butyl-.</SUBJECT>
          <SECTNO>721.4106</SECTNO>
          <SUBJECT>Bicyclo[2.2.1]hept-2-ene, 5-hexyl-.</SUBJECT>
          <SECTNO>721.4107</SECTNO>
          <SUBJECT>Bicyclo[2.2.1]hept-2-ene, 5-octyl-.</SUBJECT>
          <SECTNO>721.4108</SECTNO>
          <SUBJECT>Bicyclo[2.2.1]hept-2-ene, 5-decyl-.</SUBJECT>
          <SECTNO>721.4110</SECTNO>
          <SUBJECT>Allyloxysubstituted heterocycle.</SUBJECT>
          <SECTNO>721.4128</SECTNO>
          <SUBJECT>Dimethyl-3-substituted heter-o-mon-o-cy-cle.</SUBJECT>
          <SECTNO>721.4133</SECTNO>
          <SUBJECT>Dimethyl-3-substituted heteromonocyclic amine.</SUBJECT>
          <SECTNO>721.4140</SECTNO>
          <SUBJECT>Hexachloronorbornadiene.</SUBJECT>
          <SECTNO>721.4155</SECTNO>
          <SUBJECT>Hexachloropropene.</SUBJECT>
          <SECTNO>721.4158</SECTNO>
          <SUBJECT>Hexadecanoic acid, ethenyl ester.</SUBJECT>
          <SECTNO>721.4160</SECTNO>
          <SUBJECT>Hexafluoropropylene oxide.</SUBJECT>
          <SECTNO>721.4180</SECTNO>
          <SUBJECT>Hexamethylphosphoramide.</SUBJECT>
          <SECTNO>721.4200</SECTNO>
          <SUBJECT>Substituted alkyl per-oxy-hexane carboxylate (mixed isomers) (generic name).</SUBJECT>
          <SECTNO>721.4215</SECTNO>
          <SUBJECT>Hexanedioic acid, diethenyl ester.</SUBJECT>
          <SECTNO>721.4240</SECTNO>
          <SUBJECT>Alkyl peroxy-2-ethyl hex-ano-ate.</SUBJECT>
          <SECTNO>721.4250</SECTNO>
          <SUBJECT>Hexanoic acid, 2-ethyl-, ethenyl ester.</SUBJECT>
          <SECTNO>721.4255</SECTNO>
          <SUBJECT>1,4,7,10,13,16-Hexaoxacyclooctadecane, 2-[(2-propenyl oxy)methyl]-.</SUBJECT>
          <SECTNO>721.4257</SECTNO>
          <SUBJECT>Hydrazine, (2-fluorophenyl).</SUBJECT>
          <SECTNO>721.4259</SECTNO>
          <SUBJECT>Aliphatic polyisocyanate homopolymer.</SUBJECT>
          <SECTNO>721.4260</SECTNO>

          <SUBJECT>Hydrazine, [4-(1-meth-yl-bu-toxy)phenyl]-, monohydrochloride.<PRTPAGE P="123"/>
          </SUBJECT>
          <SECTNO>721.4265</SECTNO>
          <SUBJECT>Hydrazinecarboxamide, N-(3,5-difluorophenyl-).</SUBJECT>
          <SECTNO>721.4270</SECTNO>
          <SUBJECT>Nitrophenoxylalkanoic acid substituted thiazino hydrazide (generic name).</SUBJECT>
          <SECTNO>721.4280</SECTNO>
          <SUBJECT>Substituted hydrazine.</SUBJECT>
          <SECTNO>721.4300</SECTNO>
          <SUBJECT>Hydrazinecarboxamide, N,N’-1,6-hexanediylbis [2,2-dimethyl-].</SUBJECT>
          <SECTNO>721.4320</SECTNO>
          <SUBJECT>Hydrazinecarboxamide, N,N’-(meth-yl-en-edi-4,1-phenylene)bis [2,2-dimethyl-.</SUBJECT>
          <SECTNO>721.4340</SECTNO>
          <SUBJECT>Substituted thiazino hydrazine salt (generic name).</SUBJECT>
          <SECTNO>721.4360</SECTNO>
          <SUBJECT>Certain hydrogen containing chlor-o-fluor-o-carbons.</SUBJECT>
          <SECTNO>721.4380</SECTNO>
          <SUBJECT>Modified hydrocarbon resin.</SUBJECT>
          <SECTNO>721.4385</SECTNO>
          <SUBJECT>Hydrofluoric acid, reaction products with heptane.</SUBJECT>
          <SECTNO>721.4390</SECTNO>
          <SUBJECT>Trisubstituted hydroquinone  diester.</SUBJECT>
          <SECTNO>721.4420</SECTNO>
          <SUBJECT>Substituted hydroxylamine.</SUBJECT>
          <SECTNO>721.4460</SECTNO>
          <SUBJECT>Amidinothiopropionic acid hydrochloride.</SUBJECT>
          <SECTNO>721.4462</SECTNO>
          <SUBJECT>Hydrochlorofluorocarbon.</SUBJECT>
          <SECTNO>721.4463</SECTNO>
          <SUBJECT>Hydrochlorofluorocarbon.</SUBJECT>
          <SECTNO>721.4464</SECTNO>
          <SUBJECT>Mixture of hydrofluoro alkanes and hydrofluoro alkene.</SUBJECT>
          <SECTNO>721.4465</SECTNO>
          <SUBJECT>Hydrofluoroalkane.</SUBJECT>
          <SECTNO>721.4466</SECTNO>
          <SUBJECT>3-Hydroxy-1,1-dimethylbutyl derivative.</SUBJECT>
          <SECTNO>721.4467</SECTNO>
          <SUBJECT>Quaternary ammonium hydroxide.</SUBJECT>
          <SECTNO>721.4468</SECTNO>
          <SUBJECT>1H-Imidazole, 2-ethyl-4,5-dihydro-4-methyl-.</SUBJECT>
          <SECTNO>721.4469</SECTNO>
          <SUBJECT>Imidazolethione.</SUBJECT>
          <SECTNO>721.4470</SECTNO>
          <SUBJECT>2,4-Imidazolidinedione, bromochloro-5,5-dimethyl-.</SUBJECT>
          <SECTNO>721.4472</SECTNO>
          <SUBJECT>Phenyl, alkyl, hydroxyalkyl substituted imidazole (generic).</SUBJECT>
          <SECTNO>721.4473</SECTNO>
          <SUBJECT>Dialkylamidoimidazoline.</SUBJECT>
          <SECTNO>721.4476</SECTNO>
          <SUBJECT>Substituted imines.</SUBJECT>
          <SECTNO>721.4480</SECTNO>
          <SUBJECT>2-Imino-1,3-thiazin-4-one-5,6-dihydromonohydrochloride.</SUBJECT>
          <SECTNO>721.4484</SECTNO>
          <SUBJECT>Halogenated indane (generic name).</SUBJECT>
          <SECTNO>721.4490</SECTNO>
          <SUBJECT>Capped aliphatic isocyanate.</SUBJECT>
          <SECTNO>721.4494</SECTNO>
          <SUBJECT>Polycyclic isocyanate.</SUBJECT>
          <SECTNO>721.4497</SECTNO>
          <SUBJECT>Aliphatic polyisocyanates (generic name).</SUBJECT>
          <SECTNO>721.4500</SECTNO>
          <SUBJECT>Isopropylamine distillation residues and ethylamine distillation residues.</SUBJECT>
          <SECTNO>721.4520</SECTNO>
          <SUBJECT>Isopropylidene, bis(1,1-di-meth-yl-pro-pyl) derivative.</SUBJECT>
          <SECTNO>721.4550</SECTNO>
          <SUBJECT>Diperoxy ketal.</SUBJECT>
          <SECTNO>721.4568</SECTNO>
          <SUBJECT>Methylpolychloro aliphatic ketone.</SUBJECT>
          <SECTNO>721.4585</SECTNO>
          <SUBJECT>Lecithins, phospholipase A2-hydrolyzed.</SUBJECT>
          <SECTNO>721.4587</SECTNO>
          <SUBJECT>Lithium manganese oxide (LiMn204) (generic name).</SUBJECT>
          <SECTNO>721.4589</SECTNO>
          <SUBJECT>Propanedioic acid, [(4-methoxyphenyl)methylene]-, bis(1,2,2,6,6-pentamethyl-4-piperidinyl) ester (9CI).</SUBJECT>
          <SECTNO>721.4590</SECTNO>
          <SUBJECT>Mannich-based adduct.</SUBJECT>
          <SECTNO>721.4594</SECTNO>
          <SUBJECT>Substituted azo metal complex dye.</SUBJECT>
          <SECTNO>721.4596</SECTNO>
          <SUBJECT>Diazo substituted carbomonocyclic metal complex.</SUBJECT>
          <SECTNO>721.4600</SECTNO>
          <SUBJECT>Recovered metal hydroxide.</SUBJECT>
          <SECTNO>721.4620</SECTNO>
          <SUBJECT>Dialkylamino alkanoate metal salt.</SUBJECT>
          <SECTNO>721.4660</SECTNO>
          <SUBJECT>Alcohol, alkali metal salt.</SUBJECT>
          <SECTNO>721.4663</SECTNO>
          <SUBJECT>Fluorinated carboxylic acid alkali metal salts.</SUBJECT>
          <SECTNO>721.4668</SECTNO>
          <SUBJECT>Hydrated alkaline earth metal salts of metalloid oxyanions.</SUBJECT>
          <SECTNO>721.4680</SECTNO>
          <SUBJECT>Metal salts of complex inorganic oxyacids (generic name).</SUBJECT>
          <SECTNO>721.4685</SECTNO>
          <SUBJECT>Substituted purine metal salt (generic name).</SUBJECT>
          <SECTNO>721.4700</SECTNO>
          <SUBJECT>Metalated alkylphenol copolymer (generic name).</SUBJECT>
          <SECTNO>721.4720</SECTNO>
          <SUBJECT>Disubstituted phenoxazine, chlor-o-me-tal-ate salt.</SUBJECT>
          <SECTNO>721.4740</SECTNO>
          <SUBJECT>Alkali metal nitrites.</SUBJECT>
          <SECTNO>721.4794</SECTNO>
          <SUBJECT>Polypiperidinol-acrylate methacrylate.</SUBJECT>
          <SECTNO>721.4820</SECTNO>
          <SUBJECT>Methane, bromodifluoro-.</SUBJECT>
          <SECTNO>721.4840</SECTNO>
          <SUBJECT>Substituted tri-phenyl-meth-ane.</SUBJECT>
          <SECTNO>721.4880</SECTNO>
          <SUBJECT>Methanol, trichloro-, carbonate (2:1).</SUBJECT>
          <SECTNO>721.4885</SECTNO>
          <SUBJECT>Methanone, [5-[[3-(2H-benzotriazol-2-yl)-2-hydroxy-5-(1,1,3,3-tetramethylbutyl)phenyl]methyl]-2-hydroxy-4-(octyloxy) phenyl]phenyl-.</SUBJECT>
          <SECTNO>721.4925</SECTNO>
          <SUBJECT>Methyl n-butyl ketone.</SUBJECT>
          <SECTNO>721.5050</SECTNO>
          <SUBJECT>2,2<E T="61">′</E>-[(1-Methyl-ethylidene)-bis[4,1-phenyl-oxy[1-(butoxy-methyl)-(2,1-ethan-ediyl]oxy-methyl-ene]]biso-xirane, reaction product with a diamine.</SUBJECT>
          <SECTNO>721.5075</SECTNO>
          <SUBJECT>Mixed methyltin mercaptoester sulfides.</SUBJECT>
          <SECTNO>721.5175</SECTNO>
          <SUBJECT>Mitomycin C.</SUBJECT>
          <SECTNO>721.5185</SECTNO>
          <SUBJECT>Morpholine, 4-(1-oxo-2-propenyl)-.</SUBJECT>
          <SECTNO>721.5192</SECTNO>
          <SUBJECT>Substituted 1,6-dihydroxy naphthalene.</SUBJECT>
          <SECTNO>721.5200</SECTNO>
          <SUBJECT>Disubstituted phenylazo tri-sub-sti-tut-ed naphthalene.</SUBJECT>
          <SECTNO>721.5225</SECTNO>
          <SUBJECT>Naphthalene,1,2,3,4-tetra-hy-dro(1-phenylethyl) (specific name).</SUBJECT>
          <SECTNO>721.5250</SECTNO>
          <SUBJECT>Trimethyl spiropolyheterocyclic naph-tha-lene compound.</SUBJECT>
          <SECTNO>721.5255</SECTNO>
          <SUBJECT>2-Naphthalenol, mono and dioctyl derivs.</SUBJECT>
          <SECTNO>721.5275</SECTNO>
          <SUBJECT>2-Napthalenecarboxamide-N-aryl-3-hydroxy-4-arylazo (generic name).</SUBJECT>
          <SECTNO>721.5276</SECTNO>

          <SUBJECT>2-Napthalenol, heptyl-1-[[(4-phenylazo)phenyl]azo]-, <E T="03">ar’, ar”</E>-Me derivs.</SUBJECT>
          <SECTNO>721.5278</SECTNO>
          <SUBJECT>Substituted naphthalenesulfonic acid, alkali salt.</SUBJECT>
          <SECTNO>721.5279</SECTNO>
          <SUBJECT>2,7-Naphthalenedisulfonic acid, 4-amino-3-[[4′2-amino-4-[(3-butoxy-2-hydroxypropyl)amino]phebyl]azo]-3,3′-dimethyl[1,1′-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)-, disodium salt.</SUBJECT>
          <SECTNO>721.5280</SECTNO>
          <SUBJECT>2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, coupled with diazotized 4-butylbenzenamine, diazotized 4,4′-cyclohexylidenebis[benzenamine] and m-phenylenediamine, sodium salt.</SUBJECT>
          <SECTNO>721.5281</SECTNO>
          <SUBJECT>2-Naphthalenesulfonic acid, 3-[[4-[(2,4-dimethyl-6-sulfophenyl)azo]-2-methoxy-5-methylphenyl]azo]-4-hydroxy-7-(phenylamino)-, sodium salt, compd. With 2,2′,2″-nitrilotris [ethanol] (9CI).</SUBJECT>
          <SECTNO>721.5282</SECTNO>

          <SUBJECT>Trisodium chloro [(trisubstituted heteromonocycle amino) <PRTPAGE P="124"/>propylamino]triazinylamino hydroxyazo naphthalenetrisulfonate.</SUBJECT>
          <SECTNO>721.5285</SECTNO>
          <SUBJECT>Ethoxylated substituted naphthol.</SUBJECT>
          <SECTNO>721.5290</SECTNO>
          <SUBJECT>Phenylazoalkoxy naphthylamines (generic).</SUBJECT>
          <SECTNO>721.5300</SECTNO>
          <SUBJECT>Neodecaneperoxoic acid, 1,1,3,3-tetramethylbutyl ester.</SUBJECT>
          <SECTNO>721.5310</SECTNO>
          <SUBJECT>Neononanoic acid, ethenyl ester.</SUBJECT>
          <SECTNO>721.5325</SECTNO>
          <SUBJECT>Nickel acrylate complex.</SUBJECT>
          <SECTNO>721.5330</SECTNO>
          <SUBJECT>Nickel salt of an organo compound containing nitrogen.</SUBJECT>
          <SECTNO>721.5350</SECTNO>
          <SUBJECT>Substituted nitrile (generic name).</SUBJECT>
          <SECTNO>721.5356</SECTNO>
          <SUBJECT>Ethanol, 2,2′2″-nitrilotris-, compound with alpha-2,4,6-tris (1-phenylethyl)phenyl]-omega-hydroxypoly (oxy-1,2-ethanediyl) phosphate.</SUBJECT>
          <SECTNO>721.5360</SECTNO>
          <SUBJECT>Substituted nitrobenezene (generic).</SUBJECT>
          <SECTNO>721.5375</SECTNO>
          <SUBJECT>Ni-tro-thio-phene-car-boxy-lic acid, ethyl es-ter, bis[[[[(substi-tut-ed)] ami-no-]alkyl-phenyl]-az-o] (ge-ner-ic name).</SUBJECT>
          <SECTNO>721.5380</SECTNO>
          <SUBJECT>Mixed alkyl phenolic novolak resin (generic).</SUBJECT>
          <SECTNO>721.5385</SECTNO>
          <SUBJECT>Octanoic acid, hydrazide.</SUBJECT>
          <SECTNO>721.5400</SECTNO>
          <SUBJECT>3,6,9,12,15,18,21-Hepta-oxa-tetra-triaoctanoic acid, sodium salt.</SUBJECT>
          <SECTNO>721.5425</SECTNO>
          <SUBJECT>
            <E T="61">α</E>-Olefin sulfonate, potassium salts.</SUBJECT>
          <SECTNO>721.5450</SECTNO>
          <SUBJECT>
            <E T="61">α</E>-Olefin sulfonate, sodium salt.</SUBJECT>
          <SECTNO>721.5460</SECTNO>
          <SUBJECT>Organosolv lignin.</SUBJECT>
          <SECTNO>721.5465</SECTNO>
          <SUBJECT>Amine salt of organic acid (generic).</SUBJECT>
          <SECTNO>721.5475</SECTNO>
          <SUBJECT>1-Oxa-4-azaspiro[4.5]decane, 4-di-chlor-o-ace-tyl-.</SUBJECT>
          <SECTNO>721.5500</SECTNO>
          <SUBJECT>7-Oxabicyclo[4.1.0]heptane, 3-ethenyl, homopolymer, ether with 2-ethyl-2-(hydroxymethyl)-1,3-pro-pane-diol (3:1), epoxidized.</SUBJECT>
          <SECTNO>721.5525</SECTNO>
          <SUBJECT>Substituted spiro oxazine.</SUBJECT>
          <SECTNO>721.5540</SECTNO>
          <SUBJECT>1<E T="03">H</E>,3<E T="03">H</E>,5<E T="03">H</E>-oxazolo [3,4-c] oxazole, dihydro-7a-methyl-.</SUBJECT>
          <SECTNO>721.5545</SECTNO>
          <SUBJECT>3-(Dichloroacetyl)-5-(2-furanyl)-2,2-dimethyl-oxazolidine.</SUBJECT>
          <SECTNO>721.5547</SECTNO>
          <SUBJECT>Antimony double oxide.</SUBJECT>
          <SECTNO>721.5548</SECTNO>
          <SUBJECT>Mixed metal oxide (generic).</SUBJECT>
          <SECTNO>721.5549</SECTNO>
          <SUBJECT>Lithiated metal oxide.</SUBJECT>
          <SECTNO>721.5550</SECTNO>
          <SUBJECT>Substituted dialkyl oxa-zo-lone (generic name).</SUBJECT>
          <SECTNO>721.5575</SECTNO>
          <SUBJECT>Oxirane, 2,2’-(1,6-hex-ane-diyl-bis (oxy-meth-y-lene)) bis-.</SUBJECT>
          <SECTNO>721.5580</SECTNO>
          <SUBJECT>Oxirane, 2,2′-[methylenebis[(2,6-dimethyl-4,1-phenylene)oxymethylene]]bis-.</SUBJECT>
          <SECTNO>721.5600</SECTNO>
          <SUBJECT>Substituted oxirane.</SUBJECT>
          <SECTNO>721.5625</SECTNO>
          <SUBJECT>Oxiranemethanamine, N,N<E T="61">′</E>-[methylenebis(2-ethyl-4,1-phenylene)]bis[N-(oxiranylmethyl)]-.</SUBJECT>
          <SECTNO>721.5645</SECTNO>
          <SUBJECT>Pentane 1,1,1,2,3,4,4,5,5,5,-decafluoro.</SUBJECT>
          <SECTNO>721.5650</SECTNO>
          <SUBJECT>Pentanediol light residues.</SUBJECT>
          <SECTNO>721.5700</SECTNO>
          <SUBJECT>Pentanenitrile, 3-amino-.</SUBJECT>
          <SECTNO>721.5708</SECTNO>
          <SUBJECT>2-Pentene, 1,1,1,2,3,4,4,5,5,5-decafluoro-.</SUBJECT>
          <SECTNO>721.5710</SECTNO>
          <SUBJECT>Phenacetin.</SUBJECT>
          <SECTNO>721.5740</SECTNO>
          <SUBJECT>Phenol, 4,4’-methy-lenebis (2,6-dimethyl-.</SUBJECT>
          <SECTNO>721.5760</SECTNO>
          <SUBJECT>Phenol, 4,4’-[methylene-bis (oxy-2,1-ethanediylthio)]bis-.</SUBJECT>
          <SECTNO>721.5763</SECTNO>
          <SUBJECT>Methylenebisbenzotriazolyl phenols.</SUBJECT>
          <SECTNO>721.5769</SECTNO>
          <SUBJECT>Mixture of nitrated alkylated phenols.</SUBJECT>
          <SECTNO>721.5775</SECTNO>
          <SUBJECT>Phenol, 5-amino-2,4-dicholoro-, hydrochloride.</SUBJECT>
          <SECTNO>721.5780</SECTNO>
          <SUBJECT>Phenol, 4,4’-(oxybis(2,1-ethan-ed-iyl-thio)bis-.</SUBJECT>
          <SECTNO>721.5800</SECTNO>
          <SUBJECT>Sulfurized alkylphenol.</SUBJECT>
          <SECTNO>721.5820</SECTNO>
          <SUBJECT>Aminophenol.</SUBJECT>
          <SECTNO>721.5840</SECTNO>
          <SUBJECT>Ethylated aminophenol.</SUBJECT>
          <SECTNO>721.5860</SECTNO>
          <SUBJECT>Methylphenol, bis(sub-sti-tut-ed)alkyl.</SUBJECT>
          <SECTNO>721.5867</SECTNO>
          <SUBJECT>Substituted phenol.</SUBJECT>
          <SECTNO>721.5880</SECTNO>
          <SUBJECT>Sulfur bridged substituted phenols (generic name).</SUBJECT>
          <SECTNO>721.5900</SECTNO>
          <SUBJECT>Trisubstituted phenol (generic name).</SUBJECT>
          <SECTNO>721.5913</SECTNO>
          <SUBJECT>Phenothiazine derivative.</SUBJECT>
          <SECTNO>721.5915</SECTNO>
          <SUBJECT>Polysubstituted phenyl-azo-poly-substi-tuted-phenyl dye.</SUBJECT>
          <SECTNO>721.5920</SECTNO>
          <SUBJECT>Phenyl(disubstitutedpolycyclic).</SUBJECT>
          <SECTNO>721.5930</SECTNO>
          <SUBJECT>Phenylenebis[imino (chlorotriazinyl)-imino (substituted napthyl)azo (substituted phenyl)-azo, sodium salt (generic name).</SUBJECT>
          <SECTNO>721.5960</SECTNO>
          <SUBJECT>N,N’-Bis(2-(2-(3-alkyl)thia-zoline) vinyl)-1,4-pheny-lene-dia-mine methyl sulfate double salt (generic name).</SUBJECT>
          <SECTNO>721.5965</SECTNO>
          <SUBJECT>Substituted S-phenylthiazole (generic).</SUBJECT>
          <SECTNO>721.5970</SECTNO>
          <SUBJECT>Phosphated polyarylphenol ethoxylate, potassium salt.</SUBJECT>
          <SECTNO>721.5980</SECTNO>
          <SUBJECT>Dialkyl phosphorodithioate phosphate compounds.</SUBJECT>
          <SECTNO>721.5995</SECTNO>
          <SUBJECT>Polyalkyl phosphate.</SUBJECT>
          <SECTNO>721.6000</SECTNO>
          <SUBJECT>Tris (2,3-dibromopropyl) phosphate.</SUBJECT>
          <SECTNO>721.6020</SECTNO>
          <SUBJECT>Phosphine, dialkylyphenyl.</SUBJECT>
          <SECTNO>721.6045</SECTNO>
          <SUBJECT>Phosphinothioic acid, bis(2,4,4-trimethylpentyl)- (9CI).</SUBJECT>
          <SECTNO>721.6060</SECTNO>
          <SUBJECT>Alkylaryl substituted phosphite.</SUBJECT>
          <SECTNO>721.6070</SECTNO>
          <SUBJECT>Alkyl phosphonate ammonium salts.</SUBJECT>
          <SECTNO>721.6075</SECTNO>
          <SUBJECT>Phosphonic acid, 1,1-methylenebis-tetrakis(1-methylethyl) ester.</SUBJECT>
          <SECTNO>721.6078</SECTNO>
          <SUBJECT>Substituted ethoxyethylamine phosphonate.</SUBJECT>
          <SECTNO>721.6080</SECTNO>
          <SUBJECT>Phosphonium salt (generic name).</SUBJECT>
          <SECTNO>721.6085</SECTNO>
          <SUBJECT>Phosphonocarboxylate salts.</SUBJECT>
          <SECTNO>721.6090</SECTNO>
          <SUBJECT>Phosphoramide.</SUBJECT>
          <SECTNO>721.6097</SECTNO>
          <SUBJECT>Phosphoric acid derivative (generic name).</SUBJECT>
          <SECTNO>721.6100</SECTNO>
          <SUBJECT>Phosphoric acid, C<E T="52">6‐12</E>-alkyl esters, compounds with 2-(dibutylamino) ethanol.</SUBJECT>
          <SECTNO>721.6110</SECTNO>
          <SUBJECT>Alkyldi(alkyloxyhydroxypropyl) derivative, phosphoric acid esters, potassium salts.</SUBJECT>
          <SECTNO>721.6120</SECTNO>
          <SUBJECT>Phosphoric acid, 1,2-ethanediyl tetrakis(2-chloro-1-methylethyl) ester.</SUBJECT>
          <SECTNO>721.6140</SECTNO>
          <SUBJECT>Dialkyldithiophosphoric acid, aliphatic amine salt.</SUBJECT>
          <SECTNO>721.6160</SECTNO>
          <SUBJECT>Piperazinone, 1,1<E T="61">′</E>,1<E T="62">″</E>-[1,3,5-triazine-2,4,6-triyltris[(cyclohexylimino)-2,1-ethanediyl]]tris-[3,3,4,5,5-pentamethyl]-.</SUBJECT>
          <SECTNO>721.6165</SECTNO>
          <SUBJECT>Polysubstituted piperidine.<PRTPAGE P="125"/>
          </SUBJECT>
          <SECTNO>721.6170</SECTNO>
          <SUBJECT>Siloxanes and silicones, Me hydrogen, reaction products with 2,2,6,6-tetramethyl-4-(2-propenyloxy)piperdine.</SUBJECT>
          <SECTNO>721.6175</SECTNO>
          <SUBJECT>2-Piperdinone, 1,3-dimethyl-.</SUBJECT>
          <SECTNO>721.6176</SECTNO>
          <SUBJECT>2-Piperdinone, 1,5-dimethyl-.</SUBJECT>
          <SECTNO>721.6186</SECTNO>
          <SUBJECT>Polyamine dithiocarbamate.</SUBJECT>
          <SECTNO>721.6193</SECTNO>
          <SUBJECT>Polyalkylene polyamine.</SUBJECT>
          <SECTNO>721.6200</SECTNO>
          <SUBJECT>Fatty acid polyamine condensate, phosphoric acid ester salts.</SUBJECT>
          <SECTNO>721.6220</SECTNO>
          <SUBJECT>Aryl sulfonate of a fatty acid mixture, polyamine condensate.</SUBJECT>
          <SECTNO>721.6440</SECTNO>
          <SUBJECT>Polyamine urea-for-malde-hyde condensate (specific name).</SUBJECT>
          <SECTNO>721.6470</SECTNO>
          <SUBJECT>Polyaminopolyacid.</SUBJECT>
          <SECTNO>721.6475</SECTNO>
          <SUBJECT>Alkyl polycarboxylic acids, esters with ethoxylated fatty alcohols.</SUBJECT>
          <SECTNO>721.6477</SECTNO>
          <SUBJECT>Alkyl polycarboxylic acids, esters with ethoxylated fatty alcohols, reaction products with maleic anhydride.</SUBJECT>
          <SECTNO>721.6485</SECTNO>
          <SUBJECT>Hydroxy terminated polyester.</SUBJECT>
          <SECTNO>721.6490</SECTNO>
          <SUBJECT>Alkyl phenyl polyetheramines.</SUBJECT>
          <SECTNO>721.6495</SECTNO>
          <SUBJECT>Aliphatic polyisocyanate.</SUBJECT>
          <SECTNO>721.6498</SECTNO>
          <SUBJECT>Modified polyisocyanates (generic).</SUBJECT>
          <SECTNO>721.6505</SECTNO>
          <SUBJECT>Polymers of C<E T="52">13</E>C<E T="52">15</E> oxoalcohol ethoxolates.</SUBJECT>
          <SECTNO>721.6520</SECTNO>
          <SUBJECT>Acrylamide, polymer with substituted alkylacrylamide salt (generic name).</SUBJECT>
          <SECTNO>721.6540</SECTNO>
          <SUBJECT>Acrylamide, polymers with tetraalkyl ammonium salt and polyalkyl, aminoalkyl methacrylamide salt.</SUBJECT>
          <SECTNO>721.6560</SECTNO>
          <SUBJECT>Acrylic acid, polymer with substituted ethene.</SUBJECT>
          <SECTNO>721.6620</SECTNO>
          <SUBJECT>Alkanaminium, polyalkyl-[(2-methyl-1-oxo-2-propenyl)oxy] salt, polymer with acrylamide and substituted alkyl methacrylate.</SUBJECT>
          <SECTNO>721.6660</SECTNO>
          <SUBJECT>Polymer of alkanepolyol and poly-alkyl-poly-iso-cyan-ato-car-bo-mo-no-cycle, acetone oxime-blocked (generic name).</SUBJECT>
          <SECTNO>721.6680</SECTNO>
          <SUBJECT>Alkanoic acid, butanediol and cyclohexanealkanol polymer (generic name).</SUBJECT>
          <SECTNO>721.6820</SECTNO>
          <SUBJECT>Polymer of substituted aryl olefin.</SUBJECT>
          <SECTNO>721.6900</SECTNO>
          <SUBJECT>Polymer of bisphenol A diglycidal ether, substituted alkenes, and butadiene.</SUBJECT>
          <SECTNO>721.6920</SECTNO>
          <SUBJECT>Butyl acrylate, polymer with substituted methyl styrene, methyl methacrylate, and substituted silane.</SUBJECT>
          <SECTNO>721.6980</SECTNO>
          <SUBJECT>Dimer acids, polymer with poly-al-ky-lene glycol, bisphenol A-diglycidyl ether, and alky-lenepolyols polyglycidyl ethers (generic name).</SUBJECT>
          <SECTNO>721.7000</SECTNO>
          <SUBJECT>Polymer of disodium maleate, allyl ether, and ethylene oxide.</SUBJECT>
          <SECTNO>721.7020</SECTNO>
          <SUBJECT>Distillates (petroleum), C(3-6), polymers with styrene and mixed terpenes (generic name).</SUBJECT>
          <SECTNO>721.7046</SECTNO>
          <SUBJECT>Formaldehyde, polymer with substituted phenols, glycidyl ether.</SUBJECT>
          <SECTNO>721.7160</SECTNO>
          <SUBJECT>2-Oxepanone, polymer with 4,4’-(1-methylethylidene)bisphenol and 2,2-[(1-methylethylidene)bis(4,1-phe-ny-lene-oxy-methyl-ene)]-bi-soxirane, graft.</SUBJECT>
          <SECTNO>721.7200</SECTNO>
          <SUBJECT>Perfluoroalkyl aromatic carbamate modified alkyl methacrylate copolymer.</SUBJECT>
          <SECTNO>721.7210</SECTNO>
          <SUBJECT>Epoxidized copolymer of phenol and substituted phenol.</SUBJECT>
          <SECTNO>721.7220</SECTNO>
          <SUBJECT>Polymer of substituted phenol, formaldehyde, epichlorohydrin, and disubstituted benzene.</SUBJECT>
          <SECTNO>721.7260</SECTNO>
          <SUBJECT>Polymer of poly-ethylene-polyamine and alkanediol diglycidyl ether.</SUBJECT>
          <SECTNO>721.7280</SECTNO>
          <SUBJECT>1,3-Propanediamine, N,N’-1,2-eth-an-ediyl-bis-, polymer with 2,4,6-trichloro-1,3,5-triazine, reaction products with N-butyl-2,2,6,6-tetramethyl-4-pip-er-i-dinamine.</SUBJECT>
          <SECTNO>721.7285</SECTNO>
          <SUBJECT>Amines, N-cocoalkyltrimethylenedi-, citrates.</SUBJECT>
          <SECTNO>721.7286</SECTNO>
          <SUBJECT>Amines, N-tallowalkyltripropylenetetra-, citrates.</SUBJECT>
          <SECTNO>721.7375</SECTNO>
          <SUBJECT>Potassium salt of polyolefin acid.</SUBJECT>
          <SECTNO>721.7378</SECTNO>
          <SUBJECT>Substituted polyoxyethylene.</SUBJECT>
          <SECTNO>721.7440</SECTNO>
          <SUBJECT>Polyalkylenepolyol alky-la-mine. (generic name).</SUBJECT>
          <SECTNO>721.7450</SECTNO>
          <SUBJECT>Aromatic amine polyols.</SUBJECT>
          <SECTNO>721.7480</SECTNO>
          <SUBJECT>Isocyanate terminated polyols.</SUBJECT>
          <SECTNO>721.7500</SECTNO>
          <SUBJECT>Nitrate polyether polyol (generic name).</SUBJECT>
          <SECTNO>721.7600</SECTNO>
          <SUBJECT>Alkyl(heterocyclicyl) phe-nyl-az-o-he-tero monocyclic poly-one (generic name).</SUBJECT>
          <SECTNO>721.7620</SECTNO>
          <SUBJECT>Alkyl(heterocyclicyl) phe-nyl-az-o-he-tero monocyclic polyone, ((alkylimidazolyl) methyl) derivative (generic name).</SUBJECT>
          <SECTNO>721.7655</SECTNO>
          <SUBJECT>Alkylsulfonium salt.</SUBJECT>
          <SECTNO>721.7700</SECTNO>
          <SUBJECT>Poly(oxy-1,2-ethanediyl), <E T="61">α</E>-hydro-<E T="61">ω</E>-(oxiranylmethoxy)-, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1).</SUBJECT>
          <SECTNO>721.7710</SECTNO>
          <SUBJECT>Polyepoxy polyol.</SUBJECT>
          <SECTNO>721.7720</SECTNO>
          <SUBJECT>Poly(oxy-1,2-ethanediyl), <E T="61">α</E>,<E T="61">α</E>’-[(1-methylethylidene) di-4,1-phenylene] bis [<E T="61">ω</E>-(oxiranyl-methoxy)-.</SUBJECT>
          <SECTNO>721.7770</SECTNO>
          <SUBJECT>Alkylphenoxypoly(oxyethylene) sulfuric acid ester, substituted amine salt.</SUBJECT>
          <SECTNO>721.7780</SECTNO>
          <SUBJECT>Poly[oxy(methyl-1,2-ethane-diyl)], <E T="61">α</E>,<E T="61">α</E>’-(2,2-dimethyl-1,3-propanediyl)bis[<E T="61">ω</E>-(oxirany-methoxy)-.</SUBJECT>
          <SECTNO>721.7785</SECTNO>
          <SUBJECT>Substituted alkyl aminomethylene polyphosphonic acid, salt (generic).</SUBJECT>
          <SECTNO>721.8079</SECTNO>
          <SUBJECT>Isophorone diisocyanate neopentyl glycol adipate polyurethane prepolymer.</SUBJECT>
          <SECTNO>721.8082</SECTNO>
          <SUBJECT>Polyester polyurethane acrylate.</SUBJECT>
          <SECTNO>721.8090</SECTNO>
          <SUBJECT>Polyurethane polymer.</SUBJECT>
          <SECTNO>721.8095</SECTNO>
          <SUBJECT>Silylated polyurethane.</SUBJECT>
          <SECTNO>721.8100</SECTNO>
          <SUBJECT>Potassium N,N-bis (hydroxy-ethyl) cocoamine oxide phosphate, and potassium N,N-bis (hydroxyethyl) tallowamine oxide phosphate.</SUBJECT>
          <SECTNO>721.8153</SECTNO>
          <SUBJECT>Di-substituted propanedione (generic).</SUBJECT>
          <SECTNO>721.8155</SECTNO>
          <SUBJECT>Propanenitrile, 3-[amino, <E T="03">N</E>-tallowalkyl] dipropylenetri- and tripropylenetri- and propanenitrile, 3-[amino, (C<E T="52">14‐18</E> and C<E T="52">16‐18</E> unsaturated alkyl)] trimethylenedi-, dipropylenetri-, and tripropylenetetra-.</SUBJECT>
          <SECTNO>721.8160</SECTNO>
          <SUBJECT>Propanoic acid, 2,2-dimethyl-, ethenyl ester.<PRTPAGE P="126"/>
          </SUBJECT>
          <SECTNO>721.8170</SECTNO>
          <SUBJECT>Propanol, [2-(1,1-dimethylethoxy)methylethoxy]-.</SUBJECT>
          <SECTNO>721.8225</SECTNO>
          <SUBJECT>2-Propenamide, N-[3-di-methyl-amino)propyl]-.</SUBJECT>
          <SECTNO>721.8250</SECTNO>
          <SUBJECT>1-Propanol, 3,3<E T="61">′</E>-oxybis[2,2-bis(bro-mo-methyl)-.</SUBJECT>
          <SECTNO>721.8350</SECTNO>
          <SUBJECT>2-Propenoic acid, 7-ox-a-bi-cy-clo[4.1.0]hept-3-ylmethyl ester.</SUBJECT>
          <SECTNO>721.8450</SECTNO>
          <SUBJECT>2-Propenoic acid, 2-methyl-, 2-[3-(2H-benzotriazol-2-yl)-4-hydroxyphenyl]ethyl ester.</SUBJECT>
          <SECTNO>721.8500</SECTNO>
          <SUBJECT>2-Propenoic acid, 2-methyl-, 7-oxabicyclo [4.1.0]hept-3-ylmethyl ester.</SUBJECT>
          <SECTNO>721.8660</SECTNO>
          <SUBJECT>Propionic acid methyl ester (generic).</SUBJECT>
          <SECTNO>721.8670</SECTNO>
          <SUBJECT>Alkylcyano substituted pyridazo benzoate.</SUBJECT>
          <SECTNO>721.8673</SECTNO>
          <SUBJECT>[(Disubstituted phenyl)]azo dihydro hydroxy alkyl oxo alkyl-substituted-pyridines (generic name).</SUBJECT>
          <SECTNO>721.8675</SECTNO>
          <SUBJECT>Halogenated pyridines.</SUBJECT>
          <SECTNO>721.8700</SECTNO>
          <SUBJECT>Halogenated alkyl pyridine.</SUBJECT>
          <SECTNO>721.8750</SECTNO>
          <SUBJECT>Halogenated substituted pyridine.</SUBJECT>
          <SECTNO>721.8775</SECTNO>
          <SUBJECT>Substituted pyridines.</SUBJECT>
          <SECTNO>721.8780</SECTNO>
          <SUBJECT>Substituted pyridine azo substituted phenyl.</SUBJECT>
          <SECTNO>721.8825</SECTNO>
          <SUBJECT>Substituted methylpyridine and substituted 2-phenoxypyridine.</SUBJECT>
          <SECTNO>721.8850</SECTNO>
          <SUBJECT>Disubstituted halogenated py-rid-i-nol.</SUBJECT>
          <SECTNO>721.8875</SECTNO>
          <SUBJECT>Substituted halogenated pyridinol.</SUBJECT>
          <SECTNO>721.8900</SECTNO>
          <SUBJECT>Substituted halogenated pyridinol, alkali salt.</SUBJECT>
          <SECTNO>721.8965</SECTNO>
          <SUBJECT>1<E T="03">H</E>-Pyrole-2, 5-dione, 1-(2,4,6-tribromophenyl)-.</SUBJECT>
          <SECTNO>721.9000</SECTNO>
          <SUBJECT>N-Nitrosopyrrolidine.</SUBJECT>
          <SECTNO>721.9005</SECTNO>
          <SUBJECT>2-Pyrrolidinone, 1,1′-(2-methyl-1,5-pentanediyl)bis-.</SUBJECT>
          <SECTNO>721.9010</SECTNO>
          <SUBJECT>2-pyrrolidone, 1-ethenyl-3-ethylidene-, (E)-.</SUBJECT>
          <SECTNO>721.9075</SECTNO>
          <SUBJECT>Quaternary ammonium salt of fluorinated alkylaryl amide.</SUBJECT>
          <SECTNO>721.9080</SECTNO>
          <SUBJECT>Nitro methyl quinoline.</SUBJECT>
          <SECTNO>721.9100</SECTNO>
          <SUBJECT>Substituted quinoline.</SUBJECT>
          <SECTNO>721.9220</SECTNO>
          <SUBJECT>Reaction products of secondary alkyl amines with a substituted benzenesulfonic acid and sulfuric acid (generic name).</SUBJECT>
          <SECTNO>721.9265</SECTNO>
          <SUBJECT>Reaction product of dichlorobenzidine and substituted alkylamide.</SUBJECT>
          <SECTNO>721.9270</SECTNO>
          <SUBJECT>Reaction product of epoxy with anhydride and glycerol and glycol.</SUBJECT>
          <SECTNO>721.9280</SECTNO>
          <SUBJECT>Reaction product of ethoxylated fatty acid oils and a phenolic pentaerythritol tetraester.</SUBJECT>
          <SECTNO>721.9285</SECTNO>
          <SUBJECT>Reaction products of formalin (37%) with amine C<E T="52">12</E>.</SUBJECT>
          <SECTNO>721.9300</SECTNO>
          <SUBJECT>Reaction products of substituted hydroxy-alkanes and polyalkyl-polyiso-cyanato-carbomono-cycle.</SUBJECT>
          <SECTNO>721.9400</SECTNO>
          <SUBJECT>Reaction product of phenolic pentaerythritol tetraesters with fatty acid esters and oils, and glyceride triesters.</SUBJECT>
          <SECTNO>721.9460</SECTNO>
          <SUBJECT>Tall oil fatty acids, reaction products with polyamines, alkyl substituted.</SUBJECT>
          <SECTNO>721.9470</SECTNO>
          <SUBJECT>Reserpine.</SUBJECT>
          <SECTNO>721.9480</SECTNO>
          <SUBJECT>Resorcinol, formaldehyde substituted carbomonocycle resin.</SUBJECT>
          <SECTNO>721.9488</SECTNO>
          <SUBJECT>Substituted resorcinols.</SUBJECT>
          <SECTNO>721.9490</SECTNO>
          <SUBJECT>Coco alklydimethyl amine salts (generic).</SUBJECT>
          <SECTNO>721.9492</SECTNO>
          <SUBJECT>Polymers of styrene, cyclohexyl methacrylate and substituted methacrylate.</SUBJECT>
          <SECTNO>721.9495</SECTNO>
          <SUBJECT>Acrylosilane resins.</SUBJECT>
          <SECTNO>721.9497</SECTNO>
          <SUBJECT>Trifunctional ketoximino silane.</SUBJECT>
          <SECTNO>721.9499</SECTNO>
          <SUBJECT>Modified silicone resin.</SUBJECT>
          <SECTNO>721.9500</SECTNO>
          <SUBJECT>Silane, (1,1-dimethylethoxy) di-meth-oxy(2-methyl propyl)-.</SUBJECT>
          <SECTNO>721.9503</SECTNO>
          <SUBJECT>Silane, (3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)trimethoxy-.</SUBJECT>
          <SECTNO>721.9505</SECTNO>
          <SUBJECT>Silanes substituted macrocycle polyethyl.</SUBJECT>
          <SECTNO>721.9507</SECTNO>
          <SUBJECT>Polyester silane.</SUBJECT>
          <SECTNO>721.9508</SECTNO>
          <SUBJECT>Perfluorinatedalkyl polyhydroxysilane (generic).</SUBJECT>
          <SECTNO>721.9509</SECTNO>
          <SUBJECT>Perfluorinatedalkyl polyalkoxysilane (generic).</SUBJECT>
          <SECTNO>721.9513</SECTNO>
          <SUBJECT>Modified magnesium silicate polymer (generic).</SUBJECT>
          <SECTNO>721.9515</SECTNO>
          <SUBJECT>Aminofunctional alkoxy alkyl siloxane.</SUBJECT>
          <SECTNO>721.9516</SECTNO>
          <SUBJECT>Siloxanes and silicones, 3-[(2-aminoethyl) amino]propyl Me, di-Me, reaction products with polyethylene-polypropylene glycol Bu glycidal ether.</SUBJECT>
          <SECTNO>721.9517</SECTNO>
          <SUBJECT>Siloxanes and silicones, de-Me, 3-[4-[[[3-(dimethyl amino) propyl] amino]carbonyl]-2-oxo-1-pyrrolidinyl] propyl Me.</SUBJECT>
          <SECTNO>721.9518</SECTNO>
          <SUBJECT>Sinorhizobuim meliloti strain RMBPC-2.</SUBJECT>
          <SECTNO>721.9526</SECTNO>
          <SUBJECT>Sodium perthiocarbonate.</SUBJECT>
          <SECTNO>721.9527</SECTNO>
          <SUBJECT>Bis(1,2,2,6,6-pentamethyl-4-piperidin-4-ol) ester of cycloaliphatic spiroketal.</SUBJECT>
          <SECTNO>721.9530</SECTNO>
          <SUBJECT>Bis(2,2,6,6-tetra-methyl-piper-idinyl) ester of cycloalkyl spiroketal.</SUBJECT>
          <SECTNO>721.9540</SECTNO>
          <SUBJECT>Polysulfide mixture.</SUBJECT>
          <SECTNO>721.9545</SECTNO>
          <SUBJECT>Substituted phenyl azo substituted sulfocarbopolycle, sodium salt.</SUBJECT>
          <SECTNO>721.9550</SECTNO>
          <SUBJECT>Sulfonamide.</SUBJECT>
          <SECTNO>721.9570</SECTNO>
          <SUBJECT>Halophenyl sulfonamide salt.</SUBJECT>
          <SECTNO>721.9573</SECTNO>
          <SUBJECT>Substituted perfluoroalkyl sulfonamide (generic).</SUBJECT>
          <SECTNO>721.9575</SECTNO>
          <SUBJECT>Chromate(3-), bis[3-[[5-(aminosulfonyl)-2-hydroxyphenyl]azo]-4-hydroxy-7-[[2-oxo-1-[(phenylamino)carbonyl] propyl]azo]-2-naphthalenesulfonato(3-)]-, trisodium (9CI).</SUBJECT>
          <SECTNO>721.9576</SECTNO>
          <SUBJECT>Chromate(3-), bis[7-[(aminohydroxyphenyl)azo]-3-[[5-(aminosulfonyl)-2-hydroxyphenyl]azo]-4-hydroxy-2-naphthalene-sulfonato (3-)]-, trisodium (9CI).</SUBJECT>
          <SECTNO>721.9577</SECTNO>

          <SUBJECT>Chromate(3-), bis[7-[(aminohydroxyphenyl)azo]-3-[[5-(aminosulfonyl)-2-hydroxyphenyl] azo]-4-hydroxy-2-naphthalene sulfonato (3-)]-,-[[5-(aminosulfonyl) -2-<PRTPAGE P="127"/>hydroxyphenyl]azo]-4-hydroxy-7-[[2-hydroxy-1-[(phenylamino) carbonyl]-1-propenyl]azo]-2-naphthalenesulfonato(3-)]-, trisodium (9CI).</SUBJECT>
          <SECTNO>721.9580</SECTNO>
          <SUBJECT>Ethyl methanesulfonate.</SUBJECT>
          <SECTNO>721.9595</SECTNO>
          <SUBJECT>Alkyl benzene sulfonic acids and alkyl sulfates, amine salts (generic).</SUBJECT>
          <SECTNO>721.9620</SECTNO>
          <SUBJECT>Aromatic sulfonic acid compound with amine.</SUBJECT>
          <SECTNO>721.9630</SECTNO>
          <SUBJECT>Polyfluorosulfonic acid salt.</SUBJECT>
          <SECTNO>721.9635</SECTNO>
          <SUBJECT>Terpene residue distillates.</SUBJECT>
          <SECTNO>721.9650</SECTNO>
          <SUBJECT>Tetramethylammonium salts of alkylbenzenesulfonic acid.</SUBJECT>
          <SECTNO>721.9656</SECTNO>
          <SUBJECT>Thiaalkanethiol.</SUBJECT>
          <SECTNO>721.9657</SECTNO>
          <SUBJECT>Disubstituted thiadiazole.</SUBJECT>
          <SECTNO>721.9658</SECTNO>
          <SUBJECT>Thiadiazole derivative.</SUBJECT>
          <SECTNO>721.9659</SECTNO>
          <SUBJECT>Disubstituted thiadiazosulfone.</SUBJECT>
          <SECTNO>721.9660</SECTNO>
          <SUBJECT>Methylthiouracil.</SUBJECT>
          <SECTNO>721.9661</SECTNO>
          <SUBJECT>Diphenol tars (generic).</SUBJECT>
          <SECTNO>721.9662</SECTNO>
          <SUBJECT>Thieno[3,4-b]-1,4-dioxin, 2,3-dihydro- (9CI).</SUBJECT>
          <SECTNO>721.9663</SECTNO>

          <SUBJECT>Poly(oxy-1,2-ethanediyl), alpha, alpha′-[thiobis (1-oxo-3,1-propanediyl)]bis [omega-hydroxy-,bis (C<E T="52">11-15</E> and C<E T="52">11-15-isoalkyl</E>) ethers.</SUBJECT>
          <SECTNO>721.9664</SECTNO>
          <SUBJECT>9H-Thioxanthen-9-one,2,4-diethyl.</SUBJECT>
          <SECTNO>721.9665</SECTNO>
          <SUBJECT>Organotin catalysts.</SUBJECT>
          <SECTNO>721.9668</SECTNO>
          <SUBJECT>Organotin lithium compound.</SUBJECT>
          <SECTNO>721.9672</SECTNO>
          <SUBJECT>Amides, tall-oil fatty, N-[2-[2-hydroxyethyl)amino]ethyl], reaction products with sulfur dioxide; fatty acids, tall-oil, reaction products with 1-piperazineethanamine and sulfur dioxide; fatty acids, tall-oil reaction products with sulfur dioxide and triethylenetetramine.</SUBJECT>
          <SECTNO>721.9675</SECTNO>
          <SUBJECT>Titanate [Ti<E T="52">6</E> O<E T="52">13</E> (2-)], di-potas-sium.</SUBJECT>
          <SECTNO>721.9680</SECTNO>
          <SUBJECT>Alkaline titania silica gel (generic name).</SUBJECT>
          <SECTNO>721.9685</SECTNO>
          <SUBJECT>Mixed trialkylamines (generic).</SUBJECT>
          <SECTNO>721.9700</SECTNO>
          <SUBJECT>Monosubstituted alkoxy-amino-tra-zines (generic name).</SUBJECT>
          <SECTNO>721.9717</SECTNO>
          <SUBJECT>Azo monochloro triazine reactive dye.</SUBJECT>
          <SECTNO>721.9719</SECTNO>
          <SUBJECT>Tris carbamoyl triazine (generic).</SUBJECT>
          <SECTNO>721.9720</SECTNO>
          <SUBJECT>Disubstituted alkyl triazines (generic name).</SUBJECT>
          <SECTNO>721.9730</SECTNO>
          <SUBJECT>1,3,5-Triazin-2-amine, 4-dimethylamino-6-substituted-.</SUBJECT>
          <SECTNO>721.9740</SECTNO>
          <SUBJECT>Brominated triazine derivative.</SUBJECT>
          <SECTNO>721.9750</SECTNO>
          <SUBJECT>2-Chloro-4,6-bis(substituted)-1,3,5-triazine, dihydrochloride.</SUBJECT>
          <SECTNO>721.9785</SECTNO>
          <SUBJECT>Benzenesulfonic acid, 2,2′-[(1E)-1,2- ethenediyl] bis[5-[[4-(methylamino)-6-[[4-[(methylamino)carbonylphenyl]amino]-1,3,5-triazin-2-yl]amino]-,disodium salt.</SUBJECT>
          <SECTNO>721.9790</SECTNO>
          <SUBJECT>Benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4-[bis(2-hydroxypropyl) amino]- 6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-, disodium salt, compd. with 2,2′,2″-nitrilo-tris[ethanol] (1:2); Benzenesulfonic acid, 5-[[4-[bis(2-hydroxyethyl)amino]-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4-[bis(2-hydroxypropyl)amino]-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]-, disodium salt, compd. with 2,2′,2″-nitrilotris[ethanol] (1:2).</SUBJECT>
          <SECTNO>721.9795</SECTNO>
          <SUBJECT>Benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[(4,6-dichloro-1,3,5-triazin-2-yl) amino]-, disodium salt, substituted with dialkyl amines (generic).</SUBJECT>
          <SECTNO>721.9798</SECTNO>
          <SUBJECT>Benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4-substituted-6-substituted-1,3,5-triazin-2-yl]amino]-, sodium salt (generic).</SUBJECT>
          <SECTNO>721.9800</SECTNO>
          <SUBJECT>Poly(substituted triazinyl) piperazine (generic name).</SUBJECT>
          <SECTNO>721.9810</SECTNO>
          <SUBJECT>Substituted amino alkyl triazinyl benzenesulfonic acid derivative (generic).</SUBJECT>
          <SECTNO>721.9820</SECTNO>
          <SUBJECT>Substituted triazole.</SUBJECT>
          <SECTNO>721.9825</SECTNO>
          <SUBJECT>Phenyl substituted triazolinones.</SUBJECT>
          <SECTNO>721.9830</SECTNO>
          <SUBJECT>1-Tridecyn-3-ol, 3-methyl.</SUBJECT>
          <SECTNO>721.9840</SECTNO>
          <SUBJECT>Tungstate (W12(OH)2O386-) hexasodium (9CI).</SUBJECT>
          <SECTNO>721.9850</SECTNO>
          <SUBJECT>2,4,8,10-Tetraoxa-3,9-diphosphaspiro[5.5]undecane, 3,9-bis[2,4,6-tris(1,1-dimethylethyl)phenoxy]-.</SUBJECT>
          <SECTNO>721.9892</SECTNO>
          <SUBJECT>Alkylated urea.</SUBJECT>
          <SECTNO>721.9900</SECTNO>

          <SUBJECT>Urea, condensate with poly[oxy(methyl-1,2ethanediyl)]-<E T="61">α</E>- (2-aminomethylethyl)-<E T="61">μ</E>-(2-amino-ethylethoxy) (generic name).</SUBJECT>
          <SECTNO>721.9920</SECTNO>
          <SUBJECT>Urea, (hexahydro-6-methyl-2-ox-o-py-rim-idinyl)-.</SUBJECT>
          <SECTNO>721.9925</SECTNO>
          <SUBJECT>Aminoethylethylene urea methacrylamide.</SUBJECT>
          <SECTNO>721.9928</SECTNO>
          <SUBJECT>Urea, tetaethyl-.</SUBJECT>
          <SECTNO>721.9930</SECTNO>
          <SUBJECT>Urethane.</SUBJECT>
          <SECTNO>721.9957</SECTNO>
          <SUBJECT>N-Nitroso-N-methylurethane.</SUBJECT>
          <SECTNO>721.9965</SECTNO>
          <SUBJECT>Fatty acids, C<E T="52">10-13</E> - branched, vinyl esters.</SUBJECT>
          <SECTNO>721.9969</SECTNO>
          <SUBJECT>3,6-Bis(dialkylamino) -9-[2-alkoxycarbonyl) phenyl]-xanthylium salt (generic).</SUBJECT>
          <SECTNO>721.9970</SECTNO>
          <SUBJECT>o-Xylene compound (generic name).</SUBJECT>
          <SECTNO>721.9973</SECTNO>
          <SUBJECT>Zirconium dichlorides (generic).</SUBJECT>
        </SUBPART>
      </CONTENTS>
      <AUTH>
        <HD SOURCE="HED">Authority:</HD>
        <P>15 U.S.C. 2604, 2607, and 2625(c).</P>
      </AUTH>
      <SUBPART>
        <HD SOURCE="HED">Subpart A—General Provisions</HD>
        <SECTION>
          <SECTNO>§ 721.1</SECTNO>
          <SUBJECT>Scope and applicability.</SUBJECT>

          <P>(a) This part identifies uses of chemical substances, except for microorganisms regulated under part 725 of this chapter, which EPA has determined are significant new uses under the authority of section 5(a)(2) of the Toxic Substances Control Act. In addition, it specifies procedures for manufacturers, importers, and processors to report on those significant new uses. This subpart A contains general provisions applicable to this part. subpart B of this part identifies generic requirements for certain significant new uses cross referenced in specific provisions of subpart E of this part. subpart C of this <PRTPAGE P="128"/>part identifies generic reporting requirements for certain significant new uses cross referenced in specific provisions of subpart E of this part. subpart E of this part identifies chemical substances and their significant new uses.</P>
          <P>(b) This subpart A contains provisions governing submission and review of notices for the chemical substances and significant new uses identified in subpart E of this part. The provisions of this subpart A apply to the chemical substances and significant new uses identified in subpart E of this part, except to the extent that they are specifically modified or supplanted by specific requirements in subpart E of this part. In the event of a conflict between the provisions of this subpart A and the provisions of subpart E of this part, the provisions of subpart E of this part shall govern.</P>
          <P>(c) The provisions of part 720 of this chapter apply to this part 721. For purposes of this part 721, wherever the phrase “new chemical substance” appears in part 720 of this chapter, it shall mean the chemical substance subject to this part 721. In the event of a conflict between the provisions of part 720 of this chapter and the provisions of this part 721, the provisions of this part 721 shall govern.</P>
          <CITA>[53 FR 28358, July 27, 1988, as amended at 62 FR 17932, Apr. 11, 1997]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.3</SECTNO>
          <SUBJECT>Definitions.</SUBJECT>
          <P>The definitions in section 3 of the Act, 15 U.S.C. 2602, and § 720.3 of this chapter apply to this part. In addition, the following definitions apply to this part:</P>
          <P>
            <E T="03">Acutely toxic effects</E> A chemical substance produces acutely toxic effects if it kills within a short time period (usually 14 days):</P>

          <P>(1) At least 50 percent of the exposed mammalian test animals following oral administration of a single dose of the test substance at 25 milligrams or less per kilogram of body weight (LD<E T="22">50</E>).</P>

          <P>(2) At least 50 percent of the exposed mammalian test animals following dermal administration of a single dose of the test substance at 50 milligrams or less per kilogram of body weight (LD<E T="22">50</E>).</P>

          <P>(3) At least 50 percent of the exposed mammalian test animals following administration of the test substance for 8 hours or less by continuous inhalation at a steady concentration in air at 0.5 milligrams or less per liter of air (LC<E T="22">50</E>).</P>
          <P>
            <E T="03">CAS Number</E> means Chemical Abstracts Service Registry Number assigned to a chemical substance on the Inventory.</P>
          <P>
            <E T="03">Chemical name</E> means the scientific designation of a chemical substance in accordance with the nomenclature system developed by the International Union of Pure and Applied Chemistry or the Chemical Abstracts Service's rules of nomenclature, or a name which will clearly identify a chemical substance for the purpose of conducting a hazard evaluation.</P>
          <P>
            <E T="03">Chemical protective clothing</E> means items of clothing that provide a protective barrier to prevent dermal contact with chemical substances of concern. Examples can include, but are not limited to: full body protective clothing, boots, coveralls, gloves, jackets, and pants.</P>
          <P>
            <E T="03">Commercial use</E> means the use of a chemical substance or any mixture containing the chemical substance in a commercial enterprise providing saleable goods or a service to consumers (e.g., a commercial dry cleaning establishment or painting contractor).</P>
          <P>
            <E T="03">Common name</E> means any designation or identification such as code name, code number, trade name, brand name, or generic chemical name used to identify a chemical substance other than by its chemical name.</P>
          <P>
            <E T="03">Consumer</E> means a private individual who uses a chemical substance or any product containing the chemical substance in or around a permanent or temporary household or residence, during recreation, or for any personal use or enjoyment.</P>
          <P>
            <E T="03">Consumer product</E> means a chemical substance that is directly, or as part of a mixture, sold or made available to consumers for their use in or around a permanent or temporary household or residence, in or around a school, or in recreation.</P>
          <P>
            <E T="03">Customer</E> means any person to whom a manufacturer, importer, or processor distributes any quantity of a chemical substance, or of a mixture containing <PRTPAGE P="129"/>the chemical substance, whether or not a sale is involved.</P>
          <P>
            <E T="03">Director of the Office of Pollution Prevention and Toxics</E> means the Director of the EPA Office of Pollution Prevention and Toxics or any EPA employee delegated by the Office Director to carry out the Office Director's functions under this part.</P>
          <P>
            <E T="03">Employer</E> means any manufacturer, importer, processor, or user of chemical substances or mixtures.</P>
          <P>
            <E T="03">Environmentally transformed</E> A chemical substance is “environmentally transformed” when its chemical structure changes as a result of the action of environmental processes on it.</P>
          <P>
            <E T="03">Facility</E> means all buildings, equipment, structures, and other stationary items which are located on a single site or on contiguous or adjacent sites and which are owned or operated by the same person (or by any person which controls, is controlled by, or under common control with such person).</P>
          <P>
            <E T="03">Identity</E> means any chemical or common name used to identify a chemical substance or a mixture containing that substance.</P>
          <P>
            <E T="03">Immediate use</E> A chemical substance is for the “immediate use” of a person if it is under the control of, and used only by, the person who transferred it from a labeled container and will only be used by that person within the work shift in which it is transferred from the labeled container.</P>
          <P>
            <E T="03">Impervious</E> Chemical protective clothing is “impervious” to a chemical substance if the substance causes no chemical or mechanical degradation, permeation, or penetration of the chemical protective clothing under the conditions of, and the duration of, exposure.</P>
          <P>
            <E T="03">Manufacturing stream</E> means all reasonably anticipated transfer, flow, or disposal of a chemical substance, regardless of physical state or concentration, through all intended operations of manufacture, including the cleaning of equipment.</P>
          <P>
            <E T="03">Metalworking fluid</E> means a liquid of any viscosity or color containing intentionally added water and used in metal machining operations for the purpose of cooling, lubricating, or rust inhibition.</P>
          <P>
            <E T="03">MSDS</E> means material safety data sheet, the written listing of data for the chemical substance as required under § 721.72(c).</P>
          <P>
            <E T="03">NIOSH</E> means the National Institute for Occupational Safety and Health of the U.S. Department of Health and Human Services.</P>
          <P>
            <E T="03">Non-enclosed process</E> means any equipment system (such as an open-top reactor, storage tank, or mixing vessel) in which a chemical substance is manufactured, processed, or otherwise used where significant direct contact of the bulk chemical substance and the workplace air may occur.</P>
          <P>
            <E T="03">Non-industrial use</E> means use other than at a facility where chemical substances or mixtures are manufactured, imported, or processed.</P>
          <P>
            <E T="03">Personal protective equipment</E> means any chemical protective clothing or device placed on the body to prevent contact with, and exposure to, an identified chemical substance or substances in the work area. Examples include, but are not limited to, chemical protective clothing, aprons, hoods, chemical goggles, face splash shields, or equivalent eye protection, and various types of respirators. Barrier creams are not included in this definition.</P>
          <P>
            <E T="03">Powder or dry solid form</E> means a state where all or part of the substance would have the potential to become fine, loose, solid particles.</P>
          <P>
            <E T="03">Principal importer</E> means the first importer who, knowing that a chemical substance will be imported for a significant new use rather than manufactured in the United States, specifies the chemical substance and the amount to be imported. Only persons who are incorporated, licensed, or doing business in the United States may be principal importers.</P>
          <P>
            <E T="03">Process for commercial purposes</E> means the preparation of a chemical substance or mixture containing the chemical substance, after manufacture of the substance, for distribution in commerce with the purpose of obtaining an immediate or eventual commercial advantage for the processor. Processing of any amount of a chemical substance or mixture containing the chemical substance is included in this definition. If a chemical substance or <PRTPAGE P="130"/>mixture containing impurities is processed for commercial purposes, the impurities also are processed for commercial purposes.</P>
          <P>
            <E T="03">Process solely for export</E> means to process for commercial purposes solely for export from the United States under the following restrictions on activity in the United States: Processing must be performed at sites under the control of the processor; distribution in commerce is limited to purposes of export; and the processor may not use the chemical substance except in small quantities solely for research and development.</P>
          <P>
            <E T="03">Process stream</E> means all reasonably anticipated transfer, flow, or disposal of a chemical substance, regardless of physical state or concentration, through all intended operations of processing, including the cleaning of equipment.</P>
          <P>
            <E T="03">Recipient</E> means any person who purchases or otherwise obtains a chemical substance directly from a person who manufacturers, imports, or processes the substance.</P>
          <P>
            <E T="03">Serious acute effects</E> means human injury or human disease processes that have a short latency period for development, result from short-term exposure to a chemical substance, or are a combination of these factors and which are likely to result in death or severe or prolonged incapacitation.</P>
          <P>
            <E T="03">Serious chronic effects</E> means human injury or human disease processes that have a long latency period for development, result from long-term exposure to a chemical substance, or are a combination of these factors and which are likely to result in death or severe or prolonged incapacitation.</P>
          <P>
            <E T="03">Short-term test indicative of carcinogenic potential</E> means either any limited bioassay that measures tumor or preneoplastic induction, or any test indicative of interaction of a chemical substance with DNA (i.e., positive response in assays for gene mutation, chromosomal aberrations, DNA damage and repair, or cellular transformation).</P>
          <P>
            <E T="03">Short-term test indicative of the potential to cause a developmentally toxic effect</E> means either any <E T="03">in vivo</E> preliminary development toxicity screen conducted in a mammalian species, or any <E T="03">in vitro</E> developmental toxicity screen, including any test system other than the intact pregnant mammal, that has been extensively evaluated and judged reliable for its ability to predict the potential to cause developmentally toxic effects in intact systems across a broad range of chemicals or within a class of chemicals that includes the substance of concern.</P>
          <P>
            <E T="03">Significant adverse environmental effects</E> means injury to the environment by a chemical substance which reduces or adversely affects the productivity, utility, value, or function of biological, commercial, or agricultural resources, or which may adversely affect a threatened or endangered species. A substance will be considered to have the potential for significant adverse environmental effects if it has one of the following:</P>
          <P>(1) An acute aquatic EC<E T="22">50</E> of 1 mg/L or less.</P>
          <P>(2) An acute aquatic EC<E T="22">50</E> of 20 mg/L or less where the ratio of aquatic vertebrate 24-hour to 48-hour EC<E T="22">50</E> is greater than or equal to 2.0.</P>
          <P>(3) A Maximum Acceptable Toxicant Concentration (MATC) of less than or equal to 100 parts per billion (100 ppb).</P>
          <P>(4) An acute aquatic EC<E T="22">50</E> of 20 mg/L or less coupled with either a measured bioconcentration factor (BCF) equal to or greater than 1,000x or in the absence of bioconcentration data a log P value equal to or greater than 4.3.</P>
          <P>
            <E T="03">Site</E> means a contiguous property unit. Property divided only by a public right-of-way is one site. There may be more than one manufacturing plant on a single site.</P>
          <P>
            <E T="03">Site-limited intermediate</E> means an intermediate manufactured, processed, and used only within a site and not distributed in commerce other than as an impurity or for disposal. Imported intermediates cannot be “site-limited.”</P>
          <P>
            <E T="03">Spray application</E> means any method of projecting a jet of vapor of finely divided liquid onto a surface to be coated; whether by compressed air, hydraulic pressure, electrostatic forces, or other methods of generating a spray.</P>
          <P>
            <E T="03">Use stream</E> means all reasonably anticipated transfer, flow, or disposal of a chemical substance, regardless of physical state or concentration, through all <PRTPAGE P="131"/>intended operations of industrial, commercial, or consumer use.</P>
          <P>
            <E T="03">Waters of the United States</E> has the meaning set forth in 40 CFR 122.2.</P>
          <P>
            <E T="03">Work area</E> means a room or defined space in a workplace where a chemical substance is manufactured, processed, or used and where employees are present.</P>
          <P>
            <E T="03">Workplace</E> means an establishment at one geographic location containing one or more work areas.</P>
          <CITA>[53 FR 28358, July 27, 1988, as amended at 54 FR 31306, July 27, 1989; 58 FR 63516, Dec. 1, 1993]</CITA>
          
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.5</SECTNO>
          <SUBJECT>Persons who must report.</SUBJECT>
          <P>(a) The following persons must submit a significant new use notice as specified under the provisions of section 5(a)(1)(B) of the Act, part 720 of this chapter, and § 721.25:</P>
          <P>(1) A person who intends to manufacture, import, or process for commercial purposes a chemical substance identified in a specific section in subpart E of this part, and intends to engage in a significant new use of the substance identified in that section.</P>
          <P>(2) A person who intends to manufacture, import, or process for commercial purposes a chemical substance identified in a specific section in subpart E of this part, and intends to distribute the substance in commerce. A person described in this paragraph is not required to submit a significant new use notice if that person can document one or more of the following as to each recipient of the substance from that person:</P>
          <P>(i) That the person has notified the recipient, in writing, of the specific section in subpart E of this part which identifies the substance and its designated significant new uses.</P>
          <P>(ii) That the recipient has knowledge of the specific section in subpart E of this part which identifies the substance and its designated significant new uses.</P>
          <P>(iii) That the recipient cannot undertake any significant new use described in the specific section in subpart E of this part.</P>
          <P>(b) A person described in paragraph (a)(2) of this section must submit a significant new use notice if that person has knowledge at the time of commercial distribution of the substance identified in the specific section in subpart E of this part that a recipient intends to engage in a designated significant new use of that substance without submitting a notice under this part.</P>
          <P>(c) A person who processes a chemical substance identified in a specific section in subpart E of this part for a significant new use of that substance is not required to submit a significant new use notice if that person can document each of the following:</P>
          <P>(1) That the person does not know the specific chemical identity of the chemical substance being processed.</P>
          <P>(2) That the person is processing the chemical substance without knowledge that the substance is identified in subpart E of this part.</P>
          <P>(d)(1) If at any time after commencing distribution in commerce of a chemical substance identified in a specific section in subpart E of this part a person described in paragraph (a)(2) of this section has knowledge that a recipient of the substance is engaging in a significant new use of that substance designated in that section without submitting a notice under this part, the person is required to cease supplying the chemical substance to that recipient and to submit a significant new use notice for that chemical substance and significant new use, unless the person is able to document each of the following:</P>
          <P>(i) That the person has notified the recipient and EPA enforcement authorities (at the address in paragraph (d)(1)(iii) of this section), in writing within 15 working days of the time the person develops knowledge that the recipient is engaging in a significant new use, that the recipient is engaging in a significant new use without submitting a significant new use notice.</P>
          <P>(ii) That, within 15 working days of notifying the recipient as described in paragraph (d)(1)(i) of this section, the person received from the recipient, in writing, a statement of assurance that the recipient is aware of the terms of the applicable section in subpart E of this part and will not engage in the significant new use.</P>

          <P>(iii) That the person has promptly provided EPA enforcement authorities <PRTPAGE P="132"/>with a copy of the recepient's statement of assurance described in paragraph (d)(1)(ii) of this section. The copy must be sent to the Office of Enforcement and Compliance Assurance, Office of Compliance (2224A), U.S. Environmental Protection Agency, Ariel Rios, 1200 Pennsylvania Ave., N.W., Washington, DC, 20044.</P>
          <P>(2) If EPA notifies the manufacturer, importer, or processor that the recipient is engaging in a significant new use after providing the statement of assurance described in paragraph (d)(1)(ii) of this section and without submitting a notice under this part, the manufacturer, importer, or processor shall immediately cease distribution to that recipient until the manufacturer, importer, or processor or the recipient has submitted a significant new use notice under this part and the notice review period has ended.</P>
          <P>(3) If, after receiving a statement of assurance from a recipient under paragraph (d)(1)(ii) of this section, a manufacturer, importer, or processor has knowledge that the recipient is engaging in a significant new use without submitting a notice under this part, the manufacturer, importer, or processor must immediately cease distributing the substance to that recipient and notify EPA enforcement authorities at the address identified in paragraph (d)(1)(iii) of this section. The manufacturer, importer, or processor may not resume distribution to that recipient until any one of the following has occurred:</P>
          <P>(i) The manufacturer, importer, or processor has submitted a significant new use notice under this part and the notice review period has ended.</P>
          <P>(ii) The recipient has submitted a significant new use notice under this part and the notice review period has ended.</P>
          <P>(iii) The manufacturer, importer, or processor has received notice from EPA enforcement authorities that it may resume distribution to that recipient.</P>
          <P>(e) Any significant new use notice relating to import of a substance must be submitted by the principal importer.</P>
          <CITA>[53 FR 28359, July 27, 1988, as amended at 60 FR 34464, July 3, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.11</SECTNO>
          <SUBJECT>Applicability determination when the specific chemical identity is confidential.</SUBJECT>

          <P>(a) A person who intends to manufacture, import, or process a chemical substance which is described by a generic chemical name is subpart E of this part may ask EPA whether the substance is subject to the requirements of this part. EPA will answer such an inquiry only if EPA determines that the person has a <E T="03">bona fide</E> intent to manufacture, import, or process the chemical substance for commercial purposes.</P>
          <P>(b) To establish a <E T="03">bona fide</E> intent to manufacture, import, or process a chemical substance, the person who intends to manufacture, import, or process the chemical substance must submit the following information in writing to the Document Control Office (7407), Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Room G-099, 401 M St., SW., Washington, DC., 20460, ATTN: SNUR Bonafide submissions.</P>
          <P>(1) The specific chemical identity of the chemical substance that the person intends to manufacture, import, or process.</P>
          <P>(2) A signed statement that the person intends to manufacture, import, or process the chemical substance for commercial purposes.</P>
          <P>(3) A description of the research and development activities conducted to date, and the purpose for which the person will manufacture, import, or process the chemical substance.</P>
          <P>(4) An elemental analysis.</P>
          <P>(5) Either an X-ray diffraction pattern (for inorganic substances), a mass spectrum (for most other substances), or an infrared spectrum of the particular chemical substance, or, if such data do not resolve uncertainties with respect to the identity of the chemical substance, additional or alternative spectra or other data to identify the substance.</P>

          <P>(c) If an importer or processor cannot provide all the information required in paragraph (b) of this section because it is claimed as confidential business information by the importer's or processor's manufacturer or supplier, the manufacturer or supplier may supply the information directly to EPA.<PRTPAGE P="133"/>
          </P>

          <P>(d) EPA will review the information submitted by the manufacturer, importer, or processor under paragraph (b) of this section to determine whether than person has shown a <E T="03">bona fide</E> intent to manufacture, import, or process the chemical substance. If necessary, EPA will compare this information either to the information requested for the confidential chemical substance under § 710.7(e)(2)(v) of this chapter or the information requested under § 720.85(b)(3)(iii) of this chapter.</P>

          <P>(e) If the manufacturer, importer, or processor has shown a <E T="03">bona fide</E> intent to manufacture, import, or process the substance and has provided sufficient unambiguous chemical identity information to enable EPA to make a conclusive determination as to the identity of the substance, EPA will inform the manufacturer, importer, or processor whether the chemical substance is subject to this part and, if so, which section in subpart E of this part applies.</P>
          <P>(f) A disclosure to a person with a <E T="03">bona fide</E> intent to manufacture, import, or process a particular chemical substance that the substance is subject to this part will not be considered public disclosure of confidential business information under section 14 of the Act.</P>
          <P>(g) EPA will answer an inquiry on whether a particular chemical substance is subject to this part within 30 days after receipt of a complete submission under paragraph (b) of this section.</P>
          <CITA>[53 FR 28359, July 27, 1988, as amended at 60 FR 34464, July 3, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.20</SECTNO>
          <SUBJECT>Exports and imports.</SUBJECT>
          <P>Persons who intend to export a chemical substance identified in subpart E of this part, or in any proposed rule which would amend subpart E of this part, are subject to the export notification provisions of section 12(b) of the Act. The regulations that interpret section 12(b) appear at 40 CFR part 707. Persons who import a substance identified in a specific section in subpart E of this part are subject to the import certification requirements under section 13 of the Act, which are codified at 19 CFR 12.118 through 12.127 and 127.28. The EPA policy in support of the import certification requirements appears at 40 CFR part 707.</P>
          <CITA>[53 FR 28360, July 27, 1988]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.25</SECTNO>
          <SUBJECT>Notice requirements and procedures.</SUBJECT>
          <P>(a) Each person who is required to submit a significant new use notice under this part must submit the notice at least 90 calendar days before commencing manufacture, import, or processing of a chemical substance identified in subpart E of this part for a significant new use. The submitter must comply with any applicable requirement of section 5(b) of the Act, and the notice must include the information and test data specified in section 5(d)(1) of the Act. The notice must be submitted on EPA Form 7710-25, and must comply with the requirements of part 720 of this chapter, except to the extent that they are inconsistent with this part 721.</P>
          <P>(b) If two or more persons are required to submit a significant new use notice for the same chemical substance and significant new use identified in subpart E of this part, they may submit a joint notice to EPA. Persons submitting a joint notice must individually complete the certification section of part I of the required notification form. Persons who are required to submit individually, but elect to submit jointly, remain individually liable for the failure to submit required information which is known to or reasonably ascertainable by them and test data in their possession or control.</P>
          <P>(c) EPA will process the notice in accordance with the procedures of part 720 of this chapter, expect to the extent they are inconsistent with this part 721.</P>
          <P>(d) Any person submitting a significant new use notice in response to the requirements of this part 721 shall not manufacture, import, or process a chemical substance identified in subpart E of this part for a significant new use until the notice review period, including all extensions and suspensions, has expired.</P>
          <CITA>[53 FR 28360, July 27, 1988, as amended at 60 FR 16311, Mar. 29, 1995]</CITA>
        </SECTION>
        <SECTION>
          <PRTPAGE P="134"/>
          <SECTNO>§ 721.30</SECTNO>
          <SUBJECT>EPA approval of alternative control measures.</SUBJECT>
          <P>(a) In certain sections of subpart E of this part, significant new uses for the identified substances are described as the failure to establish and implement programs providing for the use of either: specific measures to control worker exposure to or release of substances which are identified in such sections, or alternative measures to control worker exposure or environmental release which EPA has determined provide substantially the same degree of protection as the specified control measures. Persons who manufacture, import, or process a chemical substance identified in such sections and who intend to employ alternative measures to control worker exposure or environmental release must submit a request to EPA for a determination of equivalency before commencing manufacture, import, or processing involving the alternative control measures.</P>
          <P>(b) A request for a determination of equivalency must be submitted in writing to the Document Control Office (7407), Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Room G-099, 401 M St., SW., Washington, DC., 20460; ATTN: SNUR Equivalency Determination, and must contain:</P>
          <P>(1) The name of the submitter.</P>
          <P>(2) The specific chemical identity of the substance.</P>
          <P>(3) The citation for the specific section in subpart E of this part which pertains to the substance for which the request is being submitted.</P>
          <P>(4) A detailed description of the activities involved.</P>
          <P>(5) The specifications of the alternative worker exposure control measures or environmental release control measures.</P>
          <P>(6) An analysis justifying why such alternative control measures provide substantially the same degree of protection as the specific control measures identified in the specific section in subpart E of this part which pertains to the substance for which the request is being submitted.</P>
          <P>(7) The data and information described in § 720.50 (a) and (b) of this chapter unless such data and information have already been submitted to the Office of Pollution Prevention and Toxics, EPA.</P>
          <P>(c) Requests for determinations of equivalency will be reviewed by EPA within 45 days. Determinations under this paragraph will be made by the Director, Office of Pollution Prevention and Toxics, or designee. Notice of the results of such determinations will be mailed to the submitter.</P>
          <P>(d) If EPA notifies the submitter under paragraph (c) of this section that EPA has determined that the alternative control measures provide substantially the same degree of protection as the specified control measures identified in the specified section of subpart E of this part which pertains to the substance for which the request is being submitted, the submitter may commence manufacture, import, or processing in accordance with the specifications for alternative worker exposure control measures or environmental release control measures identified in the submitter's request, and may alter any corresponding notification to workers to reflect such alternative controls. Deviations from the activities described in the EPA notification constitute a significant new use and are subject to the requirements of this part.</P>
          <CITA>[53 FR 28360, July 27, 1988, as amended at 60 FR 34464, July 3, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.35</SECTNO>
          <SUBJECT>Compliance and enforcement.</SUBJECT>
          <P>(a) Failure to comply with any provision of this part is a violation of section 15(1) of the Act (15 U.S.C. 2614).</P>
          <P>(b) Using for commercial purposes a chemical substance which a person knew or had reason to know was manufactured, imported, or processed in violation of this part is a violation of section 15(2) of the Act (15 U.S.C. 2614).</P>
          <P>(c) Failure or refusal to permit access to or copying of records, as required by section 11 of the Act, is a violation of section 15(3) of the Act (15 U.S.C. 2614).</P>
          <P>(d) Failure or refusal to permit entry or inspection, as required by section 11 of the Act, is a violation of section 15(4) of the Act.</P>

          <P>(e) Violators of the Act or of this part may be subject to the civil and criminal penalties in section 16 of the <PRTPAGE P="135"/>Act (15 U.S.C. 2615) for each violation. The submission of false or misleading information in connection with the requirement of any provision of this part may subject persons to penalties calculated as if they never filed a notice.</P>
          <P>(f) Under the authority of sections 7 and 17 of the Act, EPA may:</P>
          <P>(1) Seek to enjoin the manufacture, import, or processing of a chemical substance in violation of this part.</P>
          <P>(2) Act to seize any chemical substance which is being manufactured, imported, or processed in violation of this part.</P>
          <P>(3) Take any other appropriate action.</P>
          <CITA>[53 FR 28361, July 27, 1988]</CITA>
          
          
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.40</SECTNO>
          <SUBJECT>Recordkeeping.</SUBJECT>
          <P>Any person subject to the requirements of this part must retain documentation of information contained in that person's significant new use notice. This documentation must be maintained for a period of 5 years from the date of the submission of the significant new use notice.</P>
          <CITA>[53 FR 28361, July 27, 1988]</CITA>
          
          
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.45</SECTNO>
          <SUBJECT>Exemptions.</SUBJECT>
          <P>The persons identified in § 721.5 are not subject to the notification requirements of § 721.25 for a chemical substance identified in subpart E of this part, unless otherwise specified in a specific section in subpart E, if:</P>
          <P>(a) The person has applied for and has been granted an exemption for test marketing the substance for a significant new use identified in subpart E of this part in accordance with section 5(h)(1) of the Act and § 720.38 of this chapter.</P>
          <P>(b) The person manufactures, imports, or processes the substance for a significant new use identified in subpart E of this part in small quantities solely for research and development in accordance with § 721.47.</P>
          <P>(c) The person has applied for and been granted an exemption under section 5(h)(5) of the Act.</P>
          <P>(d) The person manufactures, imports, or processes the substance only as an impurity.</P>
          <P>(e) The person manufactures, imports, or processes the substance only as a byproduct which is used only by public or private organizations that (1) burn it as a fuel, (2) dispose of it as a waste, including in a landfill or for enriching soil, or (3) extract component chemical substances from it for commercial purposes.</P>
          <P>(f) The person imports or processes the substance as part of an article.</P>
          <P>(g) The person manufactures or processes the substance solely for export and, when distributing the substance in commerce, labels the substance in accordance with section 12(a)(1)(B) of the Act.</P>
          <P>(h) The person submits a significant new use notice for the substance prior to the promulgation date of the section in subpart E of this part which identifies the substance, and the person receives written notification of compliance from EPA prior to the effective date of such section. The notice submitter must comply with any applicable requirement of section 5(b) of the Act. The notice must include the information and test data specified in section 5(d)(1) of the Act and must be submitted on the notice form in Appendix A to part 720 of this chapter. For purposes of this exemption, the specific section in subpart E of this part which identifies the substance and §§ 721.1, 721.3, 721.11, 721.35, and 721.40 apply; after the effective date of the section in subpart E of this part which identifies the substance, § 721.5 applies and § 721.20 continues to apply. EPA will provide the notice submitter with written notification of compliance only if one of the following occurs:</P>
          <P>(1) EPA is unable to make the finding that the activities described in the significant new use notice will or may present an unreasonable risk of injury to health or the environment under reasonably foreseeable circumstances.</P>
          <P>(2) EPA and the person negotiate a consent order under section 5(e) of the Act, such order to take effect on the effective date of the section in subpart E of this part which identifies the substance.</P>

          <P>(i) The person is operating under the terms of a consent order issued under section 5(e) of the Act applicable to <PRTPAGE P="136"/>that person. If a provision of such section 5(e) order is inconsistent with a specific significant new use identified in subpart E of this part, abiding by the provision of the section 5(e) order exempts the person from submitting a significant new use notice for that specific significant new use.</P>
          <CITA>[53 FR 28361, July 27, 1988]</CITA>
          
          
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.47</SECTNO>
          <SUBJECT>Conditions for research and development exemption.</SUBJECT>
          <P>(a) A person who manufactures, imports, or processes a chemical substance identifies in subpart E of this part for a significant new use identified in subpart E of this part is not subject to the notification requirements of § 721.25 if the following conditions are met:</P>
          <P>(1) The person manufactures, imports, or processes the substance for the significant new use in small quantities solely for research and development.</P>
          <P>(2) The manufacturer, importer, or processor notifies all persons in its employ or to whom it directly distributes the chemical substance, who are engaged in experimentation, research, or analysis on the chemical substance, including the manufacture, processing, use, transport, storage, and disposal of the substance associated with research and development activities, of any risk to health, identified under paragraph (b) of this section, which may be associated with the substance. The notification must be made in accordance with paragraph (c) of this section.</P>
          <P>(3) The chemical substance is used by, or directly under the supervision of, a technically qualified individual.</P>
          <P>(b)(1) To determine whether notification under paragraph (a)(2) of this section is required, the manufacturer, importer, or processor must review and evaluate the following information to determine whether there is reason to believe there is any risk to health which may be associated with the chemicals substance:</P>
          <P>(i) Information in its possession or control concerning any significant adverse reaction by persons exposed to the chemical substance which may reasonably be associated with such exposure.</P>
          <P>(ii) Information provided to the manufacturer, importer, or processor by a supplier or any other person concerning a health risk believed to be associated with the substance.</P>
          <P>(iii) Health and environmental effects data in its possession or control concerning the substance.</P>
          <P>(iv) Information on health effects which accompanies any EPA rule or order issued under section 4, 5, or 6 of the Act that applies to the substance and of which the manufacturer, importer, or processor has knowledge.</P>
          <P>(2) When the research and development activity is conducted solely in a laboratory and exposure to the chemical substance is controlled through the implementation of prudent laboratory practices for handling chemical substances of unknown toxicity, and any distribution, except for purposes of disposal, is to other such laboratories for further research and development activity, the information specified in paragraph (b)(1) of this section need not be reviewed and evaluated. (For purposes of this paragraph (b)(2), a laboratory is defined as a contained research facility where relatively small quantities of chemical substances are used on a pro-production basis, and where activities involve the use of containers for reactions, transfers, and other handling of substances designed to be easily manipulated by a single individual).</P>
          <P>(c)(1) The manufacturer, importer, or processor must notify the persons identified in paragraph (a)(2) of this section by means of a container labeling system, conspicuous placement of notices in areas where exposure may occur, written notification to each person potentially exposed, or any other method of notification which adequately informs persons of health risks which the manufacturer, importer, or processor has reason to believe may be associated with the substance, as determined under paragraph (b)(1) of this section.</P>

          <P>(2) If the manufacturer, importer, or processor distributes a chemical substance manufactured, imported, or processed under this section to persons not in its employ, the manufacturer, importer, or processor must in written form:<PRTPAGE P="137"/>
          </P>
          <P>(i) Notify those persons that the substance is to be used only for research and development purposes.</P>
          <P>(ii) Provide the notice of health risks specified in paragraph (c)(1) of this section.</P>
          <P>(3) The adequacy of any notification under this section is the responsibility of the manufacturer, importer, or processor.</P>
          <P>(d) Quantities of the chemical substance, or of mixtures or articles containing the chemical substance, remaining after completion of research and development activities may be:</P>
          <P>(1) Disposed of as a waste in accordance with applicable Federal, State, and local regulations, to the extent the disposal activity is not identified as a significant new use for the substance in subpart E of this part, or</P>
          <P>(2) Used for a commercial purpose, to the extent the use is not identified as a significant new use of the substance in subpart E of this part.</P>
          <P>(e)(1) Persons who manufacture, import, or process a chemical substance under this section must retain the following records:</P>
          <P>(i) Copies of or citations to information reviewed and evaluated under paragraph (b)(1) of this section to determine the need to make any notification of risk.</P>
          <P>(ii) Documentation of the nature and method of notification under paragraph (c)(1) of this section including copies of any labels or written notices used.</P>
          <P>(iii) Documentation of prudent laboratory practices used instead of notification and evaluation under paragraph (b)(2) of this section.</P>
          <P>(iv) The names and addresses of any persons other than the manufacturer, importer, or processor to whom the substance is distributed, the identity of the substance, the amount distributed, and copies of the notifications required under paragraph (c)(2) of this section.</P>
          <P>(2) [Reserved]</P>
          <CITA>[53 FR 28361, July 27, 1988, as amended at 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
      </SUBPART>
      <SUBPART>
        <HD SOURCE="HED">Subpart B—Certain Significant New Uses</HD>
        <SOURCE>
          <HD SOURCE="HED">Source:</HD>
          <P>54 FR 31308, July 27, 1989, unless otherwise noted.</P>
        </SOURCE>
        <SECTION>
          <SECTNO>§ 721.50</SECTNO>
          <SUBJECT>Applicability.</SUBJECT>

          <P>This subpart B identifies certain significant new uses of chemical substances identified in subpart E of this part. The provisions of this subpart B apply only when referenced as applying to a chemical substance identified in subpart E of this part.
            
          </P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.63</SECTNO>
          <SUBJECT>Protection in the workplace.</SUBJECT>
          <P>(a) Whenever a substance is identified in subpart E of this part as being subject to this section, a significant new use of the substance is any manner or method of manufacturing, importing, or processing associated with any use of the substance without establishing a program whereby:</P>
          <P>(1) Each person who is reasonably likely to be dermally exposed in the work area to the chemical substance through direct handling of the substance or through contact with equipment on which the substance may exist, or because the substance becomes airborne in the form listed in paragraph (a)(6) of this section, and cited in subpart E of this part for the chemical substance, is provided with, and is required to wear, personal protective equipment that provides a barrier to prevent dermal exposure to the substance in the specific work area where it is selected for use. Each such item of personal protective equipment must be selected and used in accordance with 29 CFR 1910.132 and 1910.133.</P>
          <P>(2) In addition to any other personal protective equipment selected in paragraph (a)(1) of this section, the following items are required:</P>
          <P>(i) Gloves.</P>
          <P>(ii) Full body chemical protective clothing.</P>
          <P>(iii) Chemical goggles or equivalent eye protection.</P>
          <P>(iv) Clothing which covers any other exposed areas of the arms, legs, and torso. Clothing provided under this paragraph need not be tested or evaluated under the requirements of paragraph (a)(3) of this section.</P>

          <P>(3) The employer is able to demonstrate that each item of chemical protective clothing, including gloves, selected provides an impervious barrier <PRTPAGE P="138"/>to prevent dermal exposure during normal and expected duration and conditions of exposure within the work area by any one or a combination of the following:</P>
          <P>(i) Testing the material used to make the chemical protective clothing and the construction of the clothing to establish that the protective clothing will be impervious for the expected duration and conditions of exposure. The testing must subject the chemical protective clothing to the expected conditions of exposure, including the likely combinations of chemical substances to which the clothing may be exposed in the work area.</P>
          <P>(ii) Evaluating the specifications from the manufacturer or supplier of the chemical protective clothing, or of the material used in construction of the clothing, to establish that the chemical protective clothing will be impervious to the chemical substance alone and in likely combination with other chemical substances in the work area.</P>
          <P>(4) Each person who is reasonably likely to be exposed to the chemical substance by inhalation in the work area in one or more of the forms listed in paragraph (a)(6) of this section and cited in subpart E of this part for the chemical substance, is provided with, and is required to wear, at a minimum, a NIOSH- approved respirator from one of the categories listed in paragraph (a)(5) of this section, and the respirator is used in accordance with 29 CFR 1910.134 and 30 CFR part 11.</P>
          <P>(5) The following NIOSH approved respirators meet the minimum requirements for paragraph (a)(4) of this section:</P>
          <P>(i) Category 19C Type C supplied-air respirator operated in pressure demand or other positive pressure mode and equipped with a full facepiece.</P>
          <P>(ii) Category 19C Type C supplied-air respirator operated in pressure demand or continuous flow mode and equipped with a tight-fitting facepiece.</P>
          <P>(iii) Category 19C Type C supplied-air respirator operated in pressure demand or continuous flow mode and equipped with a hood or helmet or tight-fitting facepiece.</P>
          <P>(iv) Category 21C air-purifying respirator equipped with a full facepiece and high efficiency particulate filters.</P>
          <P>(v) Category 21C powered air-purifying respirator equipped with a tight-fitting facepiece and high efficiency particulate filters.</P>
          <P>(vi) Category 21C powered air-purifying respirator equipped with a loose-fitting hood or helmet and high efficiency particulate filters.</P>
          <P>(vii) Category 21C air-purifying respirator equipped with a high efficiency particulate filter including disposable respirators.</P>
          <P>(viii) Category 23C air-purifying respirator equipped with a full facepiece and combination cartridges approved for paints, lacquers, and enamels. (Approval label may preclude use for some paints, lacquers, or enamels.)</P>
          <P>(ix) Category 23C powered air-purifying respirator equipped with a tight-fitting facepiece and combination cartridges approved for paints, lacquers, and enamels. (Approval label may preclude use for some paints, lacquers, or enamels.)</P>
          <P>(x) Category 23C powered air-purifying respirator equipped with a loose-fitting hood or helmet and combination cartridges approved for paints, lacquers, and enamels. (Approval label may preclude use for some paints, lacquers, or enamels.)</P>
          <P>(xi) Category 23C air-purifying respirator equipped with combination cartridges approved for paints, lacquers, and enamels, including disposable respirators. (Approval label may preclude use for some paints, lacquers, or enamels.)</P>
          <P>(xii) Category 23C air-purifying respirator equipped with a full facepiece and organic gas/vapor cartridges.</P>
          <P>(xiii) Category 23C powered air-purifying respirator equipped with a tight-fitting facepiece and organic gas/vapor cartridges.</P>
          <P>(xiv) Category 23C powered air-purifying respirator equipped with a loose-fitting hood or helmet and organic gas/vapor cartridges.</P>

          <P>(xv) Category 23C air-purifying respirator equipped with organic gas/vapor cartridges, including disposable respirators.<PRTPAGE P="139"/>
          </P>
          <P>(6) When cited in subpart E of this part for a substance, the following airborne form(s) of the substance apply to paragraphs (a) (1) and (4) of this section:</P>
          <P>(i) Dust.</P>
          <P>(ii) Mist.</P>
          <P>(iii) Fume.</P>
          <P>(iv) Smoke.</P>
          <P>(v) Vapor.</P>
          <P>(vi) Gas.</P>
          <P>(b) If a substance identified in subpart E of this part is present in the work area only as a mixture, an employer is exempt from the provisions of this section if the concentration of the substance in the mixture does not exceed a concentration set in subpart E of this part. The exemption does not apply if the employer has reason to believe that during intended use or processing in the work area, the substance in the mixture may be concentrated above the level set in subpart E of this part.</P>
          <P>(c)(1) If at any time after commencing distribution in commerce of a chemical substance that is identified in subpart E of this part as subject to this section, the person has knowledge that a recipient of the substance is engaging in an activity that is not consistent with the implementation of a program specified in paragraph (a) of this section, the person is considered to have knowledge that the recipient is engaging in a significant new use and is required to follow the procedures in § 721.5(d) unless the person is able to document the following:</P>
          <P>(i) That the person has notified the recipient in writing within 15 working days of the time the person first has knowledge that the recipient is engaging in an activity that is not consistent with the implementation of a program specified in paragraph (a) of this section, and that the person has knowledge of the failure of implementation.</P>
          <P>(ii) That within 15 working days of notifying the recipient that the recipient is engaging in an activity that is not consistent with the implementation of a program specified in paragraph (a) of this section the person has received from the recipient, in writing, a statement of assurance that the recipient has established the program required under paragraph (a) of this section, and will take appropriate measures to avoid activities that are inconsistent with implementation of the program required under paragraph (a) of this section.</P>

          <P>(2) If, after receiving a statement of assurance from a recipient under paragraph (c)(1)(ii) of this section, a manufacturer, importer, or processor has knowledge that the recipient is engaging in an activity that is not consistent with the implementation of the program specified in paragraph (a) of this section, that person is considered to have knowledge that the person is engaging in a significant new use and is required to follow the procedures in § 721.5(d).
            
          </P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.72</SECTNO>
          <SUBJECT>Hazard communication program.</SUBJECT>
          <P>Whenever a substance is identified in subpart E of this part as being subject to this section, a significant new use of that substance is any manner or method of manufacture, import, or processing associated with any use of that substance without establishing a hazard communication program as described in this section.</P>
          <P>(a) <E T="03">Written hazard communication program.</E> Each employer shall develop and implement a written hazard communication program for the substance in each workplace. The written program will, at a minimum, describe how the requirements of this section for labels, MSDSs, and other forms of warning material will be satisfied. The employer must make the written hazard communication program available, upon request, to all employees, contractor employees, and their designated representatives. The employer may rely on an existing hazard communication program, including an existing program established under the Occupational Health and Safety Administration (OSHA) Hazard Communication Standard (29 CFR 1900.1200), to comply with this paragraph provided that the existing hazard communication program satisfies the requirements of this paragraph. The written program shall include the following:</P>

          <P>(1) A list of each substance identified in subpart E of this part as subject to this section known to be present in the <PRTPAGE P="140"/>work area. The list must be maintained in the work area and must use the identity provided on the appropriate MSDS for each substance required under paragraph (c) of this section. The list may be compiled for the workplace or for individual work areas.</P>
          <P>(2) The methods the employer will use to inform employees of the hazards of non-routine tasks involving the substance, for example, the cleaning of reactor vessels, and the hazards associated with the substance contained in unlabeled pipes in their work area.</P>
          <P>(3) The methods the employer will use to inform contractors of the presence of the substance in the employer's workplace and of the provisions of this part applicable to the substance if employees of the contractor work in the employer's workplace and are reasonably likely to be exposed to the substance while in the employer's workplace.</P>
          <P>(b) <E T="03">Labeling.</E> (1) Each employer shall ensure that each container of the substance in the workplace is labeled in accordance with this paragraph (b)(1).</P>
          <P>(i) The label shall, at a minimum, contain the following information:</P>
          <P>(A) A statement of health hazard(s) and precautionary measure(s) for the substance, if any, identified in subpart E of this part or by the employer.</P>
          <P>(B) The identity by which the substance may be commonly recognized.</P>
          <P>(C) A statement of environmental hazard(s) and precautionary measure(s) for the substance, if any, identified in subpart E of this part or by the employer.</P>
          <P>(D) A statement of exposure and precautionary measure(s), if any, identified in subpart E of this part or by the employer.</P>
          <P>(ii) The employer may use signs, placards, process sheets, batch tickets, operating procedures, or other such written materials in lieu of affixing labels to individual stationary process containers, as long as the alternative method identifies the containers to which it is applicable and conveys information specified by paragraph (b)(1)(i) of this section. Any written materials must be readily accessible to the employees in their work areas throughout each work shift.</P>
          <P>(iii) The employer need not label portable containers into which the substance is transferred from labeled containers, and which are intended only for the immediate use of the employee who performs the transfer.</P>
          <P>(iv) The employer shall not remove or deface an existing label on incoming containers of the substance unless the container is immediately relabeled with the information specified in paragraph (b)(1)(i) of this section.</P>
          <P>(2) Each employer shall ensure that each container of the substance leaving its workplace for distribution in commerce is labeled in accordance with this paragraph.</P>
          <P>(i) The label shall, at a minimum, contain the following information:</P>
          <P>(A) The information required under paragraph (b)(1)(i) of this section.</P>
          <P>(B) The name and address of the manufacturer or a responsible party who can provide additional information on the substance for hazard evaluation and any appropriate emergency procedures.</P>
          <P>(ii) The label shall not conflict with the requirements of the Hazardous Materials Transportation Act (18 U.S.C. 1801 et. seq.) and regulations issued under that Act by the Department of Transportation.</P>
          <P>(3) The label, or alternative forms of warning, shall be legible and prominently displayed.</P>
          <P>(4) The label, or alternative forms of warning, shall be in English; however, the information may be repeated in other languages.</P>

          <P>(5) If the label or alternative form of warning is to be applied to a mixture containing a substance identified in subpart E of this part as subject to this section in combination with another substance identified in subpart E of this part and/or a substance defined as a “hazardous chemical” under the Occupational Safety and Health Administration (OSHA) Hazard Communication Standard (29 CFR 1900.1200), the employer may prescribe on the label, MSDS, or alternative form of warning, the measures to control worker exposure or environmental release which the employer determines provide the greatest degree of protection. However, should these control measures differ from the applicable measures required <PRTPAGE P="141"/>under subpart E of this part, the employer must seek a determination of equivalency for such alternative control measures pursuant to § 721.30 before prescribing them under this paragraph.</P>
          <P>(c) <E T="03">Material safety data sheets.</E> (1) Each employer must obtain or develop a MSDS for the substance.</P>
          <P>(2) Each MSDS shall contain, at a minimum, the following information:</P>
          <P>(i) The identity used on the container label of the substance under this section, and, if not claimed confidential, the chemical and common name of the substance. If the chemical and common name are claimed confidential, a generic chemical name must be used.</P>
          <P>(ii) Physical and chemical characteristics of the substance known to the employer (such as vapor pressure, flash point).</P>
          <P>(iii) The physical hazards of the substance known to the employer, including the potential for fire, explosion, and reactivity.</P>
          <P>(iv) The potential human and environmental hazards as specified in subpart E of this part for the substance.</P>
          <P>(v) Signs and symptoms of exposure, and any medical conditions which are expected to be aggravated by exposure to the substance known to the employer.</P>
          <P>(vi) The primary routes of exposure to the substance.</P>
          <P>(vii) Precautionary measures to control worker exposure and/or environmental release identified in subpart E of this part for the substance, or alternative control measures which EPA has determined under § 721.30 provide substantially the same degree of protection as the identified control measures.</P>
          <P>(viii) Any generally applicable precautions for safe handling and use of the substance which are known to the employer, including appropriate hygienic practices, protective measures during repair and maintenance of contaminated equipment, and procedures for response to spills and leaks.</P>
          <P>(ix) Any generally applicable control measures which are known to the employer, such as appropriate engineering controls, work practices, or personal protective equipment.</P>
          <P>(x) Emergency first aid procedures known to the employer.</P>
          <P>(xi) The date of preparation of the MSDS or of its last revision.</P>
          <P>(xii) The name, address, and telephone number of the individual preparing or distributing the MSDS, or a responsible party who can provide additional information on the substance for hazard evaluation and any appropriate emergency procedures.</P>
          <P>(3) If no relevant information is found or known for any given category on the MSDS, the employer must mark the MSDS to indicate that no applicable information was found.</P>
          <P>(4) Where multiple mixtures containing the substance have similar compositions (i.e., the chemical ingredients are essentially the same, but the specific composition varies from mixture to mixture) and similar hazards, the employer may prepare one MSDS to apply to all of these multiple mixtures.</P>
          <P>(5) If the employer becomes aware of any significant new information regarding the hazards of the substance or ways to protect against the hazards, this new information must be added to the MSDS within 3 months from the time the employer becomes aware of the new information. If the substance is not currently being manufactured, imported, processed, or used in the employer's workplace, the employer must add the new information to the MSDS before the substance is reintroduced into the workplace.</P>
          <P>(6) The employer must ensure that persons receiving the substance from the employer are provided an appropriate MSDS with their initial shipment and with the first shipment after an MSDS is revised. The employer may either provide the MSDS with the shipped containers or send it to the person prior to or at the time of shipment.</P>
          <P>(7) The employer must maintain a copy of the MSDS in its workplace, and must ensure that it is readily accessible during each work shift to employees when they are in their work areas.</P>

          <P>(8) The MSDS may be kept in any form, including as operating procedures, and may be designed to cover groups of substances in a work area where it may be more appropriate to <PRTPAGE P="142"/>address the potential hazards of a process rather than individual substances. However, in all cases, the required information must be provided for each substance and must be readily accessible during each work shift to employees when they are in their work areas.</P>
          <P>(9) The MSDS must be printed in English; however, the information may be repeated in other languages.</P>
          <P>(d) <E T="03">Employee information and training.</E> Each employer must ensure that employees are provided with information and training on the substance identified in subpart E of this part. This information and training must be provided at the time of each employee's initial assignment to a work area containing the substance and whenever the substance subject to this section is introduced into the employee's work area for the first time.</P>
          <P>(1) Information provided to employees under this paragraph shall include:</P>
          <P>(i) The requirements of this section.</P>
          <P>(ii) Any operations in the work area where the substance is present.</P>
          <P>(iii) The location and availability of the written hazard communication program required under paragraph (a) of this section, including the list of substances identified in subpart E of this part as subject to this section, and MSDSs required by paragraph (c) of this section.</P>
          <P>(2) Training provided to employees shall include:</P>
          <P>(i) Methods and observations that may be used to detect the presence or release of the substance in or from an employee's work area (such as monitoring conducted by the employer, continuous monitoring devices, visual appearance, or odor of the substance when being released).</P>
          <P>(ii) The potential human health and environmental hazards of the substance as specified in subpart E of this part.</P>
          <P>(iii) The measures employees can take to protect themselves and the environment from the substance, including specific procedures the employer has implemented to protect employees and the environment from exposure to the substance, including appropriate work practices, emergency procedures, personal protective equipment, engineering controls, and other measures to control worker exposure and/or environmental release required under subpart E of the part, or alternative control measures which EPA has determined under § 721.30 provide substantially the same degree of protection as the specified control measures.</P>
          <P>(iv) The requirements of the hazard communication program developed by the employer under this section, including an explanation of the labeling system and the MSDS required by this section and guidance on obtaining and using appropriate hazard information.</P>
          <P>(e) <E T="03">Low concentrations in mixtures.</E> If a substance identified in subpart E of this part is present in the work area only as a mixture, an employer is exempt from the provisions of this section if the concentration of the substance in the mixture does not exceed a concentration set in subpart E of this part. The exemption does not apply if the employer has reason to believe that during intended use or processing in the work area, the substance in the mixture may be concentrated above the level set in subpart E of this part.</P>
          <P>(f) <E T="03">Existing hazard communication program.</E> The employer need not take additional actions if existing programs and procedures satisfy the requirements of this section.</P>
          <P>(g) <E T="03">Human health, environmental hazard, exposure, and precautionary statements.</E> Whenever referenced in subpart E of this part for a substance, the following human health and environmental hazard, exposure, and precautionary statements shall appear on each label as specified in paragraph (b) of this section and the MSDS as specified in paragraph (c) of this section. Additional statements may be included as long as they are true and do not alter the meaning of the required statements.</P>
          <P>(1) Human health hazard statements: This substance may cause:</P>
          <P>(i) Skin irritation.</P>
          <P>(ii) Respiratory complications.</P>
          <P>(iii) Central nervous system effects.</P>
          <P>(iv) Internal organ effects.</P>
          <P>(v) Birth defects.</P>
          <P>(vi) Reproductive effects.</P>
          <P>(vii) Cancer.</P>
          <P>(viii) Immune system effects.</P>
          <P>(ix) Developmental effects.<PRTPAGE P="143"/>
          </P>
          <P>(2) Human health hazard precautionary statements: When using this substance:</P>
          <P>(i) Avoid skin contact.</P>
          <P>(ii) Avoid breathing substance.</P>
          <P>(iii) Avoid ingestion.</P>
          <P>(iv) Use respiratory protection.</P>
          <P>(v) Use skin protection.</P>
          <P>(3) Environmental hazard statements: This substance may be:</P>
          <P>(i) Toxic to fish.</P>
          <P>(ii) Toxic to aquatic organisms.</P>
          <P>(4) Environmental hazard precautionary statements: Notice to users:</P>
          <P>(i) Disposal restrictions apply.</P>
          <P>(ii) Spill clean-up restrictions apply.</P>
          <P>(iii) Do not release to water.</P>
          <P>(5) Each human health or environmental hazard precautionary statement identified in subpart E of this part for the label on the substance container must be followed by the statement, “See MSDS for details.”</P>
          <P>(h) <E T="03">Human health, environmental hazard exposure and precautionary statements.</E> (1) Whenever referenced in subpart E of this part for a substance, the following human health, environmental hazard, exposure, and precautionary statements shall appear on each label as specified in paragraph (b) of this section. Additional statements may be included as long as they are true and do not alter the meaning of the required statements.</P>
          <P>(i) <E T="03">Precautionary statements.</E> (A) The health effects of this chemical substance have not been determined.</P>
          <P>(B) When using this substance, use skin protection.</P>
          <P>(C) Use respiratory protection when there is a reasonable likelihood of exposure in the work area from dust, mist, or smoke from spray application.</P>
          <P>(D) Chemicals similar in structure to this substance have been found to cause cancer in laboratory animals.</P>
          <P>(ii) <E T="03">Human health hazard statements.</E> This substance may cause:</P>
          <P>(A) Skin irritation</P>
          <P>(B) Respiratory complications</P>
          <P>(C) Central nervous system effects</P>
          <P>(D) Internal organ effects</P>
          <P>(E) Birth defects</P>
          <P>(F) Reproductive effects</P>
          <P>(G) Cancer</P>
          <P>(H) Immune system effects</P>
          <P>(I) Developmental effects</P>
          <P>(iii) <E T="03">Human health hazard precautionary statements.</E> When using this substance:</P>
          <P>(A) Avoid skin contact</P>
          <P>(B) Avoid breathing substance</P>
          <P>(C) Avoid ingestion</P>
          <P>(D) Use respiratory protection</P>
          <P>(E) Use skin protection</P>
          <P>(iv) <E T="03">Environmental hazard statements.</E> This substance may be:</P>
          <P>(A) Toxic to fish</P>
          <P>(B) Toxic to aquatic organisms</P>
          <P>(v) <E T="03">Environmental hazard precautionary statements.</E> Notice to Users:</P>
          <P>(A) Disposal restrictions apply</P>
          <P>(B) Spill clean-up restrictions apply</P>
          <P>(C) Do not release to water.</P>
          <P>(vi) <E T="03">Additional statements.</E> Each human health or environmental precautionary statement identified in subpart E of this part for the label on the substance container must be followed by the statement, “See MSDS for details.”</P>
          <P>(2) Whenever referenced in subpart E of this part for a substance, the following human health, environmental hazard, exposure, and precautionary statements shall appear on each MSDS as specified in paragraph (c) of this section. Additional statements may be included as long as they are true and do not alter the meaning of the required statements.</P>
          <P>(i) <E T="03">Precautionary statements.</E> (A) The health effects of this chemical substance have not been determined.</P>
          <P>(B) When using this substance, use skin protection.</P>
          <P>(C) Use respiratory protection when there is a reasonable likelihood of exposure in the work area from dust, mist, or smoke from spray application.</P>
          <P>(D) Chemicals similar in structure to this substance have been found to cause cancer in laboratory animals.</P>
          <P>(ii) <E T="03">Human health hazard statements.</E> This substance may cause:</P>
          <P>(A) Skin irritation</P>
          <P>(B) Respiratory complications</P>
          <P>(C) Central nervous system effects</P>
          <P>(D) Internal organ effects</P>
          <P>(E) Birth defects</P>
          <P>(F) Reproductive effects</P>
          <P>(G) Cancer</P>
          <P>(H) Immune system effects</P>
          <P>(I) Developmental effects<PRTPAGE P="144"/>
          </P>
          <P>(iii) <E T="03">Human health hazard precautionary statements.</E> When using this substance:</P>
          <P>(A) Avoid skin contact</P>
          <P>(B) Avoid breathing substance</P>
          <P>(C) Avoid ingestion</P>
          <P>(D) Use respiratory protection</P>
          <P>(E) Use skin protection</P>
          <P>(iv) <E T="03">Environmental hazard statements.</E> This substance may be:</P>
          <P>(A) Toxic to fish</P>
          <P>(B) Toxic to aquatic organisms</P>
          <P>(v) <E T="03">Environmental hazard precautionary statements.</E> Notice to Users:</P>
          <P>(A) Disposal restrictions apply</P>
          <P>(B) Spill clean-up restrictions apply</P>
          <P>(C) Do not release to water.</P>
          <CITA>[54 FR 31308, July 27, 1989, as amended at 55 FR 45996, Oct. 31, 1990; 58 FR 34204, June 23, 1993]</CITA>
          
          
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.80</SECTNO>
          <SUBJECT>Industrial, commercial, and consumer activities.</SUBJECT>
          <P>Whenever a substance is identified in subpart E of this part as being subject to this section, a significant new use of the substance is:</P>
          <P>(a) Use in non-enclosed processes.</P>
          <P>(b) Any manner or method of manufacture in non-enclosed processes associated with any use.</P>
          <P>(c) Any manner or method of processing in non-enclosed processes associated with any use.</P>
          <P>(d) Use beyond the site of manufacture or import.</P>
          <P>(e) Processing beyond the site of manufacture or import.</P>
          <P>(f) Any manner or method of manufacture (excluding import) of the substance associated with any use.</P>
          <P>(g) Use other than as an intermediate.</P>
          <P>(h) Use other than as a site-limited intermediate.</P>
          <P>(i) Use as an intermediate where the concentration of the intermediate substance in the product intended for distribution in commerce exceeds the concentration specified in subpart E of this part for the substance.</P>
          <P>(j) Use other than as described in the premanufacture notice referenced in subpart E of this part for the substance.</P>
          <P>(k) Use other than allowed by the section 5(e) consent order referenced in subpart E of this part for the substance.</P>
          <P>(l) Non-industrial use.</P>
          <P>(m) Commercial use.</P>
          <P>(n) Non-commercial use.</P>
          <P>(o) Use in a consumer product.</P>
          <P>(p) Aggregate manufacture and importation volume for any use greater than that specified in subpart E of this part for the substance.</P>
          <P>(q) Aggregate manufacture and importation volume for any use greater than that allowed by the section 5(e) consent order referenced in subpart E of this part for the substance.</P>
          <P>(r) Aggregate manufacture and importation volume for any use greater than that specified in subpart E of this part for the substance unless the manufacturer or importer has submitted the results of the health or environmental effects studies identified in subpart E of this part for the substance and those studies comply with the procedures and criteria for developing and evaluating data identified in subpart E of this part for the substance.</P>
          <P>(s) Annual manufacture and importation volume for any use greater than that specified in subpart E of this part for the substance.</P>
          <P>(t) Annual manufacture and importation volume for any use greater than that allowed by the section 5(e) consent order referenced in subpart E of this part for the substance.</P>
          <P>(u) Annual manufacture and importation volume for any use greater than that specified in subpart E of this part for the substance unless the manufacturer or importer has submitted the results of the health or environmental effects studies identified in subpart E of this part for the substance and those studies comply with the procedures and criteria for developing and evaluating data identified in subpart E of this part for the substance.</P>
          <P>(v) Use in the form of:</P>
          <P>(1) A powder.</P>
          <P>(2) A solid.</P>
          <P>(3) A liquid.</P>
          <P>(4) A gas.</P>
          <P>(w) Any manner or method of manufacture of the substance in the following form associated with any use:</P>
          <P>(1) A powder.</P>
          <P>(2) A solid.</P>
          <P>(3) A liquid.</P>
          <P>(4) A gas.<PRTPAGE P="145"/>
          </P>
          <P>(x) Any manner or method of processing of the substance in the following form associated with any use:</P>
          <P>(1) A powder.</P>
          <P>(2) A solid.</P>
          <P>(3) A liquid.</P>
          <P>(4) A gas.</P>
          <P>(y) Use involving an application method that generates:</P>
          <P>(1) A vapor, mist, or aerosol.</P>
          <P>(2) A dust.
            
          </P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.85</SECTNO>
          <SUBJECT>Disposal.</SUBJECT>
          <P>Whenever a substance is identified in subpart E of this part as being subject to this section, a significant new use of the substance is any method of:</P>
          <P>(a) Disposal of the process stream associated with any use of the substance or with any manner or method of manufacturing associated with any use of the substance other than by the following. This provision does not supercede any applicable Federal, State, or local laws and regulations.</P>
          <P>(1) Incineration.</P>
          <P>(2) Landfill.</P>
          <P>(3) Deep well injection.</P>
          <P>(b) Disposal of the process stream associated with any use or with any manner or method of processing associated with any use other than by the following. This provision does not supercede any applicable Federal, State, or local laws and regulations.</P>
          <P>(1) Incineration.</P>
          <P>(2) Landfill.</P>
          <P>(3) Deep well injection.</P>
          <P>(c) Disposal of the use stream associated with any use, other than by the following. This provision does not supercede any applicable Federal, State, or local laws and regulations.</P>
          <P>(1) Incineration.</P>
          <P>(2) Landfill.</P>
          <P>(3) Deep well injection.</P>

          <P>(d) Disposal of the substance associated with any use of the substance, or with any manner or method of manufacture or processing in association with any use. This provision does not supercede any applicable Federal, State, or local laws and regulations.
            
          </P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.90</SECTNO>
          <SUBJECT>Release to water.</SUBJECT>
          <P>Whenever a substance is identified in subpart E of this part as being subject to this section, a significant new use of the substance is:</P>
          <P>(a) Any predictable or purposeful release of a manufacturing stream associated with any use of the substance, from any site:</P>
          <P>(1) Into the waters of the United States.</P>
          <P>(2) Into the waters of the United States without application of one or more of the following treatment technologies as specified in subpart E of this part either by the discharger or, in the case of a release through publicly-owned treatment works, by a combination of treatment by the discharger and the publicly-owned treatment works:</P>
          <P>(i) Chemical precipitation and settling.</P>
          <P>(ii) Biological treatment (activated sludge or equivalent) plus clarification.</P>
          <P>(iii) Steam stripping.</P>
          <P>(iv) Resin or activated carbon adsorption.</P>
          <P>(v) Chemical destruction or conversion.</P>
          <P>(vi) Primary wastewater treatment.</P>
          <P>(3) Into the waters of the United States without primary wastewater treatment, and secondary wastewater treatment as defined in 40 CFR part 133.</P>
          <P>(4) Into the waters of the United States if the quotient from the following formula:</P>
          <GPOTABLE CDEF="s50,3,r50" COLS="3" OPTS="L1(0,0,0)">
            <BOXHD>
              <CHED H="1">number of kilograms/day/site released</CHED>
              <CHED H="2"> receiving stream flow (million liters/day)</CHED>
              <CHED H="1"> X</CHED>
              <CHED H="1">1000 = N parts per billion</CHED>
            </BOXHD>
            <ROW>
              <ENT I="22"/>
            </ROW>
          </GPOTABLE>

          <FP>exceeds the level specified in subpart E of this part when calculated using the methods described in § 721.91. In lieu of calculating the above quotient, monitoring or alternative calculations may be used to predict the surface water concentration which will result from the intended release of the substance, if the monitoring procedures or calculations have been approved for such purpose by EPA. EPA will review and act on written requests to approve monitoring procedures or alternative calculations within 90 days after such requests are received. EPA will inform submitters of the disposition of such requests in writing, and will explain <PRTPAGE P="146"/>the reasons therefor when they are denied.</FP>
          <P>(b) Any predictable or purposeful release of a process stream containing the substance associated with any use of the substance from any site:</P>
          <P>(1) Into the waters of the United States.</P>
          <P>(2) Into the waters of the United States without application of one or more of the following treatment technologies as specified in subpart E of this part either by the discharger or, in the case of a release through publicly-owned treatment works, by a combination of treatment by the discharger and the publicly-owned treatment works:</P>
          <P>(i) Chemical precipitation and settling.</P>
          <P>(ii) Biological treatment (activated sludge or equivalent) plus clarification.</P>
          <P>(iii) Steam stripping.</P>
          <P>(iv) Resin or activated carbon adsorption.</P>
          <P>(v) Chemical destruction or conversion.</P>
          <P>(vi) Primary wastewater treatment.</P>
          <P>(3) Into the waters of the United States without primary wastewater treatment, and secondary wastewater treatment as defined in 40 CFR part 133.</P>
          <P>(4) Into the waters of the United States if the quotient from the following formula:</P>
          <GPOTABLE CDEF="s50,3,r50" COLS="3" OPTS="L1(0,0,0)">
            <BOXHD>
              <CHED H="1">number of kilograms/day/site released</CHED>
              <CHED H="2"> receiving stream flow (million liters/day)</CHED>
              <CHED H="1"> X</CHED>
              <CHED H="1"> 1000 = N parts per billion</CHED>
            </BOXHD>
            <ROW>
              <ENT I="22"/>
            </ROW>
          </GPOTABLE>
          <FP>exceeds the level specified in subpart E of this part when calculated using the methods described in § 721.91. In lieu of calculating the above quotient, monitoring or alternative calculations may be used to predict the surface water concentration which will result from the intended release of the substance, if the monitoring procedures or calculations have been approved for such purpose by EPA. EPA will review and act on written requests to approve monitoring procedures or alternative calculations within 90 days after such requests are received. EPA will inform submitters of the disposition of such requests in writing, and will explain the reasons therefor when they are denied.</FP>
          <P>(c) Any predictable or purposeful release of a use stream containing the substance associated with any use of the substance from any site:</P>
          <P>(1) Into the waters of the United States.</P>
          <P>(2) Into the waters of the United States without application of one or more of the following treatment technologies as specified in subpart E of this part either by the discharger or, in the case of a release through publicly-owned treatment works, by a combination of treatment by the discharger and the publicly-owned treatment works:</P>
          <P>(i) Chemical precipitation and settling.</P>
          <P>(ii) Biological treatment (activated sludge or equivalent) plus clarification.</P>
          <P>(iii) Steam stripping.</P>
          <P>(iv) Resin or activated carbon adsorption.</P>
          <P>(v) Chemical destruction or conversion.</P>
          <P>(vi) Primary wastewater treatment.</P>
          <P>(3) Into the waters of the United States without primary wastewater treatment, and secondary wastewater treatment as defined in 40 CFR part 133.</P>
          <P>(4) Into the waters of the United States if the quotient from:</P>
          <GPOTABLE CDEF="s50,3,r50" COLS="3" OPTS="L1(0,0,0)">
            <BOXHD>
              <CHED H="1">number of kilograms/day/site released</CHED>
              <CHED H="2"> receiving stream flow (million liters/day)</CHED>
              <CHED H="1"> X</CHED>
              <CHED H="1">1000 = N parts per billion</CHED>
            </BOXHD>
            <ROW>
              <ENT I="22"/>
            </ROW>
          </GPOTABLE>

          <FP>exceeds the level specified in subpart E of this part, when calculated using the methods described in § 721.91. In lieu of calculating the above quotient, however, monitoring or alternative calculations may be used to predict the surface water concentration expected to result from intended release of the substance, if the monitoring procedures or calculations have been approved for such purpose by EPA. EPA will review and act on written requests to approve monitoring procedures or alternative calculations within 90 days after such requests are received. EPA will inform submitters of the disposition of such requests in writing, and <PRTPAGE P="147"/>will explain the reasons therefor when they are denied.</FP>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.91</SECTNO>
          <SUBJECT>Computation of estimated surface water concentrations: Instructions.</SUBJECT>
          <P>These instructions describe the use of the equation specified in § 721.90(a)(4) and (b)(4) to compute estimated surface water concentrations which will result from release of a substance identified in subpart E of this part. The equation shall be computed for each site using the stream flow rate appropriate for the site according to paragraph (b) of this section, and the highest number of kilograms calculated to be released for that site on a given day according to paragraph (a) of this section. Two variables shall be considered in computing the equation, the number of kilograms released, and receiving stream flow.</P>
          <P>(a) <E T="03">Number of kilograms released.</E> (1) To calculate the number of kilograms of substance to be released from manufacturing, processing, or use operations, as specified in the numerator of the equation, develop a process description diagram which describes each manufacturing, processing, or use operation involving the substance. The process description must include the major unit operation steps and chemical conversions. A unit operation is a functional step in a manufacturing, processing, or use operation where substances undergo chemical changes and/or changes in location, temperature, pressure, physical state, or similar characteristics. Include steps in which the substance is formulated into mixtures, suspensions, solutions, etc.</P>
          <P>(2) Indicate on each diagram the entry point of all feedstocks (e.g., reactants, solvents, and catalysts) used in the operation. Identify each feedstock and specify its approximate weight regardless of whether the process is continuous or batch.</P>
          <P>(3) Identify all release points from which the substance or wastes containing the substance will be released into air, land, or water. Indicate these release points on the diagram. Do not include accidental releases or fugitive emissions.</P>
          <P>(4) For releases identified in the diagram that are destined for water, estimate the amount of substance that will be released before the substance enters control technology. The kilograms of substance released may be estimated based on:</P>
          <P>(i) The mass balance of the operation, i.e., totaling inputs and outputs, including wastes for each part of the process such that outputs equal inputs. The amount released to water may be the difference between the amount of the substance in the starting material (or formed in a reaction) minus the amount of waste material removed from each part of the process and not released to water and the amount of the substance in the final product.</P>
          <P>(ii) Physical properties such as water solubility where a known volume of water being discharged is assumed to contain the substance at concentrations equal to its solubility in water. This approach is particularly useful where the waste stream results from separation of organic/water phases or filtration of the substance from an aqueous stream to be discharged.</P>
          <P>(iii) Measurements of flow rates of the process/use stream and known concentrations of the substance in the stream.</P>
          <P>(5) After releases of a substance to water are estimated for each operation on a site, total the releases of the substance to water from all operations at that site. The value (number of kilograms) specified in the numerator of the equation should reflect total kilograms of substance released to water per day from all operations at a single site.</P>
          <P>(6) Use the highest expected daily release of the substance for each site.</P>
          <P>(b) <E T="03">Receiving stream flow.</E> (1) The receiving stream flow shall be expressed in million liters per day (MLD). The flow rate data to be used must be for the point of release on the water body that first receives release of the substance whether by direct discharge from a site, or by indirect discharge through a Publicly-Owned Treatment Works (POTW) for each site. The flow rate reported shall be the lowest 7-day average stream flow with a recurrence interval of 10 years (7-Q-10). If the 7-Q-10 flow rate is not available for the actual point of release, the stream flow rate should be used from the U.S. Geological Survey (USGS) gauging station <PRTPAGE P="148"/>that is nearest the point of release that is expected to have a flow rate less than or equal to the receiving stream flow at the point of release.</P>
          <P>(2) Receiving stream flow data may be available from the National Pollutant Discharge Elimination System (NPDES) permit for the site or the POTW releasing the substance to surface water, from the NPDES permit-writing authority for the site or the POTW, or from USGS publications, such as the water-data report series.</P>
          <P>(3) If receiving stream flow data are not available for a stream, either the value of 10 MLD or the daily flow of wastewater from the site or the POTW releasing the substance must be used as an assumed minimum stream flow. Similarly, if stream flow data are not available because the location of the point of release of the substance to surface water is a lake, estuary, bay, or ocean, then the flow rate to be used must be the daily flow of wastewater from the site or the POTW releasing the substance to surface water. Wastewater flow data may be available from the NPDES permit or NPDES authority for the site or the POTW releasing the substance to water.</P>
        </SECTION>
      </SUBPART>
      <SUBPART>
        <HD SOURCE="HED">Subpart C—Recordkeeping Requirements</HD>
        <SECTION>
          <SECTNO>§ 721.100</SECTNO>
          <SUBJECT>Applicability.</SUBJECT>
          <P>This subpart C identifies certain additional recordkeeping requirements applicable to manufacturers, importers, and processors of substances identified in subpart E of this part for each specific substance. The provisions of this subpart C apply only when referenced in subpart E of this part for a substance and significant new use identified in that subpart E. If the provisions in this subpart C conflict with general provisions of subpart A of this part, the provisions of this subpart C shall apply.</P>
          <CITA>[54 FR 31313, July 27, 1989]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.125</SECTNO>
          <SUBJECT>Recordkeeping requirements.</SUBJECT>
          <P>At the time EPA adds a substance to subpart E of this part, EPA will specify appropriate recordkeeping requirements which correspond to the significant new use designations for the substance selected from subpart B of this part. Each manufacturer, importer, and processor of the substance shall maintain the records for 5 years from the date of their creation. In addition to the records specified in § 721.40, the records whose maintenance this section requires may include the following:</P>
          <P>(a) Records documenting the manufacture and importation volume of the substance and the corresponding dates of manufacture and import.</P>
          <P>(b) Records documenting volumes of the substance purchased in the United States by processors of the substance, names and addresses of suppliers, and corresponding dates of purchase.</P>
          <P>(c) Records documenting the names and addresses (including shipment destination address, if different) of all persons outside the site of manufacture, importation, or processing to whom the manufacturer, importer, or processor directly sells or transfers the substance, the date of each sale or transfer, and the quantity of the substance sold or transferred on such date.</P>
          <P>(d) Records documenting establishment and implementation of a program for the use of any applicable personal protective equipment required under § 721.63.</P>
          <P>(e) Records documenting the determinations required by § 721.63(a)(3) that chemical protective clothing is impervious to the substance.</P>
          <P>(f) Records documenting establishment and implementation of the hazard communication program required under § 721.72.</P>
          <P>(g) Copies of labels required under § 721.72(b).</P>
          <P>(h) Copies of material safety data sheets required under § 721.72(c).</P>
          <P>(i) Records documenting compliance with any applicable industrial, commercial, and consumer use limitations under § 721.80.</P>

          <P>(j) Records documenting compliance with any applicable disposal requirements under § 721.85, including the method of disposal, location of disposal sites, dates of disposal, and volume of the substance disposed. Where the estimated disposal volume is not known to or reasonably ascertainable by the manufacturer, importer, or processor, that person must maintain other <PRTPAGE P="149"/>records which demonstrate establishment and implementation of a program that ensures compliance with any applicable disposal requirements.</P>
          <P>(k) Records documenting establishment and implementation of procedures that ensure compliance with any applicable water discharge limitations under § 721.90.</P>
          <CITA>[54 FR 31313, July 27, 1989]</CITA>
        </SECTION>
      </SUBPART>
      <SUBPART>
        <HD SOURCE="HED">Subpart D—Expedited Process for Issuing Significant New Use Rules for Selected Chemical Substances and Limitation or Revocation of Selected Significant New Use Rules</HD>
        <SOURCE>
          <HD SOURCE="HED">Source:</HD>
          <P>54 FR 31314, July 27, 1989, unless otherwise noted.</P>
        </SOURCE>
        <SECTION>
          <SECTNO>§ 721.160</SECTNO>
          <SUBJECT>Notification requirements for new chemical substances subject to section 5(e) orders.</SUBJECT>
          <P>(a) <E T="03">Selection of substances.</E> (1) In accordance with the expedited process specified in this section, EPA will issue significant new use notification requirements and other specific requirements for each new chemical substance that is the subject of a final order issued under section 5(e) of the Act, except for an order that prohibits manufacture and import of the substance, unless EPA determines that significant new use notification requirements are not needed for the substance.</P>

          <P>(2) If EPA determines that significant new use notification requirements are not needed for a substance that is subject to a final order issued under section 5(e) of the Act, except for an order that prohibits manufacture or import of the substance, EPA will issue a notice in the <E T="04">Federal Register</E> explaining why the significant new use requirements are not needed.</P>
          <P>(b) <E T="03">Designation of requirements.</E> (1) The significant new use notification and other specific requirements will be based on and be consistent with the provisions included in the final order issued for the substance under section 5(e) of the Act. EPA may also designate additional activities as significant new uses which will be subject to notification. Designation of additional activities as significant new uses will be done in accordance with the criteria and procedures under § 721.170, or through a separate rulemaking proceeding.</P>
          <P>(2) Significant new use requirements and other specific requirements designated under this section will be listed in subpart E of this part. For each substance, subpart E will identify:</P>
          <P>(i) The chemical name.</P>
          <P>(ii) The activities designated as significant new uses.</P>
          <P>(iii) Other specific requirements applicable to the substance, including recordkeeping requirements or any other requirements included in the final section 5(e) order.</P>
          <P>(c) <E T="03">Procedures for issuing significant new use rules.</E> (1) EPA will issue significant new use rules under this section by one of the following three processes: direct final rulemaking, interim final rulemaking, or notice and comment rulemaking. EPA will use the direct final rulemaking process to issue significant new use rules unless it determines that, in a particular case, one of the other processes is more appropriate.</P>
          <P>(2) <E T="04">Federal Register</E> documents issued to propose or establish significant new uses under this section will contain the following:</P>
          <P>(i) The chemical identity of the substance or, if its specific identity is claimed confidential, an appropriate generic chemical name and an accession number assigned by EPA.</P>
          <P>(ii) The premanufacture notice number.</P>
          <P>(iii) The CAS number, where available and not claimed confidential.</P>
          <P>(iv) A summary of EPA's findings under section 5(e)(1)(A) of the Act for the final order issued under section 5(e).</P>
          <P>(v) Designation of the significant new uses subject to, or proposed to be subject to, notification and any other applicable requirements.</P>
          <P>(vi) Any modifications of subpart A of this part applicable to the specific substance and significant new uses.</P>
          <P>(vii) If the <E T="04">Federal Register</E> document establishes a final rule, or notifies the public that a final rule will not be issued after public comment has <PRTPAGE P="150"/>been received, the document will describe comments received and EPA's response.</P>
          <P>(3) <E T="03">Direct final rulemaking.</E> (i) When EPA uses the direct final rulemaking procedure to issue a significant new use rule, it will issue a final rule in the <E T="04">Federal Register</E> following its decision to develop a significant new use rule under this section for a specific new chemical substance.</P>
          <P>(ii) The <E T="04">Federal Register</E> document will state that, unless written notice is received by EPA within 30 days of publication that someone wishes to submit adverse or critical comments, the rule will be effective 60 days from the date of publication. The written notice of intent to submit adverse or critical comments should state which SNUR(s) will be the subject of the adverse or critical comments, if several SNURs are established through the direct final rule. If notice is received within 30 days that someone wishes to submit adverse or critical comments, the section(s) of the direct final rule containing the SNUR(s) for which a notice of intent to comment was received will be withdrawn by EPA issuing a document in the final rule section of the <E T="04">Federal Register</E>, and a proposal will be published in the proposed rule section of the <E T="04">Federal Register</E>. The proposal will establish a 30-day comment period.</P>
          <P>(iii) If EPA, having considered any timely comments submitted in response to the proposal, decides to establish notification requirements under this section, EPA will issue a final rule adding the substance to subpart E of this part and designating the significant new uses subject to notification.</P>
          <P>(4) <E T="03">Notice and comment rulemaking.</E> (i) When EPA uses a notice and comment procedure to issue a significant new use rule, EPA will issue a proposal in the <E T="04">Federal Register</E> following its decision to develop a significant new use rule under this section for a specific new chemical substance. Persons will be given 30 days to comment on whether EPA should establish notification requirements for the substance under this part.</P>
          <P>(ii) If EPA, having considered any timely comments, decides to establish notification requirements under this section, EPA will issue a final rule adding the substance to subpart E of this part and designating the significant new uses subject to notification.</P>
          <P>(5) <E T="03">Interim final rulemaking.</E> (i) When EPA uses the interim final rulemaking procedure to issue a significant new use rule, EPA will issue an interim final rule in the final rule section of the <E T="04">Federal Register</E> following its decision to develop a significant new use rule for a specific new chemical substance. The document will state EPA's reasons for using the interim final rulemaking procedure.</P>
          <P>(A) The significant new use rule will take effect on the date of publication.</P>
          <P>(B) Persons will be given 30 days from the date of publication to submit comments.</P>

          <P>(ii) Interim final rules issued under this section shall cease to be in effect 180 days after publication unless, within the 180-day period, EPA issues a final rule in the <E T="04">Federal Register</E> responding to any written comments received during the 30-day comment period specified in paragraph (c)(5)(i)(B) of this section and promulgating final significant new use notification requirements and other requirements for the substance.</P>
          <P>(d) <E T="03">Schedule for issuing significant new use rules.</E> (1) Unless EPA determines that a significant new use rule should not be issued under this section, EPA will issue a proposed rule, a direct final rule, or an interim final rule within 180 days of receipt of a valid notice of commencement under § 720.102 of this chapter for any substance for which the notice of commencement was received on or after October 10, 1989.</P>
          <P>(2) Unless EPA determines that a significant new use rule should not be issued under this section, EPA will issue a proposed rule, a direct final rule, or an interim final rule within 1 year of October 10, 1989, for any substance for which the valid notice of commencement under § 720.102 of this chapter was received before October 10, 1989.</P>

          <P>(3) If EPA receives adverse or critical significant comments following publication of a proposed or interim final rule, EPA will either withdraw the rule <PRTPAGE P="151"/>or issue a final rule addressing the comments received.</P>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.170</SECTNO>
          <SUBJECT>Notification requirements for selected new chemical substances that have completed pre-manu-facture review.</SUBJECT>
          <P>(a) <E T="03">Selection of substances.</E> In accordance with the expedited process specified in this section, EPA may issue significant new use notification and recordkeeping requirements for any new chemical substance for which a premanufacture notice has been submitted under part 720 of this chapter if EPA determines that activities other than those described in the premanufacture notice may result in significant changes in human exposure or environmental release levels and/or that concern exists about the substance's health or environmental effects.</P>
          <P>(b) <E T="03">Concern criteria.</E> EPA may determine that concern exists about a substance's health or environmental effects if EPA makes any one of the following findings:</P>
          <P>(1)(i) The substance may cause carcinogenic effects because the substance:</P>
          <P>(A) Has been shown by valid test data to cause carcinogenic effects in humans or in at least one species of laboratory animal.</P>
          <P>(B) Has been shown to be a possible carcinogen based on the weight of the evidence in short-term tests indicative of the potential to cause carcinogenic effects.</P>
          <P>(C) Is closely analogous, based on toxicologically relevant similarities in molecular structure and physical properties, to another substance that has been shown by test data to cause carcinogenic effects in humans or in at least one species of laboratory animal, provided that if there is more than one such analogue, the greatest weight will be given to the relevant data for the most appropriate analogues.</P>
          <P>(D) Is known or can reasonably be anticipated, based on valid scientific data or established scientific principles, to be metabolized in humans or transformed in the environment to a substance which may have the potential to cause carcinogenic effects under the criteria in paragraphs (b)(1)(i) (A), (B), or (C) of this section.</P>
          <P>(ii) No substance may be regulated based on a finding under paragraph (b)(1) of this section unless EPA has also made the finding under § 721.170(c)(2)(ii).</P>
          <P>(2) The substance has been shown by valid test data to cause acutely toxic effects in at least one species of laboratory animal or is closely analogous, based on toxicologically relevant similarities in molecular structure and physical properties, to another substance that has been shown by valid test data to cause acutely toxic effects in at least one species of laboratory animal, provided that if there is more than one such analogue, the greatest weight will be given to the relevant data for the most appropriate analogues.</P>
          <P>(3) The substance may cause serious chronic effects, serious acute effects, or developmentally toxic effects under reasonably anticipated conditions of exposure because the substance:</P>
          <P>(i) Has been shown by valid test data to cause serious chronic effects, serious acute effects, or developmentally toxic effects in humans or in at least one species of laboratory animal at dose levels that could be of concern under reasonably anticipated conditions of exposure.</P>
          <P>(ii) Is closely analogous, based on toxicologically relevant similarities in molecular structure and physical properties, to another chemical substance that has been shown by valid test data to cause serious chronic effects, serious acute effects, or developmentally toxic effects in humans or in at least one species of laboratory animal at dose levels that could be of concern under reasonably anticipated conditions of exposure, provided that if there is more than one such analogue, the greatest weight will be given to the relevant data for the most appropriate analogues.</P>

          <P>(iii) Is known or can reasonably be anticipated, based on valid scientific data or established scientific principles, to be metabolized in humans or transformed in the environment to a substance which may have the potential to cause serious chronic effects, serious acute effects, or developmentally <PRTPAGE P="152"/>toxic effects under the criteria in paragraph (b)(3) (i) and (ii) of this section.</P>
          <P>(iv) Has been shown to potentially cause developmentally toxic effects based on the weight of the evidence in short-term tests indicative of the potential to cause developmentally toxic effects.</P>
          <P>(4) The substance may cause significant adverse environmental effects under reasonably anticipated conditions of release because the substance:</P>
          <P>(i) Has been shown by valid test data to cause significant adverse environmental effects at dose levels that could be of concern under reasonably anticipated conditions of release.</P>
          <P>(ii) Is closely analogous, based on toxicologically relevant similarities in molecular structure and physical properties, to another substance that has been shown by valid test data to cause significant adverse environmental effects at dose levels that could be of concern under reasonably anticipated conditions of release, provided that if there is more than one such analogue, the greatest weight will be given to the relevant data for the most appropriate analogues.</P>
          <P>(iii) Has been determined, based on calculations using the substance's physical and chemical properties, to be potentially able to cause significant adverse environmental effects at dose levels that could be of concern under reasonably anticipated conditions of release.</P>
          <P>(iv) Is known or can reasonably be anticipated, based on valid scientific data or established scientific principles, to be environmentally transformed to a substance which may have the potential to cause significant adverse environmental effects under the criteria in paragraph (b)(4) (i), (ii), and (iii) of this section.</P>
          <P>(5) Concern exists about the health or environmental effects of one or more impurities or byproducts of the substance because the impurity or byproduct meets one or more of the criteria in paragraph (b) (1) through (4) of this section and either:</P>
          <P>(i) The impurity or byproduct is a new chemical substance and may be present in concentrations that could cause adverse health or environmental effects under reasonably anticipated conditions of exposure or release.</P>
          <P>(ii) Reasonably anticipated manufacture, processing, or use activities involving the substance for which a premanufacture notice has been submitted may result in significantly increased human exposure to or environmental release of the impurity or byproduct compared to exposure or release levels resulting from existing activities involving the impurity or byproduct.</P>
          <P>(c) <E T="03">Designation of requirements.</E> (1) When EPA decides to establish significant new use reporting requirements under this section, EPA may designate as a significant new use any one or more of the activities set forth in subpart B of this part. In addition, EPA may designate specific recordkeeping requirements described under subpart C of this part that are applicable to the substance.</P>
          <P>(2) EPA may designate as a significant new use only those activities that (i) are different from those described in the premanufacture notice for the substance, including any amendments, deletions, and additions of activities to the premanufacture notice, and (ii) may be accompanied by changes in exposure or release levels that are significant in relation to the health or environmental concerns identified under paragraph (b) of this section.</P>
          <P>(d) <E T="03">Procedures for issuing significant new use rules.</E> (1) Significant new use requirements designated under this section will be listed in subpart E of this part. For each substance, subpart E of this part will identify:</P>
          <P>(i) The chemical name.</P>
          <P>(ii) The activities designated as significant new uses, which may include one or more of the activities described in paragraph (c) of this section.</P>
          <P>(iii) Other specific requirements applicable to the substance.</P>

          <P>(2) When EPA determines that a substance is a candidate for a significant new use rule under this section, it will notify the person that submitted the premanufacture notice for the substance no later than 7 calendar days before the expiration of the notice review period under § 720.75 of this chapter. In providing this notice, EPA will describe the health or environmental <PRTPAGE P="153"/>concerns identified under paragraph (b) of this section and the activities under consideration for designation as significant new uses. Such notice may be by telephone, but in this event will be confirmed in writing no later than 30 days after completion of the notice review period.</P>
          <P>(3) <E T="04">Federal Register</E> documents issued to propose or establish significant new uses under this section will contain the following:</P>
          <P>(i) The chemical identity of the substance or, if its specific identity is claimed confidential, an appropriate generic chemical name and an accession number assigned by EPA.</P>
          <P>(ii) The premanufacture notice number.</P>
          <P>(iii) The CAS number, where available and not claimed confidential.</P>
          <P>(iv) A summary of the basis for action under this section.</P>
          <P>(v) Designation of the significant new uses subject to, or proposed to be subject to, notification and any other applicable requirements.</P>
          <P>(vi) Any modifications of subpart A of this part applicable to the specific substance and significant new uses.</P>
          <P>(vii) If the <E T="04">Federal Register</E> document establishes a final rule, or notifies the public that a final rule will not be issued after public comment has been received, the document will describe comments received and EPA's response.</P>
          <P>(4) EPA will issue significant new use rules under this section by one of the following three processes: direct final rulemaking, interim final rulemaking, or notice and comment rulemaking. EPA will use the direct final rulemaking process to issue significant new use rules unless it determines that, in a particular case, one of the other processes is more appropriate.</P>

          <P>(i)(A) When EPA uses the direct final rulemaking procedure to issue a significant new use rule it will issue a direct final rule in the final rule section of the <E T="04">Federal Register</E> following its decision to develop a significant new use rule under this section for a specific new chemical substance.</P>
          <P>(B) The <E T="04">Federal Register</E> document will state that, unless written notice is received by EPA within 30 days after the date of publication that someone wishes to submit adverse or critical comments, the SNUR will be effective 60 days from date of publication. The written notice of intent to submit adverse or critical comments should state which SNUR(s) will be the subject of the adverse or critical comments, if several SNURs are established through the direct final rule. If notice is received within 30 days after the date of publication that someone wishes to submit adverse or critical comments, the section(s) of the direct final rule containing the SNUR(s) for which a notice of intent to comment was received will be withdrawn by EPA issuing a document in the final rule section of the <E T="04">Federal Register</E>, and EPA will issue a proposed rule in the proposed rule section of the <E T="04">Federal Register</E>. The proposed rule will establish a 30-day comment period.</P>
          <P>(C) If EPA, having considered any timely comments submitted in response to the proposal, decides to establish notification requirements under this section, EPA will issue a final rule adding the substance to subpart E of this part and designating the significant new uses subject to notification.</P>

          <P>(ii)(A) When EPA uses a notice and comment procedure to issue a significant new use rule, EPA will issue a proposed rule in the <E T="04">Federal Register</E> following its decision to develop a significant new use rule under this section for a specific new chemical substance. Persons will be given 30 days to comment on whether EPA should establish notification requirements for the substance under this part.</P>
          <P>(B) If EPA, having considered any timely comments, decides to establish notification requirements under this section, EPA will issue a final rule adding the substance to subpart E of this part and designating the significant new uses subject to notification.</P>

          <P>(iii)(A) When EPA uses the interim final rulemaking procedure to issue a significant new use rule, EPA will issue an interim final rule in the final rule section of the <E T="04">Federal Register</E> following its decision to develop a significant new use rule for a specific new chemical substance. The document will state EPA's reasons for using the interim final rulemaking procedure.<PRTPAGE P="154"/>
          </P>
          <P>(<E T="03">1</E>) The significant new use rule will take effect on the date of publication.</P>
          <P>(<E T="03">2</E>) Persons will be given 30 days from the date of publication to submit comments.</P>

          <P>(B) An interim final rule issued under this section shall cease to be in effect 180 days after publication unless, within the 180-day period, EPA issues a final rule in the <E T="04">Federal Register</E> responding to any written comments received during the 30-day comment period specified in paragraph (d)(4)(iii)(A)(<E T="03">2</E>) of this section and promulgating final significant new use notification requirements and other requirements for the substance.</P>
          <P>(e) <E T="03">Schedule for issuing significant new use rules.</E> (1) EPA will issue a proposed rule, an interim final rule, or a direct final rule within 270 days of receipt of the notice of commencement under § 720.102 of this chapter for any substance for which the notice of commencement was received on or after October 10, 1989.</P>
          <P>(2) If EPA receives adverse or critical comments within the designated comment period following publication of a proposed rule or an interim final rule, EPA will either withdraw the rule or issue a final rule addressing the comments received.</P>
          <CITA>[54 FR 31314, July 27, 1989, as amended at 60 FR 16316, Mar. 29, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.185</SECTNO>
          <SUBJECT>Limitation or revocation of certain notification requirements.</SUBJECT>
          <P>(a) <E T="03">Criteria for modification or revocation.</E> EPA may at any time modify or revoke significant new use notification requirements for a chemical substance which has been added to subpart E of this part using the procedures under § 721.160 or § 721.170. Such action may be taken under this section if EPA makes one of the following determinations, unless other information shows that the requirements should be retained:</P>
          <P>(1) Test data or other information obtained by EPA provide a reasonable basis for concluding that activities designated as significant new uses of the substance will not present an unreasonable risk of injury to human health or the environment.</P>
          <P>(2) EPA has promulgated a rule under section 4 or 6 of the Act, or EPA or another agency has taken action under another law for the substance that eliminates the need for significant new use notification under section 5(a)(2) of the Act.</P>
          <P>(3) EPA has received significant new use notices for some or all of the activities designated as significant new uses of the substance and, after reviewing such notices, concluded that there is no need to require additional notice from persons who propose to engage in identical or similar activities.</P>
          <P>(4) EPA has examined new information, or has reexamined the test data or other information or analysis supporting its decision to add the substance to subpart E of this part under § 721.170 and has concluded that the substance does not meet the criteria under § 721.170(b).</P>
          <P>(5) For a substance added to subpart E of this part under § 721.160, EPA has examined new information, or has reexamined the test data or other in-for-ma-tion or analysis supporting its finding under section 5(e)(1)(A)(ii)(I) of the Act, and has concluded that a rational basis no longer exists for the findings that activities involving the substance may present an unreasonable risk of injury to human health or the environment required under section 5(e)(1)(A) of the Act.</P>
          <P>(6) For a substance added to subpart E of this part under § 721.160, certain activities involving the substance have been designated as significant new uses pending the completion of testing, and adequate test data developed in accordance with applicable procedures and criteria have been submitted to EPA.</P>
          <P>(b) <E T="03">Procedures for limitation or revocation.</E> Modification or revocation of significant new use notification requirements for a substance that has been added to subpart E of this part using the procedures described under § 721.160 or § 721.170 may occur either at EPA's initiative or in response to a written request.</P>

          <P>(1) Any affected person may request modification or revocation of significant new use notification requirements for a substance that has been added to subpart E of this part using the procedures described in § 721.160 or § 721.170 by writing to the Director of the Office of Pollution Prevention and Toxics and stating the basis for such request. All <PRTPAGE P="155"/>requests should be sent to the Document Control Office (7407), Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Room G-099, 401 M St., SW., Washington, DC., 20460. ATTN: Request to amend significant new use rule. The request must be accompanied by information sufficient to support the request.</P>
          <P>(2) The Director of the Office of Pollution Prevention and Toxics will consider the request, make a determination whether to initiate rulemaking to modify the requirements, and notify the requester of that determination by certified letter. If the request is denied, the letter will explain why EPA has concluded that the significant new use notification requirements for that substance should remain in effect.</P>

          <P>(3) If EPA concludes that significant new use notification requirements for a substance should be limited or revoked, EPA will propose the changes in the <E T="04">Federal Register</E>, briefly describe the grounds for the action, and provide interested parties an opportunity to comment.</P>
          <CITA>[54 FR 31314, July 27, 1989, as amended at 58 FR 34204, June 23, 1993; 60 FR 34464, July 3, 1995]</CITA>
        </SECTION>
      </SUBPART>
      <SUBPART>
        <HD SOURCE="HED">Subpart E—Significant New Uses for Specific Chemical Substances</HD>
        <SECTION>
          <SECTNO>§ 721.225</SECTNO>
          <SUBJECT>2-Chloro-N-methyl-N-substituted acetamide (generic name).</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E>  (1) The chemical substance 2-chloro-<E T="03">N</E>-methyl-<E T="03">N</E>-substituted acetamide (PMN P-84-393) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63(a)(1), (a)(3), (b) (concentration set at 1.0 percent), and (c).</P>
          <P>(ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(2), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(iv), (g)(2)(i), and (g)(2)(v). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and MSDSs do not apply when the written program and MSDSs are not required under § 721.72 (a) and (c), respectively. The provision of § 721.72(g) requiring placement of specific information on an MSDS does not apply when an MSDS is not required under § 721.72(c).</P>
          <P>(iii) <E T="03">Industrial, commercial, and con-sumer activities.</E> Requirements as specified § 721.80(g).</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> The recordkeeping requirements as specified in § 721.125 (a) through (g) and (i) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule.</P>
          <CITA>[55 FR 32412, Aug. 9, 1990, as amended at 57 FR 20424, May 13, 1992. Redesignated at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA>
          
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.267</SECTNO>
          <SUBJECT>N-[2-[(substituted dinitrophenyl)azo]diallylamino-4- substituted phenyl] acetamide (generic name).</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as <E T="03">N</E>-[2-[(substituted dinitrophenyl)azo]diallylamino-4-substituted phenyl] acetamide (PMN P-95-513) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance.<PRTPAGE P="156"/>
          </P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
          <CITA>[61 FR 63734, Dec. 2, 1996]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.275</SECTNO>
          <SUBJECT>Halogenated-N-(2-propenyl)-N-(substituted phenyl) acetamide.</SUBJECT>
          <P>(a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as halogenated-<E T="03">N</E>-(2-propenyl)-<E T="03">N</E>-(substituted phenyl) acetamide (P-83-1085) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1) and (a)(3).</P>
          <P>(ii) <E T="03">Industrial, commercial, and con-sumer activities.</E> Requirements as specified in § 721.80(g).</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance: § 721.125 (a) through (e), and (i).</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
          <CITA>[56 FR 25988, June 5, 1991. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.285</SECTNO>
          <SUBJECT>Acetamide, <E T="03">N</E>-[4-(pentyloxy)phenyl]-, acetamide, <E T="03">N</E>-[2-nitro-4-(pentyloxy)phenyl]-, and acetamide, <E T="03">N</E>-[2-amino-4-(pentyloxy)phenyl]-.</SUBJECT>
          <P>(a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances identified as acetamide, <E T="03">N</E>-[4-(pentyloxy)phenyl]- (PMN P-92-31), acetamide, <E T="03">N</E>-[2-nitro-4-(pentyloxy)phenyl]- (PMN P-92-32), and acetamide, <E T="03">N</E>-[2-amino-4-(pentyloxy)phenyl]- (PMN P-92-33) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are: (i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(h).</P>
          <P>(ii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 90 ppb for PMNs P-92-31 and P-92-32, and N = 30 ppb for P-92-33). When calculating the surface water concentrations according to the instructions in § 721.90(a)(4), the statement that the amount of the substance that will be released will be calculated before the substance enters control technology does not apply. Instead, if the waste stream containing the substance will be treated before release, then the amount of the substance reasonably likely to be removed from the waste stream by such treatment may be subtracted in calculating the number of kilograms released. No more than 25 percent removal efficiency may be attributed to such treatment.</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (i), and (k) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
          <CITA>[58 FR 51702, Oct. 4, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.305</SECTNO>
          <SUBJECT>Di-substituted acetophenone (generic).</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substance identified generically as di-substituted acetophenone (PMN P-97-93) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace</E>. Requirements as specified in  § 721.63 (a)(1), (a)(2)(i), (a)(2)(ii), (a)(2)(iii), (a)(3), (b) (concentration set at 1.0 percent), and (c).</P>
          <P>(ii) <E T="03">Hazard communication program</E>. Requirements as specified in  § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(2)(i), (g)(2)(v). The following statement shall appear on each label as specified in § 721.72(b) and the MSDS as specified in § 721.72(c): This substance is expected to be dermally absorbed and may cause effects to the <PRTPAGE P="157"/>liver, kidney, adrenal glands, and the heart.</P>
          <P>(iii) <E T="03">Industrial, commercial, and consumer activities</E>. Requirements as specified in § 721.80(q).</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in  § 721.125 (a), (b), (c), (d), (e), (f), (g), (h), and (i) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <P>(3) <E T="03">Determining whether a specific use is subject to this section</E>. The provisions of § 721.1725(b)(1) apply to this section.</P>
          <CITA>[63 FR 44574, Aug. 20, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.320</SECTNO>
          <SUBJECT>Acrylamide-substituted epoxy.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as acrylamide-substituted epoxy (PMN P-92-660) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (a)(2)(ii), (a)(2)(iii), (a)(2)(iv), (a)(3), (a)(4), (a)(5)(i), (a)(6)(i), (a)(6)(ii), (b) (concentration set at 0.1 percent), and (c).</P>
          <P>(ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(1)(iii), (g)(1)(iv), (g)(1)(vi), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(3)(i), (g)(3)(ii), (g)(4)(iii), and (g)(5).</P>
          <P>(iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q).</P>
          <P>(iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1).</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i) and (k) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
          <P>(3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section.</P>
          <CITA>[58 FR 51681, Oct. 4, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.323</SECTNO>
          <SUBJECT>Substituted acrylamide.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance generically identified as substituted acrylamide (PMN P-90-1687) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are: (i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(iii), (a)(3), (a)(4), (a)(6)(ii), (a)(6)(v), (b) (concentration set at 0.1 percent), and (c). Section 721.63 (a)(5)(i), (a)(5)(ii), and (a)(5)(iii) apply to manufacturing operations only; § 721.63(a)(5)(ix), (a)(5)(x), and (a)(5)(xi) apply to processing and use operations only.</P>
          <P>(ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(vi), (g)(1)(vii), (g)(2)(ii) (g)(2)(iii), (g)(2)(iv), (g)(2)(v), and (g)(5). The following additional statement shall appear on each label and MSDS as required by this paragraph: This substance may cause nervous system effects.</P>
          <P>(iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q).</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section.</P>
          <P>(1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
          <P>(3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section.</P>
          <CITA>[58 FR 51702, Oct. 4, 1993]</CITA>
        </SECTION>
        <SECTION>
          <PRTPAGE P="158"/>
          <SECTNO>§ 721.324</SECTNO>
          <SUBJECT>Alkoxylated acrylate polymer (generic).</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substance identified generically as alkoxylated acrylate polymer (PMN P-98-807) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Release to water</E>. Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <CITA>[65 FR 366, Jan. 5, 2000]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.329</SECTNO>
          <SUBJECT>Halogenated benzyl ester acrylate (generic).</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substance identified generically as halogenated benzyl ester acrylate (PMN P-90-1527) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace</E>. Requirements as specified in § 721.63 (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iv), (a)(5)(v), (a)(6)(i), (b), and (c) (concentration set at 1.0 percent). The reporting requirement for § 721.63(a)(5)(i) applies only during manufacture. The reporting requirement for § 721.63 (a)(5)(ii), (a)(5)(iv), and (a)(5)(v) applies only during processing.</P>
          <P>(ii) <E T="03">Hazard communication program</E>. Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g), (g)(1)(iv), (g)(2)(ii), (g)(2)(iv), and (g)(5). The following statement shall appear on each label as specified in § 721.72(b) and the Material Safety Data Sheet (MSDS) as specified in § 721.72 (c): The substance may cause internal organ effects (kidney and blood). The requirements of this section do not apply when the PMN substance is bound or embedded into a plastic, resin matrix, or pellet.</P>
          <P>(iii) <E T="03">Industrial, commercial, and consumer activities</E>. Requirements as specified in § 721.80(q).</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance as specified in § 721.125 (a), (b), (c), (d), (f), (g), (h), and (i).</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <P>(3) <E T="03">Determining whether a specific use is subject to this section</E>. The provisions of § 721.1725(b)(1) apply to this section.</P>
          <CITA>[65 FR 366, Jan. 5, 2000]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.336</SECTNO>
          <SUBJECT>Perfluoroalkylethyl acrylate copolymer (generic name).</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a perfluoroalkylethyl acrylate copolymer (PMN P-94-241) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Industrial, commercial and consumer activities.</E> Requirements as specified in § 721.80(y)(1).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
          <CITA>[61 FR 63734, Dec. 2, 1996]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.405</SECTNO>
          <SUBJECT>Polyether acrylate.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The <PRTPAGE P="159"/>chemical substance identified generically as a polyether acrylate (PMN P-95-666) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Release to water</E>. Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in  § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <CITA>[63 FR 3419, Jan. 22, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.430</SECTNO>
          <SUBJECT>Oxo-substituted amino-al-kanoic acid derivative.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as oxo-substituted amino al-kan-oic acid derivative (PMN No. P-92-692) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iv), (a)(5)(v), (a)(6)(i), (a)(6)(ii), (b) (concentration set at 0.1 percent), and (c).</P>
          <P>(ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a) through (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iii), (g)(1)(iv), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(3)(ii), (g)(4)(iii), and (g)(5).</P>
          <P>(iii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (a)(2), and (a)(3).</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule.</P>
          <P>(3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section.</P>
          <CITA>[58 FR 32236, June 8, 1993, as amended at 58 FR 29946, May 24, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.435</SECTNO>
          <SUBJECT>Alkylphenylpolyether-alk-a-nol-a-mines (generic).</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substances identified generically as alkylphenylpolyether-alk-a-nol-a-mines (PMNs P-97-880/881/882) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Release to water</E>. Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in  § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <CITA>[63 FR 44574, Aug. 20, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.445</SECTNO>
          <SUBJECT>Substituted ethyl alken-a-mide.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted ethyl alkenamide (PMN No. P-86-1315) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (b) (concentration set at 0.1 percent), and (c).</P>
          <P>(ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), <PRTPAGE P="160"/>(b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(ii), (g)(1)(vii), (g)(2)(i), (g)(2)(iv), (g)(2)(v), and (g)(5).</P>
          <P>(iii) <E T="03">Industrial, commercial, and con-sumer activities.</E> Use other than polymerizing all residual materials from the manufacture, processing, and equipment rinsing of the PMN substance so that no monomers of the PMN substance are released to the environment.</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule.</P>
          <CITA>[58 FR 32236, June 8, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.450</SECTNO>
          <SUBJECT>Hydrofluorochloroalkene (generic).</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substance identified generically as a hydrofluorochloroalkene (PMN P-97-593) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Industrial, commercial, and consumer activities</E>. Requirements as specified in § 721.80(g).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. The recordkeeping requirements specified in  § 721.125 (a), (b), (c) and (i) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <CITA>[63 FR 44574, Aug. 20, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.484</SECTNO>
          <SUBJECT>Fluorinated acrylic copolymer (generic name).</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a fluorinated acrylic copolymer (PMN P-95-1208) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (v)(1), (w)(1), (x)(1), and (y)(1).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
          <CITA>[61 FR 63735, Dec. 2, 1996]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.505</SECTNO>
          <SUBJECT>Halogenated acrylonitrile.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as halogenated acrylonitrile, (PMN P-90-299) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iii), (a)(6)(ii), (a)(6)(v), (b) (concentration set at 0.1 percent), and (c).</P>
          <P>(ii) Hazard communication program. Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(i), (g)(1)(iii), (g)(1)(iv), (g)(1)(v), (g)(1)(vi), (g)(1)(vii), (g)(1)(ix), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), and (g)(5).</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping requirements.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (h).<PRTPAGE P="161"/>
          </P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule.</P>
          <CITA>[56 FR 15792, Apr. 17, 1991. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.520</SECTNO>
          <SUBJECT>Alanine, N-(2-carboxyethyl)-N-alkyl-, salt.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as alanine, <E T="03">N-</E>(2-carboxyethyl)-<E T="03">N-</E> alkyl-, salt (P-89-336) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (f), (g)(3)(ii), (g)(4)(i), and (g)(5).</P>
          <P>(ii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(k) and (q).</P>
          <P>(iii) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), (c)(4) (where N = 100). The requirement of 40 CFR 721.91(a)(4) that the amount of the substance estimated to be released to water is calculated before entering control technology is not retained. Instead, if the waste stream containing the PMN substance will be treated using biological treatment (activated sludge or equivalent) plus clarification, then the amount of PMN substance reasonably likely to be removed from the waste stream by such treatment may be subtracted in calculating the number of kilograms released. No more than 90 percent removal efficiency may be attributed to such treatment.</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping requirements.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance as specified in § 721.125 (a), (b), (c), (f), (g), (h), (i), and (k).</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule.</P>
          <P>(3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section.</P>
          <CITA>[56 FR 15789, Apr. 17, 1991. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.524</SECTNO>
          <SUBJECT>Alcohols, C<E T="52">6-12</E>, ethoxylated, reaction product with maleic anhydride.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substance identified generically as alcohols, C<E T="52">6-12</E>, ethoxylated, reaction product with maleic anhydride (PMN P-88-1108) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Release to water</E>. Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 300).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in  § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <CITA>[63 FR 3419, Jan. 22, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.530</SECTNO>
          <SUBJECT>Substituted aliphatic acid halide (generic name).</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance substituted aliphatic acid halide (PMN P-84-491) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i) through (a)(5)(iii), (a)(6)(v), (a)(6)(vi), (b) (concentration set at 0.1 percent), and (c).</P>
          <P>(ii) <E T="03">Hazard communication program</E>. Requirements as specified in § 721.72 (b)(2), (d), (e) (concentration set at 0.1 percent), (f) and (g)(1)(vii), (g)(2)(i) <PRTPAGE P="162"/>through (g)(2)(v), and (g)(4)(i). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and MSDSs do not apply when the written program and MSDS are not required under § 721.72 (a) and (c), respectively. The provision of § 721.72(g) requiring placement of specific information on an MSDS does not apply when an MSDS is not required under § 721.72(c).</P>
          <P>(iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(k).</P>
          <P>(iv) <E T="03">Disposal</E>. Requirements as specified in § 721.85 (a)(1), (b)(1) and (c)(1). (In lieu of incineration, persons subject to this section may dispose of wastes containing the substance by chemically treating liquid wastes so that the first hydrolysis product is less than 10 ppm prior to discharge or purifying the waste stream so that the first hydrolysis product is less than 10 ppm. Those purified waste streams may be reused or sold. All of the substance removed by these processes must be incinerated or treated and released as described in this paragraph (a)(2)(iv).)</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (c), (e) through (f), (i) and (j).</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule.</P>
          <P>(3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section.</P>
          <CITA>[55 FR 32412, Aug. 9, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.536</SECTNO>
          <SUBJECT>Halogenated phenyl alkane.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as halogenated phenyl alkane (PMN P-89-867) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply once the substance has been incorporated into a resin.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iv), (a)(5)(v), (6)(i), (b) (concentration set at 0.1 percent), and (c). As an alternative to the respiratory requirements in this section, manufacturers, importers, and processors may use the New Chemical Exposure Limits provisions, including sampling and analytical methods which have previously been approved by EPA for this substance, found in the 5(e) consent order for this substance. As an alternative to the respiratory requirements in this section manufacturers, importers, and processors may use the New Chemical Exposure Limits provisions, including sampling and analytical methods which have previously been approved by EPA for this substance, found in the 5(e) consent order for this substance.</P>
          <P>(ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (g)(1)(vii), (g)(2)(iv), (g)(2)(v), (g)(3)(ii), (g)(4)(iii), and (g)(5).</P>
          <P>(iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q).</P>
          <P>(iv) [Reserved]</P>
          <P>(v) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1).</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i), and (k) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
          <P>(3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section.</P>
          <CITA>[58 FR 51681, Oct. 4, 1993]</CITA>
        </SECTION>
        <SECTION>
          <PRTPAGE P="163"/>
          <SECTNO>§ 721.537</SECTNO>
          <SUBJECT>Organosilane ester.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substance identified generically as an organosilane ester (PMN P-96-1661/P-95-1654) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Industrial, commercial, and consumer activities</E>. Requirements as specified in § 721.80(r) (370,000 kilogram (kg)) (90-day subchronic inhalation study in rats-(40 CFR 799.9346) (62 FR 43828, August 15, 1997) (FRL-5719-5). A person may not manufacture or import the substance beyond the aggregate production volume limit, unless that person conducts this study on the substance and submits all final reports and underlying data in accordance with the procedures and criteria specified in paragraphs (a)(2)(i)(A), (a)(2)(i)(B), (a)(2)(i)(C), and (a)(2)(i)(D) of this section.</P>

          <P>(A) Each study required to be performed pursuant to this section must be scientifically valid. <E T="03">Scientific valid</E> means that the study was conducted according to:</P>
          <P>(<E T="03">1</E>) The test guidelines specified in paragraph (a)(2)(i) of this section.</P>
          <P>(<E T="03">2</E>) An EPA-approved protocol.</P>
          <P>(<E T="03">3</E>) TSCA Good Laboratory Practice Standards at 40 CFR part 792.</P>
          <P>(<E T="03">4</E>) Using methodologies generally accepted at the time the study is initiated.</P>
          <P>(<E T="03">5</E>) Any deviation from these requirements must be approved in writing by EPA.</P>
          <P>(B) Before starting to conduct any of the studies in paragraph (a)(2)(i) of this section, the person must obtain approval of test protocols from EPA by submitting written protocols. EPA will respond to the person within 4 weeks of receiving the written protocols. Published test guidelines specified in paragraph (a)(2)(i) of this section (e.g., 40 CFR part 797 or part 798) provide general guidance for development of test protocols, but are not themselves acceptable protocols.</P>
          <P>(C) The person shall:</P>
          <P>(<E T="03">1</E>) Conduct each study in good faith with due care.</P>
          <P>(<E T="03">2</E>) Promptly furnish to EPA the results of any interim phase of each study.</P>
          <P>(<E T="03">3</E>) Submit, in triplicate (with an additional sanitized copy, if confidential business information is involved), the final report of each study and all underlying data (“the report and data”) to EPA no later than 14 weeks prior to exceeding the applicable production volume limit. The final report shall contain the contents specified in 40 CFR 792.185.</P>
          <P>(D)(<E T="03">1</E>) Except as described in paragraph (a)(2)(i)(D)(<E T="03">2</E>) of this section, if, within 6 weeks of EPA's receipt of a test report and data, the person receives written notice that EPA finds that the data generated by a study are scientifically invalid, the person is prohibited from further manufacture and import of the PMN substance beyond the applicable production volume limit.</P>
          <P>(<E T="03">2</E>) The person may continue to manufacture and import the PMN substance beyond the applicable production limit only if so notified, in writing, by EPA in response to the person's compliance with either of the following paragraphs (a)(2)(i)(D)(<E T="03">2</E>)(<E T="03">i</E>) or (a)(2)(i)(D)(<E T="03">2</E>)(<E T="03">ii</E>) of this section.</P>
          <P>(<E T="03">i</E>) The person may reconduct the study. If there is sufficient time to reconduct the study and submit the report and data to EPA at least 14 weeks before exceeding the production limit as required by paragraph (a)(2)(i)(C)(<E T="03">3</E>) of this section, the person shall comply with paragraph (a)(2)(i)(C)(<E T="03">3</E>) of this section. If there is insufficient time for the person to comply with paragraph (a)(2)(ii)(C)(<E T="03">3</E>) of this section, the person may exceed the production limit and shall submit the report and data in triplicate to EPA within a reasonable period of time, all as specified by EPA in the notice described in paragraph (a)(2)(i)(D)(<E T="03">1</E>) of this section. EPA will respond to the person in writing, within 6 weeks of receiving the person's report and data.</P>
          <P>(<E T="03">ii</E>) The person may, within 4 weeks of receiving from EPA the notice described in paragraph (a)(2)(i)(D)(<E T="03">1</E>) of this section, submit to EPA a written report refuting EPA's finding. EPA will <PRTPAGE P="164"/>respond to the person in writing, within 4 weeks of receiving the person's report.</P>
          <P>(E) The person is not required to conduct a study specified in paragraph (a)(2)(i) of this section if notified in writing by EPA that it is unnecessary to conduct that study.</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in  § 721.125 (a), (b), (c) and (i) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <CITA>[63 FR 3419, Jan. 22, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.538</SECTNO>
          <SUBJECT>Phenol, 4-(1,1-dimethyl- ethyl)-, homopolymer.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substance identified as phenol, 4-(1,1-dimethylethyl)-, homopolymer (PMN P-95-243; CAS No. 30813-81-1) is subject to reporting under this section for the significant new uses described in paragraph (a)(3) of this section.</P>
          <P>(2) <E T="03">High moleculation weight exemption</E>. A batch of the chemical substance may be exempt from the provisions of this rule if the average number molecular weight of the substance is greater than 1,000 and the low molecular weight species below 1,000 and 500 are less than 25 percent and 10 percent, respectively. To be eligible for this exemption, the batch must be individually measured.</P>
          <P>(3) The significant new uses are:</P>
          <P>(i) <E T="03">Hazard communication program</E>. Requirements as specified in  § 721.72 (a), (b), (d), (f), (g)(3)(i), (g)(4)(i), and (g)(5). The label and material safety data sheet (MSDS) as required by this paragraph shall also include the following statement: This substance is toxic to aquatic invertebrate.</P>
          <P>(ii) <E T="03">Industrial, commercial, and consumer activites</E>. Requirements as specified in § 721.80(q).</P>
          <P>(iii) <E T="03">Release to water</E>. Requirements as specified in § 721.90 (a)(4) and (b)(4) (N = 9). When calculating the surface water concentrations according to the instructions in § 721.91, the statement that the amount of the substance that will be released will be calculated before the substance enters control technology does not apply. Instead, if the waste stream containing the substance will be treated using primary and secondary wastewater treatment with control of suspended solids, before release, then the amount of the substance reasonably likely to be removed from the waste stream by such treatment may be subtracted in calculating the number of kilograms released. No more than 95 percent removal efficiency may be attributed to such treatment. These requirements do not apply to the sites specifically exempted in the TSCA section 5(e) consent order for this substance.</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in  § 721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <P>(3) <E T="03">Determining whether a specific use is subject to this section</E>. The provisions of § 721.1725(b)(1) apply to this section.</P>
          <CITA>[63 FR 3420, Jan. 22, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.539</SECTNO>
          <SUBJECT>Poly(oxy-1,2-ethanediyl), <E T="61">a</E>-sulfo-<E T="61">v</E>-[1-[(4-nonylphenoxy)methyl]-2-(2-propenyloxy)ethoxy]-, branched, ammonium salts.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substance identified as Poly(oxy-1,2-ethanediyl), <E T="61">a</E>-sulfo-<E T="61">v</E>-[1-[(4-nonylphenoxy)methyl]-2-(2-propenyloxy)ethoxy]-, branched, ammonium salts (PMN P-96-1240; CAS No. 184719-88-8) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Industrial, commercial, and consumer activities</E>. Requirements as specified in § 721.80(f).</P>
          <P>(ii) [Reserved]<PRTPAGE P="165"/>
          </P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in  § 721.125 (a) and (i) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <CITA>[63 FR 3420, Jan. 22, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.540</SECTNO>
          <SUBJECT>Alkylphenoxypolyalkoxy-amine (generic name).</SUBJECT>
          <P>(a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as akylphenoxypolyalkoxyamine (PMN P-86-1489) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(2), (c), (f), and (g)(3)(ii), (g)(4)(iii), and (g)(5).</P>
          <P>(ii) <E T="03">Release to water.</E> Section 721.90 (a)(1), (b)(1), and (c)(1).</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (f), (g), (h), and (k).</P>
          <P>(2) <E T="03">Limitations or revocation of certain requirements.</E> The provisions of § 721.185 apply to this significant new use rule.</P>
          <CITA>[55 FR 26097, June 26, 1990. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.550</SECTNO>
          <SUBJECT>Alkyl alkenoate, azobis-.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substance identified generically as alkyl alkenoate, azobis- (PMN P-88-2470) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace</E>. Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i) through (a)(5)(iii), (a)(6)(ii), (b) (concentration set at 1.0 percent), and (c).</P>
          <P>(ii) <E T="03">Hazard communication program</E>. Requirements as specified in § 721.72 (b)(2), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(iii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(v), and (g)(5). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and MSDSs do not apply when the written program and MSDS are not required under § 721.72 (a) and (c), respectively. The provision of § 721.72(g) requiring placement of specific information on an MSDS does not apply when an MSDS is not required under § 721.72(c).</P>
          <P>(iii) <E T="03">Industrial, commercial, and consumer activities</E>. Requirements as specified in § 721.80 (l) and (q).</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), (e), (f), (g), and (h).</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this significant new use rule.</P>
          <P>(3) <E T="03">Determining whether a specific use is subject to this section</E>. The provisions of § 721.1725(b)(1) apply to this section.</P>
          <CITA>[55 FR 46771, Nov. 6, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.555</SECTNO>
          <SUBJECT>Alkyl amino nitriles (generic).</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substances identified generically as alkyl amino nitriles (PMNs P-96-1674 and P-96-1675) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace</E>. Requirements as specified in § 721.63 (a)(2)(iii), (a)(4), (a)(5)(i), (a)(6)(ii),(a)(6)(v), and (c). A full face <PRTPAGE P="166"/>shield is required if splashing or spraying occurs.</P>
          <P>(ii) <E T="03">Hazard communication program</E>. Requirements as specified in § 721.72 (c)(1) and (c)(2)(iv). The MSDS required by this paragraph shall include the following statement: Ocular exposure may cause death.</P>
          <P>(iii) <E T="03">Industrial, commercial, and consumer activities</E>. Requirements as specified in § 721.80 (g) and (l).</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (h), and (i) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <CITA>[63 FR 65709, Nov. 30, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.558</SECTNO>
          <SUBJECT>Salt of a fatty alkylamine derivative (generic).</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substance identified generically as a salt of a fatty alkylamine derivative (PMN P-96-1426) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Release to water</E>. Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in  § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <CITA>[63 FR 44575, Aug. 20, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.562</SECTNO>
          <SUBJECT>Substituted alkylamine salt.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted alkylamine salt (PMN P-85-941) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where n = 70).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
          <CITA>[60 FR 45080, Aug. 30, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.575</SECTNO>
          <SUBJECT>Substituted alkyl halide.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substance identified generically as substituted alkyl halide (PMN P-83-1222) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace</E>. Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(i) through (a)(5)(iii), (a)(6)(v), (a)(6)(vi), (b) (concentration set at 0.1 percent), and (c).</P>
          <P>(ii) <E T="03">Hazard communication program</E>. Requirements as specified in § 721.72 (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(ii), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), and (g)(2)(v). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and MSDSs do not apply when the written program and MSDS are not required under § 721.72 (a), and (c), respectively. The provisions of § 721.72(g) requiring placement of specific information on a label and MSDS do not apply when a label and MSDS are not required under § 721.72 (b), and (c), respectively.<PRTPAGE P="167"/>
          </P>
          <P>(iii) <E T="03">Industrial, commercial, and consumer activities</E>. Requirements as specified in § 721.80(h).</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), (e), and (f).</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this significant new use rule.</P>
          <CITA>[55 FR 46772, Nov. 6, 1990. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.600</SECTNO>
          <SUBJECT>3-Alkyl-2-(2-anilino)vinyl thi-azolinium salt (generic name).</SUBJECT>
          <P>(a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as 3-alkyl-2-(2-ani-lino)vin-yl-thi-azo-li-nium salt (PMN P-84-1007) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iii), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), (a)(5)(vii), (a)(6)(i), (b) (concentration set at 1 percent), and (c).</P>
          <P>(ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b)(2), (c), (d), (e), (f) [concentration set at 1 percent], (g)(1)(iii), (g)(1) (may be lethal if inhaled or in contact with eyes), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), (g)(2)(v), and (g)(5). The provision of § 721.72(d) requiring that employees be provided with information on the location and availability of MSDSs does not apply when an MSDS is not required under § 721.72(c). The provision of § 721.72(g) requiring placement of specific information on an MSDS does not apply when an MSDS in not required under § 721.72(c).</P>
          <P>(iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(j).</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (i), and (k).</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
          <CITA>[55 FR 26102, June 26, 1990. Redesignated at 58 FR 29947, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.625</SECTNO>
          <SUBJECT>Alkylated diarylamine, sul-furized (generic name).</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as alkylated diarylamine, sul-furized (PMN P-89-506) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(q)</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), and (c).</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule.</P>
          <P>(3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section.</P>
          <CITA>[55 FR 26099, June 26, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.630</SECTNO>
          <SUBJECT>Salt of a modified tallow alkylenediamine (generic).</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substance identified generically as a salt of a modified tallow alkylenediamine (PMN P-96-1425) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.<PRTPAGE P="168"/>
          </P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Release to water</E>. Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in  § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <CITA>[63 FR 44575, Aug. 20, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.639</SECTNO>
          <SUBJECT>Amine aldehyde condensate.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as an amine aldehyde condensate (PMN P-94-1810) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1).</P>
          <P>(ii)[Reserved]</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
          <CITA>[60 FR 45080, Aug. 30, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.640</SECTNO>
          <SUBJECT>Amine substituted metal salts.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substances identified generically as amine substituted metal salts (PMNs P-96-1337/1338/1339) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Release to water</E>. Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 4).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in  § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of these substances.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <CITA>[63 FR 3421, Jan. 22, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.641</SECTNO>
          <SUBJECT>Alkylpoly(oxyalkylene)amine.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substance identified generically as a alkylpoly(oxyalkylene)amine (PMN P-96-1430) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Industrial, commercial, and consumer activities</E>. Requirements as specified in § 721.80(g).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in  § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <CITA>[63 FR 3421, Jan. 22, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.642</SECTNO>
          <SUBJECT>Amines, <E T="03">N</E>-(C<E T="52">14-18</E> and C<E T="52">16-18</E> unsaturated alkyl)] dipropylene-tri-, tripropylenetetra-, and tetrapropylenepenta-.</SUBJECT>
          <P>(a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substances amines, <E T="03">N</E>-(C<E T="52">14-18</E> and C<E T="52">16-18</E> unsaturated alkyl)] dipropylenetri-, (PMN P-94-1244), tripropylenetetra- (PMN P-94-1245), and tetrapropylenepenta- (PMN P-94-1246) are subject to reporting under this section for the significant new <PRTPAGE P="169"/>uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
          <CITA>[60 FR 11041, Mar. 1, 1995]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.643</SECTNO>
          <SUBJECT>Ethoxylated alcohol, phosphated, amine salt.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substance identified as an ethoxylated alcohol, phosphated, amine salt (PMN P-96-1478) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Release to water</E>. Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (N = 8).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in  § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <CITA>[63 FR 3421, Jan. 22, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.644</SECTNO>
          <SUBJECT>Amines, C<E T="52">12-14</E>-tert-alkyl, sulfonates.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substance identified as amines, C<E T="52">12-14</E>-tert-alkyl, sulfonates (PMN P-98-400; CAS No. 197527-19-8) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Release to water</E>. Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <CITA>[65 FR 366, Jan. 5, 2000]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.646</SECTNO>
          <SUBJECT>Aminofluoran derivative (generic name).</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as aminofluoran derivative (PMN P-95-512) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(f).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
          <CITA>[61 FR 63735, Dec. 2, 1996]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.650</SECTNO>
          <SUBJECT>11-Aminoundecanoic acid.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new use subject to reporting.</E> (1) The chemical substance 11-ami-no-un-de-ca-noic acid, CAS Number 2432-99-7, is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section.<PRTPAGE P="170"/>
          </P>
          <P>(2) The significant new use is any use other than as.</P>
          <P>(i) An intermediate in the manufacture of polymers in an enclosed process when it is expected that the 11-aminoundecanoic acid will be fully polymerized during the manufacturing process, or</P>
          <P>(ii) A component in photoprocessing solutions.</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of Subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Definitions.</E> In addition to the definitions in § 721.3, the following definitions apply to this section:</P>
          <P>(i) <E T="03">Enclosed process</E> means a process that is designed and operated so that there is no intentional release of any substance present in the process. A process with fugitive, inadvertent, or emergency pressure relief releases remains an enclosed process so long as measures are taken to prevent worker exposure to and environmental contamination from the releases.</P>
          <P>(ii) <E T="03">Internal subunit</E> means a subunit that is covalently linked to at least two other subunits. <E T="03">Internal subunits</E> of polymer molecules are chemically derived from monomer molecules that have formed covalent links between two or more other molecules.</P>
          <P>(iii) <E T="03">Monomer</E> means a chemical substance that has the capacity to form links between two or more other molecules.</P>
          <P>(iv) <E T="03">Polymer</E> means a chemical substance that consists of at least a simple weight majority of polymer molecules but consists of less than a simple weight majority of molecules with the same molecular weight. Collectively, such polymer molecules must be distributed over a range of molecular weights wherein differences in molecular weight are primarly attributable to differences in the number of internal subunits.</P>
          <P>(v) <E T="03">Polymer molecule</E> means a molecule which includes at least four covalently linked subunits, at least two of which are internal subunits.</P>
          <P>(vi) <E T="03">Subunit</E> means an atom or group of associated atoms chemically derived from corresponding reactants.</P>
          <P>(2) [Reserved]</P>
          <CITA>[52 FR 19865, May 28, 1987. Redesignated at 53 FR 2845, Feb. 2, 1988. Further redesignated at 58 FR 29946, May 24, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.655</SECTNO>
          <SUBJECT>Ethoxylated alkyl quaternary ammonium compound.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substance identified generically as an ethoxylated alkyl quaternary ammonium compound (PMN P-96-573) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Industrial, commercial and consumer activities</E>. Requirements as specified in § 721.80(j).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in  § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <CITA>[63 FR 3421, Jan. 22, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.715</SECTNO>
          <SUBJECT>Trisubstituted anthracene.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as trisubstituted anthracene (PMN P-91-689) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (a)(2)(iii), (a)(2)(iv), (a)(3), (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iii), (a)(6)(i), (a)(6)(ii), (a)(6)(iv), (b) (concentration set at 0.1 percent), and (c).</P>
          <P>(ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set 0.1 percent), (f), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(3)(ii), (g)(4)(i), and (g)(5).<PRTPAGE P="171"/>
          </P>
          <P>(iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(p) (First limit set at 500 kg; second limit set at 25,000 kg).</P>
          <P>(iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (where N = 10 ppb).</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a) through (i) and (k) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
          <CITA>[59 FR 27481, May 27, 1994]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.720</SECTNO>
          <SUBJECT>Alkoxylated fatty acid amide, alkylsulfate salt.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substance identified generically as an alkoxylated fatty acid amide, alkylsulfate salt (PMN P-97-136) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Industrial, commercial, and consumer activities</E>. Requirements as specified in § 721.80(l).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in  § 721.125 (a), (b), (c) and (i) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <CITA>[63 FR 3422, Jan. 22, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.750</SECTNO>
          <SUBJECT>Aromatic amine compound.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance aromatic amine compound (PMN P-86-334) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (b) (concentration set at 0.1 percent) and (c).</P>
          <P>(ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (b)(2), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iv), (g)(1)(vii), (g)(2)(i) through (g)(2)(iii), and (g)(2)(v). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and MSDSs do not apply when the written program and MSDS are not required under § 721.72 (a) and (c), respectively. The provisions of § 721.72(g) requiring placement of specific information on a label and MSDS do not apply when a label and MSDS are not required under § 721.72 (b) and (c), respectively.</P>
          <P>(iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g).</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), (e) and (f).</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule.</P>
          <CITA>[55 FR 39899, Sept. 28, 1990. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.757</SECTNO>
          <SUBJECT>Polyoxyalkylene substituted aromatic azo colorant.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as polyoxyalkylene substituted aromatic azo colorant (PMN P-92-1131) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:<PRTPAGE P="172"/>
          </P>
          <P>(i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (w)(1) and (w)(2).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
          <CITA>[58 FR 51681, Oct. 4, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.775</SECTNO>
          <SUBJECT>Brominated aromatic com-pound (generic name).</SUBJECT>
          <P>(a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a brominated aromatic compound (PMN P-84-824) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iii), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), (a)(5)(vii), (a)(6)(i), (b) (concentration set at 0.1 percent), and (c).</P>
          <P>(ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b)(1), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(i), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), and (g)(2)(v). The provision of § 721.72(d) requiring that employees be provided with information on the location and availability of MSDSs does not apply when an MSDS is not required under § 721.72(c). The provision of § 721.72(g) requiring placement of specific information on an MSDS does not apply when an MSDS in not required under § 721.72(c).</P>
          <P>(iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (j) (use as an additive flame retardant for plastics) and (q).</P>
          <P>(iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1).</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (g), (i), and (k).</P>
          <P>(2) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section.</P>
          <P>(3) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
          <CITA>[55 FR 26098, June 26, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.785</SECTNO>
          <SUBJECT>Halogenated alkane aromatic compound (generic name).</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a halogenated alkane aromatic compound (PMN P-94-1747) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iv), (a)(5)(v), (6)(i), (b) (concentration set at 0.1 percent), and (c).</P>
          <P>(ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (g)(1)(vii), (g)(2)(iv), (g)(2)(v), (g)(3)(ii), (g)(4)(iii), and (g)(5).</P>
          <P>(iii) <E T="03">Industrial, commercial, and consumer activites.</E> Requirements as specified in § 721.80(q).</P>
          <P>(iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1).</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (e), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.<PRTPAGE P="173"/>
          </P>
          <P>(3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section.</P>
          <CITA>[61 FR 63735, Dec. 2, 1996]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.805</SECTNO>
          <SUBJECT>Benzenamine, 4,4<E T="61">′</E>-[1,3-phenylenebis(1-methylethyl idene)]bis[2,6-dimethyl-.</SUBJECT>

          <P>(a) Chemical substances and significant new uses subject to reporting. (1) The chemical substance benzenamine, 4,4<E T="61">′</E>-[1,3-phenylenebis(1-methyl ethylidene)]bis[2,6-dimethyl- (CAS Registry Number 2716-12-3; PMN P-86-501) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iv) through (a)(5)(xv), (a)(6)(i), (a)(6)(ii), (b) (concentration set at 0.1 percent), and (c).</P>
          <P>(ii) <E T="03">Hazard communication.</E> Requirements as specified in § 721.72 (a), (b)(2), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iv), (g)(1)(vii), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), (g)(2)(v), and (g)(5).</P>
          <P>(iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(l).</P>
          <P>(iv) <E T="03">Disposal.</E> Requirements as specified in § 721.85 (a)(1), (b)(1), (c)(1), (a)(2), (b)(2), and (c)(2).</P>
          <P>(v) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(2)(vi), (b)(2)(vi), and (c)(2)(vi).</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping requirements.</E> Recordkeeping requirements as specified in § 721.125 (a) through (k) are applicable to manufacturers, importers, and processors of these substances .</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule.</P>
          <P>(3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section.</P>
          <CITA>[57 FR 31330, July 15, 1992, as amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.825</SECTNO>
          <SUBJECT>Certain aromatic ether diamines.</SUBJECT>
          <P>(a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The following chemical substances are subject to reporting under this section for the significant new uses described in paragraphs (a)(2), (a)(3), and (a)(4) of this section: Benzenamine, 4,4<E T="61">′</E>-[[1,1<E T="61">′</E>-biphenyl]-2,5-diylbis(oxy)]bis- (CAS Number 94148-67-1, Premanufacture notice (PMN) P-85-335); 1,2,4,5-benzenetetracarboxylic acid, diethyl ester, compound with 4,4<E T="61">′</E>-[[1,1<E T="61">′</E>-biphenyl]-2,5-diylbis(oxy)]bis[benzenamine] (1:1) (PMN P-85-336); and 1,2,4,5-benzenetetracarboxylic acid, 1,4-diethyl ester, compound with 4,4<E T="61">′</E>-[[1,1<E T="61">′</E>-biphenyl]-2,5-diylbis(oxy)]bis[benzenamine] (1:1), polymer with 4,4<E T="61">′</E>-[[1,1<E T="61">′</E>-biphenyl]-2,5-diylbis(oxy)]bis[benzenamine]-1,5-diethyl-1,2,4,5-benzenetetra carboxylate (1:1), reaction products with phthalic anhydride (PMN P-86-1153).</P>
          <P>(2) The significant new use for P-85-335 is: Manufacture, import, or processing in a quantity of 100,000 pounds per year, or greater, for any use.</P>
          <P>(3) The significant new use for P-85-336 is: Any use.</P>
          <P>(4) The significant new use for P-86-1153 is: Manufacture, import, or processing in a quantity of 225,000 pounds per year, or greater, for any use.</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Persons who must report.</E> Section 721.5 applies to this section except § 721.5(a)(2). A person who intends to manufacture, import, or process for commercial purposes a substance identified in paragraph (a)(3) of this section and intends to distribute the substance in commerce must submit a significant new use notice.</P>
          <P>(2) [Reserved]</P>
          <CITA>[59 FR 43296, Aug. 23, 1994]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.840</SECTNO>
          <SUBJECT>Alkyl substituted diaromatic hydrocarbons.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The <PRTPAGE P="174"/>chemical substance identified generically as an alkyl substituted di-aro-matic hydrocarbons (PMN P-91-710) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping requirements.</E> Requirements as specified in § 721.125 (a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
          <CITA>[57 FR 46464, Oct. 8, 1992, as amended at 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.875</SECTNO>
          <SUBJECT>Aromatic nitro compound.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance aromatic nitro compound (PMN P-86-335) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iv) through (a)(5)(vii), (a)(6)(i), (b) (concentration set at 0.1 percent), and (c).</P>
          <P>(ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iv), (g)(1)(vii), and (g)(2)(i) through (g)(2)(v). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and MSDSs do not apply when the written program and MSDS are not required under § 721.72 (a) and (c), respectively. The provisions of § 721.72(g) requiring placement of specific information on a label and MSDS do not apply when a label and MSDS are not required under § 721.72 (b) and (c), respectively.</P>
          <P>(iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g).</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), (e), and (f).</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this significant new use rule.</P>
          <CITA>[55 FR 39899, Sept. 28, 1990. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.925</SECTNO>
          <SUBJECT>Substituted aromatic   (generic).</SUBJECT>
          <P>(a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a substituted aromatic (PMN P-84-954) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(1), (a)(3), (b) (concentration set at 0.1 percent), and (c).</P>
          <P>(ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(vii), (g)(2)(i), and (g)(2)(v). The provision of § 721.72(d) requiring that employees be provided with information on the location and availability of MSDSs does not apply when an MSDS is not required under § 721.72(c). The provisions of § 721.72(g) requiring placement of specific information on a label and MSDS do not apply when a label and MSDS are not required under § 721.72 (b) and (c), respectively.</P>
          <P>(iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(g).</P>
          <P>(iv) <E T="03">Release to water.</E> Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) (level set at 0.25 ppm).</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to <PRTPAGE P="175"/>this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (i), and (k).</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
          <CITA>[55 FR 26098, June 26, 1990. Redesignated at 58 FR 29946, May 24, 1993, as amended at 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.950</SECTNO>
          <SUBJECT>Sodium salt of an alkylated, sulfonated aromatic (generic name).</SUBJECT>
          <P>(a) <E T="03">Chemical substances and significant new uses subject to reporting.</E> (1) The chemical substance identified generically as a sodium salt of an alkylated, sulfonated aromatic (PMN P-84-591) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80 (j) (use as a dye leveler) and (q).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping.</E> The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a), (b), (c), and (i).</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements.</E> The provisions of § 721.185 apply to this section.</P>
          <P>(3) <E T="03">Determining whether a specific use is subject to this section.</E> The provisions of § 721.1725(b)(1) apply to this section.</P>
          <CITA>[55 FR 26098, June 26, 1990. Redesignated and amended at 58 FR 29946, May 24, 1993; 58 FR 34204, June 23, 1993]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.977</SECTNO>
          <SUBJECT>Aryloxyarene.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substance identified generically as aryloxyarene (PMN P-92-314) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Hazard communication program</E>. Requirements as specified in  § 721.72 (a), (b), (c), (d), (f), (g)(3)(ii), (g)(4)(iii), and (g)(5). The label and MSDS as required by this paragraph shall also include the following statement: This substance may be toxic to sediment organisms.</P>
          <P>(ii) <E T="03">Release to water</E>. Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1).</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in  § 721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <CITA>[63 FR 3422, Jan. 22, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.980</SECTNO>
          <SUBJECT>Sodium salt of azo acid dye.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The chemical substance identified generically as a sodium salt of azo acid dye (PMN P-95-633) is subject to eporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Industrial, commercial, and consumer activities</E>. Requirements as specified in § 721.80 (v)(1), (w)(1), and (x)(1).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in  § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <CITA>[63 FR 3422, Jan. 22, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.981</SECTNO>
          <SUBJECT>Substituted naphtholoazo-substituted naphthalenyl-substituted azonaphthol chromium complex.</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting</E>. (1) The <PRTPAGE P="176"/>chemical substance identified generically as a substituted naphtholoazo-substituted naphthalenyl-substituted azonaphthol chromium complex (PMN P-93-1631) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Industrial, commercial, and consumer activities</E>. Requirements as specified in § 721.80 (f), (v)(2), (w)(2), and (x)(2).</P>
          <P>(ii) [Reserved]</P>
          <P>(b) <E T="03">Specific requirements</E>. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">Recordkeeping</E>. Recordkeeping requirements as specified in  § 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance.</P>
          <P>(2) <E T="03">Limitations or revocation of certain notification requirements</E>. The provisions of § 721.185 apply to this section.</P>
          <CITA>[63 FR 3422, Jan. 22, 1998]</CITA>
        </SECTION>
        <SECTION>
          <SECTNO>§ 721.982</SECTNO>
          <SUBJECT>Calcium, bis(2,4-pentanedionato-<E T="03">O,O</E>
            <E T="61">′</E>).</SUBJECT>
          <P>(a) <E T="03">Chemical substance and significant new uses subject to reporting.</E> (1) The chemical substance calcium, bis(2,4-pentanedionato-O,O<E T="61">′</E>) (PMN P-93-214, CAS no. 19372-44-2) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply if the substance is embedded or encapsulated in a plastic matrix.</P>
          <P>(2) The significant new uses are:</P>
          <P>(i) <E T="03">Protection in the workplace.</E> Requirements as specified in § 721.63 (a)(4), (a)(5)(iii), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), (a)(6)(i), (a)(6)(ii), (a)(6)(iv), (b) (concentration set a 1.0 percent); and (c). As an alternative to the respiratory requirements in this section, manufacturers, importers, and processors may use the New Chemical Exposure Limits provisions, including sampling and analytical methods which have previously been approved by EPA for this substance, found in the 5(e) consent order for this substance.</P>
          <P>(ii) <E T="03">Hazard communication program.</E> Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(iii), (g)(1)(ix), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), and (g)(5).</P>
          <P>(iii) <E T="03">Industrial, commercial, and consumer activities.</E> Requirements as specified in § 721.80(l).</P>
          <P>(b) <E T="03">Specific requirements.</E> The provisions of subpart A of this part apply to this section except as modified by this paragraph.</P>
          <P>(1) <E T="03">R